data_2jgx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jgx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.753 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 8.6 mtt-85 . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 122.038 0.923 . . . . 0.0 113.127 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.431 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -129.13 98.32 4.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.395 177.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 434' ' ' ASN . 6.2 m -57.32 125.64 23.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.002 -175.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -86.74 130.22 34.56 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 168.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -80.86 120.59 79.33 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.539 0.209 . . . . 0.0 110.476 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.72 179.2 3.45 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.098 2.532 . . . . 0.0 113.819 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -86.91 127.43 35.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.176 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -93.69 118.0 30.82 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -65.38 -36.69 84.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.945 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -117.89 28.13 8.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.311 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -143.96 162.32 27.79 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.067 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -83.64 108.46 16.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.265 0.555 . . . . 0.0 110.052 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.522 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 2.0 p30 -80.67 54.78 2.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.045 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -63.47 -32.75 74.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.353 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.469 ' ND2' HD11 ' A' ' 412' ' ' ILE . 49.3 m-20 -100.46 -0.3 38.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.011 -173.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.522 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 64.8 t80 -62.95 120.41 11.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.018 0.437 . . . . 0.0 110.402 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.8 -14.64 19.65 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.843 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -90.86 156.88 17.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 111.434 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -126.1 132.91 51.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.146 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -127.84 148.08 50.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.044 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 16.9 m -81.99 148.53 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.515 0.198 . . . . 0.0 110.61 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 1.012 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.4 tt0 -61.09 133.04 55.62 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.314 0.578 . . . . 0.0 111.229 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.3 27.02 6.67 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -127.69 163.66 23.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.135 -0.532 . . . . 0.0 110.637 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 44.3 t -135.04 161.17 36.06 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.469 HD11 ' ND2' ' A' ' 401' ' ' ASN . 0.3 OUTLIER -164.88 143.77 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.544 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.454 ' H ' HD12 ' A' ' 412' ' ' ILE . 13.5 t70 -78.92 138.11 37.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.731 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 37.9 t -127.4 102.03 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.073 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -78.19 117.71 19.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.975 0.417 . . . . 0.0 111.115 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.444 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 35.2 m -103.54 167.61 9.69 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -65.24 158.92 69.73 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.497 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.58 110.34 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 123.518 2.812 . . . . 0.0 112.573 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 103.58 7.23 42.78 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.903 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.489 ' CE1' ' HB2' ' A' ' 444' ' ' ARG . 95.1 m-85 -125.85 139.16 53.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -159.81 -172.34 3.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.058 0.456 . . . . 0.0 111.049 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 440' ' ' PRO . 82.9 mt -97.06 161.4 26.39 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.435 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.09 152.18 15.05 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.254 2.636 . . . . 0.0 112.074 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 63.69 26.16 14.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.143 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.27 24.71 13.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.638 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.415 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 25.1 mt-30 -86.68 161.35 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.134 0.492 . . . . 0.0 111.4 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.0 t -121.01 -6.48 9.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -114.31 140.04 48.95 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.626 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.441 HG12 ' HB3' ' A' ' 440' ' ' PRO . 5.1 m -107.34 144.34 16.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.25 0.548 . . . . 0.0 110.57 176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 26.0 m -101.98 121.86 42.95 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.2 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.1 t -66.78 113.55 4.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 1.012 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 7.5 mtt -143.18 136.29 28.01 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.29 0.567 . . . . 0.0 111.353 174.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 34.46 46.03 0.16 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.699 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.753 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 55.3 t30 71.97 -24.14 0.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.601 175.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -108.03 33.29 6.37 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.136 -1.031 . . . . 0.0 113.893 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.536 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 95.7 m95 40.56 111.34 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.509 1.124 . . . . 0.0 113.891 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.693 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 73.0 m -40.28 -60.59 1.43 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -172.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 48.6 Cg_endo -88.6 -6.86 5.84 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.737 1.625 . . . . 0.0 112.871 -176.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 54.8 m 71.88 116.05 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.551 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 66.0 Cg_endo -80.49 109.52 2.3 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.84 2.36 . . . . 0.0 111.072 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -147.65 -14.78 0.38 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 61.3 m 56.63 83.34 0.1 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.939 0.399 . . . . 0.0 111.839 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.8 mt -85.61 157.8 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . 0.489 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 30.5 ttp180 -86.73 105.95 17.32 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.345 1.069 . . . . 0.0 111.374 -175.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 36.9 t . . . . . 0 C--N 1.31 -1.129 0 CA-C-N 113.014 -1.903 . . . . 0.0 110.285 178.272 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.444 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 9.2 mtt180 . . . . . 0 CA--C 1.514 -0.412 0 CA-C-O 121.388 0.614 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.502 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -133.62 101.4 5.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.162 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 6.8 p -68.43 144.76 54.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.694 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -107.08 132.1 53.37 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 168.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 39.9 t80 -81.57 118.87 73.93 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.337 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 86.1 Cg_endo -90.95 -173.58 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.44 2.76 . . . . 0.0 113.549 -176.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -93.32 138.68 31.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.215 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.96 -96.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 173.79 -33.36 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.574 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -145.07 38.75 1.19 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.317 -1.31 . . . . 0.0 108.825 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -127.88 147.43 17.24 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.505 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.25 99.9 1.61 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.005 0.431 . . . . 0.0 110.013 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.472 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 2.5 p30 -79.16 51.34 1.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.928 -175.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -71.29 -24.45 62.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.186 0.517 . . . . 0.0 110.171 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -93.96 -9.63 36.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.738 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.472 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 83.1 t80 -63.9 114.29 3.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.391 0.615 . . . . 0.0 110.749 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 118.48 -19.14 10.74 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.82 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -82.66 153.5 25.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.152 0.501 . . . . 0.0 111.366 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -127.52 134.13 49.8 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.136 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.635 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 96.2 m-85 -125.5 151.92 45.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 31.8 m -82.97 148.12 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.843 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 3.4 tt0 -59.24 140.79 55.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.799 0.333 . . . . 0.0 110.504 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.64 6.9 57.12 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -103.4 167.66 9.66 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.431 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 39.4 t -138.33 160.22 40.04 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.912 0.387 . . . . 0.0 110.12 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.9 tp -159.5 139.38 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.094 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -76.0 135.69 39.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.35 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.617 ' HB ' HD13 ' A' ' 422' ' ' LEU . 56.1 t -126.71 101.09 7.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.311 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.2 122.12 28.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.186 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.456 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 73.5 m -98.03 163.12 12.89 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -67.21 155.97 89.24 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.284 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.01 122.17 10.07 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.762 2.975 . . . . 0.0 112.277 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.76 30.74 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 70.3 m-85 -122.0 144.06 49.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.721 0.296 . . . . 0.0 110.291 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -142.87 178.64 7.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.132 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.617 HD13 ' HB ' ' A' ' 414' ' ' VAL . 34.2 mt -95.68 148.33 34.41 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.884 0.373 . . . . 0.0 110.561 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 441' ' ' ARG . 31.7 Cg_exo -59.14 150.02 76.38 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.97 2.447 . . . . 0.0 112.115 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 67.04 28.4 8.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.393 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.31 44.43 27.39 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.772 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 24.5 mt-30 -106.9 161.93 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.14 -175.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.7 p -128.91 -13.4 4.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.987 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.15 139.63 50.97 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.253 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.48 HG12 ' HG2' ' A' ' 438' ' ' PRO . 21.6 t -108.43 133.83 52.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 89.6 m -92.78 130.66 38.32 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.19 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.84 106.95 6.62 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.106 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.843 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 11.6 mtm -141.8 141.45 33.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.748 173.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.6 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 61.9 mm-40 46.89 36.37 3.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.876 -1.966 . . . . 0.0 111.476 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 6.2 t30 69.18 -20.94 0.16 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.803 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -112.64 49.96 0.81 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.511 -0.852 . . . . 0.0 114.061 -172.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 93.5 m95 35.69 106.81 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 169.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.835 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 55.8 m -51.7 -59.17 8.64 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 35.4 Cg_endo -85.53 -3.85 9.24 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.675 1.583 . . . . 0.0 113.079 -175.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.692 HG21 ' HG2' ' A' ' 441' ' ' ARG . 23.0 m 72.6 113.45 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.197 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -68.62 94.12 0.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.4 2.067 . . . . 0.0 110.812 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.692 ' HG2' HG21 ' A' ' 439' ' ' THR . 24.9 mmm180 -131.53 118.95 20.84 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 66.7 m -83.47 82.69 8.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.088 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 6.3 pt -76.4 144.89 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.657 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -73.17 111.24 8.1 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.577 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.319 -0.74 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.998 -173.27 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.878 ' HG3' ' HG3' ' A' ' 433' ' ' GLU . 1.4 mmp_? . . . . . 0 CA--C 1.514 -0.412 0 CA-C-O 121.216 0.531 . . . . 0.0 111.793 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -135.51 99.92 4.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.774 -175.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 10.4 m -67.87 146.49 53.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.932 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -107.57 128.22 54.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.176 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -74.15 122.31 87.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.97 -177.23 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.167 2.578 . . . . 0.0 113.475 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -93.63 117.16 29.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.683 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 440' ' ' PRO . 0.0 OUTLIER -80.37 8.13 8.22 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -171.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 59.97 -84.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -97.17 13.23 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.463 0.649 . . . . 0.0 110.246 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -112.9 -161.11 14.81 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.76 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . 0.515 ' HB2' ' HB2' ' A' ' 415' ' ' ALA . 57.6 m-85 -92.79 162.65 14.03 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.184 0.516 . . . . 0.0 109.782 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 1.6 p30 -129.47 41.62 3.42 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.519 0.676 . . . . 0.0 109.685 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.42 ' HG3' ' HB3' ' A' ' 398' ' ' TYR . 75.1 mt-30 -61.05 -46.36 91.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.149 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -94.08 -1.05 54.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.04 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.487 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 73.1 t80 -61.8 119.36 8.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.325 0.584 . . . . 0.0 110.28 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 110.22 -12.63 31.25 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.307 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -95.22 150.65 19.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -118.53 134.6 54.96 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.134 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.97 140.76 52.63 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.215 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.91 147.38 8.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.368 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.738 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 8.3 tt0 -56.47 129.43 40.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.077 0.465 . . . . 0.0 110.667 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 115.43 -22.19 12.24 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -81.74 150.99 27.69 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 24.2 t -140.07 146.7 39.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.824 0.821 . . . . 0.0 111.406 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.7 tp 177.72 132.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.865 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.665 ' HB2' HG22 ' A' ' 429' ' ' VAL . 27.3 t70 -125.71 -89.46 0.57 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.478 -1.237 . . . . 0.0 107.953 173.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.9 t 34.74 75.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 111.728 -2.487 . . . . 0.0 112.943 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 398' ' ' TYR . . . -176.06 52.06 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.771 -172.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 56.4 m -130.99 133.95 46.26 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 173.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -61.05 157.42 42.03 Favored Pre-proline 0 N--CA 1.463 0.209 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.34 115.21 1.63 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.522 2.815 . . . . 0.0 112.522 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 113.52 -11.69 23.54 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.633 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.523 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 63.6 m-85 -113.66 144.04 43.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.537 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.34 -177.95 6.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.034 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 61.1 mt -90.49 151.45 44.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 174.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.95 153.24 58.86 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.79 2.327 . . . . 0.0 111.554 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm 65.73 28.24 11.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.037 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.82 40.16 30.67 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.472 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 26.2 mt-30 -90.15 152.43 21.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.431 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 413' ' ' ASP . 2.1 p -140.93 20.3 2.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.563 ' HA ' ' CB ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -152.39 136.74 16.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.344 0.593 . . . . 0.0 110.108 -177.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.961 HG11 ' HD2' ' A' ' 438' ' ' PRO . 79.4 t -115.81 132.03 66.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.118 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.522 ' HB ' ' OG ' ' A' ' 437' ' ' SER . 49.1 m -91.5 134.92 34.24 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.543 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 18.3 t -75.14 120.2 20.32 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.738 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 21.2 ptm -107.39 -140.13 0.37 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.878 ' HG3' ' HG3' ' A' ' 387' ' ' ARG . 44.8 tt0 -70.35 71.39 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.233 0.924 . . . . 0.0 111.657 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.718 ' HB2' ' HD3' ' A' ' 387' ' ' ARG . 4.0 t30 78.43 -11.43 1.21 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.755 168.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -111.2 170.83 14.0 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 170.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.591 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 98.7 m95 -93.44 128.46 39.52 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.732 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 35.2 p -56.28 -54.03 57.35 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -165.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.961 ' HD2' HG11 ' A' ' 429' ' ' VAL . 6.9 Cg_endo -98.04 -4.31 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.693 1.595 . . . . 0.0 111.875 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.446 HG21 ' HG3' ' A' ' 441' ' ' ARG . 24.8 m 72.66 117.65 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.546 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.538 ' HB2' HD12 ' A' ' 394' ' ' LEU . 18.2 Cg_exo -64.44 93.81 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.858 2.372 . . . . 0.0 111.563 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.446 ' HG3' HG21 ' A' ' 439' ' ' THR . 43.8 mtp180 -125.82 91.66 3.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.675 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 66.3 m -63.07 98.89 0.15 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.579 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 2.4 pp -98.75 170.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.088 0.47 . . . . 0.0 110.313 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -93.75 118.58 31.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.426 -173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.817 178.847 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.709 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 32.1 mtp180 . . . . . 0 CA--C 1.516 -0.35 0 CA-C-O 121.505 0.669 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -128.55 109.79 11.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.805 174.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 7.6 p -70.52 144.7 51.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.363 0.601 . . . . 0.0 112.246 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -104.67 126.31 51.63 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 171.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.473 ' HZ ' HG21 ' A' ' 414' ' ' VAL . 2.5 t80 -76.27 117.93 67.74 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -177.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -84.71 -179.14 3.59 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.101 2.534 . . . . 0.0 113.481 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -80.77 128.7 33.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.879 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.73 HD21 ' HA ' ' A' ' 399' ' ' ASN . 1.4 mm? -89.92 103.22 15.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 396' ' ' ASN . 33.4 tt0 -71.4 117.03 12.43 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 395' ' ' GLU . 52.1 m-80 71.86 28.51 2.63 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.955 0.785 . . . . 0.0 109.984 -173.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -136.08 164.05 25.05 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.485 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -80.9 99.56 8.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.73 ' HA ' HD21 ' A' ' 394' ' ' LEU . 3.1 p30 -77.77 44.49 0.46 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.753 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.9 -29.96 70.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.672 0.749 . . . . 0.0 109.607 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -96.39 -7.51 34.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.34 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -64.06 122.57 16.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.882 0.373 . . . . 0.0 110.269 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.17 -10.98 33.94 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.11 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -82.5 166.42 19.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.243 0.544 . . . . 0.0 111.299 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -137.04 136.5 38.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.699 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.612 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 55.8 m-85 -132.14 153.1 50.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.138 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 14.7 m -79.38 139.14 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.734 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.85 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 33.1 tt0 -61.98 135.52 57.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.566 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 99.24 22.22 13.48 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 13.7 mmtm -127.4 173.79 9.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.029 -0.586 . . . . 0.0 109.819 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 30.6 t -144.65 163.5 33.76 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -160.84 145.73 5.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.155 -177.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.441 ' N ' HD12 ' A' ' 412' ' ' ILE . 14.2 t70 -81.14 138.66 35.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.317 -174.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.516 ' HB ' HD12 ' A' ' 422' ' ' LEU . 48.4 t -119.76 119.77 61.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -100.8 106.33 17.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.048 0.452 . . . . 0.0 111.105 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.41 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 56.8 m -94.72 172.57 8.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -73.19 156.75 89.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.846 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.88 112.28 0.98 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.447 2.765 . . . . 0.0 111.984 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.68 -11.79 13.72 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -118.84 143.36 47.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.183 -0.508 . . . . 0.0 109.777 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.75 39.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.49 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 91.3 mt -73.65 158.67 85.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.273 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.466 ' HG3' HD12 ' A' ' 443' ' ' ILE . 31.6 Cg_exo -57.84 149.05 71.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.838 2.359 . . . . 0.0 111.609 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 68.81 17.43 8.78 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.987 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.83 36.8 28.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.051 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.574 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 24.2 mt-30 -94.47 162.14 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.846 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 26.2 p -115.62 -11.3 11.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.357 0.599 . . . . 0.0 110.477 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.46 142.69 51.12 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.115 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.469 HG12 ' HG2' ' A' ' 438' ' ' PRO . 17.0 t -114.2 129.78 69.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.634 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 25.7 m -80.87 135.49 35.93 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.176 177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.73 110.13 15.94 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.905 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.85 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 0.6 OUTLIER -149.65 143.12 25.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.923 0.868 . . . . 0.0 112.579 179.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.697 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 37.0 mt-10 45.27 35.06 1.63 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.358 -176.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 389' ' ' CYS . 5.7 t-20 67.9 -16.51 0.18 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.763 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -114.67 25.23 10.42 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.586 -172.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.56 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 84.7 m95 58.31 148.15 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.908 0.883 . . . . 0.0 112.955 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.743 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 58.3 m -71.12 -63.68 1.42 Allowed Pre-proline 0 C--N 1.321 -0.639 0 O-C-N 121.967 -0.458 . . . . 0.0 111.171 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.743 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 36.2 Cg_endo -89.03 -2.64 6.25 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.044 1.829 . . . . 0.0 113.149 -176.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 29.8 m 71.71 111.08 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.765 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 12.2 Cg_exo -63.18 111.13 1.34 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.131 2.554 . . . . 0.0 111.989 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 422' ' ' LEU . 75.6 mtm180 -146.23 124.71 12.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.746 -176.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 74.9 m -89.82 82.53 6.22 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.466 HD12 ' HG3' ' A' ' 423' ' ' PRO . 3.9 mt -87.11 150.92 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.823 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -79.43 126.16 30.48 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.656 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--N 1.315 -0.898 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.674 179.676 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.771 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 26.9 mtt180 . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.708 0.766 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -134.33 93.0 3.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.697 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 12.3 m -59.76 141.6 54.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.579 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . 0.452 ' CZ ' ' HA3' ' A' ' 403' ' ' GLY . 68.0 t80 -104.57 137.3 42.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 414' ' ' VAL . 2.3 t80 -93.97 115.06 64.68 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.718 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -92.75 -176.3 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.465 2.776 . . . . 0.0 113.63 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -80.15 134.71 36.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 440' ' ' PRO . 8.1 mt -110.38 128.2 55.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.491 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.6 151.92 44.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 43.17 41.85 3.1 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.672 0.607 . . . . 0.0 111.665 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -139.87 147.8 19.47 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.28 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -89.16 96.28 10.65 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.695 0.748 . . . . 0.0 110.362 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.477 ' HB3' ' CB ' ' A' ' 402' ' ' TYR . 35.7 m-80 -78.05 70.15 4.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.562 -173.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -79.2 -26.55 42.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.102 0.477 . . . . 0.0 110.418 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -108.45 14.84 24.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.674 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.477 ' CB ' ' HB3' ' A' ' 399' ' ' ASN . 21.5 t80 -70.87 132.24 44.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.781 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.452 ' HA3' ' CZ ' ' A' ' 390' ' ' TYR . . . 95.12 15.16 45.9 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.234 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -103.19 156.34 17.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.022 0.439 . . . . 0.0 111.676 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -120.15 125.29 47.85 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.624 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -120.44 137.59 54.25 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.3 144.19 14.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.311 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.833 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.8 tt0 -66.29 144.57 56.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.644 -173.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 100.99 7.06 51.08 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -107.43 175.8 5.37 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.485 -0.857 . . . . 0.0 109.667 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 31.9 t -152.3 147.79 26.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.868 0.842 . . . . 0.0 111.475 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.49 ' HA ' ' CG2' ' A' ' 428' ' ' THR . 9.9 tp 173.44 134.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.425 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 1.027 ' H ' HG21 ' A' ' 428' ' ' THR . 34.9 t70 -130.97 -140.79 0.22 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.229 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.581 HG21 ' CG ' ' A' ' 413' ' ' ASP . 0.6 OUTLIER -147.17 147.75 17.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.226 -151.506 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.98 88.06 7.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.793 167.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.49 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 14.7 m -80.04 167.17 20.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.186 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -54.37 157.03 5.21 Favored Pre-proline 0 N--CA 1.469 0.484 0 CA-C-O 121.079 0.466 . . . . 0.0 111.528 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.21 110.78 0.49 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.709 2.939 . . . . 0.0 112.629 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.07 -2.09 38.09 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.691 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.617 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 87.8 m-85 -114.3 129.05 56.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . 0.429 ' C ' ' HA ' ' A' ' 442' ' ' CYS . . . -162.71 161.34 26.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.289 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.447 ' CD2' ' H ' ' A' ' 441' ' ' ARG . 73.9 mt -61.55 145.18 91.69 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.152 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.54 158.15 42.82 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.75 2.3 . . . . 0.0 111.09 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 68.96 21.36 7.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.467 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.61 50.92 8.39 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.385 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 23.9 mt-30 -109.66 160.91 15.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.049 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' THR . . . . . 0.832 ' O ' ' HB3' ' A' ' 413' ' ' ASP . 2.9 p -141.62 12.86 2.12 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.313 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 1.027 HG21 ' H ' ' A' ' 413' ' ' ASP . 0.5 OUTLIER -148.47 125.54 11.39 Favored 'General case' 0 N--CA 1.436 -1.129 0 O-C-N 123.66 0.6 . . . . 0.0 111.652 178.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.671 HG11 ' HG2' ' A' ' 438' ' ' PRO . 2.1 t -90.88 136.36 24.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.998 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.627 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 64.2 m -81.55 132.21 35.3 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 24.4 t -77.19 109.32 10.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.833 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 27.0 mtp -148.56 153.29 38.18 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.652 0.739 . . . . 0.0 112.394 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.518 ' C ' ' H ' ' A' ' 435' ' ' GLY . 4.1 mt-10 28.54 43.09 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 112.782 -2.008 . . . . 0.0 113.36 -164.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 65.13 -17.76 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.869 0.868 . . . . 0.0 112.147 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -112.79 41.82 2.12 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.912 -172.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.513 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 98.3 m95 42.55 111.22 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.749 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 60.6 m -50.1 -66.48 0.62 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.201 -0.908 . . . . 0.0 113.278 -167.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.671 ' HG2' HG11 ' A' ' 429' ' ' VAL . 31.8 Cg_endo -85.76 -2.76 9.04 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.54 1.493 . . . . 0.0 112.313 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.779 ' HB ' ' HD2' ' A' ' 441' ' ' ARG . 51.5 m 76.01 131.16 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.96 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 11.5 Cg_endo -70.72 84.5 0.81 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.841 2.361 . . . . 0.0 110.885 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.779 ' HD2' ' HB ' ' A' ' 439' ' ' THR . 0.5 OUTLIER -132.55 70.94 1.46 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.269 -172.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 421' ' ' ALA . 4.2 p -70.64 90.78 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.799 0.809 . . . . 0.0 110.501 175.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 14.6 pt -85.84 176.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.339 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -86.67 107.89 18.4 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.917 0.865 . . . . 0.0 110.475 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.308 -1.23 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.651 -177.589 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 1.084 ' HG3' ' HB3' ' A' ' 408' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.44 -0.95 0 N-CA-C 115.616 1.709 . . . . 0.0 115.616 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 387' ' ' ARG . 5.3 mptp? 73.39 37.55 0.71 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.338 -1.756 . . . . 0.0 111.947 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 32.3 m -51.68 120.4 5.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.731 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -97.5 127.46 43.48 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -79.42 115.46 53.36 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.049 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -87.32 174.38 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.156 2.571 . . . . 0.0 112.731 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -77.41 116.95 18.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.282 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.478 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 8.2 mt -71.63 127.5 32.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.267 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.606 ' HG2' ' HB2' ' A' ' 442' ' ' CYS . 1.4 pm0 -65.1 108.59 1.89 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.014 0.435 . . . . 0.0 110.279 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 63.74 36.52 10.56 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.483 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -129.26 172.31 19.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.919 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -77.33 88.2 3.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.341 0.591 . . . . 0.0 110.71 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.553 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 3.1 p30 -80.58 49.3 1.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.364 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -67.76 -22.79 65.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.844 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -104.06 -1.7 27.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.052 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.553 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 45.7 t80 -62.75 115.48 4.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.278 0.561 . . . . 0.0 110.427 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.61 -11.36 21.26 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.873 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.39 150.61 22.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.064 0.459 . . . . 0.0 110.949 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 405' ' ' LYS . 8.9 mptt -121.72 148.51 44.52 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.711 176.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.402 ' CD2' ' HH2' ' A' ' 436' ' ' TRP . 98.6 m-85 -142.32 156.46 45.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.206 0.527 . . . . 0.0 110.541 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.27 143.37 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.279 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 1.084 ' HB3' ' HG3' ' A' ' 387' ' ' ARG . 0.9 OUTLIER -57.86 139.94 53.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.408 -176.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.8 19.19 12.32 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -125.39 169.91 11.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.629 -0.785 . . . . 0.0 110.145 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.1 t -148.02 157.51 43.55 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.331 0.586 . . . . 0.0 110.415 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.6 tp -151.08 140.45 15.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.2 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.8 133.52 37.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.363 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.92 139.42 48.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.662 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -142.44 133.66 26.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.232 0.539 . . . . 0.0 111.406 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 0.1 OUTLIER -103.07 -178.43 3.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.578 ' NE2' ' HE2' ' A' ' 420' ' ' TYR . 19.1 p-80 -77.72 157.46 79.51 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.842 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 417' ' ' HIS . 9.9 Cg_exo -34.4 120.71 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.385 3.39 . . . . 0.0 115.007 -171.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.71 -20.42 46.25 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.589 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.625 ' HB2' ' HB3' ' A' ' 416' ' ' CYS . 51.6 m-85 -109.83 142.48 41.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.954 0.377 . . . . 0.0 110.757 -174.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -175.75 -170.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.411 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.608 HD23 ' HA ' ' A' ' 440' ' ' PRO . 94.7 mt -80.88 162.23 60.64 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.403 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.72 147.1 73.64 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.021 2.481 . . . . 0.0 110.761 171.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.6 10.6 7.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.605 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 62.44 35.07 15.03 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.697 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -66.93 152.44 45.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.071 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.4 p -123.79 -3.38 8.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.272 0.558 . . . . 0.0 110.341 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.84 136.29 44.3 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.961 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.507 HG11 HD13 ' A' ' 422' ' ' LEU . 5.5 m -104.28 134.77 44.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.554 0.692 . . . . 0.0 110.205 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 14.8 m -92.92 117.91 30.56 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.219 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 47.3 t -66.81 116.9 8.21 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.946 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 23.4 mtp -131.82 -166.8 1.77 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.37 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.59 ' OE1' ' HB3' ' A' ' 432' ' ' MET . 1.7 mp0 -37.49 76.97 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.841 1.338 . . . . 0.0 114.454 -170.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 432' ' ' MET . 15.6 t-20 64.7 23.99 12.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.777 175.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -173.92 119.16 0.73 Allowed Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.254 -174.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.402 ' HH2' ' CD2' ' A' ' 406' ' ' PHE . 47.5 m95 -37.87 113.56 0.28 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.976 0.91 . . . . 0.0 110.374 165.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 6.6 m -56.92 -50.88 85.61 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.793 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.407 ' HG2' HG13 ' A' ' 429' ' ' VAL . 33.1 Cg_endo -83.41 -8.11 10.65 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.149 1.233 . . . . 0.0 112.379 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.414 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 9.1 m 70.99 112.81 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.957 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.608 ' HA ' HD23 ' A' ' 422' ' ' LEU . 35.9 Cg_endo -66.46 86.08 0.27 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.747 2.298 . . . . 0.0 112.392 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -114.08 130.93 56.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.85 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.606 ' HB2' ' HG2' ' A' ' 395' ' ' GLU . 56.7 m -90.41 83.09 5.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.119 0.485 . . . . 0.0 110.821 173.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 2.5 pt -99.68 153.43 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 172.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -79.3 113.69 17.64 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.489 0.661 . . . . 0.0 109.703 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.408 -174.435 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.551 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 24.1 mtt180 . . . . . 0 CA--C 1.51 -0.558 0 CA-C-O 121.375 0.607 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -118.94 90.72 3.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.934 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 31.1 m -56.72 122.85 13.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.842 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -91.36 113.47 25.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.502 ' HD1' ' CZ2' ' A' ' 436' ' ' TRP . 27.0 t80 -76.57 117.95 68.13 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -94.78 -175.9 0.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.402 2.735 . . . . 0.0 113.479 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . 0.561 ' CE2' ' HA ' ' A' ' 395' ' ' GLU . 47.7 t80 -75.51 130.81 39.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.831 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.452 HD22 ' HE2' ' A' ' 391' ' ' PHE . 2.5 mm? -81.11 -5.39 57.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -171.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.561 ' HA ' ' CE2' ' A' ' 393' ' ' TYR . 63.0 mm-40 66.49 -71.67 0.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.482 0.489 . . . . 0.0 110.996 -173.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.56 24.08 7.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.851 -175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -140.8 169.25 24.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.466 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -82.9 138.8 33.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 3.6 p30 -105.68 59.26 0.66 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.01 0.433 . . . . 0.0 112.162 -173.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -78.74 -14.54 59.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.726 0.298 . . . . 0.0 110.732 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -117.7 9.65 13.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.728 0.299 . . . . 0.0 111.008 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 24.9 t80 -64.75 127.82 33.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 0.0 111.007 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 91.87 16.34 51.75 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.111 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -105.81 149.39 26.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.851 0.358 . . . . 0.0 110.915 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -112.17 126.69 55.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.525 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -118.65 150.84 39.04 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.595 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 35.6 m -83.12 147.53 5.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.553 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.791 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 3.2 tt0 -64.18 128.27 35.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.374 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.38 7.79 36.69 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 7.3 mmtt -114.79 163.32 15.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 20.3 t -138.89 164.88 28.51 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.367 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.0 tp -155.96 142.17 10.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.931 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -84.39 133.25 34.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.567 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 69.5 t -117.89 128.45 75.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.598 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.26 113.74 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.722 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.593 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 56.0 m -95.66 170.4 9.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -65.21 154.97 85.99 Favored Pre-proline 0 C--N 1.332 -0.164 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.025 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.9 105.92 0.16 Allowed 'Trans proline' 0 CA--C 1.521 -0.14 0 C-N-CA 123.747 2.965 . . . . 0.0 112.63 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.16 -11.75 11.52 Favored Glycine 0 C--N 1.317 -0.523 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.513 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -115.35 146.58 41.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.16 -179.05 7.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.703 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 97.9 mt -79.77 158.1 73.47 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-O 120.971 0.415 . . . . 0.0 110.544 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.41 ' HA ' HD12 ' A' ' 443' ' ' ILE . 50.2 Cg_exo -55.33 150.37 41.57 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.528 2.152 . . . . 0.0 110.771 171.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . 0.62 ' HB3' ' HZ2' ' A' ' 424' ' ' LYS . 6.9 mtpm? 64.06 19.08 11.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.941 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 61.19 26.63 16.48 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.173 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 51.8 mt-30 -73.67 158.99 33.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.907 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 28.1 p -124.62 -23.13 4.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.313 0.578 . . . . 0.0 110.22 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.88 135.95 49.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.52 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.415 HG12 ' HG2' ' A' ' 438' ' ' PRO . 2.5 t -110.5 125.07 67.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 60.8 m -88.32 135.17 33.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.777 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 31.4 t -72.7 112.67 8.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.791 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 7.3 mtt -146.84 142.1 27.33 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.705 0.764 . . . . 0.0 111.321 174.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.543 ' C ' ' HD2' ' A' ' 387' ' ' ARG . 5.8 mm-40 39.09 40.32 0.47 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.232 -1.804 . . . . 0.0 113.084 -170.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 46.1 t30 70.33 -24.05 0.16 Allowed 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.704 0.628 . . . . 0.0 111.706 174.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -104.81 22.3 34.09 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.562 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.538 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 94.0 m95 56.35 128.78 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.804 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 71.8 m -51.38 -64.45 1.4 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.359 -169.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.804 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 42.6 Cg_endo -89.11 -2.53 6.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.049 1.832 . . . . 0.0 112.478 -176.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 18.6 m 73.74 121.61 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.295 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 30.7 Cg_endo -66.6 94.64 0.32 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.727 2.284 . . . . 0.0 111.699 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -131.03 106.54 8.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.778 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 76.4 m -83.36 81.39 8.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.916 0.389 . . . . 0.0 110.63 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 423' ' ' PRO . 9.8 pt -87.76 161.42 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.884 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -75.38 121.77 22.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.385 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.336 -174.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.714 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 8.7 mtt-85 . . . . . 0 N--CA 1.442 -0.831 0 CA-C-O 121.672 0.748 . . . . 0.0 112.388 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 38.9 mmtm -117.65 90.57 3.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.014 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 15.2 m -59.62 120.97 10.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.511 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -90.33 124.81 35.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.655 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -80.32 120.72 80.31 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.278 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -83.53 -179.2 4.07 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.295 2.663 . . . . 0.0 112.636 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -93.87 121.99 35.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.4 0.619 . . . . 0.0 110.715 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.2 mp -89.31 129.26 35.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.392 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.89 -47.84 64.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.948 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -107.5 16.54 23.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.914 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -132.26 155.75 21.66 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.512 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -77.7 111.23 13.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.536 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 1.7 p30 -79.22 61.61 3.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.869 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -66.18 -19.57 65.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.257 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -117.9 1.8 12.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.309 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.536 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 37.4 t80 -63.12 124.86 22.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 111.302 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.65 -9.79 41.24 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.304 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -100.66 152.76 20.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.69 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 52.2 mtmt -116.91 152.93 33.48 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.846 173.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 97.4 m-85 -134.9 150.31 50.41 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.914 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.7 m -80.08 144.93 9.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.159 0.504 . . . . 0.0 110.349 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.818 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.8 OUTLIER -62.01 125.68 24.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.555 -173.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.97 -0.95 24.28 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -95.88 161.61 13.93 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.153 -0.524 . . . . 0.0 110.387 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.1 t -141.33 163.29 33.36 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.1 tp -170.02 130.39 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.673 0.749 . . . . 0.0 110.517 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.749 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 14.1 t70 -83.66 132.55 34.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.336 -171.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 22.6 t -113.05 120.81 63.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.677 -175.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.02 122.87 29.86 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.464 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 67.5 m -116.02 173.11 6.75 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -62.48 158.15 51.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.212 0.529 . . . . 0.0 110.956 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.89 114.55 1.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.556 2.837 . . . . 0.0 111.949 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 444' ' ' ARG . . . 110.22 -5.03 30.1 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.207 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.631 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 84.6 m-85 -115.62 145.09 43.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.141 0.496 . . . . 0.0 110.946 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 442' ' ' CYS . . . -160.08 160.19 32.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.259 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.522 HD13 HG21 ' A' ' 429' ' ' VAL . 69.6 mt -71.55 151.45 93.79 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 121.064 0.459 . . . . 0.0 111.792 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.14 147.66 34.03 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.415 2.743 . . . . 0.0 111.913 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . 0.459 ' HB2' HE21 ' A' ' 426' ' ' GLN . 99.7 mttt 70.1 27.5 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.71 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.32 53.78 8.42 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.391 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.459 HE21 ' HB2' ' A' ' 424' ' ' LYS . 48.5 mt-30 -119.51 160.66 21.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.53 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 41.7 p -119.88 -17.15 8.57 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.004 0.431 . . . . 0.0 110.143 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.749 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 0.5 OUTLIER -120.11 160.1 23.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.837 0.827 . . . . 0.0 111.603 178.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.522 HG21 HD13 ' A' ' 422' ' ' LEU . 1.4 t -116.6 148.6 19.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.344 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 86.7 m -108.55 122.99 48.21 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.816 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.418 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.1 t -67.96 111.13 4.22 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.818 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 4.7 mtm -144.45 135.79 25.47 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.966 0.889 . . . . 0.0 112.583 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.709 ' H ' ' HG3' ' A' ' 408' ' ' GLN . 0.8 OUTLIER 46.66 37.41 4.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.064 -178.316 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.714 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 8.1 t30 72.66 -24.95 0.19 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.929 0.892 . . . . 0.0 112.7 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -108.13 43.75 1.64 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.037 -1.078 . . . . 0.0 114.257 -169.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.503 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.3 m95 36.25 105.41 0.0 OUTLIER 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 172.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.794 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 69.5 m -45.64 -59.57 4.41 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.244 -168.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 13.5 Cg_endo -90.65 -6.19 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.631 1.554 . . . . 0.0 113.248 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.622 HG21 ' HG3' ' A' ' 441' ' ' ARG . 24.4 m 71.95 121.9 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.517 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.503 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 1.2 Cg_endo -78.67 97.48 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.51 2.807 . . . . 0.0 111.413 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.622 ' HG3' HG21 ' A' ' 439' ' ' THR . 53.8 mtm180 -131.38 -45.77 0.99 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.608 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 68.0 m 64.78 91.97 0.07 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.074 0.94 . . . . 0.0 111.301 -177.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 7.0 mt -96.9 159.53 3.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.096 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 419' ' ' GLY . 31.7 ttt180 -64.67 121.91 15.61 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.986 0.898 . . . . 0.0 110.613 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 80.5 t . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.914 178.394 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.858 ' HG3' ' HA ' ' A' ' 433' ' ' GLU . 34.2 mmt180 . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.1 0.476 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.468 ' HD2' ' C ' ' A' ' 387' ' ' ARG . 0.1 OUTLIER -124.45 79.6 1.77 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.732 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 19.8 m -59.86 125.92 25.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.249 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -90.3 127.53 36.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 172.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.447 ' HE1' HD22 ' A' ' 394' ' ' LEU . 2.0 t80 -81.71 111.76 28.81 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . 0.408 ' C ' ' HD1' ' A' ' 402' ' ' TYR . 95.9 Cg_endo -88.92 -166.65 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.245 2.63 . . . . 0.0 113.241 -176.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . 0.437 ' HD1' HD21 ' A' ' 399' ' ' ASN . 55.3 t80 -78.14 134.84 37.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.002 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.618 HD21 ' HA ' ' A' ' 399' ' ' ASN . 2.6 mm? -86.05 106.97 17.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.656 177.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.723 ' O ' ' HB2' ' A' ' 442' ' ' CYS . 12.8 pt-20 -63.49 116.87 5.99 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 69.16 25.34 5.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.023 0.44 . . . . 0.0 110.351 -174.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -135.73 176.05 20.41 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.451 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -99.16 120.86 40.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.263 0.554 . . . . 0.0 110.45 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.618 ' HA ' HD21 ' A' ' 394' ' ' LEU . 9.2 p30 -79.37 59.56 2.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.759 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -70.13 -28.87 65.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.9 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -111.75 7.55 20.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.215 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.52 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 81.2 t80 -63.97 126.07 26.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.144 0.497 . . . . 0.0 110.371 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.66 -5.31 54.22 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.86 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.31 150.03 21.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.977 0.418 . . . . 0.0 110.888 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 59.3 mtpt -126.75 136.61 52.65 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.208 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -126.97 153.59 45.67 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.783 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 387' ' ' ARG . 27.0 m -86.66 144.94 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.972 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.3 tt0 -57.5 132.03 51.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 0.0 110.914 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.05 12.72 23.27 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 53.9 mmtt -115.14 155.51 26.98 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.185 -0.507 . . . . 0.0 110.533 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.6 t -132.4 161.53 33.4 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.3 tp -162.39 138.31 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.439 0.638 . . . . 0.0 110.294 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -89.3 137.24 32.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.835 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.42 137.57 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.288 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.89 118.84 34.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.281 0.562 . . . . 0.0 111.343 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.509 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 58.2 m -89.0 -175.9 4.99 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.598 173.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -64.5 152.05 90.18 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.05 103.07 0.14 Allowed 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 123.204 2.602 . . . . 0.0 111.58 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.674 ' O ' ' HB3' ' A' ' 444' ' ' ARG . . . 126.92 -10.08 7.07 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.571 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 1.048 ' HA ' ' CB ' ' A' ' 444' ' ' ARG . 59.8 m-85 -119.66 159.81 23.71 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.18 173.66 14.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.821 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 427' ' ' THR . 3.2 mm? -73.96 160.14 82.51 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 171.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.469 ' HG3' HD13 ' A' ' 443' ' ' ILE . 71.8 Cg_exo -48.61 136.74 26.85 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.947 2.431 . . . . 0.0 111.237 174.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 78.81 20.36 0.79 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.349 1.031 . . . . 0.0 110.061 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.76 44.2 20.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.071 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 422' ' ' LEU . 23.6 mt-30 -100.21 169.94 8.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.753 -177.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' THR . . . . . 0.507 ' HA ' HD21 ' A' ' 422' ' ' LEU . 74.8 p -123.05 -8.62 8.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.357 0.599 . . . . 0.0 109.477 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -113.76 149.85 34.28 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.474 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 19.9 m -124.83 144.74 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 172.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 39.1 m -108.1 129.19 55.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.326 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.2 t -72.33 110.03 6.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.972 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 9.1 mtt -142.02 137.6 31.24 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.812 0.815 . . . . 0.0 111.698 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.858 ' HA ' ' HG3' ' A' ' 387' ' ' ARG . 1.2 tp10 40.43 40.14 0.82 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.732 -2.031 . . . . 0.0 112.759 -174.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 9.3 t30 73.02 -16.33 0.47 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.021 0.528 . . . . 0.0 112.009 174.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -118.91 45.87 1.2 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.741 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.532 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.1 m95 35.21 106.2 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 172.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.705 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 64.0 m -41.15 -62.13 1.13 Allowed Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -172.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.705 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 62.6 Cg_endo -88.67 -2.86 6.56 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.681 1.588 . . . . 0.0 113.156 -174.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.754 HG23 ' HG3' ' A' ' 441' ' ' ARG . 28.8 m 72.94 119.37 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.575 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 61.5 Cg_endo -74.57 82.71 1.85 Allowed 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.729 2.286 . . . . 0.0 112.205 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.754 ' HG3' HG23 ' A' ' 439' ' ' THR . 49.5 mtp180 -133.18 132.29 41.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.825 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 395' ' ' GLU . 81.6 m -95.42 74.68 3.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.716 0.77 . . . . 0.0 111.38 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.469 HD13 ' HG3' ' A' ' 423' ' ' PRO . 1.6 pt -101.27 144.01 13.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.703 174.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . 1.048 ' CB ' ' HA ' ' A' ' 420' ' ' TYR . 0.0 OUTLIER -175.35 -154.64 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -177.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.636 ' H ' ' HD2' ' A' ' 444' ' ' ARG . 7.6 p . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 111.488 -2.596 . . . . 0.0 111.643 -169.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.694 ' HG3' ' N ' ' A' ' 408' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.726 ' H ' ' HB2' ' A' ' 434' ' ' ASN . 0.1 OUTLIER -166.97 65.32 0.09 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 112.615 -2.084 . . . . 0.0 106.792 152.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 61.5 m -50.84 108.8 0.26 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.47 -1.695 . . . . 0.0 113.271 -166.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -90.64 120.95 32.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -69.55 122.84 87.05 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.75 167.15 24.39 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.187 2.591 . . . . 0.0 113.155 -175.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -85.96 116.41 24.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.598 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.5 117.17 28.98 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.784 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 0.0 OUTLIER -75.21 -31.51 60.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.111 0.481 . . . . 0.0 110.338 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.4 ' ND2' ' HG2' ' A' ' 395' ' ' GLU . 41.6 m-80 -98.48 20.05 13.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.047 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -134.19 178.49 18.35 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.207 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -90.01 -10.12 46.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.779 0.323 . . . . 0.0 111.591 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 6.8 p30 42.21 36.69 0.75 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.355 1.062 . . . . 0.0 113.558 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -62.99 -26.06 68.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.778 0.323 . . . . 0.0 111.183 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -94.88 -6.76 41.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.352 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -61.23 118.64 7.12 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.36 -10.22 22.14 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.511 -174.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -100.38 146.64 26.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.719 0.295 . . . . 0.0 110.723 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 56.7 mtpt -119.46 152.17 37.33 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.261 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.461 ' CD1' ' HH2' ' A' ' 436' ' ' TRP . 94.8 m-85 -139.79 162.87 34.09 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.385 0.612 . . . . 0.0 111.437 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 35.3 m -97.54 146.22 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.644 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.894 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 6.1 tt0 -69.42 122.76 19.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.041 0.448 . . . . 0.0 110.558 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.45 12.67 11.47 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 1.1 tmtm? -116.41 162.68 17.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.813 -0.693 . . . . 0.0 109.481 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.5 t -132.25 158.23 42.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.934 0.397 . . . . 0.0 110.171 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.1 tp -149.68 140.73 16.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.146 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -82.41 132.2 35.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.738 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.538 HG23 HG22 ' A' ' 429' ' ' VAL . 92.3 t -111.83 139.97 33.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.156 0.503 . . . . 0.0 111.191 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -113.35 103.07 10.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.17 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.573 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 70.7 m -99.17 165.8 11.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 171.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -68.3 153.17 95.92 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.107 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.77 108.71 0.3 Allowed 'Trans proline' 0 CA--C 1.521 -0.156 0 C-N-CA 123.702 2.935 . . . . 0.0 112.278 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.76 -11.03 11.14 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.578 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 99.3 m-85 -116.49 141.33 48.31 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -144.47 178.9 7.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.066 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.631 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 59.4 mt -92.27 156.93 41.38 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.85 0.357 . . . . 0.0 111.044 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 58.2 Cg_exo -54.1 144.65 57.23 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.174 2.583 . . . . 0.0 111.562 173.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 29.1 mtpp 72.45 19.14 4.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.188 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.1 26.29 13.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.317 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.631 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 27.3 mt-30 -85.26 157.31 20.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.062 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.9 p -116.37 0.92 12.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.541 0.686 . . . . 0.0 109.846 173.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.25 140.43 52.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.941 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.538 HG22 HG23 ' A' ' 414' ' ' VAL . 45.6 t -115.4 132.29 65.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.102 0.477 . . . . 0.0 109.718 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.608 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 19.3 m -88.02 129.66 35.21 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.138 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 33.8 t -71.41 111.59 6.86 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.894 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 1.0 OUTLIER -141.96 121.83 13.59 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 122.466 1.126 . . . . 0.0 112.105 172.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 433' ' ' GLU . 35.5 tt0 51.51 36.65 17.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 111.978 -2.374 . . . . 0.0 112.295 177.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.726 ' HB2' ' H ' ' A' ' 388' ' ' LYS . 63.9 t30 61.98 15.46 7.28 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.066 0.936 . . . . 0.0 109.681 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -123.2 17.05 8.05 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.768 -173.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.461 ' HH2' ' CD1' ' A' ' 406' ' ' PHE . 93.4 m95 36.42 101.42 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.92 1.012 . . . . 0.0 113.073 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.701 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 62.6 m -44.52 -61.81 1.92 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -165.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 41.2 Cg_endo -83.31 -3.12 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.043 1.828 . . . . 0.0 112.961 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.634 HG23 ' HG3' ' A' ' 441' ' ' ARG . 26.3 m 74.35 114.19 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.972 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.407 ' HG3' HG13 ' A' ' 429' ' ' VAL . 13.1 Cg_exo -68.78 95.95 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.948 2.432 . . . . 0.0 111.94 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.634 ' HG3' HG23 ' A' ' 439' ' ' THR . 51.6 mtp180 -135.89 117.84 15.27 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.732 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 62.4 m -82.05 82.86 7.49 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 5.1 pt -82.88 144.67 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.378 0.608 . . . . 0.0 111.066 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.5 ttm105 -71.49 120.22 16.76 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.416 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.957 -173.376 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.958 ' HD3' ' HA ' ' A' ' 434' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 387' ' ' ARG . 0.0 OUTLIER -115.64 108.16 16.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.063 0.459 . . . . 0.0 111.897 -170.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 71.2 m -86.98 143.89 27.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.327 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -125.78 119.77 28.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 26.7 t80 -70.12 118.86 67.75 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.749 0.309 . . . . 0.0 110.41 -174.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 93.2 Cg_endo -90.26 -175.57 0.95 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.194 2.596 . . . . 0.0 113.525 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . 0.438 ' HA ' ' OD1' ' A' ' 399' ' ' ASN . 87.7 t80 -91.04 116.92 29.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.61 -173.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.428 HD12 ' HB2' ' A' ' 440' ' ' PRO . 3.5 mm? -74.41 117.91 16.77 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.44 -26.63 63.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.535 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -136.41 38.58 2.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.395 0.617 . . . . 0.0 110.519 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -124.29 168.32 16.45 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.4 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -87.39 -4.96 59.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 393' ' ' TYR . 53.7 m-80 44.04 47.55 7.31 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 170.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -65.45 -15.31 62.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.743 0.306 . . . . 0.0 111.039 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -122.38 12.34 10.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -68.91 129.21 39.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.66 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 102.17 8.4 44.49 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.174 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -98.84 152.34 19.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.401 0.62 . . . . 0.0 111.888 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -116.64 143.42 45.65 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.434 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -141.22 151.24 43.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.274 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 29.3 m -93.81 150.99 3.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 170.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 1.026 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.4 tt0 -62.48 138.19 58.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.341 0.591 . . . . 0.0 111.207 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.16 14.17 23.15 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -174.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 7.7 mmmt -118.92 161.37 20.31 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.699 -0.75 . . . . 0.0 110.05 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.2 t -131.81 165.96 22.64 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.26 144.16 11.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.173 0.511 . . . . 0.0 110.722 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -84.32 143.05 29.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.853 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.57 127.61 70.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.962 0.411 . . . . 0.0 110.922 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -97.43 95.01 7.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.616 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 34.3 m -87.04 145.73 26.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.616 ' ND1' ' HD2' ' A' ' 418' ' ' PRO . 16.4 t60 -59.19 144.44 83.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 0.0 110.979 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . 0.616 ' HD2' ' ND1' ' A' ' 417' ' ' HIS . 95.3 Cg_exo -45.21 106.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.477 1 C-N-CA 125.427 4.084 . . . . 0.0 112.734 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 125.11 -17.5 7.09 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.127 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -110.16 150.14 29.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.001 0.429 . . . . 0.0 111.117 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -149.3 166.96 27.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.733 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 62.9 mt -88.88 153.14 49.44 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 120.69 0.281 . . . . 0.0 110.892 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.61 144.27 33.93 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.192 2.595 . . . . 0.0 112.141 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 68.88 23.7 6.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.876 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 54.18 47.22 23.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.249 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 25.8 mt-30 -108.33 167.64 9.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.534 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 12.2 t -126.57 0.09 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -119.7 145.84 46.16 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.161 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.621 HG11 ' HG2' ' A' ' 438' ' ' PRO . 12.5 t -115.7 133.23 62.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.945 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 18.0 m -93.99 124.47 38.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.81 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.5 t -71.86 111.41 7.09 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.604 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 1.026 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 30.0 mtp -140.08 -177.38 4.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.466 ' HA ' ' OE1' ' A' ' 433' ' ' GLU . 9.4 mm-40 -32.98 88.55 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 125.95 2.031 . . . . 0.0 114.387 -175.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.958 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 10.3 t-20 68.9 12.28 8.59 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 112.088 -2.324 . . . . 0.0 110.653 168.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 179.23 134.64 2.2 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.403 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.428 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 91.1 m95 -38.93 117.89 0.71 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 165.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.603 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 14.8 m -67.1 -52.27 31.52 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -168.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.621 ' HG2' HG11 ' A' ' 429' ' ' VAL . 25.5 Cg_endo -83.56 -9.14 10.26 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 120.919 1.079 . . . . 0.0 112.196 -175.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.568 HG23 ' HG2' ' A' ' 441' ' ' ARG . 11.0 m 71.61 109.53 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.23 173.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.428 ' HB2' HD12 ' A' ' 394' ' ' LEU . 37.5 Cg_endo -69.42 98.31 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.35 2.033 . . . . 0.0 110.945 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.568 ' HG2' HG23 ' A' ' 439' ' ' THR . 21.9 mmm180 -120.58 -36.89 3.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.735 -175.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 416' ' ' CYS . 82.9 m 56.68 69.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.498 0.666 . . . . 0.0 110.117 -174.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 5.7 pt -87.04 154.42 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.714 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -61.09 121.72 13.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.989 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.032 -171.125 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.788 ' NH1' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.728 0 CA-C-O 122.085 0.945 . . . . 0.0 112.571 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -164.61 88.63 0.49 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.602 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.502 ' SG ' ' HA ' ' A' ' 434' ' ' ASN . 58.6 m -51.3 111.99 0.66 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.584 0.553 . . . . 0.0 111.295 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -89.45 118.28 28.99 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -72.8 123.22 89.31 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.805 0.336 . . . . 0.0 110.128 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.74 169.02 18.74 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.094 2.53 . . . . 0.0 113.765 -174.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -88.34 106.83 18.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.813 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.38 108.25 17.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -63.22 -40.2 96.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.867 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.431 ' C ' ' HD2' ' A' ' 417' ' ' HIS . 2.0 p30 -100.49 19.69 16.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.568 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -132.14 172.98 20.88 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.093 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -88.03 104.47 16.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 2.3 p30 -74.54 55.41 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.38 -178.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -64.62 -42.85 95.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.779 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -101.72 0.88 36.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.419 -170.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.426 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 23.6 t80 -61.5 124.07 19.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.112 0.482 . . . . 0.0 110.38 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.42 -9.3 38.44 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.704 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -89.75 147.32 23.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.247 0.546 . . . . 0.0 111.134 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -121.66 135.47 54.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.797 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -129.25 158.15 39.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.213 0.53 . . . . 0.0 111.34 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.8 m -87.78 144.48 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.006 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.818 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.2 tt0 -52.55 139.79 24.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.963 0.411 . . . . 0.0 111.492 177.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.47 10.89 57.71 Favored Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -110.89 154.62 23.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 30.8 t -132.47 159.15 40.19 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.047 0.451 . . . . 0.0 110.409 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.2 tp -155.57 141.43 10.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.501 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -91.56 139.99 30.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.822 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 19.3 t -126.05 146.08 32.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.277 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -122.63 131.43 53.81 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.574 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 56.4 m -103.79 170.54 7.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.431 ' HD2' ' C ' ' A' ' 396' ' ' ASN . 94.3 m-70 -72.7 156.7 89.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.814 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.32 110.68 0.48 Allowed 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.821 3.014 . . . . 0.0 112.529 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.45 -6.02 16.82 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.788 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 96.1 m-85 -122.97 145.6 48.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.792 0.33 . . . . 0.0 110.769 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -149.83 157.16 42.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.945 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.639 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 46.6 mt -78.44 156.21 78.55 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.82 0.343 . . . . 0.0 111.199 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.473 ' HG3' HD12 ' A' ' 443' ' ' ILE . 50.2 Cg_exo -53.04 144.49 45.91 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.067 2.511 . . . . 0.0 112.018 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 71.73 14.76 6.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.436 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 60.4 30.47 19.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.515 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.639 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 27.6 mt-30 -92.18 168.77 11.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.846 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 79.8 p -126.12 -26.11 3.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.474 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.89 134.53 35.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.426 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.548 HG11 ' HG2' ' A' ' 438' ' ' PRO . 3.5 t -109.88 142.89 21.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.451 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 27.6 m -103.91 126.81 51.31 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.212 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 34.6 t -70.08 108.72 4.21 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.818 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 9.7 mtt -144.55 132.89 21.86 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.324 1.059 . . . . 0.0 112.42 174.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.626 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 2.4 tm-20 46.38 32.16 1.48 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.09 -2.323 . . . . 0.0 110.687 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.502 ' HA ' ' SG ' ' A' ' 389' ' ' CYS . 45.5 t-20 76.03 -27.71 0.18 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.45 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -97.91 40.05 2.61 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.237 -171.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.533 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.0 m95 35.99 106.44 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 172.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.74 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 72.2 m -44.54 -60.09 3.31 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -170.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.74 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 31.3 Cg_endo -88.36 -6.6 6.13 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.882 1.722 . . . . 0.0 112.874 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 80.9 m 72.8 116.33 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 114.898 -1.047 . . . . 0.0 113.072 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.533 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 18.4 Cg_endo -88.76 109.76 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.498 2.799 . . . . 0.0 110.734 174.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -147.2 -17.65 0.39 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 77.2 m 58.1 87.07 0.07 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.406 0.622 . . . . 0.0 111.489 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.473 HD12 ' HG3' ' A' ' 423' ' ' PRO . 11.0 mt -85.54 158.84 3.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -78.88 124.86 28.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.215 0.531 . . . . 0.0 109.923 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--N 1.313 -1.01 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.119 -177.768 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.745 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 2.0 mmp_? . . . . . 0 CA--C 1.514 -0.407 0 CA-C-O 121.539 0.685 . . . . 0.0 111.801 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -125.17 94.56 4.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.932 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 20.5 m -62.52 113.45 2.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.129 0.49 . . . . 0.0 111.707 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . 0.502 ' CZ ' ' HA3' ' A' ' 403' ' ' GLY . 53.2 t80 -79.65 112.01 16.5 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.779 173.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -62.68 123.38 79.14 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.23 172.03 13.22 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.259 2.639 . . . . 0.0 113.297 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -90.62 125.17 35.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.323 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 29.3 mt -103.92 130.06 51.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.571 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -91.79 -32.76 15.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.668 0.747 . . . . 0.0 109.105 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -94.63 5.04 53.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.61 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -142.19 170.9 24.81 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.202 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -87.59 113.94 23.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.941 0.401 . . . . 0.0 110.356 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -83.31 51.77 2.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.577 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -70.31 -17.24 63.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.94 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -114.25 1.16 14.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.992 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -63.0 127.99 33.8 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.31 0.576 . . . . 0.0 111.473 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.502 ' HA3' ' CZ ' ' A' ' 390' ' ' TYR . . . 103.05 -0.24 47.88 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.684 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -108.72 141.93 39.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.868 0.366 . . . . 0.0 110.472 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -105.66 130.43 53.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.617 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -109.52 150.86 27.53 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.747 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.34 139.33 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.276 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.851 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 12.6 tt0 -60.28 126.21 26.64 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.557 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 101.07 13.42 33.81 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -173.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -110.25 151.71 27.02 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.2 t -124.84 160.63 28.32 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.596 ' C ' ' HG1' ' A' ' 428' ' ' THR . 0.0 OUTLIER -170.8 127.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.666 0.746 . . . . 0.0 110.013 -176.358 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.706 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 29.8 t70 -79.09 130.0 35.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.876 -172.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 429' ' ' VAL . 31.6 t -106.38 157.53 6.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.278 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -120.55 94.34 4.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.864 0.364 . . . . 0.0 111.221 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 92.9 m -83.79 150.96 25.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.618 ' NE2' ' HE2' ' A' ' 420' ' ' TYR . 1.5 p-80 -74.68 152.23 87.14 Favored Pre-proline 0 N--CA 1.461 0.103 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.765 -170.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -32.32 112.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.856 3.704 . . . . 0.0 114.639 -173.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.21 -5.14 35.76 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.22 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.618 ' HE2' ' NE2' ' A' ' 417' ' ' HIS . 63.2 m-85 -120.74 144.49 48.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.989 0.423 . . . . 0.0 111.147 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -152.09 -167.12 2.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.574 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.481 HD12 HG23 ' A' ' 429' ' ' VAL . 70.4 mt -108.27 160.43 27.05 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-O 120.904 0.383 . . . . 0.0 111.918 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.416 ' HG3' HD12 ' A' ' 443' ' ' ILE . 87.7 Cg_exo -47.69 143.26 12.8 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.597 2.865 . . . . 0.0 112.715 175.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt 67.47 30.45 6.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.729 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.49 33.02 20.15 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.609 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -97.35 169.41 9.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.028 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' THR . . . . . 0.469 ' C ' HD11 ' A' ' 422' ' ' LEU . 39.2 p -126.94 1.19 6.61 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.781 173.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.706 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 1.9 t -124.46 163.81 21.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.635 0.731 . . . . 0.0 111.654 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.502 HG11 ' HG2' ' A' ' 438' ' ' PRO . 2.0 t -129.77 142.56 43.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.34 -177.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 78.6 m -99.94 136.9 39.15 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.101 174.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 13.6 t -74.93 119.67 19.43 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.851 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 11.5 mtp -152.1 136.9 17.09 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.73 0.776 . . . . 0.0 111.657 174.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.717 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 18.9 mt-10 45.33 38.83 3.83 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.149 -1.842 . . . . 0.0 111.947 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.454 ' HB2' ' HD3' ' A' ' 387' ' ' ARG . 43.3 t30 68.89 -24.57 0.14 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.232 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -102.26 18.54 51.25 Favored Glycine 0 CA--C 1.501 -0.834 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.898 -169.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.656 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 96.4 m95 59.45 128.87 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 124.539 0.788 . . . . 0.0 112.989 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.726 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 71.1 m -49.76 -64.55 1.18 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.224 -170.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.726 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 28.2 Cg_endo -87.69 -7.6 6.42 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.692 1.594 . . . . 0.0 112.278 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.3 m 74.39 123.3 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.841 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.656 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 11.2 Cg_exo -62.99 93.35 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.166 2.577 . . . . 0.0 111.721 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -130.49 108.94 10.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 82.1 m -75.55 90.01 2.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.228 0.537 . . . . 0.0 110.567 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.416 HD12 ' HG3' ' A' ' 423' ' ' PRO . 11.2 mt -87.24 159.43 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.543 -0.753 . . . . 0.0 108.969 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -80.4 119.77 23.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.278 0.561 . . . . 0.0 110.303 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 445' ' ' VAL . 10.5 p . . . . . 0 C--N 1.32 -0.712 0 CA-C-O 122.209 1.004 . . . . 0.0 110.679 -172.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 1.03 ' HG2' ' HB3' ' A' ' 408' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.427 -1.593 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 0.0 OUTLIER 53.3 62.71 2.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 112.012 -2.358 . . . . 0.0 111.757 -168.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 14.5 m -67.57 134.02 50.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.223 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -91.89 132.36 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.425 ' HB3' ' O ' ' A' ' 401' ' ' ASN . 26.7 t80 -93.72 111.69 53.69 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.754 0.311 . . . . 0.0 110.702 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -92.61 -163.4 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.235 2.624 . . . . 0.0 113.442 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -85.88 140.66 30.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.355 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -89.14 15.77 8.27 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 67.59 -69.54 0.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.498 0.666 . . . . 0.0 111.497 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.574 ' O ' ' HD2' ' A' ' 417' ' ' HIS . 0.2 OUTLIER -131.76 45.52 2.77 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.798 -177.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -142.07 177.03 21.75 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.053 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -88.8 118.99 28.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.222 0.534 . . . . 0.0 111.263 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . 2.5 p30 -87.62 86.52 7.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.034 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.79 -19.24 49.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.508 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 44.9 m-80 -136.73 28.92 2.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.426 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 50.4 t80 -69.09 122.24 18.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.09 0.471 . . . . 0.0 110.624 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 100.93 0.11 55.07 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.977 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -97.46 154.51 17.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.932 0.396 . . . . 0.0 111.304 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 39.0 mtmt -127.35 138.86 53.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.131 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.505 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 98.8 m-85 -128.84 158.45 38.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 -173.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.9 m -76.4 155.5 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.304 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 1.03 ' HB3' ' HG2' ' A' ' 387' ' ' ARG . 1.3 tt0 -77.5 124.43 27.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.466 0.651 . . . . 0.0 109.859 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.45 5.7 26.01 Favored Glycine 0 C--N 1.315 -0.633 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -104.12 149.06 25.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.536 -0.832 . . . . 0.0 109.15 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.4 t -129.75 158.71 38.64 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.046 0.45 . . . . 0.0 110.211 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.6 tp -156.54 139.09 6.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.079 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.63 133.48 34.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.145 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 35.2 t -123.41 133.44 69.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.166 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -109.21 128.07 54.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.575 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 0.8 OUTLIER -100.77 -169.25 1.68 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 174.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.574 ' HD2' ' O ' ' A' ' 396' ' ' ASN . 85.8 m-70 -82.13 157.44 68.45 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -54.08 110.99 0.58 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.43 2.753 . . . . 0.0 112.206 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.08 -9.95 10.21 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.185 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 77.2 m-85 -119.74 132.13 55.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -153.72 159.68 42.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.565 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 92.4 mt -70.1 153.41 95.34 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.643 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.36 150.88 47.82 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.593 2.195 . . . . 0.0 110.805 172.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . 0.499 ' HB2' ' HG3' ' A' ' 426' ' ' GLN . 53.2 mttp 70.84 21.11 5.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.65 0.594 . . . . 0.0 110.492 -177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.97 26.73 15.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.489 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 53.7 mt-30 -84.44 158.03 21.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.195 0.521 . . . . 0.0 111.225 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 65.9 p -126.34 -9.54 6.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.87 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.24 137.62 41.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.441 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.586 HG12 ' HG2' ' A' ' 438' ' ' PRO . 2.6 t -112.98 128.07 69.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 26.0 m -99.29 124.68 44.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.593 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 38.1 t -69.03 115.91 8.88 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.907 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 29.9 mtp -138.48 129.33 26.66 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 122.745 1.26 . . . . 0.0 113.064 175.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.694 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 2.2 tp10 46.43 43.48 11.99 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 111.872 -2.422 . . . . 0.0 111.428 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 433' ' ' GLU . 26.3 t-20 78.77 -9.49 1.5 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.408 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -131.64 88.89 0.28 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.712 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -12.55 114.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.793 1.237 . . . . 0.0 112.713 170.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.721 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 30.3 m -62.88 -54.49 46.54 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.279 -171.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.586 ' HG2' HG12 ' A' ' 429' ' ' VAL . 24.2 Cg_endo -85.36 -8.15 8.69 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.54 1.493 . . . . 0.0 111.957 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 9.9 m 71.17 121.27 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.59 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.07 76.95 2.47 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.636 2.224 . . . . 0.0 112.207 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -139.16 95.89 3.02 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.681 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 420' ' ' TYR . 2.1 p -76.33 92.21 3.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.386 0.612 . . . . 0.0 110.336 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.1 pt -73.22 160.39 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.782 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -81.48 114.2 20.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.141 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--N 1.316 -0.881 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.992 -178.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.564 ' HD2' ' C ' ' A' ' 433' ' ' GLU . 62.5 mtt180 . . . . . 0 CA--C 1.516 -0.359 0 CA-C-O 121.051 0.453 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 12.5 mptt -118.54 109.56 16.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.481 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 5.5 p -69.82 144.14 52.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.283 0.563 . . . . 0.0 112.196 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -116.24 120.8 40.12 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 21.2 t80 -77.87 121.62 84.39 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 -176.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 78.8 Cg_endo -88.83 -177.14 1.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.491 2.794 . . . . 0.0 112.942 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -94.45 126.9 40.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.695 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 3.4 mm? -81.93 6.18 16.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.432 ' HB2' ' H ' ' A' ' 396' ' ' ASN . 5.4 mm-40 57.14 -89.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.248 0.547 . . . . 0.0 110.312 -176.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.483 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 0.1 OUTLIER -83.22 50.67 1.8 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.841 175.266 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -153.08 163.63 30.6 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -77.03 -22.74 52.55 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.586 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . 8.1 p30 39.54 54.62 2.39 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.423 0.689 . . . . 0.0 112.426 175.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -22.92 63.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.141 -173.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -127.18 34.28 4.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.243 0.544 . . . . 0.0 111.613 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 27.9 t80 -63.95 133.45 53.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.194 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 92.6 15.91 51.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.495 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -107.07 154.69 20.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.294 0.568 . . . . 0.0 111.644 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 49.8 mtmt -118.97 140.84 49.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.46 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.633 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 88.2 m-85 -140.13 159.6 41.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.645 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.52 147.2 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.973 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.7 tt0 -63.15 141.18 58.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.111 0.482 . . . . 0.0 111.337 -176.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.15 8.97 35.1 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 61.9 mmtt -113.23 179.56 3.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.365 -176.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.8 t -150.45 160.97 43.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.11 0.481 . . . . 0.0 110.365 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -154.15 149.65 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.574 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -90.7 141.89 28.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.75 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 28.9 t -126.63 141.22 46.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.27 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -125.23 118.16 25.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.833 0.349 . . . . 0.0 110.736 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 74.7 m -103.46 -178.64 3.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -58.32 154.14 33.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.169 174.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.83 108.53 0.49 Allowed 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.7 2.934 . . . . 0.0 112.179 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.63 -13.12 15.34 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -113.3 147.98 36.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.375 -0.412 . . . . 0.0 109.908 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -159.47 179.23 9.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.162 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.63 HD11 HG12 ' A' ' 429' ' ' VAL . 87.2 mt -76.86 160.7 76.01 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.9 141.11 22.35 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.978 2.452 . . . . 0.0 111.937 173.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 68.0 30.5 5.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.173 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.44 30.09 16.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.659 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 22.4 mt-30 -91.29 158.53 16.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.991 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 8.2 p -118.38 -4.82 10.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.141 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.66 140.72 52.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.96 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.63 HG12 HD11 ' A' ' 422' ' ' LEU . 3.3 m -108.61 133.23 54.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.129 0.49 . . . . 0.0 110.16 174.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 76.9 m -85.44 128.18 34.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.513 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 53.4 t -69.54 106.09 2.88 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.973 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 6.4 mtt -143.09 139.26 30.38 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.633 0.73 . . . . 0.0 111.552 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.703 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 7.0 mm-40 41.41 40.5 1.29 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 112.956 -1.929 . . . . 0.0 112.637 -176.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 389' ' ' CYS . 4.3 t-20 70.22 -23.6 0.16 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.49 176.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -103.9 15.35 52.05 Favored Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.799 -170.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 85.1 m95 56.04 125.72 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.735 0.814 . . . . 0.0 112.523 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.718 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 58.5 m -44.47 -61.87 1.88 Allowed Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -172.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.718 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 64.3 Cg_endo -88.42 -3.62 6.71 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.704 1.603 . . . . 0.0 112.817 -175.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.433 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 28.5 m 68.98 109.3 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.606 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 439' ' ' THR . 11.5 Cg_endo -55.14 102.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.794 2.996 . . . . 0.0 112.455 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -141.76 131.62 24.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.992 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 76.6 m -87.05 91.21 8.63 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.137 0.494 . . . . 0.0 109.869 175.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 8.9 mt -94.28 157.73 3.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -88.84 108.18 19.38 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.4 0.619 . . . . 0.0 109.712 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.753 -173.021 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.947 ' HG3' ' HB3' ' A' ' 408' ' ' GLN . 7.8 mpt_? . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 39.3 ttmt 73.98 79.17 0.12 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 112.471 -2.15 . . . . 0.0 112.362 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 435' ' ' GLY . 3.2 m -87.28 155.87 19.88 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.755 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -119.18 128.53 54.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -81.25 122.43 81.3 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.587 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.6 172.27 11.45 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.205 2.603 . . . . 0.0 113.388 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -85.94 123.33 31.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.07 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 394' ' ' LEU . 2.2 mm? -95.74 119.49 34.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -76.91 -32.09 57.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.319 0.58 . . . . 0.0 109.867 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 8.9 m120 -100.63 10.37 41.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.556 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -131.46 175.95 19.37 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.582 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -92.81 109.99 21.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 2.9 p30 -81.12 48.04 1.08 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.239 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.89 -32.86 74.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.328 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.52 ' ND2' HD11 ' A' ' 412' ' ' ILE . 78.7 m-20 -95.63 -9.42 32.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.126 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 52.0 t80 -59.94 129.74 43.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.221 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 95.29 5.15 60.71 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.247 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -104.43 148.3 26.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.086 0.47 . . . . 0.0 110.759 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -124.59 143.78 50.52 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.86 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 87.4 m-85 -139.39 156.39 47.02 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.306 -173.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 26.2 m -88.03 137.59 20.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.818 174.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.947 ' HB3' ' HG3' ' A' ' 387' ' ' ARG . 1.5 tt0 -53.14 137.84 32.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.016 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.79 7.76 25.15 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -112.75 151.55 30.16 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.439 -0.88 . . . . 0.0 110.025 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 35.6 t -131.4 153.32 49.8 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.52 HD11 ' ND2' ' A' ' 401' ' ' ASN . 0.2 OUTLIER -152.72 144.14 15.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.781 -173.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.468 ' N ' HD12 ' A' ' 412' ' ' ILE . 28.5 t70 -81.89 137.64 35.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.392 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 64.3 t -121.84 126.83 75.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.46 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.72 128.25 54.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.315 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.58 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 61.2 m -105.92 -178.45 3.65 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -76.13 154.95 84.56 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.12 112.07 0.77 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.655 2.904 . . . . 0.0 112.457 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.08 -12.76 19.7 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.905 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -111.06 148.73 31.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.709 0.29 . . . . 0.0 110.643 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.87 162.11 39.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.453 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.14 158.38 81.67 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.809 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.67 135.17 61.31 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.771 2.314 . . . . 0.0 111.555 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 69.86 17.46 7.56 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.992 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 63.53 39.67 8.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.436 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.566 HE22 ' HB2' ' A' ' 438' ' ' PRO . 23.4 mt-30 -78.46 158.84 28.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.492 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 49.9 p -121.93 -13.58 8.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.48 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.83 149.74 47.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.585 -175.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.643 HG12 ' HG3' ' A' ' 440' ' ' PRO . 13.0 t -126.88 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.533 HG22 ' HE1' ' A' ' 432' ' ' MET . 38.6 m -103.53 123.1 46.29 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.49 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 43.2 t -64.12 116.35 5.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.313 174.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.818 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 32.7 mtt -145.46 133.27 21.16 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.704 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 33.4 tt0 28.47 68.09 0.08 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.135 -169.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 56.57 31.31 18.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.224 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' A' ' 389' ' ' CYS . . . -150.55 -158.19 8.14 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.723 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.439 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 96.9 m95 -136.36 113.25 10.34 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -174.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 12.7 t -66.32 -51.24 44.75 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.951 -168.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.566 ' HB2' HE22 ' A' ' 426' ' ' GLN . 25.7 Cg_endo -91.29 0.97 4.7 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.44 1.427 . . . . 0.0 112.504 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.531 HG23 ' HG3' ' A' ' 441' ' ' ARG . 13.3 m 73.71 112.0 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.928 171.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.643 ' HG3' HG12 ' A' ' 429' ' ' VAL . 1.3 Cg_endo -79.77 93.53 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.031 2.487 . . . . 0.0 112.07 175.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.531 ' HG3' HG23 ' A' ' 439' ' ' THR . 78.7 mtp180 -138.94 114.74 10.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.271 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 396' ' ' ASN . 76.2 m -81.88 83.32 7.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.491 . . . . 0.0 110.557 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 10.5 mt -83.12 158.08 3.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -78.92 114.58 17.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.264 0.554 . . . . 0.0 109.879 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.316 -0.851 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.163 -177.605 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.943 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 9.9 mmt180 . . . . . 0 N--CA 1.463 0.215 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.88 90.93 3.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.379 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 23.9 m -64.79 133.72 52.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.773 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . 0.558 ' CZ ' ' HA3' ' A' ' 403' ' ' GLY . 55.9 t80 -102.63 123.98 47.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 401' ' ' ASN . 27.5 t80 -80.46 119.46 76.42 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -87.76 -171.03 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.387 2.725 . . . . 0.0 113.323 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -105.59 111.94 24.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.497 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.07 117.79 25.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.46 -36.1 82.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.155 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -108.04 28.2 8.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.905 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -138.9 165.75 25.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.589 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -90.74 111.11 22.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.156 0.503 . . . . 0.0 110.139 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.589 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . 42.3 m-80 -92.63 70.03 4.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.106 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -76.71 -6.57 52.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.255 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 40.4 m-80 -135.22 23.23 3.49 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.591 0.234 . . . . 0.0 111.372 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.589 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 22.9 t80 -68.89 129.35 39.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 110.931 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.558 ' HA3' ' CZ ' ' A' ' 390' ' ' TYR . . . 90.44 14.51 58.47 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.702 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -111.04 145.38 38.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.931 0.396 . . . . 0.0 110.903 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 98.0 mttt -108.72 134.87 50.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.287 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -126.88 149.87 49.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.651 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 32.3 m -85.6 148.68 4.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 1.036 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.8 tt0 -59.6 140.25 56.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.189 0.518 . . . . 0.0 111.175 -176.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.03 10.92 35.67 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -109.93 152.99 25.14 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.537 -0.831 . . . . 0.0 109.417 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 41.1 t -128.48 157.21 41.78 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 11.1 tp -148.86 139.69 16.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.545 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.84 132.5 36.13 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.808 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.607 ' HB ' HD13 ' A' ' 422' ' ' LEU . 46.7 t -130.77 101.63 5.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.017 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.72 115.74 27.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.406 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.609 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 82.9 m -84.81 174.12 10.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.906 174.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -62.84 156.75 64.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.722 0.296 . . . . 0.0 110.485 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.21 110.08 0.44 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.657 2.905 . . . . 0.0 112.53 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.55 -12.04 15.95 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.898 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.33 156.05 26.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.946 0.403 . . . . 0.0 110.706 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -157.21 167.63 29.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.153 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.607 HD13 ' HB ' ' A' ' 414' ' ' VAL . 87.3 mt -72.74 153.23 91.4 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.851 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.58 141.58 62.79 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.949 2.433 . . . . 0.0 111.63 176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 64.8 mttm 71.4 24.85 3.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.044 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.01 51.3 7.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.319 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.78 HE22 ' HB2' ' A' ' 438' ' ' PRO . 23.9 mt-30 -114.45 165.44 12.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.217 -176.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 29.0 p -129.7 -4.1 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.14 137.93 53.07 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.555 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.534 HG11 ' HG2' ' A' ' 438' ' ' PRO . 16.3 t -113.63 132.94 61.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.639 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 25.1 m -101.02 124.19 46.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.719 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.7 t -64.01 113.88 3.77 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 44.0 mtt -142.07 132.37 24.96 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.742 0.782 . . . . 0.0 111.838 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.59 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 0.7 OUTLIER 28.78 52.74 0.07 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.05 -171.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.943 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 0.2 OUTLIER 76.29 -25.18 0.21 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.561 171.351 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -115.71 60.91 0.4 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-O 119.361 -0.688 . . . . 0.0 112.971 -174.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.414 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 96.3 m95 20.39 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.033 1.333 . . . . 0.0 114.346 169.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.652 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 31.1 t -47.51 -59.56 5.39 Favored Pre-proline 0 N--CA 1.467 0.421 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -168.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.78 ' HB2' HE22 ' A' ' 426' ' ' GLN . 44.3 Cg_endo -85.45 -5.04 9.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.497 1.464 . . . . 0.0 113.384 -174.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.438 HG21 ' HG3' ' A' ' 441' ' ' ARG . 28.2 m 73.42 116.64 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.989 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.47 109.34 2.85 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.547 2.164 . . . . 0.0 112.273 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.525 ' O ' HD22 ' A' ' 422' ' ' LEU . 71.7 mtp180 -146.52 151.84 38.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.18 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 74.0 m -111.29 90.7 3.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.119 0.485 . . . . 0.0 110.311 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 12.7 mt -92.59 155.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -82.22 121.77 27.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.438 0.637 . . . . 0.0 110.138 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--N 1.315 -0.899 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.522 -175.064 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 2.9 mptp? -113.87 96.23 5.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.464 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 7.9 p -68.44 136.86 53.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.922 0.392 . . . . 0.0 111.094 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -99.78 130.83 46.02 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.463 ' HZ ' HG21 ' A' ' 414' ' ' VAL . 1.2 t80 -92.44 104.34 10.91 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.89 -90.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.369 2.713 . . . . 0.0 114.609 -170.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . 0.453 ' HA ' ' CE1' ' A' ' 402' ' ' TYR . 0.9 OUTLIER 167.52 128.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.736 0.814 . . . . 0.0 110.278 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.608 ' HG ' ' SG ' ' A' ' 442' ' ' CYS . 0.9 OUTLIER -73.4 -131.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.045 0.45 . . . . 0.0 110.408 173.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -155.63 -40.99 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -105.49 17.22 24.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.514 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -119.11 141.19 15.66 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.59 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . 0.404 ' HD1' ' O ' ' A' ' 415' ' ' ALA . 71.6 m-85 -65.78 114.53 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.239 0.542 . . . . 0.0 111.128 -176.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.781 ' HA ' ' HD2' ' A' ' 402' ' ' TYR . 0.4 OUTLIER -80.2 68.59 6.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.685 0.755 . . . . 0.0 110.321 176.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -70.95 -64.21 0.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.658 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -108.11 39.11 2.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.69 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.781 ' HD2' ' HA ' ' A' ' 399' ' ' ASN . 0.9 OUTLIER -92.58 148.2 22.27 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.535 -173.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 90.61 11.44 62.18 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -104.54 162.9 12.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.477 0.656 . . . . 0.0 111.995 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' A' ' 405' ' ' LYS . 10.2 mtmp? -117.72 134.36 54.98 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.324 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.645 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 97.0 m-85 -124.31 163.17 22.23 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 27.2 m -100.48 148.33 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.075 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.814 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.9 tt0 -57.12 139.38 52.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.99 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.5 7.64 56.73 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 5.4 mmtm -107.73 175.41 5.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.144 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 35.6 t -146.83 165.8 28.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.6 tp -156.1 137.79 5.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.382 0.61 . . . . 0.0 110.094 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -83.72 129.83 34.95 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.914 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.463 HG21 ' HZ ' ' A' ' 391' ' ' PHE . 46.4 t -117.02 114.19 45.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.609 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . 0.404 ' O ' ' HD1' ' A' ' 398' ' ' TYR . . . -94.68 93.49 7.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.056 0.455 . . . . 0.0 111.102 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.453 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 60.1 m -73.94 154.59 39.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 171.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -60.29 157.18 35.72 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.724 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.41 115.97 2.24 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.817 3.011 . . . . 0.0 112.641 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.24 -16.79 17.35 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.547 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 81.6 m-85 -110.75 148.09 33.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.593 0.235 . . . . 0.0 110.42 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -152.88 168.7 24.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.75 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.573 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 77.7 mt -83.09 155.74 67.12 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.118 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.12 155.87 27.13 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.396 2.731 . . . . 0.0 112.001 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 64.98 23.77 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.351 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 51.95 41.41 29.59 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.328 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.573 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 25.3 mt-30 -105.11 163.02 12.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.13 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 32.6 p -120.07 -6.0 9.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.471 0.653 . . . . 0.0 109.988 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 146.3 49.37 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.223 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.55 HG11 ' HG2' ' A' ' 438' ' ' PRO . 6.1 t -112.2 132.13 61.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 51.7 m -93.71 131.53 38.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.389 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 51.0 t -77.25 110.26 11.81 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.324 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.814 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 28.1 mtt -143.38 142.74 31.36 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.682 0.753 . . . . 0.0 112.977 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 434' ' ' ASN . 5.1 tt0 37.91 42.84 0.46 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.213 -174.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 433' ' ' GLU . 8.9 t-20 71.24 -20.62 0.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.125 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -117.88 60.74 0.46 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.381 -172.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 88.7 m95 24.72 107.43 0.0 OUTLIER 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.097 1.359 . . . . 0.0 114.282 169.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.779 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 58.6 m -51.12 -58.97 8.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.333 -166.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 24.6 Cg_endo -86.08 -7.67 8.05 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.831 1.687 . . . . 0.0 112.595 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.561 HG23 ' HG3' ' A' ' 441' ' ' ARG . 55.4 m 73.61 118.46 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.719 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -70.61 101.85 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.732 2.288 . . . . 0.0 111.804 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.561 ' HG3' HG23 ' A' ' 439' ' ' THR . 72.3 mtp180 -141.98 124.23 15.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.086 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.608 ' SG ' ' HG ' ' A' ' 394' ' ' LEU . 73.8 m -92.66 97.65 10.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.1 mt -99.93 155.65 4.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -81.14 116.59 21.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.475 0.655 . . . . 0.0 109.748 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.313 -1.002 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.491 -172.635 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.565 ' HD2' ' CB ' ' A' ' 434' ' ' ASN . 1.8 mmt180 . . . . . 0 CA--C 1.506 -0.732 0 CA-C-O 121.409 0.623 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.516 ' HE2' HG11 ' A' ' 407' ' ' VAL . 1.5 mptm? -118.25 106.92 13.29 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.224 -178.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 8.2 p -74.24 141.6 45.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.661 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -102.31 128.79 48.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -82.85 113.36 44.8 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.79 -176.89 2.37 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.047 2.498 . . . . 0.0 113.356 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -90.6 118.05 29.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.6 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.31 110.59 19.76 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -67.27 -29.81 69.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.0 109.728 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -100.71 15.36 28.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.093 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -134.1 -179.14 16.14 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.38 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -90.25 -1.66 57.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.71 0.29 . . . . 0.0 111.773 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 2.3 p30 40.9 41.04 1.12 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.445 1.098 . . . . 0.0 113.266 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -61.32 -26.58 67.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.382 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -114.25 18.24 17.13 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.553 -174.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -58.99 121.19 10.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.555 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.2 -6.75 36.95 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.917 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -85.04 147.23 26.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.049 0.452 . . . . 0.0 110.867 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -118.91 133.27 55.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.448 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.682 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 63.8 m-85 -124.3 159.33 30.5 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.516 HG11 ' HE2' ' A' ' 388' ' ' LYS . 27.1 m -92.21 146.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.988 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.7 tt0 -60.05 136.5 58.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.031 0.443 . . . . 0.0 110.824 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 104.57 12.79 27.71 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 22.8 mmtp -112.62 175.65 5.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.28 -0.46 . . . . 0.0 111.036 -176.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.0 t -149.77 162.82 39.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.28 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.3 tp -169.73 125.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.623 0.725 . . . . 0.0 110.507 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.742 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 18.4 t70 -77.27 137.52 38.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.314 -172.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.82 123.59 71.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.256 0.55 . . . . 0.0 111.303 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.92 112.45 23.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.193 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.608 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 80.5 m -112.59 163.31 14.67 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -63.06 149.14 91.34 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.338 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.83 107.6 0.22 Allowed 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.926 3.084 . . . . 0.0 112.676 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 123.89 -15.15 7.92 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.051 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.553 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 91.8 m-85 -108.04 136.37 47.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 176.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 442' ' ' CYS . . . -153.65 160.19 42.31 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.263 -176.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.5 HD12 HG23 ' A' ' 429' ' ' VAL . 84.5 mt -75.65 152.76 85.29 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.909 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 54.1 Cg_exo -53.69 144.75 52.16 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.758 2.305 . . . . 0.0 110.564 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 90.2 mttt 77.34 16.18 1.66 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.064 0.852 . . . . 0.0 109.843 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.8 40.34 19.61 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.917 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -93.54 159.33 15.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.097 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 60.2 p -110.18 -22.53 11.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.21 172.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.742 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 1.3 t -121.52 164.35 17.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.483 0.659 . . . . 0.0 111.662 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 440' ' ' PRO . 2.2 t -120.59 137.13 55.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.645 -175.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 83.5 m -94.13 130.65 40.23 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.205 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.2 t -75.83 113.4 13.27 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.988 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 20.0 mtp -145.24 139.68 27.33 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.532 0.682 . . . . 0.0 111.743 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.601 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 6.1 mm-40 41.77 38.95 1.07 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.783 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.565 ' CB ' ' HD2' ' A' ' 387' ' ' ARG . 4.5 t-20 69.56 -19.8 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.359 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -107.37 20.76 32.08 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.663 -170.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.547 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 96.7 m95 52.73 124.49 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.143 0.977 . . . . 0.0 113.615 -178.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.741 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 73.1 m -50.33 -61.87 3.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.741 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 33.5 Cg_endo -89.73 -5.25 5.32 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.98 1.786 . . . . 0.0 113.413 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.6 m 74.15 113.41 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.964 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 42.4 Cg_endo -73.49 113.16 3.71 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.623 2.216 . . . . 0.0 110.907 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -154.13 -39.28 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.346 -173.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 91.6 m 60.47 89.9 0.07 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.877 0.846 . . . . 0.0 111.872 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 10.1 mt -84.61 160.46 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.643 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 444' ' ' ARG . 21.3 ttp-105 -81.91 111.51 18.17 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.642 0.734 . . . . 0.0 109.898 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--N 1.309 -1.159 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.661 -177.795 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.864 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 8.5 mmt180 . . . . . 0 CA--C 1.51 -0.589 0 CA-C-O 121.738 0.78 . . . . 0.0 112.925 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 2.6 mptp? -121.68 91.49 3.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.792 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 23.9 m -61.47 130.36 45.64 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.018 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -98.13 127.73 44.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.456 ' CE2' HD22 ' A' ' 394' ' ' LEU . 16.6 t80 -83.3 120.22 75.35 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.431 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -88.34 -171.99 0.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.26 2.64 . . . . 0.0 112.997 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . 0.401 ' HE1' ' ND2' ' A' ' 399' ' ' ASN . 75.9 t80 -92.54 129.68 38.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.596 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.456 HD22 ' CE2' ' A' ' 391' ' ' PHE . 2.7 mm? -89.78 124.15 34.39 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.67 130.78 45.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 8.2 p30 50.32 26.1 2.12 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 124.206 0.942 . . . . 0.0 111.796 -173.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -115.49 169.85 13.07 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.387 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -90.3 102.72 15.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.534 0.683 . . . . 0.0 110.288 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.401 ' ND2' ' HE1' ' A' ' 393' ' ' TYR . 2.0 p30 -78.47 60.64 2.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.792 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -88.12 -29.9 20.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.148 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -97.26 -6.5 34.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.175 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -62.14 129.15 39.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.085 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.22 13.7 47.86 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.35 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 404' ' ' ARG . 53.6 mtt180 -108.53 149.43 28.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.136 0.493 . . . . 0.0 111.509 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -111.91 131.36 55.42 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.431 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.4 ' CD2' ' HH2' ' A' ' 436' ' ' TRP . 96.9 m-85 -128.86 138.81 52.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.163 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.1 m -76.2 152.44 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.464 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.697 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 9.2 tt0 -60.75 127.04 29.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.258 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.73 -18.13 17.37 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.218 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -86.79 145.59 26.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.864 0.364 . . . . 0.0 110.853 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.3 t -121.12 158.79 27.15 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.987 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.6 tp -155.22 146.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.04 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.82 133.93 38.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.377 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.01 137.23 30.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.778 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -105.69 112.34 25.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.994 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 48.4 m -124.77 172.35 9.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.069 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 12.3 m170 -54.89 159.98 3.3 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-O 121.125 0.488 . . . . 0.0 111.67 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 73.3 Cg_endo -75.46 103.45 1.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.243 2.629 . . . . 0.0 111.475 -175.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.01 -4.57 13.96 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.921 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -111.87 133.93 53.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.1 162.9 40.89 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.645 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' A' ' 440' ' ' PRO . 92.0 mt -69.29 155.55 93.32 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.654 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.95 152.12 30.75 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.912 2.408 . . . . 0.0 111.978 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 73.46 23.93 2.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.93 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.11 42.08 26.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.043 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 22.7 mt-30 -116.21 162.75 17.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.92 -176.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 61.8 p -124.45 -6.8 7.55 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.62 144.66 41.75 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.759 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.702 HG13 ' HG2' ' A' ' 438' ' ' PRO . 23.6 m -120.43 158.78 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.055 0.455 . . . . 0.0 109.954 172.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 90.6 m -113.79 132.63 55.78 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.425 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.2 t -68.34 118.62 11.67 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 177.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.697 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 6.2 ptt? -142.87 133.68 25.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.12 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 434' ' ' ASN . 0.9 OUTLIER 34.65 40.68 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.783 -174.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.864 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 7.5 t30 76.67 -23.85 0.24 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.384 0.674 . . . . 0.0 111.952 176.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -103.39 109.59 3.49 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.521 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 94.0 m95 -39.64 125.09 1.76 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 124.17 0.571 . . . . 0.0 112.073 -175.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.743 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 74.1 p -43.06 -52.08 12.31 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -166.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.743 ' HD3' ' OG ' ' A' ' 437' ' ' SER . 5.2 Cg_endo -105.53 2.05 0.22 Allowed 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.084 1.856 . . . . 0.0 112.495 -176.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.429 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 25.5 m 72.76 116.49 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.21 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.527 ' HA ' ' CD2' ' A' ' 422' ' ' LEU . 32.0 Cg_endo -64.32 92.15 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.801 2.334 . . . . 0.0 111.592 174.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -105.21 -50.33 3.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.221 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 83.1 m 60.0 81.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.599 0.714 . . . . 0.0 110.918 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 3.7 pt -95.57 155.08 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.274 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -73.68 107.66 6.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.002 0.906 . . . . 0.0 111.192 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 85.8 t . . . . . 0 C--N 1.31 -1.145 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.79 176.431 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 31.0 mt . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 121.965 0.888 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.753 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 8.6 mtt-85 -98.88 178.16 5.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.127 -168.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.431 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -129.13 98.32 4.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.395 177.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 434' ' ' ASN . 6.2 m -57.32 125.64 23.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.002 -175.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -86.74 130.22 34.56 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 168.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -80.86 120.59 79.33 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.539 0.209 . . . . 0.0 110.476 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.72 179.2 3.45 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.098 2.532 . . . . 0.0 113.819 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -86.91 127.43 35.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.176 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -93.69 118.0 30.82 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -65.38 -36.69 84.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.945 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -117.89 28.13 8.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.311 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -143.96 162.32 27.79 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.067 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -83.64 108.46 16.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.265 0.555 . . . . 0.0 110.052 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.522 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 2.0 p30 -80.67 54.78 2.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.045 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -63.47 -32.75 74.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.353 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.469 ' ND2' HD11 ' A' ' 412' ' ' ILE . 49.3 m-20 -100.46 -0.3 38.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.011 -173.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.522 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 64.8 t80 -62.95 120.41 11.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.018 0.437 . . . . 0.0 110.402 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.8 -14.64 19.65 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.843 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -90.86 156.88 17.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 111.434 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -126.1 132.91 51.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.146 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -127.84 148.08 50.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.044 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 16.9 m -81.99 148.53 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.515 0.198 . . . . 0.0 110.61 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 1.012 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.4 tt0 -61.09 133.04 55.62 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.314 0.578 . . . . 0.0 111.229 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.3 27.02 6.67 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -127.69 163.66 23.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.135 -0.532 . . . . 0.0 110.637 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 44.3 t -135.04 161.17 36.06 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.469 HD11 ' ND2' ' A' ' 401' ' ' ASN . 0.3 OUTLIER -164.88 143.77 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.544 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.454 ' H ' HD12 ' A' ' 412' ' ' ILE . 13.5 t70 -78.92 138.11 37.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.731 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 37.9 t -127.4 102.03 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.073 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -78.19 117.71 19.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.975 0.417 . . . . 0.0 111.115 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.444 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 35.2 m -103.54 167.61 9.69 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -65.24 158.92 69.73 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.497 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.58 110.34 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 123.518 2.812 . . . . 0.0 112.573 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 103.58 7.23 42.78 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.903 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.489 ' CE1' ' HB2' ' A' ' 444' ' ' ARG . 95.1 m-85 -125.85 139.16 53.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -159.81 -172.34 3.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.058 0.456 . . . . 0.0 111.049 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 440' ' ' PRO . 82.9 mt -97.06 161.4 26.39 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.435 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.09 152.18 15.05 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.254 2.636 . . . . 0.0 112.074 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 63.69 26.16 14.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.143 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.27 24.71 13.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.638 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.415 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 25.1 mt-30 -86.68 161.35 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.134 0.492 . . . . 0.0 111.4 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.0 t -121.01 -6.48 9.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -114.31 140.04 48.95 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.626 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.441 HG12 ' HB3' ' A' ' 440' ' ' PRO . 5.1 m -107.34 144.34 16.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.25 0.548 . . . . 0.0 110.57 176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 26.0 m -101.98 121.86 42.95 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.2 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.1 t -66.78 113.55 4.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 1.012 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 7.5 mtt -143.18 136.29 28.01 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.29 0.567 . . . . 0.0 111.353 174.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 34.46 46.03 0.16 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.699 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.753 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 55.3 t30 71.97 -24.14 0.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.601 175.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -108.03 33.29 6.37 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.136 -1.031 . . . . 0.0 113.893 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.536 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 95.7 m95 40.56 111.34 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.509 1.124 . . . . 0.0 113.891 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.693 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 73.0 m -40.28 -60.59 1.43 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -172.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 48.6 Cg_endo -88.6 -6.86 5.84 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.737 1.625 . . . . 0.0 112.871 -176.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 54.8 m 71.88 116.05 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.551 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 66.0 Cg_endo -80.49 109.52 2.3 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.84 2.36 . . . . 0.0 111.072 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -147.65 -14.78 0.38 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 61.3 m 56.63 83.34 0.1 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.939 0.399 . . . . 0.0 111.839 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.8 mt -85.61 157.8 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . 0.489 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 30.5 ttp180 -86.73 105.95 17.32 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.345 1.069 . . . . 0.0 111.374 -175.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 36.9 t -73.72 -38.08 50.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 113.014 -1.903 . . . . 0.0 110.285 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? . . . . . 0 C--O 1.248 0.985 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.532 -171.949 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.634 0 CA-C-O 121.456 0.646 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.444 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 9.2 mtt180 -83.93 165.3 18.79 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.262 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.502 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -133.62 101.4 5.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.162 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 6.8 p -68.43 144.76 54.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.694 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -107.08 132.1 53.37 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 168.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 39.9 t80 -81.57 118.87 73.93 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.337 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 86.1 Cg_endo -90.95 -173.58 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.44 2.76 . . . . 0.0 113.549 -176.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -93.32 138.68 31.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.215 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.96 -96.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 173.79 -33.36 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.574 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -145.07 38.75 1.19 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.317 -1.31 . . . . 0.0 108.825 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -127.88 147.43 17.24 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.505 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.25 99.9 1.61 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.005 0.431 . . . . 0.0 110.013 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.472 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 2.5 p30 -79.16 51.34 1.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.928 -175.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -71.29 -24.45 62.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.186 0.517 . . . . 0.0 110.171 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -93.96 -9.63 36.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.738 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.472 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 83.1 t80 -63.9 114.29 3.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.391 0.615 . . . . 0.0 110.749 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 118.48 -19.14 10.74 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.82 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -82.66 153.5 25.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.152 0.501 . . . . 0.0 111.366 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -127.52 134.13 49.8 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.136 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.635 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 96.2 m-85 -125.5 151.92 45.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 31.8 m -82.97 148.12 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.843 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 3.4 tt0 -59.24 140.79 55.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.799 0.333 . . . . 0.0 110.504 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.64 6.9 57.12 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -103.4 167.66 9.66 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.431 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 39.4 t -138.33 160.22 40.04 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.912 0.387 . . . . 0.0 110.12 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.9 tp -159.5 139.38 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.094 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -76.0 135.69 39.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.35 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.617 ' HB ' HD13 ' A' ' 422' ' ' LEU . 56.1 t -126.71 101.09 7.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.311 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.2 122.12 28.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.186 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.456 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 73.5 m -98.03 163.12 12.89 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -67.21 155.97 89.24 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.284 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.01 122.17 10.07 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.762 2.975 . . . . 0.0 112.277 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.76 30.74 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 70.3 m-85 -122.0 144.06 49.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.721 0.296 . . . . 0.0 110.291 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -142.87 178.64 7.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.132 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.617 HD13 ' HB ' ' A' ' 414' ' ' VAL . 34.2 mt -95.68 148.33 34.41 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.884 0.373 . . . . 0.0 110.561 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 441' ' ' ARG . 31.7 Cg_exo -59.14 150.02 76.38 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.97 2.447 . . . . 0.0 112.115 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 67.04 28.4 8.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.393 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.31 44.43 27.39 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.772 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 24.5 mt-30 -106.9 161.93 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.14 -175.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.7 p -128.91 -13.4 4.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.987 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.15 139.63 50.97 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.253 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.48 HG12 ' HG2' ' A' ' 438' ' ' PRO . 21.6 t -108.43 133.83 52.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 89.6 m -92.78 130.66 38.32 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.19 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.84 106.95 6.62 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.106 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.843 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 11.6 mtm -141.8 141.45 33.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.748 173.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.6 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 61.9 mm-40 46.89 36.37 3.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.876 -1.966 . . . . 0.0 111.476 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 6.2 t30 69.18 -20.94 0.16 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.803 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -112.64 49.96 0.81 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.511 -0.852 . . . . 0.0 114.061 -172.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 93.5 m95 35.69 106.81 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 169.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.835 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 55.8 m -51.7 -59.17 8.64 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 35.4 Cg_endo -85.53 -3.85 9.24 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.675 1.583 . . . . 0.0 113.079 -175.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.692 HG21 ' HG2' ' A' ' 441' ' ' ARG . 23.0 m 72.6 113.45 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.197 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -68.62 94.12 0.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.4 2.067 . . . . 0.0 110.812 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.692 ' HG2' HG21 ' A' ' 439' ' ' THR . 24.9 mmm180 -131.53 118.95 20.84 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 66.7 m -83.47 82.69 8.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.088 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 6.3 pt -76.4 144.89 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.657 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -73.17 111.24 8.1 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.577 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.9 p -78.66 -16.85 13.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.998 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.69 -0.671 . . . . 0.0 110.002 178.027 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.443 -0.825 0 CA-C-O 121.328 0.585 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.878 ' HG3' ' HG3' ' A' ' 433' ' ' GLU . 1.4 mmp_? -97.1 172.23 7.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.793 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -135.51 99.92 4.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.774 -175.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 10.4 m -67.87 146.49 53.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.932 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -107.57 128.22 54.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.176 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -74.15 122.31 87.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.97 -177.23 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.167 2.578 . . . . 0.0 113.475 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -93.63 117.16 29.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.683 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 440' ' ' PRO . 0.0 OUTLIER -80.37 8.13 8.22 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -171.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 59.97 -84.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -97.17 13.23 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.463 0.649 . . . . 0.0 110.246 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -112.9 -161.11 14.81 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.76 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . 0.515 ' HB2' ' HB2' ' A' ' 415' ' ' ALA . 57.6 m-85 -92.79 162.65 14.03 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.184 0.516 . . . . 0.0 109.782 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 1.6 p30 -129.47 41.62 3.42 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.519 0.676 . . . . 0.0 109.685 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.42 ' HG3' ' HB3' ' A' ' 398' ' ' TYR . 75.1 mt-30 -61.05 -46.36 91.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.149 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -94.08 -1.05 54.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.04 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.487 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 73.1 t80 -61.8 119.36 8.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.325 0.584 . . . . 0.0 110.28 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 110.22 -12.63 31.25 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.307 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -95.22 150.65 19.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -118.53 134.6 54.96 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.134 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.97 140.76 52.63 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.215 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.91 147.38 8.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.368 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.738 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 8.3 tt0 -56.47 129.43 40.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.077 0.465 . . . . 0.0 110.667 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 115.43 -22.19 12.24 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -81.74 150.99 27.69 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 24.2 t -140.07 146.7 39.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.824 0.821 . . . . 0.0 111.406 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.7 tp 177.72 132.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.865 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.665 ' HB2' HG22 ' A' ' 429' ' ' VAL . 27.3 t70 -125.71 -89.46 0.57 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.478 -1.237 . . . . 0.0 107.953 173.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.9 t 34.74 75.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 111.728 -2.487 . . . . 0.0 112.943 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 398' ' ' TYR . . . -176.06 52.06 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.771 -172.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 56.4 m -130.99 133.95 46.26 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 173.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -61.05 157.42 42.03 Favored Pre-proline 0 N--CA 1.463 0.209 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.34 115.21 1.63 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.522 2.815 . . . . 0.0 112.522 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 113.52 -11.69 23.54 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.633 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.523 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 63.6 m-85 -113.66 144.04 43.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.537 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.34 -177.95 6.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.034 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 61.1 mt -90.49 151.45 44.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 174.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.95 153.24 58.86 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.79 2.327 . . . . 0.0 111.554 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm 65.73 28.24 11.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.037 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.82 40.16 30.67 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.472 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 26.2 mt-30 -90.15 152.43 21.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.431 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 413' ' ' ASP . 2.1 p -140.93 20.3 2.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.563 ' HA ' ' CB ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -152.39 136.74 16.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.344 0.593 . . . . 0.0 110.108 -177.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.961 HG11 ' HD2' ' A' ' 438' ' ' PRO . 79.4 t -115.81 132.03 66.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.118 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.522 ' HB ' ' OG ' ' A' ' 437' ' ' SER . 49.1 m -91.5 134.92 34.24 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.543 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 18.3 t -75.14 120.2 20.32 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.738 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 21.2 ptm -107.39 -140.13 0.37 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.878 ' HG3' ' HG3' ' A' ' 387' ' ' ARG . 44.8 tt0 -70.35 71.39 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.233 0.924 . . . . 0.0 111.657 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.718 ' HB2' ' HD3' ' A' ' 387' ' ' ARG . 4.0 t30 78.43 -11.43 1.21 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.755 168.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -111.2 170.83 14.0 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 170.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.591 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 98.7 m95 -93.44 128.46 39.52 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.732 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 35.2 p -56.28 -54.03 57.35 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -165.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.961 ' HD2' HG11 ' A' ' 429' ' ' VAL . 6.9 Cg_endo -98.04 -4.31 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.693 1.595 . . . . 0.0 111.875 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.446 HG21 ' HG3' ' A' ' 441' ' ' ARG . 24.8 m 72.66 117.65 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.546 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.538 ' HB2' HD12 ' A' ' 394' ' ' LEU . 18.2 Cg_exo -64.44 93.81 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.858 2.372 . . . . 0.0 111.563 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.446 ' HG3' HG21 ' A' ' 439' ' ' THR . 43.8 mtp180 -125.82 91.66 3.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.675 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 66.3 m -63.07 98.89 0.15 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.579 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 2.4 pp -98.75 170.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.088 0.47 . . . . 0.0 110.313 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -93.75 118.58 31.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.426 -173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.07 -48.26 41.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.817 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.575 ' HD3' ' OXT' ' A' ' 446' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.33 172.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 121.207 0.527 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.709 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 32.1 mtp180 -127.64 -176.23 3.7 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.505 0.669 . . . . 0.0 111.461 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -128.55 109.79 11.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.805 174.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 7.6 p -70.52 144.7 51.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.363 0.601 . . . . 0.0 112.246 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -104.67 126.31 51.63 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 171.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.473 ' HZ ' HG21 ' A' ' 414' ' ' VAL . 2.5 t80 -76.27 117.93 67.74 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -177.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -84.71 -179.14 3.59 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.101 2.534 . . . . 0.0 113.481 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -80.77 128.7 33.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.879 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.73 HD21 ' HA ' ' A' ' 399' ' ' ASN . 1.4 mm? -89.92 103.22 15.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 396' ' ' ASN . 33.4 tt0 -71.4 117.03 12.43 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 395' ' ' GLU . 52.1 m-80 71.86 28.51 2.63 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.955 0.785 . . . . 0.0 109.984 -173.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -136.08 164.05 25.05 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.485 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -80.9 99.56 8.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.73 ' HA ' HD21 ' A' ' 394' ' ' LEU . 3.1 p30 -77.77 44.49 0.46 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.753 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.9 -29.96 70.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.672 0.749 . . . . 0.0 109.607 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -96.39 -7.51 34.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.34 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -64.06 122.57 16.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.882 0.373 . . . . 0.0 110.269 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.17 -10.98 33.94 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.11 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -82.5 166.42 19.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.243 0.544 . . . . 0.0 111.299 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -137.04 136.5 38.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.699 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.612 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 55.8 m-85 -132.14 153.1 50.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.138 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 14.7 m -79.38 139.14 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.734 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.85 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 33.1 tt0 -61.98 135.52 57.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.566 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 99.24 22.22 13.48 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 13.7 mmtm -127.4 173.79 9.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.029 -0.586 . . . . 0.0 109.819 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 30.6 t -144.65 163.5 33.76 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -160.84 145.73 5.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.155 -177.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.441 ' N ' HD12 ' A' ' 412' ' ' ILE . 14.2 t70 -81.14 138.66 35.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.317 -174.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.516 ' HB ' HD12 ' A' ' 422' ' ' LEU . 48.4 t -119.76 119.77 61.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -100.8 106.33 17.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.048 0.452 . . . . 0.0 111.105 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.41 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 56.8 m -94.72 172.57 8.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -73.19 156.75 89.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.846 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.88 112.28 0.98 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.447 2.765 . . . . 0.0 111.984 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.68 -11.79 13.72 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -118.84 143.36 47.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.183 -0.508 . . . . 0.0 109.777 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.75 39.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.49 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 91.3 mt -73.65 158.67 85.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.273 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.466 ' HG3' HD12 ' A' ' 443' ' ' ILE . 31.6 Cg_exo -57.84 149.05 71.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.838 2.359 . . . . 0.0 111.609 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 68.81 17.43 8.78 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.987 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.83 36.8 28.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.051 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.574 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 24.2 mt-30 -94.47 162.14 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.846 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 26.2 p -115.62 -11.3 11.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.357 0.599 . . . . 0.0 110.477 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.46 142.69 51.12 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.115 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.469 HG12 ' HG2' ' A' ' 438' ' ' PRO . 17.0 t -114.2 129.78 69.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.634 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 25.7 m -80.87 135.49 35.93 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.176 177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.73 110.13 15.94 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.905 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.85 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 0.6 OUTLIER -149.65 143.12 25.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.923 0.868 . . . . 0.0 112.579 179.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.697 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 37.0 mt-10 45.27 35.06 1.63 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.358 -176.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 389' ' ' CYS . 5.7 t-20 67.9 -16.51 0.18 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.763 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -114.67 25.23 10.42 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.586 -172.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.56 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 84.7 m95 58.31 148.15 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.908 0.883 . . . . 0.0 112.955 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.743 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 58.3 m -71.12 -63.68 1.42 Allowed Pre-proline 0 C--N 1.321 -0.639 0 O-C-N 121.967 -0.458 . . . . 0.0 111.171 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.743 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 36.2 Cg_endo -89.03 -2.64 6.25 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.044 1.829 . . . . 0.0 113.149 -176.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 29.8 m 71.71 111.08 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.765 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 12.2 Cg_exo -63.18 111.13 1.34 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.131 2.554 . . . . 0.0 111.989 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 422' ' ' LEU . 75.6 mtm180 -146.23 124.71 12.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.746 -176.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 74.9 m -89.82 82.53 6.22 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.466 HD12 ' HG3' ' A' ' 423' ' ' PRO . 3.9 mt -87.11 150.92 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.823 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 446' ' ' LYS . 8.9 ttm180 -79.43 126.16 30.48 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.656 -175.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.569 HG13 ' HG3' ' A' ' 446' ' ' LYS . 78.6 t -68.93 -52.09 37.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.674 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.569 ' HG3' HG13 ' A' ' 445' ' ' VAL . 97.7 mttt . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.116 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.44 -0.933 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.771 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 26.9 mtt180 -66.73 -170.89 0.11 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.708 0.766 . . . . 0.0 111.052 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -134.33 93.0 3.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.697 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 12.3 m -59.76 141.6 54.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.579 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.452 ' CZ ' ' HA3' ' A' ' 403' ' ' GLY . 68.0 t80 -104.57 137.3 42.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 414' ' ' VAL . 2.3 t80 -93.97 115.06 64.68 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.718 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -92.75 -176.3 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.465 2.776 . . . . 0.0 113.63 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -80.15 134.71 36.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 440' ' ' PRO . 8.1 mt -110.38 128.2 55.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.491 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.6 151.92 44.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 43.17 41.85 3.1 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.672 0.607 . . . . 0.0 111.665 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -139.87 147.8 19.47 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.28 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -89.16 96.28 10.65 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.695 0.748 . . . . 0.0 110.362 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.477 ' HB3' ' CB ' ' A' ' 402' ' ' TYR . 35.7 m-80 -78.05 70.15 4.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.562 -173.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -79.2 -26.55 42.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.102 0.477 . . . . 0.0 110.418 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -108.45 14.84 24.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.674 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.477 ' CB ' ' HB3' ' A' ' 399' ' ' ASN . 21.5 t80 -70.87 132.24 44.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.781 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.452 ' HA3' ' CZ ' ' A' ' 390' ' ' TYR . . . 95.12 15.16 45.9 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.234 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -103.19 156.34 17.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.022 0.439 . . . . 0.0 111.676 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -120.15 125.29 47.85 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.624 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -120.44 137.59 54.25 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.3 144.19 14.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.311 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.833 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.8 tt0 -66.29 144.57 56.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.644 -173.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 100.99 7.06 51.08 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -107.43 175.8 5.37 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.485 -0.857 . . . . 0.0 109.667 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 31.9 t -152.3 147.79 26.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.868 0.842 . . . . 0.0 111.475 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.49 ' HA ' ' CG2' ' A' ' 428' ' ' THR . 9.9 tp 173.44 134.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.425 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 1.027 ' H ' HG21 ' A' ' 428' ' ' THR . 34.9 t70 -130.97 -140.79 0.22 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.229 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.581 HG21 ' CG ' ' A' ' 413' ' ' ASP . 0.6 OUTLIER -147.17 147.75 17.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.226 -151.506 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.98 88.06 7.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.793 167.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.49 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 14.7 m -80.04 167.17 20.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.186 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -54.37 157.03 5.21 Favored Pre-proline 0 N--CA 1.469 0.484 0 CA-C-O 121.079 0.466 . . . . 0.0 111.528 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.21 110.78 0.49 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.709 2.939 . . . . 0.0 112.629 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.07 -2.09 38.09 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.691 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.617 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 87.8 m-85 -114.3 129.05 56.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . 0.429 ' C ' ' HA ' ' A' ' 442' ' ' CYS . . . -162.71 161.34 26.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.289 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.447 ' CD2' ' H ' ' A' ' 441' ' ' ARG . 73.9 mt -61.55 145.18 91.69 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.152 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.54 158.15 42.82 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.75 2.3 . . . . 0.0 111.09 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 68.96 21.36 7.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.467 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.61 50.92 8.39 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.385 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 23.9 mt-30 -109.66 160.91 15.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.049 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' THR . . . . . 0.832 ' O ' ' HB3' ' A' ' 413' ' ' ASP . 2.9 p -141.62 12.86 2.12 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.313 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 1.027 HG21 ' H ' ' A' ' 413' ' ' ASP . 0.5 OUTLIER -148.47 125.54 11.39 Favored 'General case' 0 N--CA 1.436 -1.129 0 O-C-N 123.66 0.6 . . . . 0.0 111.652 178.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.671 HG11 ' HG2' ' A' ' 438' ' ' PRO . 2.1 t -90.88 136.36 24.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.998 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.627 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 64.2 m -81.55 132.21 35.3 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 24.4 t -77.19 109.32 10.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.833 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 27.0 mtp -148.56 153.29 38.18 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.652 0.739 . . . . 0.0 112.394 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.518 ' C ' ' H ' ' A' ' 435' ' ' GLY . 4.1 mt-10 28.54 43.09 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 112.782 -2.008 . . . . 0.0 113.36 -164.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 65.13 -17.76 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.869 0.868 . . . . 0.0 112.147 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -112.79 41.82 2.12 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.912 -172.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.513 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 98.3 m95 42.55 111.22 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.749 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 60.6 m -50.1 -66.48 0.62 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.201 -0.908 . . . . 0.0 113.278 -167.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.671 ' HG2' HG11 ' A' ' 429' ' ' VAL . 31.8 Cg_endo -85.76 -2.76 9.04 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.54 1.493 . . . . 0.0 112.313 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.779 ' HB ' ' HD2' ' A' ' 441' ' ' ARG . 51.5 m 76.01 131.16 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.96 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 11.5 Cg_endo -70.72 84.5 0.81 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.841 2.361 . . . . 0.0 110.885 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.779 ' HD2' ' HB ' ' A' ' 439' ' ' THR . 0.5 OUTLIER -132.55 70.94 1.46 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.269 -172.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 421' ' ' ALA . 4.2 p -70.64 90.78 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.799 0.809 . . . . 0.0 110.501 175.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 14.6 pt -85.84 176.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.339 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -86.67 107.89 18.4 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.917 0.865 . . . . 0.0 110.475 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.28 -13.38 10.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.651 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 12.3 ttpp . . . . . 0 C--O 1.247 0.928 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.237 -178.724 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 386' ' ' LEU . 2.3 pt? . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 122.136 0.97 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 1.084 ' HG3' ' HB3' ' A' ' 408' ' ' GLN . 0.9 OUTLIER 48.52 -172.15 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 115.616 1.709 . . . . 0.0 115.616 173.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 387' ' ' ARG . 5.3 mptp? 73.39 37.55 0.71 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.338 -1.756 . . . . 0.0 111.947 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 32.3 m -51.68 120.4 5.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.731 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -97.5 127.46 43.48 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -79.42 115.46 53.36 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.049 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -87.32 174.38 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.156 2.571 . . . . 0.0 112.731 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -77.41 116.95 18.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.282 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.478 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 8.2 mt -71.63 127.5 32.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.267 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.606 ' HG2' ' HB2' ' A' ' 442' ' ' CYS . 1.4 pm0 -65.1 108.59 1.89 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.014 0.435 . . . . 0.0 110.279 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 63.74 36.52 10.56 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.483 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -129.26 172.31 19.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.919 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -77.33 88.2 3.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.341 0.591 . . . . 0.0 110.71 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.553 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 3.1 p30 -80.58 49.3 1.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.364 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -67.76 -22.79 65.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.844 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -104.06 -1.7 27.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.052 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.553 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 45.7 t80 -62.75 115.48 4.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.278 0.561 . . . . 0.0 110.427 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.61 -11.36 21.26 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.873 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.39 150.61 22.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.064 0.459 . . . . 0.0 110.949 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 405' ' ' LYS . 8.9 mptt -121.72 148.51 44.52 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.711 176.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.402 ' CD2' ' HH2' ' A' ' 436' ' ' TRP . 98.6 m-85 -142.32 156.46 45.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.206 0.527 . . . . 0.0 110.541 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.27 143.37 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.279 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 1.084 ' HB3' ' HG3' ' A' ' 387' ' ' ARG . 0.9 OUTLIER -57.86 139.94 53.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.408 -176.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.8 19.19 12.32 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -125.39 169.91 11.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.629 -0.785 . . . . 0.0 110.145 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.1 t -148.02 157.51 43.55 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.331 0.586 . . . . 0.0 110.415 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.6 tp -151.08 140.45 15.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.2 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.8 133.52 37.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.363 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.92 139.42 48.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.662 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -142.44 133.66 26.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.232 0.539 . . . . 0.0 111.406 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 0.1 OUTLIER -103.07 -178.43 3.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.578 ' NE2' ' HE2' ' A' ' 420' ' ' TYR . 19.1 p-80 -77.72 157.46 79.51 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.842 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 417' ' ' HIS . 9.9 Cg_exo -34.4 120.71 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.385 3.39 . . . . 0.0 115.007 -171.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.71 -20.42 46.25 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.589 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.625 ' HB2' ' HB3' ' A' ' 416' ' ' CYS . 51.6 m-85 -109.83 142.48 41.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.954 0.377 . . . . 0.0 110.757 -174.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -175.75 -170.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.411 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.608 HD23 ' HA ' ' A' ' 440' ' ' PRO . 94.7 mt -80.88 162.23 60.64 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.403 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.72 147.1 73.64 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.021 2.481 . . . . 0.0 110.761 171.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.6 10.6 7.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.605 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 62.44 35.07 15.03 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.697 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -66.93 152.44 45.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.071 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.4 p -123.79 -3.38 8.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.272 0.558 . . . . 0.0 110.341 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.84 136.29 44.3 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.961 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.507 HG11 HD13 ' A' ' 422' ' ' LEU . 5.5 m -104.28 134.77 44.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.554 0.692 . . . . 0.0 110.205 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 14.8 m -92.92 117.91 30.56 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.219 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 47.3 t -66.81 116.9 8.21 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.946 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 23.4 mtp -131.82 -166.8 1.77 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.37 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.59 ' OE1' ' HB3' ' A' ' 432' ' ' MET . 1.7 mp0 -37.49 76.97 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.841 1.338 . . . . 0.0 114.454 -170.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 432' ' ' MET . 15.6 t-20 64.7 23.99 12.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.777 175.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -173.92 119.16 0.73 Allowed Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.254 -174.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.402 ' HH2' ' CD2' ' A' ' 406' ' ' PHE . 47.5 m95 -37.87 113.56 0.28 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.976 0.91 . . . . 0.0 110.374 165.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 6.6 m -56.92 -50.88 85.61 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.793 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.407 ' HG2' HG13 ' A' ' 429' ' ' VAL . 33.1 Cg_endo -83.41 -8.11 10.65 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.149 1.233 . . . . 0.0 112.379 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.414 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 9.1 m 70.99 112.81 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.957 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.608 ' HA ' HD23 ' A' ' 422' ' ' LEU . 35.9 Cg_endo -66.46 86.08 0.27 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.747 2.298 . . . . 0.0 112.392 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -114.08 130.93 56.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.85 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.606 ' HB2' ' HG2' ' A' ' 395' ' ' GLU . 56.7 m -90.41 83.09 5.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.119 0.485 . . . . 0.0 110.821 173.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 2.5 pt -99.68 153.43 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 172.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -79.3 113.69 17.64 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.489 0.661 . . . . 0.0 109.703 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.66 -29.6 5.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.408 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 56.0 tptt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.095 177.281 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 121.671 0.748 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.551 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 24.1 mtt180 -96.08 164.66 12.6 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.304 -173.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -118.94 90.72 3.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.934 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 31.1 m -56.72 122.85 13.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.842 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -91.36 113.47 25.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.502 ' HD1' ' CZ2' ' A' ' 436' ' ' TRP . 27.0 t80 -76.57 117.95 68.13 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -94.78 -175.9 0.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.402 2.735 . . . . 0.0 113.479 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . 0.561 ' CE2' ' HA ' ' A' ' 395' ' ' GLU . 47.7 t80 -75.51 130.81 39.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.831 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.452 HD22 ' HE2' ' A' ' 391' ' ' PHE . 2.5 mm? -81.11 -5.39 57.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -171.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.561 ' HA ' ' CE2' ' A' ' 393' ' ' TYR . 63.0 mm-40 66.49 -71.67 0.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.482 0.489 . . . . 0.0 110.996 -173.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.56 24.08 7.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.851 -175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -140.8 169.25 24.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.466 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -82.9 138.8 33.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 3.6 p30 -105.68 59.26 0.66 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.01 0.433 . . . . 0.0 112.162 -173.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -78.74 -14.54 59.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.726 0.298 . . . . 0.0 110.732 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -117.7 9.65 13.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.728 0.299 . . . . 0.0 111.008 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 24.9 t80 -64.75 127.82 33.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 0.0 111.007 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 91.87 16.34 51.75 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.111 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -105.81 149.39 26.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.851 0.358 . . . . 0.0 110.915 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -112.17 126.69 55.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.525 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -118.65 150.84 39.04 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.595 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 35.6 m -83.12 147.53 5.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.553 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.791 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 3.2 tt0 -64.18 128.27 35.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.374 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.38 7.79 36.69 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 7.3 mmtt -114.79 163.32 15.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 20.3 t -138.89 164.88 28.51 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.367 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.0 tp -155.96 142.17 10.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.931 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -84.39 133.25 34.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.567 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 69.5 t -117.89 128.45 75.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.598 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.26 113.74 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.722 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.593 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 56.0 m -95.66 170.4 9.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -65.21 154.97 85.99 Favored Pre-proline 0 C--N 1.332 -0.164 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.025 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.9 105.92 0.16 Allowed 'Trans proline' 0 CA--C 1.521 -0.14 0 C-N-CA 123.747 2.965 . . . . 0.0 112.63 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.16 -11.75 11.52 Favored Glycine 0 C--N 1.317 -0.523 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.513 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -115.35 146.58 41.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.16 -179.05 7.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.703 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 97.9 mt -79.77 158.1 73.47 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-O 120.971 0.415 . . . . 0.0 110.544 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.41 ' HA ' HD12 ' A' ' 443' ' ' ILE . 50.2 Cg_exo -55.33 150.37 41.57 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.528 2.152 . . . . 0.0 110.771 171.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . 0.62 ' HB3' ' HZ2' ' A' ' 424' ' ' LYS . 6.9 mtpm? 64.06 19.08 11.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.941 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 61.19 26.63 16.48 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.173 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 51.8 mt-30 -73.67 158.99 33.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.907 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 28.1 p -124.62 -23.13 4.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.313 0.578 . . . . 0.0 110.22 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.88 135.95 49.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.52 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.415 HG12 ' HG2' ' A' ' 438' ' ' PRO . 2.5 t -110.5 125.07 67.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 60.8 m -88.32 135.17 33.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.777 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 31.4 t -72.7 112.67 8.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.791 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 7.3 mtt -146.84 142.1 27.33 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.705 0.764 . . . . 0.0 111.321 174.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.543 ' C ' ' HD2' ' A' ' 387' ' ' ARG . 5.8 mm-40 39.09 40.32 0.47 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.232 -1.804 . . . . 0.0 113.084 -170.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 46.1 t30 70.33 -24.05 0.16 Allowed 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.704 0.628 . . . . 0.0 111.706 174.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -104.81 22.3 34.09 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.562 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.538 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 94.0 m95 56.35 128.78 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.804 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 71.8 m -51.38 -64.45 1.4 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.359 -169.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.804 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 42.6 Cg_endo -89.11 -2.53 6.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.049 1.832 . . . . 0.0 112.478 -176.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 18.6 m 73.74 121.61 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.295 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 30.7 Cg_endo -66.6 94.64 0.32 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.727 2.284 . . . . 0.0 111.699 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -131.03 106.54 8.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.778 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 76.4 m -83.36 81.39 8.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.916 0.389 . . . . 0.0 110.63 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 423' ' ' PRO . 9.8 pt -87.76 161.42 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.884 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -75.38 121.77 22.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.385 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.9 p -112.05 13.68 8.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.336 -174.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 53.6 mttp . . . . . 0 C--O 1.25 1.106 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.211 179.669 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 73.0 mt . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 122.366 1.079 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.714 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 8.7 mtt-85 -78.95 166.49 22.31 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.591 -1.64 . . . . 0.0 112.388 -172.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 38.9 mmtm -117.65 90.57 3.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.014 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 15.2 m -59.62 120.97 10.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.511 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -90.33 124.81 35.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.655 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -80.32 120.72 80.31 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.278 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -83.53 -179.2 4.07 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.295 2.663 . . . . 0.0 112.636 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -93.87 121.99 35.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.4 0.619 . . . . 0.0 110.715 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.2 mp -89.31 129.26 35.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.392 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.89 -47.84 64.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.948 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -107.5 16.54 23.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.914 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -132.26 155.75 21.66 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.512 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -77.7 111.23 13.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.536 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 1.7 p30 -79.22 61.61 3.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.869 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -66.18 -19.57 65.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.257 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -117.9 1.8 12.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.309 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.536 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 37.4 t80 -63.12 124.86 22.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 111.302 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.65 -9.79 41.24 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.304 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -100.66 152.76 20.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.69 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 52.2 mtmt -116.91 152.93 33.48 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.846 173.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 97.4 m-85 -134.9 150.31 50.41 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.914 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.7 m -80.08 144.93 9.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.159 0.504 . . . . 0.0 110.349 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.818 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.8 OUTLIER -62.01 125.68 24.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.555 -173.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.97 -0.95 24.28 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -95.88 161.61 13.93 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.153 -0.524 . . . . 0.0 110.387 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.1 t -141.33 163.29 33.36 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.1 tp -170.02 130.39 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.673 0.749 . . . . 0.0 110.517 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.749 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 14.1 t70 -83.66 132.55 34.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.336 -171.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 22.6 t -113.05 120.81 63.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.677 -175.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.02 122.87 29.86 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.464 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 67.5 m -116.02 173.11 6.75 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -62.48 158.15 51.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.212 0.529 . . . . 0.0 110.956 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.89 114.55 1.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.556 2.837 . . . . 0.0 111.949 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 444' ' ' ARG . . . 110.22 -5.03 30.1 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.207 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.631 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 84.6 m-85 -115.62 145.09 43.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.141 0.496 . . . . 0.0 110.946 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 442' ' ' CYS . . . -160.08 160.19 32.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.259 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.522 HD13 HG21 ' A' ' 429' ' ' VAL . 69.6 mt -71.55 151.45 93.79 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 121.064 0.459 . . . . 0.0 111.792 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.14 147.66 34.03 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.415 2.743 . . . . 0.0 111.913 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . 0.459 ' HB2' HE21 ' A' ' 426' ' ' GLN . 99.7 mttt 70.1 27.5 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.71 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.32 53.78 8.42 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.391 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.459 HE21 ' HB2' ' A' ' 424' ' ' LYS . 48.5 mt-30 -119.51 160.66 21.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.53 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 41.7 p -119.88 -17.15 8.57 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.004 0.431 . . . . 0.0 110.143 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.749 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 0.5 OUTLIER -120.11 160.1 23.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.837 0.827 . . . . 0.0 111.603 178.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.522 HG21 HD13 ' A' ' 422' ' ' LEU . 1.4 t -116.6 148.6 19.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.344 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 86.7 m -108.55 122.99 48.21 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.816 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.418 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.1 t -67.96 111.13 4.22 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.818 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 4.7 mtm -144.45 135.79 25.47 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.966 0.889 . . . . 0.0 112.583 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.709 ' H ' ' HG3' ' A' ' 408' ' ' GLN . 0.8 OUTLIER 46.66 37.41 4.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.064 -178.316 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.714 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 8.1 t30 72.66 -24.95 0.19 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.929 0.892 . . . . 0.0 112.7 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -108.13 43.75 1.64 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.037 -1.078 . . . . 0.0 114.257 -169.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.503 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.3 m95 36.25 105.41 0.0 OUTLIER 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 172.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.794 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 69.5 m -45.64 -59.57 4.41 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.244 -168.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 13.5 Cg_endo -90.65 -6.19 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.631 1.554 . . . . 0.0 113.248 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.622 HG21 ' HG3' ' A' ' 441' ' ' ARG . 24.4 m 71.95 121.9 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.517 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.503 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 1.2 Cg_endo -78.67 97.48 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.51 2.807 . . . . 0.0 111.413 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.622 ' HG3' HG21 ' A' ' 439' ' ' THR . 53.8 mtm180 -131.38 -45.77 0.99 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.608 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 68.0 m 64.78 91.97 0.07 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.074 0.94 . . . . 0.0 111.301 -177.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 7.0 mt -96.9 159.53 3.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.096 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 419' ' ' GLY . 31.7 ttt180 -64.67 121.91 15.61 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.986 0.898 . . . . 0.0 110.613 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 80.5 t -48.56 -45.24 14.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.914 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 446' ' ' LYS . 21.4 tptp . . . . . 0 C--O 1.243 0.716 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.392 171.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 121.312 0.577 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.858 ' HG3' ' HA ' ' A' ' 433' ' ' GLU . 34.2 mmt180 -76.08 171.2 14.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.448 -174.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.468 ' HD2' ' C ' ' A' ' 387' ' ' ARG . 0.1 OUTLIER -124.45 79.6 1.77 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.732 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 19.8 m -59.86 125.92 25.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.249 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -90.3 127.53 36.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 172.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.447 ' HE1' HD22 ' A' ' 394' ' ' LEU . 2.0 t80 -81.71 111.76 28.81 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . 0.408 ' C ' ' HD1' ' A' ' 402' ' ' TYR . 95.9 Cg_endo -88.92 -166.65 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.245 2.63 . . . . 0.0 113.241 -176.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . 0.437 ' HD1' HD21 ' A' ' 399' ' ' ASN . 55.3 t80 -78.14 134.84 37.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.002 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.618 HD21 ' HA ' ' A' ' 399' ' ' ASN . 2.6 mm? -86.05 106.97 17.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.656 177.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.723 ' O ' ' HB2' ' A' ' 442' ' ' CYS . 12.8 pt-20 -63.49 116.87 5.99 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 69.16 25.34 5.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.023 0.44 . . . . 0.0 110.351 -174.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -135.73 176.05 20.41 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.451 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -99.16 120.86 40.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.263 0.554 . . . . 0.0 110.45 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.618 ' HA ' HD21 ' A' ' 394' ' ' LEU . 9.2 p30 -79.37 59.56 2.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.759 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -70.13 -28.87 65.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.9 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -111.75 7.55 20.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.215 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.52 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 81.2 t80 -63.97 126.07 26.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.144 0.497 . . . . 0.0 110.371 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.66 -5.31 54.22 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.86 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.31 150.03 21.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.977 0.418 . . . . 0.0 110.888 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 59.3 mtpt -126.75 136.61 52.65 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.208 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -126.97 153.59 45.67 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.783 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 387' ' ' ARG . 27.0 m -86.66 144.94 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.972 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.3 tt0 -57.5 132.03 51.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 0.0 110.914 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.05 12.72 23.27 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 53.9 mmtt -115.14 155.51 26.98 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.185 -0.507 . . . . 0.0 110.533 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.6 t -132.4 161.53 33.4 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.3 tp -162.39 138.31 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.439 0.638 . . . . 0.0 110.294 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -89.3 137.24 32.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.835 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.42 137.57 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.288 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.89 118.84 34.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.281 0.562 . . . . 0.0 111.343 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.509 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 58.2 m -89.0 -175.9 4.99 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.598 173.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -64.5 152.05 90.18 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.05 103.07 0.14 Allowed 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 123.204 2.602 . . . . 0.0 111.58 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.674 ' O ' ' HB3' ' A' ' 444' ' ' ARG . . . 126.92 -10.08 7.07 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.571 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 1.048 ' HA ' ' CB ' ' A' ' 444' ' ' ARG . 59.8 m-85 -119.66 159.81 23.71 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.18 173.66 14.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.821 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 427' ' ' THR . 3.2 mm? -73.96 160.14 82.51 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 171.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.469 ' HG3' HD13 ' A' ' 443' ' ' ILE . 71.8 Cg_exo -48.61 136.74 26.85 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.947 2.431 . . . . 0.0 111.237 174.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 78.81 20.36 0.79 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.349 1.031 . . . . 0.0 110.061 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.76 44.2 20.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.071 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 422' ' ' LEU . 23.6 mt-30 -100.21 169.94 8.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.753 -177.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' THR . . . . . 0.507 ' HA ' HD21 ' A' ' 422' ' ' LEU . 74.8 p -123.05 -8.62 8.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.357 0.599 . . . . 0.0 109.477 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -113.76 149.85 34.28 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.474 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 19.9 m -124.83 144.74 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 172.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 39.1 m -108.1 129.19 55.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.326 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.2 t -72.33 110.03 6.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.972 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 9.1 mtt -142.02 137.6 31.24 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.812 0.815 . . . . 0.0 111.698 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.858 ' HA ' ' HG3' ' A' ' 387' ' ' ARG . 1.2 tp10 40.43 40.14 0.82 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.732 -2.031 . . . . 0.0 112.759 -174.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 9.3 t30 73.02 -16.33 0.47 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.021 0.528 . . . . 0.0 112.009 174.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -118.91 45.87 1.2 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.741 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.532 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.1 m95 35.21 106.2 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 172.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.705 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 64.0 m -41.15 -62.13 1.13 Allowed Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -172.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.705 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 62.6 Cg_endo -88.67 -2.86 6.56 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.681 1.588 . . . . 0.0 113.156 -174.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.754 HG23 ' HG3' ' A' ' 441' ' ' ARG . 28.8 m 72.94 119.37 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.575 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 61.5 Cg_endo -74.57 82.71 1.85 Allowed 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.729 2.286 . . . . 0.0 112.205 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.754 ' HG3' HG23 ' A' ' 439' ' ' THR . 49.5 mtp180 -133.18 132.29 41.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.825 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 395' ' ' GLU . 81.6 m -95.42 74.68 3.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.716 0.77 . . . . 0.0 111.38 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.469 HD13 ' HG3' ' A' ' 423' ' ' PRO . 1.6 pt -101.27 144.01 13.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.703 174.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . 1.048 ' CB ' ' HA ' ' A' ' 420' ' ' TYR . 0.0 OUTLIER -175.35 -154.64 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -177.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.636 ' H ' ' HD2' ' A' ' 444' ' ' ARG . 7.6 p -87.06 -6.54 10.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 111.488 -2.596 . . . . 0.0 111.643 -169.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.082 176.272 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 N--CA 1.445 -0.692 0 CA-C-O 122.967 1.365 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.694 ' HG3' ' N ' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -59.42 174.98 0.37 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 112.846 -1.979 . . . . 0.0 116.041 -167.07 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.726 ' H ' ' HB2' ' A' ' 434' ' ' ASN . 0.1 OUTLIER -166.97 65.32 0.09 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 112.615 -2.084 . . . . 0.0 106.792 152.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 61.5 m -50.84 108.8 0.26 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.47 -1.695 . . . . 0.0 113.271 -166.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -90.64 120.95 32.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -69.55 122.84 87.05 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.75 167.15 24.39 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.187 2.591 . . . . 0.0 113.155 -175.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -85.96 116.41 24.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.598 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.5 117.17 28.98 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.784 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 0.0 OUTLIER -75.21 -31.51 60.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.111 0.481 . . . . 0.0 110.338 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.4 ' ND2' ' HG2' ' A' ' 395' ' ' GLU . 41.6 m-80 -98.48 20.05 13.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.047 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -134.19 178.49 18.35 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.207 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -90.01 -10.12 46.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.779 0.323 . . . . 0.0 111.591 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 6.8 p30 42.21 36.69 0.75 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.355 1.062 . . . . 0.0 113.558 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -62.99 -26.06 68.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.778 0.323 . . . . 0.0 111.183 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -94.88 -6.76 41.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.352 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -61.23 118.64 7.12 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.36 -10.22 22.14 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.511 -174.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -100.38 146.64 26.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.719 0.295 . . . . 0.0 110.723 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 56.7 mtpt -119.46 152.17 37.33 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.261 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.461 ' CD1' ' HH2' ' A' ' 436' ' ' TRP . 94.8 m-85 -139.79 162.87 34.09 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.385 0.612 . . . . 0.0 111.437 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 35.3 m -97.54 146.22 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.644 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.894 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 6.1 tt0 -69.42 122.76 19.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.041 0.448 . . . . 0.0 110.558 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.45 12.67 11.47 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 1.1 tmtm? -116.41 162.68 17.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.813 -0.693 . . . . 0.0 109.481 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.5 t -132.25 158.23 42.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.934 0.397 . . . . 0.0 110.171 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.1 tp -149.68 140.73 16.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.146 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -82.41 132.2 35.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.738 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.538 HG23 HG22 ' A' ' 429' ' ' VAL . 92.3 t -111.83 139.97 33.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.156 0.503 . . . . 0.0 111.191 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -113.35 103.07 10.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.17 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.573 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 70.7 m -99.17 165.8 11.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 171.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -68.3 153.17 95.92 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.107 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.77 108.71 0.3 Allowed 'Trans proline' 0 CA--C 1.521 -0.156 0 C-N-CA 123.702 2.935 . . . . 0.0 112.278 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.76 -11.03 11.14 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.578 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 99.3 m-85 -116.49 141.33 48.31 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -144.47 178.9 7.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.066 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.631 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 59.4 mt -92.27 156.93 41.38 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.85 0.357 . . . . 0.0 111.044 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 58.2 Cg_exo -54.1 144.65 57.23 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.174 2.583 . . . . 0.0 111.562 173.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 29.1 mtpp 72.45 19.14 4.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.188 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.1 26.29 13.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.317 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.631 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 27.3 mt-30 -85.26 157.31 20.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.062 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.9 p -116.37 0.92 12.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.541 0.686 . . . . 0.0 109.846 173.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.25 140.43 52.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.941 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.538 HG22 HG23 ' A' ' 414' ' ' VAL . 45.6 t -115.4 132.29 65.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.102 0.477 . . . . 0.0 109.718 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.608 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 19.3 m -88.02 129.66 35.21 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.138 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 33.8 t -71.41 111.59 6.86 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.894 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 1.0 OUTLIER -141.96 121.83 13.59 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 122.466 1.126 . . . . 0.0 112.105 172.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 433' ' ' GLU . 35.5 tt0 51.51 36.65 17.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 111.978 -2.374 . . . . 0.0 112.295 177.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.726 ' HB2' ' H ' ' A' ' 388' ' ' LYS . 63.9 t30 61.98 15.46 7.28 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.066 0.936 . . . . 0.0 109.681 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -123.2 17.05 8.05 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.768 -173.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.461 ' HH2' ' CD1' ' A' ' 406' ' ' PHE . 93.4 m95 36.42 101.42 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.92 1.012 . . . . 0.0 113.073 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.701 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 62.6 m -44.52 -61.81 1.92 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -165.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 41.2 Cg_endo -83.31 -3.12 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.043 1.828 . . . . 0.0 112.961 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.634 HG23 ' HG3' ' A' ' 441' ' ' ARG . 26.3 m 74.35 114.19 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.972 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.407 ' HG3' HG13 ' A' ' 429' ' ' VAL . 13.1 Cg_exo -68.78 95.95 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.948 2.432 . . . . 0.0 111.94 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.634 ' HG3' HG23 ' A' ' 439' ' ' THR . 51.6 mtp180 -135.89 117.84 15.27 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.732 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 62.4 m -82.05 82.86 7.49 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 5.1 pt -82.88 144.67 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.378 0.608 . . . . 0.0 111.066 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.5 ttm105 -71.49 120.22 16.76 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.416 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.6 p -96.63 15.57 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.957 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.705 175.825 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 N--CA 1.443 -0.786 0 CA-C-O 121.401 0.619 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.958 ' HD3' ' HA ' ' A' ' 434' ' ' ASN . 0.3 OUTLIER -71.2 162.52 29.29 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.585 178.264 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 387' ' ' ARG . 0.0 OUTLIER -115.64 108.16 16.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.063 0.459 . . . . 0.0 111.897 -170.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 71.2 m -86.98 143.89 27.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.327 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -125.78 119.77 28.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 26.7 t80 -70.12 118.86 67.75 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.749 0.309 . . . . 0.0 110.41 -174.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 93.2 Cg_endo -90.26 -175.57 0.95 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.194 2.596 . . . . 0.0 113.525 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . 0.438 ' HA ' ' OD1' ' A' ' 399' ' ' ASN . 87.7 t80 -91.04 116.92 29.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.61 -173.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.428 HD12 ' HB2' ' A' ' 440' ' ' PRO . 3.5 mm? -74.41 117.91 16.77 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.44 -26.63 63.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.535 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -136.41 38.58 2.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.395 0.617 . . . . 0.0 110.519 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -124.29 168.32 16.45 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.4 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -87.39 -4.96 59.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 393' ' ' TYR . 53.7 m-80 44.04 47.55 7.31 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 170.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -65.45 -15.31 62.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.743 0.306 . . . . 0.0 111.039 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -122.38 12.34 10.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -68.91 129.21 39.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.66 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 102.17 8.4 44.49 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.174 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -98.84 152.34 19.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.401 0.62 . . . . 0.0 111.888 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -116.64 143.42 45.65 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.434 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -141.22 151.24 43.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.274 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 29.3 m -93.81 150.99 3.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 170.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 1.026 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.4 tt0 -62.48 138.19 58.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.341 0.591 . . . . 0.0 111.207 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.16 14.17 23.15 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -174.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 7.7 mmmt -118.92 161.37 20.31 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.699 -0.75 . . . . 0.0 110.05 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.2 t -131.81 165.96 22.64 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.26 144.16 11.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.173 0.511 . . . . 0.0 110.722 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -84.32 143.05 29.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.853 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.57 127.61 70.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.962 0.411 . . . . 0.0 110.922 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -97.43 95.01 7.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.616 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 34.3 m -87.04 145.73 26.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.616 ' ND1' ' HD2' ' A' ' 418' ' ' PRO . 16.4 t60 -59.19 144.44 83.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 0.0 110.979 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . 0.616 ' HD2' ' ND1' ' A' ' 417' ' ' HIS . 95.3 Cg_exo -45.21 106.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.477 1 C-N-CA 125.427 4.084 . . . . 0.0 112.734 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 125.11 -17.5 7.09 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.127 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -110.16 150.14 29.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.001 0.429 . . . . 0.0 111.117 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -149.3 166.96 27.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.733 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 62.9 mt -88.88 153.14 49.44 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 120.69 0.281 . . . . 0.0 110.892 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.61 144.27 33.93 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.192 2.595 . . . . 0.0 112.141 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 68.88 23.7 6.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.876 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 54.18 47.22 23.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.249 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 25.8 mt-30 -108.33 167.64 9.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.534 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 12.2 t -126.57 0.09 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -119.7 145.84 46.16 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.161 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.621 HG11 ' HG2' ' A' ' 438' ' ' PRO . 12.5 t -115.7 133.23 62.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.945 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 18.0 m -93.99 124.47 38.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.81 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.5 t -71.86 111.41 7.09 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.604 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 1.026 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 30.0 mtp -140.08 -177.38 4.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.466 ' HA ' ' OE1' ' A' ' 433' ' ' GLU . 9.4 mm-40 -32.98 88.55 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 125.95 2.031 . . . . 0.0 114.387 -175.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.958 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 10.3 t-20 68.9 12.28 8.59 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 112.088 -2.324 . . . . 0.0 110.653 168.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 179.23 134.64 2.2 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.403 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.428 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 91.1 m95 -38.93 117.89 0.71 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 165.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.603 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 14.8 m -67.1 -52.27 31.52 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -168.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.621 ' HG2' HG11 ' A' ' 429' ' ' VAL . 25.5 Cg_endo -83.56 -9.14 10.26 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 120.919 1.079 . . . . 0.0 112.196 -175.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.568 HG23 ' HG2' ' A' ' 441' ' ' ARG . 11.0 m 71.61 109.53 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.23 173.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.428 ' HB2' HD12 ' A' ' 394' ' ' LEU . 37.5 Cg_endo -69.42 98.31 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.35 2.033 . . . . 0.0 110.945 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.568 ' HG2' HG23 ' A' ' 439' ' ' THR . 21.9 mmm180 -120.58 -36.89 3.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.735 -175.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 416' ' ' CYS . 82.9 m 56.68 69.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.498 0.666 . . . . 0.0 110.117 -174.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 5.7 pt -87.04 154.42 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.714 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -61.09 121.72 13.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.989 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.4 p -74.44 -5.79 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.032 -171.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 48.7 pttt . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.55 -1.214 . . . . 0.0 111.971 -178.862 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 386' ' ' LEU . 14.0 mt . . . . . 0 N--CA 1.432 -1.349 0 CA-C-O 123.762 1.744 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.788 ' NH1' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -109.45 -156.41 0.58 Allowed 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 110.456 -3.065 . . . . 0.0 112.571 -168.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -164.61 88.63 0.49 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.602 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.502 ' SG ' ' HA ' ' A' ' 434' ' ' ASN . 58.6 m -51.3 111.99 0.66 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.584 0.553 . . . . 0.0 111.295 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -89.45 118.28 28.99 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -72.8 123.22 89.31 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.805 0.336 . . . . 0.0 110.128 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.74 169.02 18.74 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.094 2.53 . . . . 0.0 113.765 -174.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -88.34 106.83 18.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.813 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.38 108.25 17.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -63.22 -40.2 96.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.867 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.431 ' C ' ' HD2' ' A' ' 417' ' ' HIS . 2.0 p30 -100.49 19.69 16.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.568 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -132.14 172.98 20.88 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.093 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -88.03 104.47 16.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 2.3 p30 -74.54 55.41 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.38 -178.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -64.62 -42.85 95.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.779 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -101.72 0.88 36.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.419 -170.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.426 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 23.6 t80 -61.5 124.07 19.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.112 0.482 . . . . 0.0 110.38 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.42 -9.3 38.44 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.704 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -89.75 147.32 23.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.247 0.546 . . . . 0.0 111.134 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -121.66 135.47 54.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.797 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -129.25 158.15 39.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.213 0.53 . . . . 0.0 111.34 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.8 m -87.78 144.48 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.006 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.818 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.2 tt0 -52.55 139.79 24.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.963 0.411 . . . . 0.0 111.492 177.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.47 10.89 57.71 Favored Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -110.89 154.62 23.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 30.8 t -132.47 159.15 40.19 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.047 0.451 . . . . 0.0 110.409 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.2 tp -155.57 141.43 10.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.501 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -91.56 139.99 30.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.822 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 19.3 t -126.05 146.08 32.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.277 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -122.63 131.43 53.81 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.574 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 56.4 m -103.79 170.54 7.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.431 ' HD2' ' C ' ' A' ' 396' ' ' ASN . 94.3 m-70 -72.7 156.7 89.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.814 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.32 110.68 0.48 Allowed 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.821 3.014 . . . . 0.0 112.529 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.45 -6.02 16.82 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.788 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 96.1 m-85 -122.97 145.6 48.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.792 0.33 . . . . 0.0 110.769 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -149.83 157.16 42.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.945 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.639 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 46.6 mt -78.44 156.21 78.55 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.82 0.343 . . . . 0.0 111.199 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.473 ' HG3' HD12 ' A' ' 443' ' ' ILE . 50.2 Cg_exo -53.04 144.49 45.91 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.067 2.511 . . . . 0.0 112.018 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 71.73 14.76 6.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.436 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 60.4 30.47 19.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.515 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.639 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 27.6 mt-30 -92.18 168.77 11.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.846 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 79.8 p -126.12 -26.11 3.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.474 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.89 134.53 35.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.426 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.548 HG11 ' HG2' ' A' ' 438' ' ' PRO . 3.5 t -109.88 142.89 21.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.451 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 27.6 m -103.91 126.81 51.31 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.212 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 34.6 t -70.08 108.72 4.21 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.818 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 9.7 mtt -144.55 132.89 21.86 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.324 1.059 . . . . 0.0 112.42 174.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.626 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 2.4 tm-20 46.38 32.16 1.48 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.09 -2.323 . . . . 0.0 110.687 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.502 ' HA ' ' SG ' ' A' ' 389' ' ' CYS . 45.5 t-20 76.03 -27.71 0.18 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.45 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -97.91 40.05 2.61 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.237 -171.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.533 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.0 m95 35.99 106.44 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 172.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.74 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 72.2 m -44.54 -60.09 3.31 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -170.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.74 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 31.3 Cg_endo -88.36 -6.6 6.13 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.882 1.722 . . . . 0.0 112.874 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 80.9 m 72.8 116.33 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 114.898 -1.047 . . . . 0.0 113.072 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.533 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 18.4 Cg_endo -88.76 109.76 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.498 2.799 . . . . 0.0 110.734 174.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -147.2 -17.65 0.39 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 77.2 m 58.1 87.07 0.07 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.406 0.622 . . . . 0.0 111.489 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.473 HD12 ' HG3' ' A' ' 423' ' ' PRO . 11.0 mt -85.54 158.84 3.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -78.88 124.86 28.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.215 0.531 . . . . 0.0 109.923 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 5.6 p -93.62 -15.16 8.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.119 -177.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.092 -179.586 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.436 -1.145 0 CA-C-O 121.007 0.432 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.745 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 2.0 mmp_? -121.81 177.1 5.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.539 0.685 . . . . 0.0 111.801 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -125.17 94.56 4.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.932 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 20.5 m -62.52 113.45 2.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.129 0.49 . . . . 0.0 111.707 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.502 ' CZ ' ' HA3' ' A' ' 403' ' ' GLY . 53.2 t80 -79.65 112.01 16.5 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.779 173.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -62.68 123.38 79.14 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.23 172.03 13.22 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.259 2.639 . . . . 0.0 113.297 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -90.62 125.17 35.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.323 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 29.3 mt -103.92 130.06 51.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.571 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -91.79 -32.76 15.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.668 0.747 . . . . 0.0 109.105 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -94.63 5.04 53.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.61 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -142.19 170.9 24.81 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.202 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -87.59 113.94 23.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.941 0.401 . . . . 0.0 110.356 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -83.31 51.77 2.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.577 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -70.31 -17.24 63.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.94 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -114.25 1.16 14.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.992 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -63.0 127.99 33.8 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.31 0.576 . . . . 0.0 111.473 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.502 ' HA3' ' CZ ' ' A' ' 390' ' ' TYR . . . 103.05 -0.24 47.88 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.684 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -108.72 141.93 39.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.868 0.366 . . . . 0.0 110.472 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -105.66 130.43 53.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.617 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -109.52 150.86 27.53 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.747 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.34 139.33 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.276 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.851 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 12.6 tt0 -60.28 126.21 26.64 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.557 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 101.07 13.42 33.81 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -173.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -110.25 151.71 27.02 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.2 t -124.84 160.63 28.32 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.596 ' C ' ' HG1' ' A' ' 428' ' ' THR . 0.0 OUTLIER -170.8 127.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.666 0.746 . . . . 0.0 110.013 -176.358 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.706 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 29.8 t70 -79.09 130.0 35.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.876 -172.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 429' ' ' VAL . 31.6 t -106.38 157.53 6.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.278 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -120.55 94.34 4.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.864 0.364 . . . . 0.0 111.221 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 92.9 m -83.79 150.96 25.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.618 ' NE2' ' HE2' ' A' ' 420' ' ' TYR . 1.5 p-80 -74.68 152.23 87.14 Favored Pre-proline 0 N--CA 1.461 0.103 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.765 -170.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -32.32 112.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.856 3.704 . . . . 0.0 114.639 -173.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.21 -5.14 35.76 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.22 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.618 ' HE2' ' NE2' ' A' ' 417' ' ' HIS . 63.2 m-85 -120.74 144.49 48.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.989 0.423 . . . . 0.0 111.147 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -152.09 -167.12 2.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.574 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.481 HD12 HG23 ' A' ' 429' ' ' VAL . 70.4 mt -108.27 160.43 27.05 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-O 120.904 0.383 . . . . 0.0 111.918 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.416 ' HG3' HD12 ' A' ' 443' ' ' ILE . 87.7 Cg_exo -47.69 143.26 12.8 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.597 2.865 . . . . 0.0 112.715 175.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt 67.47 30.45 6.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.729 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.49 33.02 20.15 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.609 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -97.35 169.41 9.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.028 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' THR . . . . . 0.469 ' C ' HD11 ' A' ' 422' ' ' LEU . 39.2 p -126.94 1.19 6.61 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.781 173.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.706 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 1.9 t -124.46 163.81 21.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.635 0.731 . . . . 0.0 111.654 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.502 HG11 ' HG2' ' A' ' 438' ' ' PRO . 2.0 t -129.77 142.56 43.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.34 -177.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 78.6 m -99.94 136.9 39.15 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.101 174.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 13.6 t -74.93 119.67 19.43 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.851 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 11.5 mtp -152.1 136.9 17.09 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.73 0.776 . . . . 0.0 111.657 174.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.717 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 18.9 mt-10 45.33 38.83 3.83 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.149 -1.842 . . . . 0.0 111.947 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.454 ' HB2' ' HD3' ' A' ' 387' ' ' ARG . 43.3 t30 68.89 -24.57 0.14 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.232 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -102.26 18.54 51.25 Favored Glycine 0 CA--C 1.501 -0.834 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.898 -169.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.656 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 96.4 m95 59.45 128.87 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 124.539 0.788 . . . . 0.0 112.989 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.726 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 71.1 m -49.76 -64.55 1.18 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.224 -170.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.726 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 28.2 Cg_endo -87.69 -7.6 6.42 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.692 1.594 . . . . 0.0 112.278 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.3 m 74.39 123.3 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.841 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.656 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 11.2 Cg_exo -62.99 93.35 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.166 2.577 . . . . 0.0 111.721 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -130.49 108.94 10.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 82.1 m -75.55 90.01 2.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.228 0.537 . . . . 0.0 110.567 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.416 HD12 ' HG3' ' A' ' 423' ' ' PRO . 11.2 mt -87.24 159.43 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.543 -0.753 . . . . 0.0 108.969 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -80.4 119.77 23.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.278 0.561 . . . . 0.0 110.303 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 445' ' ' VAL . 10.5 p -106.35 45.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.209 1.004 . . . . 0.0 110.679 -172.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.818 ' H ' ' HD3' ' A' ' 446' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.542 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.43 -1.473 0 CA-C-O 122.279 1.037 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 1.03 ' HG2' ' HB3' ' A' ' 408' ' ' GLN . 1.0 OUTLIER 55.53 -169.11 0.08 Allowed 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 159.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 0.0 OUTLIER 53.3 62.71 2.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 112.012 -2.358 . . . . 0.0 111.757 -168.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 14.5 m -67.57 134.02 50.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.223 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -91.89 132.36 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.425 ' HB3' ' O ' ' A' ' 401' ' ' ASN . 26.7 t80 -93.72 111.69 53.69 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.754 0.311 . . . . 0.0 110.702 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -92.61 -163.4 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.235 2.624 . . . . 0.0 113.442 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -85.88 140.66 30.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.355 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -89.14 15.77 8.27 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 67.59 -69.54 0.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.498 0.666 . . . . 0.0 111.497 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.574 ' O ' ' HD2' ' A' ' 417' ' ' HIS . 0.2 OUTLIER -131.76 45.52 2.77 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.798 -177.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -142.07 177.03 21.75 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.053 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -88.8 118.99 28.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.222 0.534 . . . . 0.0 111.263 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . 2.5 p30 -87.62 86.52 7.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.034 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.79 -19.24 49.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.508 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 44.9 m-80 -136.73 28.92 2.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.426 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 50.4 t80 -69.09 122.24 18.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.09 0.471 . . . . 0.0 110.624 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 100.93 0.11 55.07 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.977 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -97.46 154.51 17.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.932 0.396 . . . . 0.0 111.304 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 39.0 mtmt -127.35 138.86 53.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.131 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.505 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 98.8 m-85 -128.84 158.45 38.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 -173.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.9 m -76.4 155.5 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.304 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 1.03 ' HB3' ' HG2' ' A' ' 387' ' ' ARG . 1.3 tt0 -77.5 124.43 27.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.466 0.651 . . . . 0.0 109.859 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.45 5.7 26.01 Favored Glycine 0 C--N 1.315 -0.633 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -104.12 149.06 25.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.536 -0.832 . . . . 0.0 109.15 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.4 t -129.75 158.71 38.64 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.046 0.45 . . . . 0.0 110.211 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.6 tp -156.54 139.09 6.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.079 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.63 133.48 34.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.145 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 35.2 t -123.41 133.44 69.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.166 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -109.21 128.07 54.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.575 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 0.8 OUTLIER -100.77 -169.25 1.68 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 174.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.574 ' HD2' ' O ' ' A' ' 396' ' ' ASN . 85.8 m-70 -82.13 157.44 68.45 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -54.08 110.99 0.58 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.43 2.753 . . . . 0.0 112.206 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.08 -9.95 10.21 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.185 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 77.2 m-85 -119.74 132.13 55.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -153.72 159.68 42.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.565 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 92.4 mt -70.1 153.41 95.34 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.643 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.36 150.88 47.82 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.593 2.195 . . . . 0.0 110.805 172.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . 0.499 ' HB2' ' HG3' ' A' ' 426' ' ' GLN . 53.2 mttp 70.84 21.11 5.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.65 0.594 . . . . 0.0 110.492 -177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.97 26.73 15.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.489 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 53.7 mt-30 -84.44 158.03 21.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.195 0.521 . . . . 0.0 111.225 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 65.9 p -126.34 -9.54 6.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.87 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.24 137.62 41.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.441 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.586 HG12 ' HG2' ' A' ' 438' ' ' PRO . 2.6 t -112.98 128.07 69.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 26.0 m -99.29 124.68 44.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.593 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 38.1 t -69.03 115.91 8.88 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.907 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 29.9 mtp -138.48 129.33 26.66 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 122.745 1.26 . . . . 0.0 113.064 175.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.694 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 2.2 tp10 46.43 43.48 11.99 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 111.872 -2.422 . . . . 0.0 111.428 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 433' ' ' GLU . 26.3 t-20 78.77 -9.49 1.5 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.408 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -131.64 88.89 0.28 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.712 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -12.55 114.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.793 1.237 . . . . 0.0 112.713 170.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.721 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 30.3 m -62.88 -54.49 46.54 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.279 -171.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.586 ' HG2' HG12 ' A' ' 429' ' ' VAL . 24.2 Cg_endo -85.36 -8.15 8.69 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.54 1.493 . . . . 0.0 111.957 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 9.9 m 71.17 121.27 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.59 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.07 76.95 2.47 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.636 2.224 . . . . 0.0 112.207 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -139.16 95.89 3.02 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.681 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 420' ' ' TYR . 2.1 p -76.33 92.21 3.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.386 0.612 . . . . 0.0 110.336 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.1 pt -73.22 160.39 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.782 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -81.48 114.2 20.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.141 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 5.9 p -106.5 -5.65 10.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.992 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp . . . . . 0 C--O 1.249 1.047 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.373 -179.15 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 63.1 mt . . . . . 0 N--CA 1.441 -0.905 0 CA-C-O 121.286 0.565 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.564 ' HD2' ' C ' ' A' ' 433' ' ' GLU . 62.5 mtt180 -91.18 158.31 16.69 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.671 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 12.5 mptt -118.54 109.56 16.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.481 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 5.5 p -69.82 144.14 52.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.283 0.563 . . . . 0.0 112.196 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -116.24 120.8 40.12 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 21.2 t80 -77.87 121.62 84.39 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 -176.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 78.8 Cg_endo -88.83 -177.14 1.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.491 2.794 . . . . 0.0 112.942 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -94.45 126.9 40.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.695 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 3.4 mm? -81.93 6.18 16.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.432 ' HB2' ' H ' ' A' ' 396' ' ' ASN . 5.4 mm-40 57.14 -89.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.248 0.547 . . . . 0.0 110.312 -176.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.483 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 0.1 OUTLIER -83.22 50.67 1.8 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.841 175.266 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -153.08 163.63 30.6 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -77.03 -22.74 52.55 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.586 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . 8.1 p30 39.54 54.62 2.39 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.423 0.689 . . . . 0.0 112.426 175.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -22.92 63.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.141 -173.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -127.18 34.28 4.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.243 0.544 . . . . 0.0 111.613 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 27.9 t80 -63.95 133.45 53.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.194 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 92.6 15.91 51.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.495 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -107.07 154.69 20.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.294 0.568 . . . . 0.0 111.644 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 49.8 mtmt -118.97 140.84 49.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.46 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.633 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 88.2 m-85 -140.13 159.6 41.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.645 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.52 147.2 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.973 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.7 tt0 -63.15 141.18 58.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.111 0.482 . . . . 0.0 111.337 -176.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.15 8.97 35.1 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 61.9 mmtt -113.23 179.56 3.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.365 -176.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.8 t -150.45 160.97 43.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.11 0.481 . . . . 0.0 110.365 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -154.15 149.65 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.574 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -90.7 141.89 28.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.75 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 28.9 t -126.63 141.22 46.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.27 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -125.23 118.16 25.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.833 0.349 . . . . 0.0 110.736 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 74.7 m -103.46 -178.64 3.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -58.32 154.14 33.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.169 174.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.83 108.53 0.49 Allowed 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.7 2.934 . . . . 0.0 112.179 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.63 -13.12 15.34 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -113.3 147.98 36.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.375 -0.412 . . . . 0.0 109.908 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -159.47 179.23 9.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.162 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.63 HD11 HG12 ' A' ' 429' ' ' VAL . 87.2 mt -76.86 160.7 76.01 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.9 141.11 22.35 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.978 2.452 . . . . 0.0 111.937 173.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 68.0 30.5 5.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.173 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.44 30.09 16.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.659 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 22.4 mt-30 -91.29 158.53 16.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.991 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 8.2 p -118.38 -4.82 10.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.141 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.66 140.72 52.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.96 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.63 HG12 HD11 ' A' ' 422' ' ' LEU . 3.3 m -108.61 133.23 54.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.129 0.49 . . . . 0.0 110.16 174.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 76.9 m -85.44 128.18 34.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.513 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 53.4 t -69.54 106.09 2.88 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.973 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 6.4 mtt -143.09 139.26 30.38 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.633 0.73 . . . . 0.0 111.552 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.703 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 7.0 mm-40 41.41 40.5 1.29 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 112.956 -1.929 . . . . 0.0 112.637 -176.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 389' ' ' CYS . 4.3 t-20 70.22 -23.6 0.16 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.49 176.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -103.9 15.35 52.05 Favored Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.799 -170.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 85.1 m95 56.04 125.72 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.735 0.814 . . . . 0.0 112.523 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.718 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 58.5 m -44.47 -61.87 1.88 Allowed Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -172.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.718 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 64.3 Cg_endo -88.42 -3.62 6.71 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.704 1.603 . . . . 0.0 112.817 -175.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.433 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 28.5 m 68.98 109.3 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.606 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 439' ' ' THR . 11.5 Cg_endo -55.14 102.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.794 2.996 . . . . 0.0 112.455 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -141.76 131.62 24.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.992 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 76.6 m -87.05 91.21 8.63 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.137 0.494 . . . . 0.0 109.869 175.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 8.9 mt -94.28 157.73 3.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -88.84 108.18 19.38 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.4 0.619 . . . . 0.0 109.712 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.87 -15.67 15.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.753 -173.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.459 ' HZ1' ' HB2' ' A' ' 446' ' ' LYS . 7.5 mtmp? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.647 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.667 ' H ' ' HG3' ' A' ' 433' ' ' GLU . 74.3 mt . . . . . 0 N--CA 1.444 -0.764 0 CA-C-O 121.836 0.826 . . . . 0.0 111.844 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.947 ' HG3' ' HB3' ' A' ' 408' ' ' GLN . 7.8 mpt_? -44.7 -174.29 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 177.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 39.3 ttmt 73.98 79.17 0.12 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 112.471 -2.15 . . . . 0.0 112.362 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 435' ' ' GLY . 3.2 m -87.28 155.87 19.88 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.755 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -119.18 128.53 54.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -81.25 122.43 81.3 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.587 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.6 172.27 11.45 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.205 2.603 . . . . 0.0 113.388 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -85.94 123.33 31.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.07 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 394' ' ' LEU . 2.2 mm? -95.74 119.49 34.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -76.91 -32.09 57.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.319 0.58 . . . . 0.0 109.867 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 8.9 m120 -100.63 10.37 41.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.556 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -131.46 175.95 19.37 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.582 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -92.81 109.99 21.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 2.9 p30 -81.12 48.04 1.08 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.239 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.89 -32.86 74.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.328 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.52 ' ND2' HD11 ' A' ' 412' ' ' ILE . 78.7 m-20 -95.63 -9.42 32.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.126 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 52.0 t80 -59.94 129.74 43.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.221 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 95.29 5.15 60.71 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.247 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -104.43 148.3 26.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.086 0.47 . . . . 0.0 110.759 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -124.59 143.78 50.52 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.86 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 87.4 m-85 -139.39 156.39 47.02 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.306 -173.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 26.2 m -88.03 137.59 20.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.818 174.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.947 ' HB3' ' HG3' ' A' ' 387' ' ' ARG . 1.5 tt0 -53.14 137.84 32.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.016 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.79 7.76 25.15 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -112.75 151.55 30.16 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.439 -0.88 . . . . 0.0 110.025 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 35.6 t -131.4 153.32 49.8 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.52 HD11 ' ND2' ' A' ' 401' ' ' ASN . 0.2 OUTLIER -152.72 144.14 15.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.781 -173.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.468 ' N ' HD12 ' A' ' 412' ' ' ILE . 28.5 t70 -81.89 137.64 35.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.392 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 64.3 t -121.84 126.83 75.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.46 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.72 128.25 54.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.315 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.58 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 61.2 m -105.92 -178.45 3.65 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -76.13 154.95 84.56 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.12 112.07 0.77 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.655 2.904 . . . . 0.0 112.457 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.08 -12.76 19.7 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.905 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -111.06 148.73 31.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.709 0.29 . . . . 0.0 110.643 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.87 162.11 39.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.453 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.14 158.38 81.67 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.809 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.67 135.17 61.31 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.771 2.314 . . . . 0.0 111.555 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 69.86 17.46 7.56 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.992 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 63.53 39.67 8.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.436 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.566 HE22 ' HB2' ' A' ' 438' ' ' PRO . 23.4 mt-30 -78.46 158.84 28.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.492 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 49.9 p -121.93 -13.58 8.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.48 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.83 149.74 47.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.585 -175.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.643 HG12 ' HG3' ' A' ' 440' ' ' PRO . 13.0 t -126.88 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.533 HG22 ' HE1' ' A' ' 432' ' ' MET . 38.6 m -103.53 123.1 46.29 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.49 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 43.2 t -64.12 116.35 5.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.313 174.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.818 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 32.7 mtt -145.46 133.27 21.16 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.704 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 33.4 tt0 28.47 68.09 0.08 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.135 -169.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 56.57 31.31 18.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.224 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' A' ' 389' ' ' CYS . . . -150.55 -158.19 8.14 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.723 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.439 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 96.9 m95 -136.36 113.25 10.34 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -174.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 12.7 t -66.32 -51.24 44.75 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.951 -168.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.566 ' HB2' HE22 ' A' ' 426' ' ' GLN . 25.7 Cg_endo -91.29 0.97 4.7 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.44 1.427 . . . . 0.0 112.504 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.531 HG23 ' HG3' ' A' ' 441' ' ' ARG . 13.3 m 73.71 112.0 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.928 171.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.643 ' HG3' HG12 ' A' ' 429' ' ' VAL . 1.3 Cg_endo -79.77 93.53 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.031 2.487 . . . . 0.0 112.07 175.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.531 ' HG3' HG23 ' A' ' 439' ' ' THR . 78.7 mtp180 -138.94 114.74 10.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.271 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 396' ' ' ASN . 76.2 m -81.88 83.32 7.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.491 . . . . 0.0 110.557 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 10.5 mt -83.12 158.08 3.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -78.92 114.58 17.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.264 0.554 . . . . 0.0 109.879 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 446' ' ' LYS . 9.8 p -87.16 -33.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.163 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 445' ' ' VAL . 58.5 tttp . . . . . 0 C--O 1.245 0.846 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.118 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 N--CA 1.44 -0.934 0 CA-C-O 121.558 0.694 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.943 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 9.9 mmt180 -63.47 166.19 6.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.291 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.88 90.93 3.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.379 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 23.9 m -64.79 133.72 52.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.773 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.558 ' CZ ' ' HA3' ' A' ' 403' ' ' GLY . 55.9 t80 -102.63 123.98 47.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 401' ' ' ASN . 27.5 t80 -80.46 119.46 76.42 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -87.76 -171.03 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.387 2.725 . . . . 0.0 113.323 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -105.59 111.94 24.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.497 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.07 117.79 25.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.46 -36.1 82.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.155 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -108.04 28.2 8.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.905 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -138.9 165.75 25.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.589 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -90.74 111.11 22.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.156 0.503 . . . . 0.0 110.139 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.589 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . 42.3 m-80 -92.63 70.03 4.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.106 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -76.71 -6.57 52.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.255 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 40.4 m-80 -135.22 23.23 3.49 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.591 0.234 . . . . 0.0 111.372 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.589 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 22.9 t80 -68.89 129.35 39.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 110.931 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.558 ' HA3' ' CZ ' ' A' ' 390' ' ' TYR . . . 90.44 14.51 58.47 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.702 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -111.04 145.38 38.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.931 0.396 . . . . 0.0 110.903 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 98.0 mttt -108.72 134.87 50.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.287 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -126.88 149.87 49.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.651 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 32.3 m -85.6 148.68 4.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 1.036 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.8 tt0 -59.6 140.25 56.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.189 0.518 . . . . 0.0 111.175 -176.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.03 10.92 35.67 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -109.93 152.99 25.14 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.537 -0.831 . . . . 0.0 109.417 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 41.1 t -128.48 157.21 41.78 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 11.1 tp -148.86 139.69 16.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.545 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.84 132.5 36.13 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.808 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.607 ' HB ' HD13 ' A' ' 422' ' ' LEU . 46.7 t -130.77 101.63 5.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.017 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.72 115.74 27.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.406 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.609 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 82.9 m -84.81 174.12 10.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.906 174.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -62.84 156.75 64.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.722 0.296 . . . . 0.0 110.485 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.21 110.08 0.44 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.657 2.905 . . . . 0.0 112.53 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.55 -12.04 15.95 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.898 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.33 156.05 26.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.946 0.403 . . . . 0.0 110.706 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -157.21 167.63 29.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.153 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.607 HD13 ' HB ' ' A' ' 414' ' ' VAL . 87.3 mt -72.74 153.23 91.4 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.851 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.58 141.58 62.79 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.949 2.433 . . . . 0.0 111.63 176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 64.8 mttm 71.4 24.85 3.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.044 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.01 51.3 7.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.319 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.78 HE22 ' HB2' ' A' ' 438' ' ' PRO . 23.9 mt-30 -114.45 165.44 12.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.217 -176.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 29.0 p -129.7 -4.1 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.14 137.93 53.07 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.555 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.534 HG11 ' HG2' ' A' ' 438' ' ' PRO . 16.3 t -113.63 132.94 61.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.639 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 25.1 m -101.02 124.19 46.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.719 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.7 t -64.01 113.88 3.77 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 44.0 mtt -142.07 132.37 24.96 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.742 0.782 . . . . 0.0 111.838 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.59 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 0.7 OUTLIER 28.78 52.74 0.07 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.05 -171.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.943 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 0.2 OUTLIER 76.29 -25.18 0.21 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.561 171.351 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -115.71 60.91 0.4 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-O 119.361 -0.688 . . . . 0.0 112.971 -174.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.414 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 96.3 m95 20.39 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.033 1.333 . . . . 0.0 114.346 169.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.652 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 31.1 t -47.51 -59.56 5.39 Favored Pre-proline 0 N--CA 1.467 0.421 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -168.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.78 ' HB2' HE22 ' A' ' 426' ' ' GLN . 44.3 Cg_endo -85.45 -5.04 9.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.497 1.464 . . . . 0.0 113.384 -174.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.438 HG21 ' HG3' ' A' ' 441' ' ' ARG . 28.2 m 73.42 116.64 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.989 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.47 109.34 2.85 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.547 2.164 . . . . 0.0 112.273 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.525 ' O ' HD22 ' A' ' 422' ' ' LEU . 71.7 mtp180 -146.52 151.84 38.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.18 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 74.0 m -111.29 90.7 3.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.119 0.485 . . . . 0.0 110.311 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 12.7 mt -92.59 155.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -82.22 121.77 27.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.438 0.637 . . . . 0.0 110.138 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 10.0 p -91.87 -12.41 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.522 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 20.4 tptp . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.673 -0.68 . . . . 0.0 110.132 179.474 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.411 ' O ' ' HD2' ' A' ' 388' ' ' LYS . 30.1 mt . . . . . 0 N--CA 1.443 -0.796 0 CA-C-O 121.259 0.552 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -50.53 151.1 2.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.733 -1.121 . . . . 0.0 113.559 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 2.9 mptp? -113.87 96.23 5.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.464 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 7.9 p -68.44 136.86 53.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.922 0.392 . . . . 0.0 111.094 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -99.78 130.83 46.02 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.463 ' HZ ' HG21 ' A' ' 414' ' ' VAL . 1.2 t80 -92.44 104.34 10.91 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.89 -90.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.369 2.713 . . . . 0.0 114.609 -170.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . 0.453 ' HA ' ' CE1' ' A' ' 402' ' ' TYR . 0.9 OUTLIER 167.52 128.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.736 0.814 . . . . 0.0 110.278 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.608 ' HG ' ' SG ' ' A' ' 442' ' ' CYS . 0.9 OUTLIER -73.4 -131.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.045 0.45 . . . . 0.0 110.408 173.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -155.63 -40.99 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -105.49 17.22 24.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.514 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -119.11 141.19 15.66 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.59 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . 0.404 ' HD1' ' O ' ' A' ' 415' ' ' ALA . 71.6 m-85 -65.78 114.53 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.239 0.542 . . . . 0.0 111.128 -176.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.781 ' HA ' ' HD2' ' A' ' 402' ' ' TYR . 0.4 OUTLIER -80.2 68.59 6.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.685 0.755 . . . . 0.0 110.321 176.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -70.95 -64.21 0.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.658 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -108.11 39.11 2.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.69 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.781 ' HD2' ' HA ' ' A' ' 399' ' ' ASN . 0.9 OUTLIER -92.58 148.2 22.27 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.535 -173.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 90.61 11.44 62.18 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -104.54 162.9 12.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.477 0.656 . . . . 0.0 111.995 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' A' ' 405' ' ' LYS . 10.2 mtmp? -117.72 134.36 54.98 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.324 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.645 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 97.0 m-85 -124.31 163.17 22.23 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 27.2 m -100.48 148.33 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.075 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.814 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.9 tt0 -57.12 139.38 52.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.99 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.5 7.64 56.73 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 5.4 mmtm -107.73 175.41 5.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.144 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 35.6 t -146.83 165.8 28.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.6 tp -156.1 137.79 5.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.382 0.61 . . . . 0.0 110.094 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -83.72 129.83 34.95 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.914 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.463 HG21 ' HZ ' ' A' ' 391' ' ' PHE . 46.4 t -117.02 114.19 45.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.609 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . 0.404 ' O ' ' HD1' ' A' ' 398' ' ' TYR . . . -94.68 93.49 7.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.056 0.455 . . . . 0.0 111.102 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.453 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 60.1 m -73.94 154.59 39.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 171.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -60.29 157.18 35.72 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.724 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.41 115.97 2.24 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.817 3.011 . . . . 0.0 112.641 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.24 -16.79 17.35 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.547 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 81.6 m-85 -110.75 148.09 33.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.593 0.235 . . . . 0.0 110.42 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -152.88 168.7 24.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.75 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.573 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 77.7 mt -83.09 155.74 67.12 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.118 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.12 155.87 27.13 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.396 2.731 . . . . 0.0 112.001 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 64.98 23.77 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.351 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 51.95 41.41 29.59 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.328 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.573 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 25.3 mt-30 -105.11 163.02 12.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.13 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 32.6 p -120.07 -6.0 9.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.471 0.653 . . . . 0.0 109.988 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 146.3 49.37 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.223 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.55 HG11 ' HG2' ' A' ' 438' ' ' PRO . 6.1 t -112.2 132.13 61.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 51.7 m -93.71 131.53 38.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.389 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 51.0 t -77.25 110.26 11.81 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.324 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.814 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 28.1 mtt -143.38 142.74 31.36 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.682 0.753 . . . . 0.0 112.977 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 434' ' ' ASN . 5.1 tt0 37.91 42.84 0.46 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.213 -174.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 433' ' ' GLU . 8.9 t-20 71.24 -20.62 0.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.125 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -117.88 60.74 0.46 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.381 -172.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 88.7 m95 24.72 107.43 0.0 OUTLIER 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.097 1.359 . . . . 0.0 114.282 169.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.779 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 58.6 m -51.12 -58.97 8.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.333 -166.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 24.6 Cg_endo -86.08 -7.67 8.05 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.831 1.687 . . . . 0.0 112.595 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.561 HG23 ' HG3' ' A' ' 441' ' ' ARG . 55.4 m 73.61 118.46 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.719 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -70.61 101.85 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.732 2.288 . . . . 0.0 111.804 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.561 ' HG3' HG23 ' A' ' 439' ' ' THR . 72.3 mtp180 -141.98 124.23 15.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.086 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.608 ' SG ' ' HG ' ' A' ' 394' ' ' LEU . 73.8 m -92.66 97.65 10.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.1 mt -99.93 155.65 4.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -81.14 116.59 21.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.475 0.655 . . . . 0.0 109.748 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.54 -7.84 11.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.491 -172.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 53.0 tptt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.352 -0.833 . . . . 0.0 109.695 -178.917 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.443 -0.808 0 CA-C-O 122.134 0.969 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.565 ' HD2' ' CB ' ' A' ' 434' ' ' ASN . 1.8 mmt180 -96.24 148.96 22.19 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.159 -1.382 . . . . 0.0 111.201 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.516 ' HE2' HG11 ' A' ' 407' ' ' VAL . 1.5 mptm? -118.25 106.92 13.29 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.224 -178.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 8.2 p -74.24 141.6 45.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.661 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -102.31 128.79 48.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -82.85 113.36 44.8 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.79 -176.89 2.37 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.047 2.498 . . . . 0.0 113.356 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -90.6 118.05 29.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.6 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.31 110.59 19.76 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -67.27 -29.81 69.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.0 109.728 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -100.71 15.36 28.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.093 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -134.1 -179.14 16.14 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.38 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -90.25 -1.66 57.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.71 0.29 . . . . 0.0 111.773 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 2.3 p30 40.9 41.04 1.12 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.445 1.098 . . . . 0.0 113.266 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -61.32 -26.58 67.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.382 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -114.25 18.24 17.13 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.553 -174.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -58.99 121.19 10.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.555 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.2 -6.75 36.95 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.917 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -85.04 147.23 26.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.049 0.452 . . . . 0.0 110.867 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -118.91 133.27 55.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.448 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.682 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 63.8 m-85 -124.3 159.33 30.5 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.516 HG11 ' HE2' ' A' ' 388' ' ' LYS . 27.1 m -92.21 146.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.988 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.7 tt0 -60.05 136.5 58.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.031 0.443 . . . . 0.0 110.824 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 104.57 12.79 27.71 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 22.8 mmtp -112.62 175.65 5.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.28 -0.46 . . . . 0.0 111.036 -176.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.0 t -149.77 162.82 39.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.28 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.3 tp -169.73 125.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.623 0.725 . . . . 0.0 110.507 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.742 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 18.4 t70 -77.27 137.52 38.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.314 -172.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.82 123.59 71.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.256 0.55 . . . . 0.0 111.303 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.92 112.45 23.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.193 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.608 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 80.5 m -112.59 163.31 14.67 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -63.06 149.14 91.34 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.338 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.83 107.6 0.22 Allowed 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.926 3.084 . . . . 0.0 112.676 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 123.89 -15.15 7.92 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.051 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.553 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 91.8 m-85 -108.04 136.37 47.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 176.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 442' ' ' CYS . . . -153.65 160.19 42.31 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.263 -176.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.5 HD12 HG23 ' A' ' 429' ' ' VAL . 84.5 mt -75.65 152.76 85.29 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.909 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 54.1 Cg_exo -53.69 144.75 52.16 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.758 2.305 . . . . 0.0 110.564 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 90.2 mttt 77.34 16.18 1.66 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.064 0.852 . . . . 0.0 109.843 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.8 40.34 19.61 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.917 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -93.54 159.33 15.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.097 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 60.2 p -110.18 -22.53 11.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.21 172.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.742 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 1.3 t -121.52 164.35 17.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.483 0.659 . . . . 0.0 111.662 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 440' ' ' PRO . 2.2 t -120.59 137.13 55.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.645 -175.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 83.5 m -94.13 130.65 40.23 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.205 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.2 t -75.83 113.4 13.27 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.988 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 20.0 mtp -145.24 139.68 27.33 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.532 0.682 . . . . 0.0 111.743 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.601 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 6.1 mm-40 41.77 38.95 1.07 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.783 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.565 ' CB ' ' HD2' ' A' ' 387' ' ' ARG . 4.5 t-20 69.56 -19.8 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.359 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -107.37 20.76 32.08 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.663 -170.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.547 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 96.7 m95 52.73 124.49 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.143 0.977 . . . . 0.0 113.615 -178.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.741 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 73.1 m -50.33 -61.87 3.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.741 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 33.5 Cg_endo -89.73 -5.25 5.32 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.98 1.786 . . . . 0.0 113.413 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.6 m 74.15 113.41 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.964 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 42.4 Cg_endo -73.49 113.16 3.71 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.623 2.216 . . . . 0.0 110.907 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -154.13 -39.28 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.346 -173.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 91.6 m 60.47 89.9 0.07 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.877 0.846 . . . . 0.0 111.872 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 10.1 mt -84.61 160.46 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.643 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 444' ' ' ARG . 21.3 ttp-105 -81.91 111.51 18.17 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.642 0.734 . . . . 0.0 109.898 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.22 6.51 9.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.661 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm . . . . . 0 C--O 1.244 0.779 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.45 -176.784 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.911 0.863 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.864 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 8.5 mmt180 -83.77 164.24 19.68 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.925 -167.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 2.6 mptp? -121.68 91.49 3.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.792 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 23.9 m -61.47 130.36 45.64 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.018 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -98.13 127.73 44.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.456 ' CE2' HD22 ' A' ' 394' ' ' LEU . 16.6 t80 -83.3 120.22 75.35 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.431 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -88.34 -171.99 0.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.26 2.64 . . . . 0.0 112.997 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . 0.401 ' HE1' ' ND2' ' A' ' 399' ' ' ASN . 75.9 t80 -92.54 129.68 38.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.596 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.456 HD22 ' CE2' ' A' ' 391' ' ' PHE . 2.7 mm? -89.78 124.15 34.39 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.67 130.78 45.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 8.2 p30 50.32 26.1 2.12 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 124.206 0.942 . . . . 0.0 111.796 -173.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -115.49 169.85 13.07 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.387 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -90.3 102.72 15.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.534 0.683 . . . . 0.0 110.288 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.401 ' ND2' ' HE1' ' A' ' 393' ' ' TYR . 2.0 p30 -78.47 60.64 2.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.792 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -88.12 -29.9 20.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.148 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -97.26 -6.5 34.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.175 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -62.14 129.15 39.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.085 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.22 13.7 47.86 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.35 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 404' ' ' ARG . 53.6 mtt180 -108.53 149.43 28.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.136 0.493 . . . . 0.0 111.509 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -111.91 131.36 55.42 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.431 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.4 ' CD2' ' HH2' ' A' ' 436' ' ' TRP . 96.9 m-85 -128.86 138.81 52.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.163 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.1 m -76.2 152.44 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.464 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.697 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 9.2 tt0 -60.75 127.04 29.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.258 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.73 -18.13 17.37 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.218 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -86.79 145.59 26.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.864 0.364 . . . . 0.0 110.853 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.3 t -121.12 158.79 27.15 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.987 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.6 tp -155.22 146.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.04 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.82 133.93 38.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.377 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.01 137.23 30.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.778 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -105.69 112.34 25.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.994 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 48.4 m -124.77 172.35 9.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.069 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 12.3 m170 -54.89 159.98 3.3 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-O 121.125 0.488 . . . . 0.0 111.67 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 73.3 Cg_endo -75.46 103.45 1.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.243 2.629 . . . . 0.0 111.475 -175.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.01 -4.57 13.96 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.921 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -111.87 133.93 53.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.1 162.9 40.89 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.645 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' A' ' 440' ' ' PRO . 92.0 mt -69.29 155.55 93.32 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.654 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.95 152.12 30.75 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.912 2.408 . . . . 0.0 111.978 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 73.46 23.93 2.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.93 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.11 42.08 26.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.043 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 22.7 mt-30 -116.21 162.75 17.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.92 -176.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 61.8 p -124.45 -6.8 7.55 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.62 144.66 41.75 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.759 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.702 HG13 ' HG2' ' A' ' 438' ' ' PRO . 23.6 m -120.43 158.78 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.055 0.455 . . . . 0.0 109.954 172.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 90.6 m -113.79 132.63 55.78 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.425 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.2 t -68.34 118.62 11.67 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 177.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.697 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 6.2 ptt? -142.87 133.68 25.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.12 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 434' ' ' ASN . 0.9 OUTLIER 34.65 40.68 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.783 -174.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.864 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 7.5 t30 76.67 -23.85 0.24 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.384 0.674 . . . . 0.0 111.952 176.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -103.39 109.59 3.49 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.521 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 94.0 m95 -39.64 125.09 1.76 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 124.17 0.571 . . . . 0.0 112.073 -175.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.743 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 74.1 p -43.06 -52.08 12.31 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -166.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.743 ' HD3' ' OG ' ' A' ' 437' ' ' SER . 5.2 Cg_endo -105.53 2.05 0.22 Allowed 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.084 1.856 . . . . 0.0 112.495 -176.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.429 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 25.5 m 72.76 116.49 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.21 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.527 ' HA ' ' CD2' ' A' ' 422' ' ' LEU . 32.0 Cg_endo -64.32 92.15 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.801 2.334 . . . . 0.0 111.592 174.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -105.21 -50.33 3.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.221 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 83.1 m 60.0 81.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.599 0.714 . . . . 0.0 110.918 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 3.7 pt -95.57 155.08 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.274 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -73.68 107.66 6.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.002 0.906 . . . . 0.0 111.192 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.66 -48.32 72.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.79 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 52.0 tttp . . . . . 0 C--O 1.249 1.031 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.019 -177.425 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.782 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 8.6 mtt-85 . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 122.038 0.923 . . . . 0.0 113.127 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -129.13 98.32 4.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.395 177.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 434' ' ' ASN . 6.2 m -57.32 125.64 23.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.002 -175.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -86.74 130.22 34.56 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 168.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -80.86 120.59 79.33 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.539 0.209 . . . . 0.0 110.476 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.72 179.2 3.45 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.098 2.532 . . . . 0.0 113.819 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -86.91 127.43 35.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.176 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 394' ' ' LEU . 2.0 mm? -93.69 118.0 30.82 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -65.38 -36.69 84.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.945 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -117.89 28.13 8.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.311 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -143.96 162.32 27.79 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.067 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -83.64 108.46 16.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.265 0.555 . . . . 0.0 110.052 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 1.7 p-10 -80.67 54.78 2.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.045 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -63.47 -32.75 74.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.353 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -100.46 -0.3 38.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.011 -173.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 64.8 t80 -62.95 120.41 11.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.018 0.437 . . . . 0.0 110.402 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.8 -14.64 19.65 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.843 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -90.86 156.88 17.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 111.434 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -126.1 132.91 51.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.146 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -127.84 148.08 50.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.044 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 16.9 m -81.99 148.53 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.515 0.198 . . . . 0.0 110.61 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 1.008 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 49.0 tt0 -61.09 133.04 55.62 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.314 0.578 . . . . 0.0 111.229 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.3 27.02 6.67 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 9.3 mmmt -127.69 163.66 23.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.135 -0.532 . . . . 0.0 110.637 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 44.3 t -135.04 161.17 36.06 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 413' ' ' ASP . 0.3 OUTLIER -164.88 143.77 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.544 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.486 ' H ' HD13 ' A' ' 412' ' ' ILE . 13.5 t70 -78.92 138.11 37.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.731 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 37.9 t -127.4 102.03 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.073 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -78.19 117.71 19.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.975 0.417 . . . . 0.0 111.115 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 35.2 m -103.54 167.61 9.69 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -65.24 158.92 69.73 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.497 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.58 110.34 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 123.518 2.812 . . . . 0.0 112.573 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 103.58 7.23 42.78 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.903 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 95.1 m-85 -125.85 139.16 53.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -159.81 -172.34 3.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.058 0.456 . . . . 0.0 111.049 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 440' ' ' PRO . 82.9 mt -97.06 161.4 26.39 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.435 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.09 152.18 15.05 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.254 2.636 . . . . 0.0 112.074 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 63.69 26.16 14.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.143 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.27 24.71 13.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.638 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 97.7 mt-30 -86.68 161.35 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.134 0.492 . . . . 0.0 111.4 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.0 t -121.01 -6.48 9.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -114.31 140.04 48.95 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.626 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 438' ' ' PRO . 5.1 m -107.34 144.34 16.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.25 0.548 . . . . 0.0 110.57 176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 26.0 m -101.98 121.86 42.95 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.2 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.1 t -66.78 113.55 4.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' MET . . . . . 1.008 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 7.5 mtt -143.18 136.29 28.01 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.29 0.567 . . . . 0.0 111.353 174.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 34.46 46.03 0.16 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.699 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.782 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 55.3 t30 71.97 -24.14 0.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.601 175.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -108.03 33.29 6.37 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.136 -1.031 . . . . 0.0 113.893 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.556 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 95.7 m95 40.56 111.34 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.509 1.124 . . . . 0.0 113.891 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.735 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 73.0 m -40.28 -60.59 1.43 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -172.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 48.6 Cg_endo -88.6 -6.86 5.84 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.737 1.625 . . . . 0.0 112.871 -176.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 54.8 m 71.88 116.05 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.551 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 66.0 Cg_endo -80.49 109.52 2.3 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.84 2.36 . . . . 0.0 111.072 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -147.65 -14.78 0.38 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 61.3 m 56.63 83.34 0.1 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.939 0.399 . . . . 0.0 111.839 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.8 mt -85.61 157.8 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 30.5 ttp180 -86.73 105.95 17.32 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.345 1.069 . . . . 0.0 111.374 -175.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 36.9 t . . . . . 0 C--N 1.31 -1.129 0 CA-C-N 113.014 -1.903 . . . . 0.0 110.285 178.272 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 9.2 mtt180 . . . . . 0 CA--C 1.514 -0.412 0 CA-C-O 121.388 0.614 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -133.62 101.4 5.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.162 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 6.8 p -68.43 144.76 54.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.694 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -107.08 132.1 53.37 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 168.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 39.9 t80 -81.57 118.87 73.93 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.337 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 86.1 Cg_endo -90.95 -173.58 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.44 2.76 . . . . 0.0 113.549 -176.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -93.32 138.68 31.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.215 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.96 -96.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 173.79 -33.36 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.574 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -145.07 38.75 1.19 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.317 -1.31 . . . . 0.0 108.825 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -127.88 147.43 17.24 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.505 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.25 99.9 1.61 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.005 0.431 . . . . 0.0 110.013 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 2.5 p30 -79.16 51.34 1.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.928 -175.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -71.29 -24.45 62.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.186 0.517 . . . . 0.0 110.171 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -93.96 -9.63 36.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.738 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.492 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 83.1 t80 -63.9 114.29 3.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.391 0.615 . . . . 0.0 110.749 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 118.48 -19.14 10.74 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.82 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -82.66 153.5 25.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.152 0.501 . . . . 0.0 111.366 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 42.6 mtmt -127.52 134.13 49.8 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.136 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.644 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 96.2 m-85 -125.5 151.92 45.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 31.8 m -82.97 148.12 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.851 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.9 OUTLIER -59.24 140.79 55.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.799 0.333 . . . . 0.0 110.504 -177.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.64 6.9 57.12 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -103.4 167.66 9.66 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.431 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 39.4 t -138.33 160.22 40.04 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.912 0.387 . . . . 0.0 110.12 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.9 tp -159.5 139.38 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.094 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -76.0 135.69 39.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.35 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.635 ' HB ' HD11 ' A' ' 422' ' ' LEU . 56.1 t -126.71 101.09 7.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.311 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.2 122.12 28.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.186 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.504 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 73.5 m -98.03 163.12 12.89 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -67.21 155.97 89.24 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.284 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.01 122.17 10.07 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.762 2.975 . . . . 0.0 112.277 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.76 30.74 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 70.3 m-85 -122.0 144.06 49.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.721 0.296 . . . . 0.0 110.291 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -142.87 178.64 7.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.132 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.635 HD11 ' HB ' ' A' ' 414' ' ' VAL . 34.2 mt -95.68 148.33 34.41 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.884 0.373 . . . . 0.0 110.561 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 441' ' ' ARG . 31.7 Cg_exo -59.14 150.02 76.38 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.97 2.447 . . . . 0.0 112.115 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 67.04 28.4 8.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.393 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.31 44.43 27.39 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.772 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.573 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 98.0 mt-30 -106.9 161.93 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.14 -175.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.7 p -128.91 -13.4 4.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.987 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.15 139.63 50.97 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.253 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 438' ' ' PRO . 21.6 t -108.43 133.83 52.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 89.6 m -92.78 130.66 38.32 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.19 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.84 106.95 6.62 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.106 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.851 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 11.6 mtm -141.8 141.45 33.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.748 173.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.638 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 61.9 mm-40 46.89 36.37 3.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.876 -1.966 . . . . 0.0 111.476 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 6.2 t30 69.18 -20.94 0.16 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.803 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -112.64 49.96 0.81 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.511 -0.852 . . . . 0.0 114.061 -172.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 93.5 m95 35.69 106.81 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 169.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.827 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 55.8 m -51.7 -59.17 8.64 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 35.4 Cg_endo -85.53 -3.85 9.24 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.675 1.583 . . . . 0.0 113.079 -175.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.752 HG22 ' HG2' ' A' ' 441' ' ' ARG . 23.0 m 72.6 113.45 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.197 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -68.62 94.12 0.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.4 2.067 . . . . 0.0 110.812 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.752 ' HG2' HG22 ' A' ' 439' ' ' THR . 24.9 mmm180 -131.53 118.95 20.84 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 66.7 m -83.47 82.69 8.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.088 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 6.3 pt -76.4 144.89 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.657 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -73.17 111.24 8.1 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.577 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.319 -0.74 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.998 -173.27 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.91 ' HG3' ' HG3' ' A' ' 433' ' ' GLU . 1.4 mmp_? . . . . . 0 CA--C 1.514 -0.412 0 CA-C-O 121.216 0.531 . . . . 0.0 111.793 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -135.51 99.92 4.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.774 -175.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 10.4 m -67.87 146.49 53.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.932 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -107.57 128.22 54.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.176 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -74.15 122.31 87.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.97 -177.23 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.167 2.578 . . . . 0.0 113.475 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -93.63 117.16 29.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.683 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.596 HD11 ' HB2' ' A' ' 440' ' ' PRO . 0.0 OUTLIER -80.37 8.13 8.22 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -171.195 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 59.97 -84.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -97.17 13.23 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.463 0.649 . . . . 0.0 110.246 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -112.9 -161.11 14.81 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.76 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' TYR . . . . . 0.516 ' HB2' ' HB1' ' A' ' 415' ' ' ALA . 57.6 m-85 -92.79 162.65 14.03 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.184 0.516 . . . . 0.0 109.782 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 1.6 p30 -129.47 41.62 3.42 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.519 0.676 . . . . 0.0 109.685 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.45 ' HG3' ' HB3' ' A' ' 398' ' ' TYR . 75.1 mt-30 -61.05 -46.36 91.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.149 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -94.08 -1.05 54.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.04 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.511 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 73.1 t80 -61.8 119.36 8.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.325 0.584 . . . . 0.0 110.28 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 110.22 -12.63 31.25 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.307 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -95.22 150.65 19.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -118.53 134.6 54.96 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.134 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.97 140.76 52.63 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.215 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.91 147.38 8.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.368 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.713 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 49.4 tt0 -56.47 129.43 40.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.077 0.465 . . . . 0.0 110.667 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 115.43 -22.19 12.24 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -81.74 150.99 27.69 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 24.2 t -140.07 146.7 39.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.824 0.821 . . . . 0.0 111.406 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.7 tp 177.72 132.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.865 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.675 ' HB2' HG23 ' A' ' 429' ' ' VAL . 27.3 t70 -125.71 -89.46 0.57 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.478 -1.237 . . . . 0.0 107.953 173.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.9 t 34.74 75.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 111.728 -2.487 . . . . 0.0 112.943 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.516 ' O ' HD23 ' A' ' 394' ' ' LEU . . . -176.06 52.06 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.771 -172.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 56.4 m -130.99 133.95 46.26 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 173.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -61.05 157.42 42.03 Favored Pre-proline 0 N--CA 1.463 0.209 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.34 115.21 1.63 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.522 2.815 . . . . 0.0 112.522 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 113.52 -11.69 23.54 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.633 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.549 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 63.6 m-85 -113.66 144.04 43.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.537 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.34 -177.95 6.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.034 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 61.1 mt -90.49 151.45 44.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 174.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.95 153.24 58.86 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.79 2.327 . . . . 0.0 111.554 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm 65.73 28.24 11.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.037 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.82 40.16 30.67 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.472 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 26.2 mt-30 -90.15 152.43 21.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.431 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 413' ' ' ASP . 2.1 p -140.93 20.3 2.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -152.39 136.74 16.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.344 0.593 . . . . 0.0 110.108 -177.074 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.926 HG13 ' HD2' ' A' ' 438' ' ' PRO . 79.4 t -115.81 132.03 66.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.118 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.526 ' HB ' ' OG ' ' A' ' 437' ' ' SER . 49.1 m -91.5 134.92 34.24 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.543 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 18.3 t -75.14 120.2 20.32 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.713 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 21.2 ptm -107.39 -140.13 0.37 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.91 ' HG3' ' HG3' ' A' ' 387' ' ' ARG . 44.8 tt0 -70.35 71.39 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.233 0.924 . . . . 0.0 111.657 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.722 ' HB2' ' HD3' ' A' ' 387' ' ' ARG . 4.0 t30 78.43 -11.43 1.21 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.755 168.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -111.2 170.83 14.0 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 170.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.621 ' HB3' HG11 ' A' ' 429' ' ' VAL . 98.7 m95 -93.44 128.46 39.52 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.742 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 35.2 p -56.28 -54.03 57.35 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -165.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.926 ' HD2' HG13 ' A' ' 429' ' ' VAL . 6.9 Cg_endo -98.04 -4.31 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.693 1.595 . . . . 0.0 111.875 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.482 HG22 ' HG3' ' A' ' 441' ' ' ARG . 24.8 m 72.66 117.65 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.546 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.596 ' HB2' HD11 ' A' ' 394' ' ' LEU . 18.2 Cg_exo -64.44 93.81 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.858 2.372 . . . . 0.0 111.563 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.482 ' HG3' HG22 ' A' ' 439' ' ' THR . 43.8 mtp180 -125.82 91.66 3.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.675 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 66.3 m -63.07 98.89 0.15 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.579 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 2.4 pp -98.75 170.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.088 0.47 . . . . 0.0 110.313 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -93.75 118.58 31.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.426 -173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.817 178.847 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.686 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 32.1 mtp180 . . . . . 0 CA--C 1.516 -0.35 0 CA-C-O 121.505 0.669 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -128.55 109.79 11.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.805 174.458 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 7.6 p -70.52 144.7 51.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.363 0.601 . . . . 0.0 112.246 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -104.67 126.31 51.63 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 171.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.609 ' HE1' HD21 ' A' ' 394' ' ' LEU . 2.5 t80 -76.27 117.93 67.74 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -177.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -84.71 -179.14 3.59 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.101 2.534 . . . . 0.0 113.481 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -80.77 128.7 33.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.879 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.701 HD23 ' HA ' ' A' ' 399' ' ' ASN . 1.4 mm? -89.92 103.22 15.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 396' ' ' ASN . 33.4 tt0 -71.4 117.03 12.43 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 395' ' ' GLU . 23.0 m120 71.86 28.51 2.63 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.955 0.785 . . . . 0.0 109.984 -173.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -136.08 164.05 25.05 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.485 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -80.9 99.56 8.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.701 ' HA ' HD23 ' A' ' 394' ' ' LEU . 3.1 p30 -77.77 44.49 0.46 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.753 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.9 -29.96 70.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.672 0.749 . . . . 0.0 109.607 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -96.39 -7.51 34.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.34 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -64.06 122.57 16.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.882 0.373 . . . . 0.0 110.269 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.17 -10.98 33.94 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.11 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -82.5 166.42 19.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.243 0.544 . . . . 0.0 111.299 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -137.04 136.5 38.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.699 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.62 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 55.8 m-85 -132.14 153.1 50.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.138 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 14.7 m -79.38 139.14 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.734 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.838 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 33.1 tt0 -61.98 135.52 57.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.566 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 99.24 22.22 13.48 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 13.7 mmtm -127.4 173.79 9.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.029 -0.586 . . . . 0.0 109.819 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 30.6 t -144.65 163.5 33.76 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.45 HD13 ' N ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -160.84 145.73 5.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.155 -177.362 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 412' ' ' ILE . 14.2 t70 -81.14 138.66 35.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.317 -174.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 422' ' ' LEU . 48.4 t -119.76 119.77 61.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -100.8 106.33 17.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.048 0.452 . . . . 0.0 111.105 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 56.8 m -94.72 172.57 8.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -73.19 156.75 89.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.846 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.88 112.28 0.98 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.447 2.765 . . . . 0.0 111.984 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.68 -11.79 13.72 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -118.84 143.36 47.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.183 -0.508 . . . . 0.0 109.777 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.75 39.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.49 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 91.3 mt -73.65 158.67 85.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.273 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.495 ' HG3' HD11 ' A' ' 443' ' ' ILE . 31.6 Cg_exo -57.84 149.05 71.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.838 2.359 . . . . 0.0 111.609 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 68.81 17.43 8.78 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.987 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.83 36.8 28.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.051 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 98.0 mt-30 -94.47 162.14 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.846 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 26.2 p -115.62 -11.3 11.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.357 0.599 . . . . 0.0 110.477 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.46 142.69 51.12 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.115 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.5 HG13 ' HG2' ' A' ' 438' ' ' PRO . 17.0 t -114.2 129.78 69.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.624 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 25.7 m -80.87 135.49 35.93 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.176 177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.73 110.13 15.94 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.905 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.838 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 0.6 OUTLIER -149.65 143.12 25.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.923 0.868 . . . . 0.0 112.579 179.041 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.741 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 37.0 mt-10 45.27 35.06 1.63 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.358 -176.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 389' ' ' CYS . 5.7 t-20 67.9 -16.51 0.18 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.763 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -114.67 25.23 10.42 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.586 -172.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.575 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 84.7 m95 58.31 148.15 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.908 0.883 . . . . 0.0 112.955 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.797 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 58.3 m -71.12 -63.68 1.42 Allowed Pre-proline 0 C--N 1.321 -0.639 0 O-C-N 121.967 -0.458 . . . . 0.0 111.171 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.797 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 36.2 Cg_endo -89.03 -2.64 6.25 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.044 1.829 . . . . 0.0 113.149 -176.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 29.8 m 71.71 111.08 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.765 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 12.2 Cg_exo -63.18 111.13 1.34 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.131 2.554 . . . . 0.0 111.989 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 422' ' ' LEU . 75.6 mtm180 -146.23 124.71 12.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.746 -176.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 74.9 m -89.82 82.53 6.22 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.495 HD11 ' HG3' ' A' ' 423' ' ' PRO . 3.9 mt -87.11 150.92 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.823 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -79.43 126.16 30.48 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.656 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--N 1.315 -0.898 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.674 179.676 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.748 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 26.9 mtt180 . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.708 0.766 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -134.33 93.0 3.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.697 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 12.3 m -59.76 141.6 54.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.579 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' TYR . . . . . 0.458 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 68.0 t80 -104.57 137.3 42.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.43 ' HZ ' ' CG2' ' A' ' 414' ' ' VAL . 2.3 t80 -93.97 115.06 64.68 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.718 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -92.75 -176.3 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.465 2.776 . . . . 0.0 113.63 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -80.15 134.71 36.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.649 HD11 HG21 ' A' ' 414' ' ' VAL . 8.1 mt -110.38 128.2 55.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.491 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.6 151.92 44.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 43.17 41.85 3.1 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.672 0.607 . . . . 0.0 111.665 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -139.87 147.8 19.47 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.28 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -89.16 96.28 10.65 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.695 0.748 . . . . 0.0 110.362 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.485 ' HB3' ' CB ' ' A' ' 402' ' ' TYR . 35.7 m-80 -78.05 70.15 4.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.562 -173.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -79.2 -26.55 42.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.102 0.477 . . . . 0.0 110.418 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -108.45 14.84 24.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.674 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.485 ' CB ' ' HB3' ' A' ' 399' ' ' ASN . 21.5 t80 -70.87 132.24 44.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.781 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.458 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 95.12 15.16 45.9 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.234 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -103.19 156.34 17.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.022 0.439 . . . . 0.0 111.676 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -120.15 125.29 47.85 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.624 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -120.44 137.59 54.25 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.3 144.19 14.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.311 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.846 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.8 tt0 -66.29 144.57 56.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.644 -173.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 100.99 7.06 51.08 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -107.43 175.8 5.37 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.485 -0.857 . . . . 0.0 109.667 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 31.9 t -152.3 147.79 26.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.868 0.842 . . . . 0.0 111.475 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.775 ' HA ' HG22 ' A' ' 428' ' ' THR . 9.9 tp 173.44 134.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.425 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.96 ' CB ' ' HA ' ' A' ' 428' ' ' THR . 34.9 t70 -130.97 -140.79 0.22 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.229 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.67 HG23 ' CG ' ' A' ' 413' ' ' ASP . 0.6 OUTLIER -147.17 147.75 17.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.226 -151.506 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.98 88.06 7.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.793 167.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.543 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 14.7 m -80.04 167.17 20.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.186 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -54.37 157.03 5.21 Favored Pre-proline 0 N--CA 1.469 0.484 0 CA-C-O 121.079 0.466 . . . . 0.0 111.528 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.21 110.78 0.49 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.709 2.939 . . . . 0.0 112.629 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.07 -2.09 38.09 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.691 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.626 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 87.8 m-85 -114.3 129.05 56.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' ALA . . . . . 0.442 ' C ' ' HA ' ' A' ' 442' ' ' CYS . . . -162.71 161.34 26.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.289 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.486 ' CD2' ' H ' ' A' ' 441' ' ' ARG . 73.9 mt -61.55 145.18 91.69 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.152 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 25.9 Cg_exo -62.54 158.15 42.82 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.75 2.3 . . . . 0.0 111.09 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 68.96 21.36 7.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.467 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.61 50.92 8.39 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.385 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 96.3 mt-30 -109.66 160.91 15.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.049 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' THR . . . . . 0.841 ' O ' ' HB3' ' A' ' 413' ' ' ASP . 2.9 p -141.62 12.86 2.12 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.313 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.96 ' HA ' ' CB ' ' A' ' 413' ' ' ASP . 0.5 OUTLIER -148.47 125.54 11.39 Favored 'General case' 0 N--CA 1.436 -1.129 0 O-C-N 123.66 0.6 . . . . 0.0 111.652 178.307 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.664 ' N ' ' HB2' ' A' ' 413' ' ' ASP . 2.1 t -90.88 136.36 24.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.998 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.648 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 64.2 m -81.55 132.21 35.3 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 24.4 t -77.19 109.32 10.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.846 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 27.0 mtp -148.56 153.29 38.18 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.652 0.739 . . . . 0.0 112.394 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 435' ' ' GLY . 4.1 mt-10 28.54 43.09 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 112.782 -2.008 . . . . 0.0 113.36 -164.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 65.13 -17.76 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.869 0.868 . . . . 0.0 112.147 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -112.79 41.82 2.12 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.912 -172.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.624 ' HB3' HG11 ' A' ' 429' ' ' VAL . 98.3 m95 42.55 111.22 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.753 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 60.6 m -50.1 -66.48 0.62 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.201 -0.908 . . . . 0.0 113.278 -167.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 31.8 Cg_endo -85.76 -2.76 9.04 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.54 1.493 . . . . 0.0 112.313 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.814 ' HB ' ' HD2' ' A' ' 441' ' ' ARG . 51.5 m 76.01 131.16 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.96 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 11.5 Cg_endo -70.72 84.5 0.81 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.841 2.361 . . . . 0.0 110.885 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.814 ' HD2' ' HB ' ' A' ' 439' ' ' THR . 0.5 OUTLIER -132.55 70.94 1.46 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.269 -172.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.442 ' HA ' ' C ' ' A' ' 421' ' ' ALA . 4.2 p -70.64 90.78 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.799 0.809 . . . . 0.0 110.501 175.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 14.6 pt -85.84 176.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.339 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -86.67 107.89 18.4 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.917 0.865 . . . . 0.0 110.475 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.308 -1.23 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.651 -177.589 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 1.075 ' HG3' ' HB3' ' A' ' 408' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.44 -0.95 0 N-CA-C 115.616 1.709 . . . . 0.0 115.616 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 387' ' ' ARG . 5.3 mptp? 73.39 37.55 0.71 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.338 -1.756 . . . . 0.0 111.947 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 32.3 m -51.68 120.4 5.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.731 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -97.5 127.46 43.48 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.411 ' HA ' ' HE1' ' A' ' 436' ' ' TRP . 31.1 t80 -79.42 115.46 53.36 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.049 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -87.32 174.38 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.156 2.571 . . . . 0.0 112.731 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -77.41 116.95 18.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.282 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.492 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 8.2 mt -71.63 127.5 32.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.267 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.625 ' HG2' ' HB2' ' A' ' 442' ' ' CYS . 1.4 pm0 -65.1 108.59 1.89 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.014 0.435 . . . . 0.0 110.279 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 63.74 36.52 10.56 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.483 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -129.26 172.31 19.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.919 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -77.33 88.2 3.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.341 0.591 . . . . 0.0 110.71 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.572 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 2.1 p-10 -80.58 49.3 1.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.364 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -67.76 -22.79 65.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.844 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -104.06 -1.7 27.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.052 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.572 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 45.7 t80 -62.75 115.48 4.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.278 0.561 . . . . 0.0 110.427 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.61 -11.36 21.26 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.873 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.39 150.61 22.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.064 0.459 . . . . 0.0 110.949 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 405' ' ' LYS . 8.9 mptt -121.72 148.51 44.52 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.711 176.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.407 ' CD2' ' HH2' ' A' ' 436' ' ' TRP . 98.6 m-85 -142.32 156.46 45.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.206 0.527 . . . . 0.0 110.541 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.27 143.37 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.279 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 1.075 ' HB3' ' HG3' ' A' ' 387' ' ' ARG . 7.9 tt0 -57.86 139.94 53.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.408 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.8 19.19 12.32 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -125.39 169.91 11.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.629 -0.785 . . . . 0.0 110.145 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.1 t -148.02 157.51 43.55 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.331 0.586 . . . . 0.0 110.415 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.6 tp -151.08 140.45 15.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.2 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.8 133.52 37.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.363 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.92 139.42 48.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.662 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -142.44 133.66 26.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.232 0.539 . . . . 0.0 111.406 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.666 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 0.1 OUTLIER -103.07 -178.43 3.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.574 ' NE2' ' HE2' ' A' ' 420' ' ' TYR . 19.1 p-80 -77.72 157.46 79.51 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.842 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 417' ' ' HIS . 9.9 Cg_exo -34.4 120.71 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.385 3.39 . . . . 0.0 115.007 -171.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 444' ' ' ARG . . . 101.71 -20.42 46.25 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.589 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.666 ' HB2' ' HB3' ' A' ' 416' ' ' CYS . 51.6 m-85 -109.83 142.48 41.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.954 0.377 . . . . 0.0 110.757 -174.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -175.75 -170.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.411 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.617 HD21 ' HA ' ' A' ' 440' ' ' PRO . 94.7 mt -80.88 162.23 60.64 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.403 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.72 147.1 73.64 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.021 2.481 . . . . 0.0 110.761 171.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.6 10.6 7.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.605 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 62.44 35.07 15.03 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.697 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -66.93 152.44 45.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.071 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.4 p -123.79 -3.38 8.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.272 0.558 . . . . 0.0 110.341 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.84 136.29 44.3 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.961 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.54 HG13 HD11 ' A' ' 422' ' ' LEU . 5.5 m -104.28 134.77 44.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.554 0.692 . . . . 0.0 110.205 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 14.8 m -92.92 117.91 30.56 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.219 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 47.3 t -66.81 116.9 8.21 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' MET . . . . . 1.009 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 23.4 mtp -131.82 -166.8 1.77 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.37 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.608 ' OE1' ' HB3' ' A' ' 432' ' ' MET . 1.7 mp0 -37.49 76.97 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.841 1.338 . . . . 0.0 114.454 -170.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 432' ' ' MET . 15.6 t-20 64.7 23.99 12.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.777 175.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -173.92 119.16 0.73 Allowed Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.254 -174.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.411 ' HE1' ' HA ' ' A' ' 391' ' ' PHE . 47.5 m95 -37.87 113.56 0.28 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.976 0.91 . . . . 0.0 110.374 165.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 6.6 m -56.92 -50.88 85.61 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.793 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.441 ' HG2' HG12 ' A' ' 429' ' ' VAL . 33.1 Cg_endo -83.41 -8.11 10.65 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.149 1.233 . . . . 0.0 112.379 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 9.1 m 70.99 112.81 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.957 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.617 ' HA ' HD21 ' A' ' 422' ' ' LEU . 35.9 Cg_endo -66.46 86.08 0.27 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.747 2.298 . . . . 0.0 112.392 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -114.08 130.93 56.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.85 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.625 ' HB2' ' HG2' ' A' ' 395' ' ' GLU . 56.7 m -90.41 83.09 5.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.119 0.485 . . . . 0.0 110.821 173.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 2.5 pt -99.68 153.43 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 172.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 419' ' ' GLY . 72.4 ttt180 -79.3 113.69 17.64 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.489 0.661 . . . . 0.0 109.703 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.408 -174.435 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 24.1 mtt180 . . . . . 0 CA--C 1.51 -0.558 0 CA-C-O 121.375 0.607 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -118.94 90.72 3.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.934 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 31.1 m -56.72 122.85 13.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.842 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -91.36 113.47 25.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.558 ' HE2' HD21 ' A' ' 394' ' ' LEU . 27.0 t80 -76.57 117.95 68.13 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -94.78 -175.9 0.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.402 2.735 . . . . 0.0 113.479 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 395' ' ' GLU . 47.7 t80 -75.51 130.81 39.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.831 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.558 HD21 ' HE2' ' A' ' 391' ' ' PHE . 2.5 mm? -81.11 -5.39 57.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -171.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.566 ' HA ' ' CE2' ' A' ' 393' ' ' TYR . 63.0 mm-40 66.49 -71.67 0.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.482 0.489 . . . . 0.0 110.996 -173.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.56 24.08 7.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.851 -175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -140.8 169.25 24.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.466 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -82.9 138.8 33.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.559 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 3.6 p30 -105.68 59.26 0.66 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.01 0.433 . . . . 0.0 112.162 -173.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -78.74 -14.54 59.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.726 0.298 . . . . 0.0 110.732 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -117.7 9.65 13.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.728 0.299 . . . . 0.0 111.008 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.559 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 24.9 t80 -64.75 127.82 33.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 0.0 111.007 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 91.87 16.34 51.75 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.111 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -105.81 149.39 26.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.851 0.358 . . . . 0.0 110.915 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 60.4 mtpt -112.17 126.69 55.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.525 175.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -118.65 150.84 39.04 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.595 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 35.6 m -83.12 147.53 5.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.553 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.799 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.8 OUTLIER -64.18 128.27 35.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.374 -177.119 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.38 7.79 36.69 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 7.3 mmtt -114.79 163.32 15.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 20.3 t -138.89 164.88 28.51 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.367 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.0 tp -155.96 142.17 10.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.931 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -84.39 133.25 34.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.567 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 69.5 t -117.89 128.45 75.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.598 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.26 113.74 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.722 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.642 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 56.0 m -95.66 170.4 9.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -65.21 154.97 85.99 Favored Pre-proline 0 C--N 1.332 -0.164 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.025 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.9 105.92 0.16 Allowed 'Trans proline' 0 CA--C 1.521 -0.14 0 C-N-CA 123.747 2.965 . . . . 0.0 112.63 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.16 -11.75 11.52 Favored Glycine 0 C--N 1.317 -0.523 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.513 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -115.35 146.58 41.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.16 -179.05 7.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.703 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 97.9 mt -79.77 158.1 73.47 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-O 120.971 0.415 . . . . 0.0 110.544 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.33 150.37 41.57 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.528 2.152 . . . . 0.0 110.771 171.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.472 ' HB2' ' HG3' ' A' ' 426' ' ' GLN . 6.9 mtpm? 64.06 19.08 11.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.941 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 61.19 26.63 16.48 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.173 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.472 ' HG3' ' HB2' ' A' ' 424' ' ' LYS . 50.4 mt-30 -73.67 158.99 33.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.907 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 28.1 p -124.62 -23.13 4.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.313 0.578 . . . . 0.0 110.22 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.88 135.95 49.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.52 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.446 HG13 ' HG2' ' A' ' 438' ' ' PRO . 2.5 t -110.5 125.07 67.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 60.8 m -88.32 135.17 33.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.777 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 31.4 t -72.7 112.67 8.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.799 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 7.3 mtt -146.84 142.1 27.33 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.705 0.764 . . . . 0.0 111.321 174.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.545 ' C ' ' HD2' ' A' ' 387' ' ' ARG . 5.8 mm-40 39.09 40.32 0.47 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.232 -1.804 . . . . 0.0 113.084 -170.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 46.1 t30 70.33 -24.05 0.16 Allowed 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.704 0.628 . . . . 0.0 111.706 174.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -104.81 22.3 34.09 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.562 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.571 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 94.0 m95 56.35 128.78 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.858 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 71.8 m -51.38 -64.45 1.4 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.359 -169.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.858 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 42.6 Cg_endo -89.11 -2.53 6.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.049 1.832 . . . . 0.0 112.478 -176.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 18.6 m 73.74 121.61 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.295 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 30.7 Cg_endo -66.6 94.64 0.32 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.727 2.284 . . . . 0.0 111.699 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -131.03 106.54 8.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.778 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 76.4 m -83.36 81.39 8.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.916 0.389 . . . . 0.0 110.63 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 9.8 pt -87.76 161.42 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.884 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -75.38 121.77 22.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.385 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.336 -174.98 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 8.7 mtt-85 . . . . . 0 N--CA 1.442 -0.831 0 CA-C-O 121.672 0.748 . . . . 0.0 112.388 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 38.9 mmtm -117.65 90.57 3.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.014 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 15.2 m -59.62 120.97 10.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.511 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -90.33 124.81 35.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.655 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -80.32 120.72 80.31 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.278 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -83.53 -179.2 4.07 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.295 2.663 . . . . 0.0 112.636 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -93.87 121.99 35.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.4 0.619 . . . . 0.0 110.715 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.2 mp -89.31 129.26 35.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.392 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.89 -47.84 64.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.948 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -107.5 16.54 23.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.914 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -132.26 155.75 21.66 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.512 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -77.7 111.23 13.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.554 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 1.7 p-10 -79.22 61.61 3.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.869 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -66.18 -19.57 65.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.257 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -117.9 1.8 12.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.309 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.554 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 37.4 t80 -63.12 124.86 22.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 111.302 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.65 -9.79 41.24 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.304 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -100.66 152.76 20.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.69 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 52.2 mtmt -116.91 152.93 33.48 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.846 173.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 97.4 m-85 -134.9 150.31 50.41 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.914 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.7 m -80.08 144.93 9.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.159 0.504 . . . . 0.0 110.349 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.828 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.3 OUTLIER -62.01 125.68 24.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.555 -173.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.97 -0.95 24.28 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -95.88 161.61 13.93 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.153 -0.524 . . . . 0.0 110.387 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 21.1 t -141.33 163.29 33.36 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.1 tp -170.02 130.39 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.673 0.749 . . . . 0.0 110.517 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.768 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 14.1 t70 -83.66 132.55 34.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.336 -171.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 22.6 t -113.05 120.81 63.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.677 -175.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.02 122.87 29.86 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.518 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 67.5 m -116.02 173.11 6.75 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -62.48 158.15 51.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.212 0.529 . . . . 0.0 110.956 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.89 114.55 1.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.556 2.837 . . . . 0.0 111.949 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 444' ' ' ARG . . . 110.22 -5.03 30.1 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.207 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.671 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 84.6 m-85 -115.62 145.09 43.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.141 0.496 . . . . 0.0 110.946 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 442' ' ' CYS . . . -160.08 160.19 32.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.259 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.516 HD11 HG22 ' A' ' 429' ' ' VAL . 69.6 mt -71.55 151.45 93.79 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 121.064 0.459 . . . . 0.0 111.792 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 72.9 Cg_exo -53.14 147.66 34.03 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.415 2.743 . . . . 0.0 111.913 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 70.1 27.5 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.71 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.32 53.78 8.42 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.391 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -119.51 160.66 21.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.53 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 41.7 p -119.88 -17.15 8.57 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.004 0.431 . . . . 0.0 110.143 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.768 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 0.5 OUTLIER -120.11 160.1 23.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.837 0.827 . . . . 0.0 111.603 178.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.516 HG22 HD11 ' A' ' 422' ' ' LEU . 1.4 t -116.6 148.6 19.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.344 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 86.7 m -108.55 122.99 48.21 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.816 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.1 t -67.96 111.13 4.22 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.828 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 4.7 mtm -144.45 135.79 25.47 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.966 0.889 . . . . 0.0 112.583 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.758 ' H ' ' HG3' ' A' ' 408' ' ' GLN . 0.8 OUTLIER 46.66 37.41 4.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.064 -178.316 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.729 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 8.1 t30 72.66 -24.95 0.19 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.929 0.892 . . . . 0.0 112.7 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -108.13 43.75 1.64 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.037 -1.078 . . . . 0.0 114.257 -169.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.514 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.3 m95 36.25 105.41 0.0 OUTLIER 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 172.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.788 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 69.5 m -45.64 -59.57 4.41 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.244 -168.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 13.5 Cg_endo -90.65 -6.19 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.631 1.554 . . . . 0.0 113.248 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.653 HG22 ' HG3' ' A' ' 441' ' ' ARG . 24.4 m 71.95 121.9 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.517 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.514 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 1.2 Cg_endo -78.67 97.48 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.51 2.807 . . . . 0.0 111.413 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.653 ' HG3' HG22 ' A' ' 439' ' ' THR . 53.8 mtm180 -131.38 -45.77 0.99 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.608 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 68.0 m 64.78 91.97 0.07 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.074 0.94 . . . . 0.0 111.301 -177.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 7.0 mt -96.9 159.53 3.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.096 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 419' ' ' GLY . 31.7 ttt180 -64.67 121.91 15.61 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.986 0.898 . . . . 0.0 110.613 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 80.5 t . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.914 178.394 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.894 ' HG3' ' HA ' ' A' ' 433' ' ' GLU . 34.2 mmt180 . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.1 0.476 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.478 ' HD2' ' C ' ' A' ' 387' ' ' ARG . 0.1 OUTLIER -124.45 79.6 1.77 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.732 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 19.8 m -59.86 125.92 25.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.249 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -90.3 127.53 36.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 172.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.538 ' HE1' HD21 ' A' ' 394' ' ' LEU . 2.0 t80 -81.71 111.76 28.81 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' PRO . . . . . 0.409 ' C ' ' HD1' ' A' ' 402' ' ' TYR . 95.9 Cg_endo -88.92 -166.65 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.245 2.63 . . . . 0.0 113.241 -176.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' TYR . . . . . 0.458 ' HD1' HD22 ' A' ' 399' ' ' ASN . 55.3 t80 -78.14 134.84 37.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.002 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.626 HD23 ' HA ' ' A' ' 399' ' ' ASN . 2.6 mm? -86.05 106.97 17.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.656 177.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.73 ' O ' ' HB2' ' A' ' 442' ' ' CYS . 12.8 pt-20 -63.49 116.87 5.99 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 69.16 25.34 5.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.023 0.44 . . . . 0.0 110.351 -174.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -135.73 176.05 20.41 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.451 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -99.16 120.86 40.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.263 0.554 . . . . 0.0 110.45 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.626 ' HA ' HD23 ' A' ' 394' ' ' LEU . 9.2 p30 -79.37 59.56 2.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.759 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -70.13 -28.87 65.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.9 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -111.75 7.55 20.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.215 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.541 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 81.2 t80 -63.97 126.07 26.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.144 0.497 . . . . 0.0 110.371 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.66 -5.31 54.22 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.86 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.31 150.03 21.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.977 0.418 . . . . 0.0 110.888 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 59.3 mtpt -126.75 136.61 52.65 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.208 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -126.97 153.59 45.67 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.783 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 387' ' ' ARG . 27.0 m -86.66 144.94 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.975 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 42.0 tt0 -57.5 132.03 51.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 0.0 110.914 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.05 12.72 23.27 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 53.9 mmtt -115.14 155.51 26.98 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.185 -0.507 . . . . 0.0 110.533 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.6 t -132.4 161.53 33.4 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.3 tp -162.39 138.31 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.439 0.638 . . . . 0.0 110.294 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -89.3 137.24 32.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.835 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.42 137.57 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.288 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.89 118.84 34.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.281 0.562 . . . . 0.0 111.343 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.56 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 58.2 m -89.0 -175.9 4.99 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.598 173.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -64.5 152.05 90.18 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.05 103.07 0.14 Allowed 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 123.204 2.602 . . . . 0.0 111.58 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.702 ' O ' ' HB3' ' A' ' 444' ' ' ARG . . . 126.92 -10.08 7.07 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.571 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 1.037 ' HA ' ' CB ' ' A' ' 444' ' ' ARG . 59.8 m-85 -119.66 159.81 23.71 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 444' ' ' ARG . . . -151.18 173.66 14.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.821 -175.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 427' ' ' THR . 3.2 mm? -73.96 160.14 82.51 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 171.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.487 ' HG3' HD11 ' A' ' 443' ' ' ILE . 71.8 Cg_exo -48.61 136.74 26.85 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.947 2.431 . . . . 0.0 111.237 174.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 78.81 20.36 0.79 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.349 1.031 . . . . 0.0 110.061 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.76 44.2 20.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.071 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 422' ' ' LEU . 91.4 mt-30 -100.21 169.94 8.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.753 -177.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' THR . . . . . 0.483 ' HA ' HD23 ' A' ' 422' ' ' LEU . 74.8 p -123.05 -8.62 8.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.357 0.599 . . . . 0.0 109.477 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -113.76 149.85 34.28 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.474 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 19.9 m -124.83 144.74 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 172.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 39.1 m -108.1 129.19 55.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.326 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.2 t -72.33 110.03 6.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.975 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 9.1 mtt -142.02 137.6 31.24 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.812 0.815 . . . . 0.0 111.698 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.894 ' HA ' ' HG3' ' A' ' 387' ' ' ARG . 1.2 tp10 40.43 40.14 0.82 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.732 -2.031 . . . . 0.0 112.759 -174.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 9.3 t30 73.02 -16.33 0.47 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.021 0.528 . . . . 0.0 112.009 174.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -118.91 45.87 1.2 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.741 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.55 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.1 m95 35.21 106.2 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 172.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.744 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 64.0 m -41.15 -62.13 1.13 Allowed Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -172.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 62.6 Cg_endo -88.67 -2.86 6.56 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.681 1.588 . . . . 0.0 113.156 -174.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.759 HG22 ' HG3' ' A' ' 441' ' ' ARG . 28.8 m 72.94 119.37 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.575 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 61.5 Cg_endo -74.57 82.71 1.85 Allowed 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.729 2.286 . . . . 0.0 112.205 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.759 ' HG3' HG22 ' A' ' 439' ' ' THR . 49.5 mtp180 -133.18 132.29 41.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.825 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.73 ' HB2' ' O ' ' A' ' 395' ' ' GLU . 81.6 m -95.42 74.68 3.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.716 0.77 . . . . 0.0 111.38 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.487 HD11 ' HG3' ' A' ' 423' ' ' PRO . 1.6 pt -101.27 144.01 13.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.703 174.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 1.037 ' CB ' ' HA ' ' A' ' 420' ' ' TYR . 0.0 OUTLIER -175.35 -154.64 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -177.299 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.652 ' H ' ' HD2' ' A' ' 444' ' ' ARG . 7.6 p . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 111.488 -2.596 . . . . 0.0 111.643 -169.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.71 ' HG3' ' N ' ' A' ' 408' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.72 ' H ' ' HB2' ' A' ' 434' ' ' ASN . 0.1 OUTLIER -166.97 65.32 0.09 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 112.615 -2.084 . . . . 0.0 106.792 152.385 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.698 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 61.5 m -50.84 108.8 0.26 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.47 -1.695 . . . . 0.0 113.271 -166.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -90.64 120.95 32.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -69.55 122.84 87.05 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.75 167.15 24.39 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.187 2.591 . . . . 0.0 113.155 -175.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -85.96 116.41 24.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.598 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.5 117.17 28.98 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.784 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 0.0 OUTLIER -75.21 -31.51 60.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.111 0.481 . . . . 0.0 110.338 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 41.6 m-80 -98.48 20.05 13.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.047 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -134.19 178.49 18.35 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.207 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -90.01 -10.12 46.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.779 0.323 . . . . 0.0 111.591 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 6.8 p30 42.21 36.69 0.75 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.355 1.062 . . . . 0.0 113.558 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -62.99 -26.06 68.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.778 0.323 . . . . 0.0 111.183 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -94.88 -6.76 41.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.352 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -61.23 118.64 7.12 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.36 -10.22 22.14 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.511 -174.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -100.38 146.64 26.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.719 0.295 . . . . 0.0 110.723 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' LYS . . . . . 0.698 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 56.7 mtpt -119.46 152.17 37.33 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.261 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.469 ' CD1' ' HH2' ' A' ' 436' ' ' TRP . 94.8 m-85 -139.79 162.87 34.09 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.385 0.612 . . . . 0.0 111.437 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 35.3 m -97.54 146.22 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.644 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.9 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 40.7 tt0 -69.42 122.76 19.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.041 0.448 . . . . 0.0 110.558 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.45 12.67 11.47 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 1.1 tmtm? -116.41 162.68 17.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.813 -0.693 . . . . 0.0 109.481 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.5 t -132.25 158.23 42.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.934 0.397 . . . . 0.0 110.171 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.1 tp -149.68 140.73 16.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.146 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -82.41 132.2 35.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.738 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 422' ' ' LEU . 92.3 t -111.83 139.97 33.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.156 0.503 . . . . 0.0 111.191 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -113.35 103.07 10.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.17 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.611 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 70.7 m -99.17 165.8 11.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 171.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -68.3 153.17 95.92 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.107 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.77 108.71 0.3 Allowed 'Trans proline' 0 CA--C 1.521 -0.156 0 C-N-CA 123.702 2.935 . . . . 0.0 112.278 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.76 -11.03 11.14 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.612 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 99.3 m-85 -116.49 141.33 48.31 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -144.47 178.9 7.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.066 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 59.4 mt -92.27 156.93 41.38 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.85 0.357 . . . . 0.0 111.044 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 58.2 Cg_exo -54.1 144.65 57.23 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.174 2.583 . . . . 0.0 111.562 173.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 29.1 mtpp 72.45 19.14 4.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.188 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.1 26.29 13.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.317 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.632 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 27.3 mt-30 -85.26 157.31 20.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.062 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.9 p -116.37 0.92 12.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.541 0.686 . . . . 0.0 109.846 173.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.25 140.43 52.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.941 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.512 HG23 HG21 ' A' ' 414' ' ' VAL . 45.6 t -115.4 132.29 65.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.102 0.477 . . . . 0.0 109.718 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 19.3 m -88.02 129.66 35.21 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.138 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 33.8 t -71.41 111.59 6.86 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.9 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 1.0 OUTLIER -141.96 121.83 13.59 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 122.466 1.126 . . . . 0.0 112.105 172.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' A' ' 433' ' ' GLU . 35.5 tt0 51.51 36.65 17.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 111.978 -2.374 . . . . 0.0 112.295 177.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.72 ' HB2' ' H ' ' A' ' 388' ' ' LYS . 63.9 t30 61.98 15.46 7.28 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.066 0.936 . . . . 0.0 109.681 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -123.2 17.05 8.05 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.768 -173.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.469 ' HH2' ' CD1' ' A' ' 406' ' ' PHE . 93.4 m95 36.42 101.42 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.92 1.012 . . . . 0.0 113.073 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.716 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 62.6 m -44.52 -61.81 1.92 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -165.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.716 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 41.2 Cg_endo -83.31 -3.12 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.043 1.828 . . . . 0.0 112.961 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.647 HG22 ' HG3' ' A' ' 441' ' ' ARG . 26.3 m 74.35 114.19 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.972 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.423 ' HG3' HG11 ' A' ' 429' ' ' VAL . 13.1 Cg_exo -68.78 95.95 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.948 2.432 . . . . 0.0 111.94 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.647 ' HG3' HG22 ' A' ' 439' ' ' THR . 51.6 mtp180 -135.89 117.84 15.27 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.732 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 62.4 m -82.05 82.86 7.49 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 5.1 pt -82.88 144.67 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.378 0.608 . . . . 0.0 111.066 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.5 ttm105 -71.49 120.22 16.76 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.416 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.957 -173.376 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.952 ' HD3' ' HA ' ' A' ' 434' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 387' ' ' ARG . 0.0 OUTLIER -115.64 108.16 16.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.063 0.459 . . . . 0.0 111.897 -170.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 71.2 m -86.98 143.89 27.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.327 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -125.78 119.77 28.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 26.7 t80 -70.12 118.86 67.75 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.749 0.309 . . . . 0.0 110.41 -174.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 93.2 Cg_endo -90.26 -175.57 0.95 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.194 2.596 . . . . 0.0 113.525 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' TYR . . . . . 0.458 ' HA ' ' OD1' ' A' ' 399' ' ' ASN . 87.7 t80 -91.04 116.92 29.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.61 -173.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 440' ' ' PRO . 3.5 mm? -74.41 117.91 16.77 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.44 -26.63 63.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.535 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -136.41 38.58 2.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.395 0.617 . . . . 0.0 110.519 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -124.29 168.32 16.45 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.4 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -87.39 -4.96 59.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 393' ' ' TYR . 53.7 m-80 44.04 47.55 7.31 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 170.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -65.45 -15.31 62.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.743 0.306 . . . . 0.0 111.039 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -122.38 12.34 10.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -68.91 129.21 39.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.66 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 102.17 8.4 44.49 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.174 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -98.84 152.34 19.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.401 0.62 . . . . 0.0 111.888 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -116.64 143.42 45.65 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.434 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -141.22 151.24 43.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.274 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 29.3 m -93.81 150.99 3.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 170.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 1.0 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 46.2 tt0 -62.48 138.19 58.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.341 0.591 . . . . 0.0 111.207 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.16 14.17 23.15 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -174.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 7.7 mmmt -118.92 161.37 20.31 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.699 -0.75 . . . . 0.0 110.05 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.2 t -131.81 165.96 22.64 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.26 144.16 11.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.173 0.511 . . . . 0.0 110.722 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -84.32 143.05 29.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.853 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.414 HG22 ' HZ ' ' A' ' 391' ' ' PHE . 46.8 t -126.57 127.61 70.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.962 0.411 . . . . 0.0 110.922 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -97.43 95.01 7.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.616 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 34.3 m -87.04 145.73 26.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.614 ' ND1' ' HD2' ' A' ' 418' ' ' PRO . 16.4 t60 -59.19 144.44 83.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 0.0 110.979 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 418' ' ' PRO . . . . . 0.614 ' HD2' ' ND1' ' A' ' 417' ' ' HIS . 95.3 Cg_exo -45.21 106.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.477 1 C-N-CA 125.427 4.084 . . . . 0.0 112.734 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 125.11 -17.5 7.09 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.127 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -110.16 150.14 29.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.001 0.429 . . . . 0.0 111.117 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -149.3 166.96 27.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.733 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 62.9 mt -88.88 153.14 49.44 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 120.69 0.281 . . . . 0.0 110.892 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.61 144.27 33.93 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.192 2.595 . . . . 0.0 112.141 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 68.88 23.7 6.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.876 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 54.18 47.22 23.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.249 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 93.7 mt-30 -108.33 167.64 9.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.534 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 12.2 t -126.57 0.09 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -119.7 145.84 46.16 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.161 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.633 HG13 ' HG2' ' A' ' 438' ' ' PRO . 12.5 t -115.7 133.23 62.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.945 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 18.0 m -93.99 124.47 38.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.81 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.5 t -71.86 111.41 7.09 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.604 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' MET . . . . . 1.0 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 30.0 mtp -140.08 -177.38 4.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.533 ' HG2' HE22 ' A' ' 408' ' ' GLN . 9.4 mm-40 -32.98 88.55 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 125.95 2.031 . . . . 0.0 114.387 -175.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.952 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 10.3 t-20 68.9 12.28 8.59 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 112.088 -2.324 . . . . 0.0 110.653 168.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 179.23 134.64 2.2 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.403 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.436 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 91.1 m95 -38.93 117.89 0.71 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 165.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.599 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 14.8 m -67.1 -52.27 31.52 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -168.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.633 ' HG2' HG13 ' A' ' 429' ' ' VAL . 25.5 Cg_endo -83.56 -9.14 10.26 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 120.919 1.079 . . . . 0.0 112.196 -175.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.581 HG22 ' HG2' ' A' ' 441' ' ' ARG . 11.0 m 71.61 109.53 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.23 173.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.416 ' HB2' HD11 ' A' ' 394' ' ' LEU . 37.5 Cg_endo -69.42 98.31 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.35 2.033 . . . . 0.0 110.945 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.581 ' HG2' HG22 ' A' ' 439' ' ' THR . 21.9 mmm180 -120.58 -36.89 3.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.735 -175.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 82.9 m 56.68 69.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.498 0.666 . . . . 0.0 110.117 -174.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 5.7 pt -87.04 154.42 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.714 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -61.09 121.72 13.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.989 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.032 -171.125 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.799 ' NH1' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.728 0 CA-C-O 122.085 0.945 . . . . 0.0 112.571 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 387' ' ' ARG . 12.9 tptt -164.61 88.63 0.49 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.602 167.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 434' ' ' ASN . 58.6 m -51.3 111.99 0.66 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.584 0.553 . . . . 0.0 111.295 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -89.45 118.28 28.99 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -72.8 123.22 89.31 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.805 0.336 . . . . 0.0 110.128 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.74 169.02 18.74 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.094 2.53 . . . . 0.0 113.765 -174.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -88.34 106.83 18.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.813 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.38 108.25 17.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -63.22 -40.2 96.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.867 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -100.49 19.69 16.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.568 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -132.14 172.98 20.88 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.093 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -88.03 104.47 16.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 2.3 p30 -74.54 55.41 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.38 -178.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -64.62 -42.85 95.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.779 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -101.72 0.88 36.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.419 -170.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 23.6 t80 -61.5 124.07 19.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.112 0.482 . . . . 0.0 110.38 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.42 -9.3 38.44 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.704 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -89.75 147.32 23.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.247 0.546 . . . . 0.0 111.134 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 37.6 mtpt -121.66 135.47 54.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.797 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -129.25 158.15 39.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.213 0.53 . . . . 0.0 111.34 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.8 m -87.78 144.48 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.006 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.827 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.8 OUTLIER -52.55 139.79 24.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.963 0.411 . . . . 0.0 111.492 177.339 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.47 10.89 57.71 Favored Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -110.89 154.62 23.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 30.8 t -132.47 159.15 40.19 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.047 0.451 . . . . 0.0 110.409 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.2 tp -155.57 141.43 10.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.501 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -91.56 139.99 30.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.822 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 19.3 t -126.05 146.08 32.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.277 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -122.63 131.43 53.81 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.614 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 56.4 m -103.79 170.54 7.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -72.7 156.7 89.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.814 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.32 110.68 0.48 Allowed 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.821 3.014 . . . . 0.0 112.529 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.45 -6.02 16.82 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.788 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 96.1 m-85 -122.97 145.6 48.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.792 0.33 . . . . 0.0 110.769 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -149.83 157.16 42.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.945 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.645 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 46.6 mt -78.44 156.21 78.55 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.82 0.343 . . . . 0.0 111.199 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.481 ' HG3' HD11 ' A' ' 443' ' ' ILE . 50.2 Cg_exo -53.04 144.49 45.91 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.067 2.511 . . . . 0.0 112.018 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 71.73 14.76 6.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.436 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 60.4 30.47 19.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.515 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.645 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 76.1 mt-30 -92.18 168.77 11.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.846 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 79.8 p -126.12 -26.11 3.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.474 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.89 134.53 35.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.426 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.546 HG13 ' HG2' ' A' ' 438' ' ' PRO . 3.5 t -109.88 142.89 21.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.451 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 27.6 m -103.91 126.81 51.31 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.212 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.404 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.6 t -70.08 108.72 4.21 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.827 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 9.7 mtt -144.55 132.89 21.86 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.324 1.059 . . . . 0.0 112.42 174.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.684 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 2.4 tm-20 46.38 32.16 1.48 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.09 -2.323 . . . . 0.0 110.687 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.492 ' HA ' ' SG ' ' A' ' 389' ' ' CYS . 45.5 t-20 76.03 -27.71 0.18 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.45 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -97.91 40.05 2.61 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.237 -171.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.548 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.0 m95 35.99 106.44 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 172.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.775 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 72.2 m -44.54 -60.09 3.31 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -170.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.775 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 31.3 Cg_endo -88.36 -6.6 6.13 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.882 1.722 . . . . 0.0 112.874 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 80.9 m 72.8 116.33 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 114.898 -1.047 . . . . 0.0 113.072 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.548 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 18.4 Cg_endo -88.76 109.76 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.498 2.799 . . . . 0.0 110.734 174.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -147.2 -17.65 0.39 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 77.2 m 58.1 87.07 0.07 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.406 0.622 . . . . 0.0 111.489 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.481 HD11 ' HG3' ' A' ' 423' ' ' PRO . 11.0 mt -85.54 158.84 3.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -78.88 124.86 28.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.215 0.531 . . . . 0.0 109.923 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--N 1.313 -1.01 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.119 -177.768 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.732 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 2.0 mmp_? . . . . . 0 CA--C 1.514 -0.407 0 CA-C-O 121.539 0.685 . . . . 0.0 111.801 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -125.17 94.56 4.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.932 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 20.5 m -62.52 113.45 2.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.129 0.49 . . . . 0.0 111.707 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' TYR . . . . . 0.505 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 53.2 t80 -79.65 112.01 16.5 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.779 173.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -62.68 123.38 79.14 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.23 172.03 13.22 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.259 2.639 . . . . 0.0 113.297 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -90.62 125.17 35.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.323 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 29.3 mt -103.92 130.06 51.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.571 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -91.79 -32.76 15.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.668 0.747 . . . . 0.0 109.105 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -94.63 5.04 53.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.61 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -142.19 170.9 24.81 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.202 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -87.59 113.94 23.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.941 0.401 . . . . 0.0 110.356 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -83.31 51.77 2.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.577 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -70.31 -17.24 63.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.94 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -114.25 1.16 14.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.992 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -63.0 127.99 33.8 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.31 0.576 . . . . 0.0 111.473 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.505 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 103.05 -0.24 47.88 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.684 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -108.72 141.93 39.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.868 0.366 . . . . 0.0 110.472 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -105.66 130.43 53.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.617 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -109.52 150.86 27.53 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.747 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.34 139.33 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.276 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.842 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 12.6 tt0 -60.28 126.21 26.64 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.557 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 101.07 13.42 33.81 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -173.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -110.25 151.71 27.02 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.2 t -124.84 160.63 28.32 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -170.8 127.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.666 0.746 . . . . 0.0 110.013 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.714 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 29.8 t70 -79.09 130.0 35.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.876 -172.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 429' ' ' VAL . 31.6 t -106.38 157.53 6.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.278 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -120.55 94.34 4.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.864 0.364 . . . . 0.0 111.221 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 92.9 m -83.79 150.96 25.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.615 ' NE2' ' HE2' ' A' ' 420' ' ' TYR . 1.5 p-80 -74.68 152.23 87.14 Favored Pre-proline 0 N--CA 1.461 0.103 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.765 -170.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 418' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 417' ' ' HIS . 2.7 Cg_exo -32.32 112.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.856 3.704 . . . . 0.0 114.639 -173.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.21 -5.14 35.76 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.22 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.615 ' HE2' ' NE2' ' A' ' 417' ' ' HIS . 63.2 m-85 -120.74 144.49 48.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.989 0.423 . . . . 0.0 111.147 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -152.09 -167.12 2.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.574 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.505 HD13 HG22 ' A' ' 429' ' ' VAL . 70.4 mt -108.27 160.43 27.05 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-O 120.904 0.383 . . . . 0.0 111.918 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.421 ' HG3' HD11 ' A' ' 443' ' ' ILE . 87.7 Cg_exo -47.69 143.26 12.8 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.597 2.865 . . . . 0.0 112.715 175.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt 67.47 30.45 6.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.729 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.49 33.02 20.15 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.609 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -97.35 169.41 9.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.028 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' THR . . . . . 0.477 ' C ' HD12 ' A' ' 422' ' ' LEU . 39.2 p -126.94 1.19 6.61 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.781 173.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.714 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 1.9 t -124.46 163.81 21.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.635 0.731 . . . . 0.0 111.654 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.523 HG13 ' HG2' ' A' ' 438' ' ' PRO . 2.0 t -129.77 142.56 43.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.34 -177.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 78.6 m -99.94 136.9 39.15 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.101 174.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 13.6 t -74.93 119.67 19.43 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.842 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 11.5 mtp -152.1 136.9 17.09 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.73 0.776 . . . . 0.0 111.657 174.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.761 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 18.9 mt-10 45.33 38.83 3.83 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.149 -1.842 . . . . 0.0 111.947 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.469 ' HB2' ' HD3' ' A' ' 387' ' ' ARG . 43.3 t30 68.89 -24.57 0.14 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.232 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -102.26 18.54 51.25 Favored Glycine 0 CA--C 1.501 -0.834 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.898 -169.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.714 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 96.4 m95 59.45 128.87 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 124.539 0.788 . . . . 0.0 112.989 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.806 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 71.1 m -49.76 -64.55 1.18 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.224 -170.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.806 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 28.2 Cg_endo -87.69 -7.6 6.42 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.692 1.594 . . . . 0.0 112.278 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 27.3 m 74.39 123.3 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.841 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.714 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 11.2 Cg_exo -62.99 93.35 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.166 2.577 . . . . 0.0 111.721 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -130.49 108.94 10.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 82.1 m -75.55 90.01 2.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.228 0.537 . . . . 0.0 110.567 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.421 HD11 ' HG3' ' A' ' 423' ' ' PRO . 11.2 mt -87.24 159.43 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.543 -0.753 . . . . 0.0 108.969 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -80.4 119.77 23.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.278 0.561 . . . . 0.0 110.303 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 445' ' ' VAL . 10.5 p . . . . . 0 C--N 1.32 -0.712 0 CA-C-O 122.209 1.004 . . . . 0.0 110.679 -172.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 1.032 ' HG2' ' HB3' ' A' ' 408' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.427 -1.593 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 0.0 OUTLIER 53.3 62.71 2.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 112.012 -2.358 . . . . 0.0 111.757 -168.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 14.5 m -67.57 134.02 50.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.223 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -91.89 132.36 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 401' ' ' ASN . 26.7 t80 -93.72 111.69 53.69 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.754 0.311 . . . . 0.0 110.702 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -92.61 -163.4 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.235 2.624 . . . . 0.0 113.442 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -85.88 140.66 30.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.355 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 394' ' ' LEU . 2.6 mm? -89.14 15.77 8.27 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -173.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 67.59 -69.54 0.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.498 0.666 . . . . 0.0 111.497 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -131.76 45.52 2.77 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.798 -177.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -142.07 177.03 21.75 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.053 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -88.8 118.99 28.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.222 0.534 . . . . 0.0 111.263 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . 2.5 p30 -87.62 86.52 7.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.034 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.79 -19.24 49.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.508 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 44.9 m-80 -136.73 28.92 2.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.49 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 50.4 t80 -69.09 122.24 18.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.09 0.471 . . . . 0.0 110.624 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 100.93 0.11 55.07 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.977 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -97.46 154.51 17.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.932 0.396 . . . . 0.0 111.304 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 39.0 mtmt -127.35 138.86 53.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.131 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 98.8 m-85 -128.84 158.45 38.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 -173.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.9 m -76.4 155.5 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.304 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 1.032 ' HB3' ' HG2' ' A' ' 387' ' ' ARG . 11.1 tt0 -77.5 124.43 27.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.466 0.651 . . . . 0.0 109.859 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.45 5.7 26.01 Favored Glycine 0 C--N 1.315 -0.633 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -104.12 149.06 25.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.536 -0.832 . . . . 0.0 109.15 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.4 t -129.75 158.71 38.64 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.046 0.45 . . . . 0.0 110.211 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.6 tp -156.54 139.09 6.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.079 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.63 133.48 34.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.145 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 35.2 t -123.41 133.44 69.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.166 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -109.21 128.07 54.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.575 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 0.8 OUTLIER -100.77 -169.25 1.68 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 174.3 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -82.13 157.44 68.45 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -54.08 110.99 0.58 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.43 2.753 . . . . 0.0 112.206 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.08 -9.95 10.21 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.185 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 77.2 m-85 -119.74 132.13 55.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -153.72 159.68 42.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 92.4 mt -70.1 153.41 95.34 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.643 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.36 150.88 47.82 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.593 2.195 . . . . 0.0 110.805 172.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.52 ' HB2' ' HG3' ' A' ' 426' ' ' GLN . 53.2 mttp 70.84 21.11 5.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.65 0.594 . . . . 0.0 110.492 -177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.97 26.73 15.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.489 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 53.7 mt-30 -84.44 158.03 21.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.195 0.521 . . . . 0.0 111.225 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 65.9 p -126.34 -9.54 6.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.87 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.24 137.62 41.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.441 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.609 HG13 ' HG2' ' A' ' 438' ' ' PRO . 2.6 t -112.98 128.07 69.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 26.0 m -99.29 124.68 44.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.593 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 38.1 t -69.03 115.91 8.88 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.911 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 29.9 mtp -138.48 129.33 26.66 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 122.745 1.26 . . . . 0.0 113.064 175.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.633 ' H ' ' CG ' ' A' ' 408' ' ' GLN . 2.2 tp10 46.43 43.48 11.99 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 111.872 -2.422 . . . . 0.0 111.428 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 433' ' ' GLU . 26.3 t-20 78.77 -9.49 1.5 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.408 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -131.64 88.89 0.28 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.712 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -12.55 114.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.793 1.237 . . . . 0.0 112.713 170.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.712 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 30.3 m -62.88 -54.49 46.54 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.279 -171.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.609 ' HG2' HG13 ' A' ' 429' ' ' VAL . 24.2 Cg_endo -85.36 -8.15 8.69 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.54 1.493 . . . . 0.0 111.957 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 9.9 m 71.17 121.27 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.59 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.07 76.95 2.47 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.636 2.224 . . . . 0.0 112.207 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -139.16 95.89 3.02 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.681 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 420' ' ' TYR . 2.1 p -76.33 92.21 3.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.386 0.612 . . . . 0.0 110.336 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.1 pt -73.22 160.39 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.782 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -81.48 114.2 20.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.141 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--N 1.316 -0.881 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.992 -178.988 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.574 ' HD2' ' C ' ' A' ' 433' ' ' GLU . 62.5 mtt180 . . . . . 0 CA--C 1.516 -0.359 0 CA-C-O 121.051 0.453 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 12.5 mptt -118.54 109.56 16.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.481 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 5.5 p -69.82 144.14 52.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.283 0.563 . . . . 0.0 112.196 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -116.24 120.8 40.12 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 21.2 t80 -77.87 121.62 84.39 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 -176.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 78.8 Cg_endo -88.83 -177.14 1.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.491 2.794 . . . . 0.0 112.942 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -94.45 126.9 40.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.695 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 3.4 mm? -81.93 6.18 16.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 57.14 -89.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.248 0.547 . . . . 0.0 110.312 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.22 50.67 1.8 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.841 175.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -153.08 163.63 30.6 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -77.03 -22.74 52.55 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.616 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . 8.1 p30 39.54 54.62 2.39 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.423 0.689 . . . . 0.0 112.426 175.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -22.92 63.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.141 -173.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.417 ' HB2' ' HD3' ' A' ' 404' ' ' ARG . 5.7 p30 -127.18 34.28 4.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.243 0.544 . . . . 0.0 111.613 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.616 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 27.9 t80 -63.95 133.45 53.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.194 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 92.6 15.91 51.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.495 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.417 ' HD3' ' HB2' ' A' ' 401' ' ' ASN . 42.0 mtp180 -107.07 154.69 20.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.294 0.568 . . . . 0.0 111.644 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 405' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 49.8 mtmt -118.97 140.84 49.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.46 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.642 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 88.2 m-85 -140.13 159.6 41.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.645 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.52 147.2 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.976 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 51.9 tt0 -63.15 141.18 58.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.111 0.482 . . . . 0.0 111.337 -176.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.15 8.97 35.1 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 61.9 mmtt -113.23 179.56 3.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.365 -176.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.8 t -150.45 160.97 43.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.11 0.481 . . . . 0.0 110.365 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.452 HD13 ' H ' ' A' ' 413' ' ' ASP . 0.4 OUTLIER -154.15 149.65 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.574 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.452 ' H ' HD13 ' A' ' 412' ' ' ILE . 15.2 t70 -90.7 141.89 28.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.75 -176.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 28.9 t -126.63 141.22 46.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.27 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -125.23 118.16 25.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.833 0.349 . . . . 0.0 110.736 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 74.7 m -103.46 -178.64 3.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -58.32 154.14 33.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.169 174.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.83 108.53 0.49 Allowed 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.7 2.934 . . . . 0.0 112.179 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.63 -13.12 15.34 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -113.3 147.98 36.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.375 -0.412 . . . . 0.0 109.908 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -159.47 179.23 9.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.162 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.656 HD13 HG13 ' A' ' 429' ' ' VAL . 87.2 mt -76.86 160.7 76.01 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.9 141.11 22.35 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.978 2.452 . . . . 0.0 111.937 173.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 68.0 30.5 5.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.173 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.44 30.09 16.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.659 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 97.6 mt-30 -91.29 158.53 16.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.991 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 8.2 p -118.38 -4.82 10.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.141 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.66 140.72 52.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.96 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.656 HG13 HD13 ' A' ' 422' ' ' LEU . 3.3 m -108.61 133.23 54.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.129 0.49 . . . . 0.0 110.16 174.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 76.9 m -85.44 128.18 34.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.513 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 53.4 t -69.54 106.09 2.88 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.976 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 6.4 mtt -143.09 139.26 30.38 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.633 0.73 . . . . 0.0 111.552 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.574 ' C ' ' HD2' ' A' ' 387' ' ' ARG . 7.0 mm-40 41.41 40.5 1.29 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 112.956 -1.929 . . . . 0.0 112.637 -176.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 4.3 t-20 70.22 -23.6 0.16 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.49 176.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -103.9 15.35 52.05 Favored Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.799 -170.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.46 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 85.1 m95 56.04 125.72 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.735 0.814 . . . . 0.0 112.523 -174.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.769 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 58.5 m -44.47 -61.87 1.88 Allowed Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -172.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 64.3 Cg_endo -88.42 -3.62 6.71 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.704 1.603 . . . . 0.0 112.817 -175.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 28.5 m 68.98 109.3 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.606 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 11.5 Cg_endo -55.14 102.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.794 2.996 . . . . 0.0 112.455 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -141.76 131.62 24.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.992 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 76.6 m -87.05 91.21 8.63 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.137 0.494 . . . . 0.0 109.869 175.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 8.9 mt -94.28 157.73 3.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -88.84 108.18 19.38 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.4 0.619 . . . . 0.0 109.712 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.753 -173.021 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.94 ' HG3' ' CB ' ' A' ' 408' ' ' GLN . 7.8 mpt_? . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 39.3 ttmt 73.98 79.17 0.12 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 112.471 -2.15 . . . . 0.0 112.362 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 435' ' ' GLY . 3.2 m -87.28 155.87 19.88 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.755 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -119.18 128.53 54.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -81.25 122.43 81.3 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.587 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.6 172.27 11.45 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.205 2.603 . . . . 0.0 113.388 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -85.94 123.33 31.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.07 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 394' ' ' LEU . 2.2 mm? -95.74 119.49 34.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -76.91 -32.09 57.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.319 0.58 . . . . 0.0 109.867 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 8.9 m120 -100.63 10.37 41.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.556 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.627 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -131.46 175.95 19.37 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.582 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -92.81 109.99 21.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 1.8 p-10 -81.12 48.04 1.08 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.239 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.89 -32.86 74.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.328 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.535 ' ND2' HD12 ' A' ' 412' ' ' ILE . 78.7 m-20 -95.63 -9.42 32.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.126 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 52.0 t80 -59.94 129.74 43.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.221 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 95.29 5.15 60.71 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.247 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -104.43 148.3 26.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.086 0.47 . . . . 0.0 110.759 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -124.59 143.78 50.52 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.86 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 87.4 m-85 -139.39 156.39 47.02 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.306 -173.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 26.2 m -88.03 137.59 20.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.818 174.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.94 ' CB ' ' HG3' ' A' ' 387' ' ' ARG . 11.7 tt0 -53.14 137.84 32.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.016 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.79 7.76 25.15 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -112.75 151.55 30.16 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.439 -0.88 . . . . 0.0 110.025 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 35.6 t -131.4 153.32 49.8 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.535 HD12 ' ND2' ' A' ' 401' ' ' ASN . 0.2 OUTLIER -152.72 144.14 15.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.781 -173.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.477 ' N ' HD13 ' A' ' 412' ' ' ILE . 28.5 t70 -81.89 137.64 35.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.392 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 64.3 t -121.84 126.83 75.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.46 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.72 128.25 54.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.315 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.627 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 61.2 m -105.92 -178.45 3.65 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -76.13 154.95 84.56 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.12 112.07 0.77 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.655 2.904 . . . . 0.0 112.457 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 445' ' ' VAL . . . 115.08 -12.76 19.7 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.905 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -111.06 148.73 31.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.709 0.29 . . . . 0.0 110.643 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.87 162.11 39.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.453 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.14 158.38 81.67 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.809 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.67 135.17 61.31 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.771 2.314 . . . . 0.0 111.555 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 69.86 17.46 7.56 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.992 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 63.53 39.67 8.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.436 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -78.46 158.84 28.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.492 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 49.9 p -121.93 -13.58 8.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.48 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.83 149.74 47.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.585 -175.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.639 HG11 ' HG3' ' A' ' 440' ' ' PRO . 13.0 t -126.88 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.469 ' H ' ' CD ' ' A' ' 438' ' ' PRO . 38.6 m -103.53 123.1 46.29 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.49 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 43.2 t -64.12 116.35 5.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.313 174.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.803 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 32.7 mtt -145.46 133.27 21.16 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.762 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 33.4 tt0 28.47 68.09 0.08 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.135 -169.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.415 ' HA ' ' C ' ' A' ' 388' ' ' LYS . 2.3 p-10 56.57 31.31 18.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.224 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' A' ' 389' ' ' CYS . . . -150.55 -158.19 8.14 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.723 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.45 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 96.9 m95 -136.36 113.25 10.34 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -174.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 12.7 t -66.32 -51.24 44.75 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.951 -168.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.526 ' CG ' ' HA ' ' A' ' 429' ' ' VAL . 25.7 Cg_endo -91.29 0.97 4.7 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.44 1.427 . . . . 0.0 112.504 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.53 HG22 ' HG3' ' A' ' 441' ' ' ARG . 13.3 m 73.71 112.0 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.928 171.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.639 ' HG3' HG11 ' A' ' 429' ' ' VAL . 1.3 Cg_endo -79.77 93.53 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.031 2.487 . . . . 0.0 112.07 175.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.53 ' HG3' HG22 ' A' ' 439' ' ' THR . 78.7 mtp180 -138.94 114.74 10.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.271 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 396' ' ' ASN . 76.2 m -81.88 83.32 7.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.491 . . . . 0.0 110.557 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 10.5 mt -83.12 158.08 3.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -78.92 114.58 17.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.264 0.554 . . . . 0.0 109.879 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 419' ' ' GLY . 9.8 p . . . . . 0 C--N 1.316 -0.851 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.163 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.955 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 9.9 mmt180 . . . . . 0 N--CA 1.463 0.215 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.88 90.93 3.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.379 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 23.9 m -64.79 133.72 52.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.773 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' TYR . . . . . 0.565 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 55.9 t80 -102.63 123.98 47.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 401' ' ' ASN . 27.5 t80 -80.46 119.46 76.42 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -87.76 -171.03 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.387 2.725 . . . . 0.0 113.323 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' TYR . . . . . 0.419 ' HA ' ' OD1' ' A' ' 399' ' ' ASN . 80.4 t80 -105.59 111.94 24.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.497 -174.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.07 117.79 25.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.46 -36.1 82.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.155 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -108.04 28.2 8.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.905 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -138.9 165.75 25.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.589 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -90.74 111.11 22.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.156 0.503 . . . . 0.0 110.139 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.63 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . 42.3 m-80 -92.63 70.03 4.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.106 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -76.71 -6.57 52.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.255 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 40.4 m-80 -135.22 23.23 3.49 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.591 0.234 . . . . 0.0 111.372 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.63 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 22.9 t80 -68.89 129.35 39.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 110.931 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.565 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 90.44 14.51 58.47 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.702 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -111.04 145.38 38.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.931 0.396 . . . . 0.0 110.903 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 98.0 mttt -108.72 134.87 50.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.287 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -126.88 149.87 49.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.651 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 32.3 m -85.6 148.68 4.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 1.068 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 49.9 tt0 -59.6 140.25 56.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.189 0.518 . . . . 0.0 111.175 -176.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.03 10.92 35.67 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -109.93 152.99 25.14 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.537 -0.831 . . . . 0.0 109.417 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 41.1 t -128.48 157.21 41.78 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 11.1 tp -148.86 139.69 16.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.545 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.84 132.5 36.13 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.808 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.621 ' HB ' HD11 ' A' ' 422' ' ' LEU . 46.7 t -130.77 101.63 5.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.017 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.72 115.74 27.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.406 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.654 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 82.9 m -84.81 174.12 10.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.906 174.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -62.84 156.75 64.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.722 0.296 . . . . 0.0 110.485 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.21 110.08 0.44 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.657 2.905 . . . . 0.0 112.53 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.55 -12.04 15.95 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.898 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.33 156.05 26.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.946 0.403 . . . . 0.0 110.706 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -157.21 167.63 29.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.153 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.621 HD11 ' HB ' ' A' ' 414' ' ' VAL . 87.3 mt -72.74 153.23 91.4 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.851 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.58 141.58 62.79 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.949 2.433 . . . . 0.0 111.63 176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 64.8 mttm 71.4 24.85 3.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.044 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.01 51.3 7.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.319 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 97.5 mt-30 -114.45 165.44 12.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.217 -176.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 29.0 p -129.7 -4.1 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.14 137.93 53.07 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.555 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.542 HG13 ' HG2' ' A' ' 438' ' ' PRO . 16.3 t -113.63 132.94 61.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.639 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 25.1 m -101.02 124.19 46.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.719 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.7 t -64.01 113.88 3.77 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' MET . . . . . 1.068 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 44.0 mtt -142.07 132.37 24.96 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.742 0.782 . . . . 0.0 111.838 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 387' ' ' ARG . 0.7 OUTLIER 28.78 52.74 0.07 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.05 -171.767 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.955 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 0.2 OUTLIER 76.29 -25.18 0.21 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.561 171.351 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -115.71 60.91 0.4 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-O 119.361 -0.688 . . . . 0.0 112.971 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.423 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 96.3 m95 20.39 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.033 1.333 . . . . 0.0 114.346 169.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.662 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 31.1 t -47.51 -59.56 5.39 Favored Pre-proline 0 N--CA 1.467 0.421 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -168.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' A' ' 437' ' ' SER . 44.3 Cg_endo -85.45 -5.04 9.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.497 1.464 . . . . 0.0 113.384 -174.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.466 HG22 ' HG3' ' A' ' 441' ' ' ARG . 28.2 m 73.42 116.64 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.989 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 51.7 Cg_endo -76.47 109.34 2.85 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.547 2.164 . . . . 0.0 112.273 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.535 ' O ' HD23 ' A' ' 422' ' ' LEU . 71.7 mtp180 -146.52 151.84 38.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.18 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 74.0 m -111.29 90.7 3.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.119 0.485 . . . . 0.0 110.311 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 12.7 mt -92.59 155.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -82.22 121.77 27.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.438 0.637 . . . . 0.0 110.138 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--N 1.315 -0.899 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.522 -175.064 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 2.9 mptp? -113.87 96.23 5.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.464 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 7.9 p -68.44 136.86 53.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.922 0.392 . . . . 0.0 111.094 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -99.78 130.83 46.02 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.475 ' HZ ' HG22 ' A' ' 414' ' ' VAL . 1.2 t80 -92.44 104.34 10.91 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.89 -90.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.369 2.713 . . . . 0.0 114.609 -170.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' TYR . . . . . 0.432 ' N ' ' CE1' ' A' ' 402' ' ' TYR . 0.9 OUTLIER 167.52 128.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.736 0.814 . . . . 0.0 110.278 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.612 ' HG ' ' SG ' ' A' ' 442' ' ' CYS . 0.9 OUTLIER -73.4 -131.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.045 0.45 . . . . 0.0 110.408 173.738 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -155.63 -40.99 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -105.49 17.22 24.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.514 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -119.11 141.19 15.66 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.59 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 398' ' ' TYR . . . . . 0.401 ' HD1' ' O ' ' A' ' 415' ' ' ALA . 71.6 m-85 -65.78 114.53 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.239 0.542 . . . . 0.0 111.128 -176.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.798 ' HA ' ' HD2' ' A' ' 402' ' ' TYR . 0.4 OUTLIER -80.2 68.59 6.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.685 0.755 . . . . 0.0 110.321 176.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -70.95 -64.21 0.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.658 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.401 ' HB3' ' HD3' ' A' ' 404' ' ' ARG . 13.6 m120 -108.11 39.11 2.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.69 -176.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.798 ' HD2' ' HA ' ' A' ' 399' ' ' ASN . 0.9 OUTLIER -92.58 148.2 22.27 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.535 -173.652 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 90.61 11.44 62.18 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.401 ' HD3' ' HB3' ' A' ' 401' ' ' ASN . 36.6 mtp180 -104.54 162.9 12.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.477 0.656 . . . . 0.0 111.995 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' LYS . . . . . 0.542 ' NZ ' ' HB2' ' A' ' 405' ' ' LYS . 10.2 mtmp? -117.72 134.36 54.98 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.324 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.658 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 97.0 m-85 -124.31 163.17 22.23 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.578 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 27.2 m -100.48 148.33 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.075 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.826 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.3 OUTLIER -57.12 139.38 52.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.99 -176.218 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.5 7.64 56.73 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 5.4 mmtm -107.73 175.41 5.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.144 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 35.6 t -146.83 165.8 28.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.6 tp -156.1 137.79 5.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.382 0.61 . . . . 0.0 110.094 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -83.72 129.83 34.95 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.914 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.475 HG22 ' HZ ' ' A' ' 391' ' ' PHE . 46.4 t -117.02 114.19 45.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.609 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.401 ' O ' ' HD1' ' A' ' 398' ' ' TYR . . . -94.68 93.49 7.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.056 0.455 . . . . 0.0 111.102 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.495 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 60.1 m -73.94 154.59 39.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 171.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -60.29 157.18 35.72 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.724 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.41 115.97 2.24 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.817 3.011 . . . . 0.0 112.641 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.24 -16.79 17.35 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.547 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 81.6 m-85 -110.75 148.09 33.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.593 0.235 . . . . 0.0 110.42 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -152.88 168.7 24.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.75 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 77.7 mt -83.09 155.74 67.12 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.118 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.12 155.87 27.13 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.396 2.731 . . . . 0.0 112.001 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 64.98 23.77 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.351 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 51.95 41.41 29.59 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.328 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.582 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 84.1 mt-30 -105.11 163.02 12.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.13 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 32.6 p -120.07 -6.0 9.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.471 0.653 . . . . 0.0 109.988 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 146.3 49.37 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.223 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.573 HG13 ' HG2' ' A' ' 438' ' ' PRO . 6.1 t -112.2 132.13 61.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 51.7 m -93.71 131.53 38.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.389 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 51.0 t -77.25 110.26 11.81 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.324 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.826 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 28.1 mtt -143.38 142.74 31.36 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.682 0.753 . . . . 0.0 112.977 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 5.1 tt0 37.91 42.84 0.46 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.213 -174.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 433' ' ' GLU . 8.9 t-20 71.24 -20.62 0.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.125 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -117.88 60.74 0.46 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.381 -172.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 88.7 m95 24.72 107.43 0.0 OUTLIER 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.097 1.359 . . . . 0.0 114.282 169.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.758 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 58.6 m -51.12 -58.97 8.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.333 -166.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.652 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 24.6 Cg_endo -86.08 -7.67 8.05 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.831 1.687 . . . . 0.0 112.595 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.58 HG22 ' HG3' ' A' ' 441' ' ' ARG . 55.4 m 73.61 118.46 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.719 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 439' ' ' THR . 5.0 Cg_exo -70.61 101.85 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.732 2.288 . . . . 0.0 111.804 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.58 ' HG3' HG22 ' A' ' 439' ' ' THR . 72.3 mtp180 -141.98 124.23 15.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.086 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.612 ' SG ' ' HG ' ' A' ' 394' ' ' LEU . 73.8 m -92.66 97.65 10.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.1 mt -99.93 155.65 4.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -81.14 116.59 21.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.475 0.655 . . . . 0.0 109.748 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.313 -1.002 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.491 -172.635 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.576 ' HD2' ' CB ' ' A' ' 434' ' ' ASN . 1.8 mmt180 . . . . . 0 CA--C 1.506 -0.732 0 CA-C-O 121.409 0.623 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.533 ' HE2' HG12 ' A' ' 407' ' ' VAL . 1.5 mptm? -118.25 106.92 13.29 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.224 -178.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 8.2 p -74.24 141.6 45.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.661 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -102.31 128.79 48.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -82.85 113.36 44.8 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.79 -176.89 2.37 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.047 2.498 . . . . 0.0 113.356 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -90.6 118.05 29.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.6 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.31 110.59 19.76 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -67.27 -29.81 69.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.0 109.728 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -100.71 15.36 28.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.093 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.677 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -134.1 -179.14 16.14 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.38 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -90.25 -1.66 57.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.71 0.29 . . . . 0.0 111.773 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 2.3 p30 40.9 41.04 1.12 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.445 1.098 . . . . 0.0 113.266 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -61.32 -26.58 67.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.382 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -114.25 18.24 17.13 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.553 -174.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -58.99 121.19 10.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.555 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.2 -6.75 36.95 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.917 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -85.04 147.23 26.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.049 0.452 . . . . 0.0 110.867 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -118.91 133.27 55.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.448 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.697 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 63.8 m-85 -124.3 159.33 30.5 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.533 HG12 ' HE2' ' A' ' 388' ' ' LYS . 27.1 m -92.21 146.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.996 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 49.8 tt0 -60.05 136.5 58.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.031 0.443 . . . . 0.0 110.824 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 104.57 12.79 27.71 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 22.8 mmtp -112.62 175.65 5.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.28 -0.46 . . . . 0.0 111.036 -176.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 40.0 t -149.77 162.82 39.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.28 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.3 tp -169.73 125.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.623 0.725 . . . . 0.0 110.507 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.748 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 18.4 t70 -77.27 137.52 38.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.314 -172.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.82 123.59 71.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.256 0.55 . . . . 0.0 111.303 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.92 112.45 23.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.193 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.677 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 80.5 m -112.59 163.31 14.67 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -63.06 149.14 91.34 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.338 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.83 107.6 0.22 Allowed 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.926 3.084 . . . . 0.0 112.676 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 123.89 -15.15 7.92 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.051 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 91.8 m-85 -108.04 136.37 47.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 176.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 442' ' ' CYS . . . -153.65 160.19 42.31 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.263 -176.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.471 HD11 HG22 ' A' ' 429' ' ' VAL . 84.5 mt -75.65 152.76 85.29 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.909 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 54.1 Cg_exo -53.69 144.75 52.16 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.758 2.305 . . . . 0.0 110.564 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 90.2 mttt 77.34 16.18 1.66 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.064 0.852 . . . . 0.0 109.843 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.8 40.34 19.61 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.917 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.408 ' HG3' ' HB2' ' A' ' 424' ' ' LYS . 96.7 mt-30 -93.54 159.33 15.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.097 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 60.2 p -110.18 -22.53 11.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.21 172.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.748 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 1.3 t -121.52 164.35 17.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.483 0.659 . . . . 0.0 111.662 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 440' ' ' PRO . 2.2 t -120.59 137.13 55.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.645 -175.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 83.5 m -94.13 130.65 40.23 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.205 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.2 t -75.83 113.4 13.27 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.996 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 20.0 mtp -145.24 139.68 27.33 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.532 0.682 . . . . 0.0 111.743 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 6.1 mm-40 41.77 38.95 1.07 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.783 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.576 ' CB ' ' HD2' ' A' ' 387' ' ' ARG . 4.5 t-20 69.56 -19.8 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.359 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -107.37 20.76 32.08 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.663 -170.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.566 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 96.7 m95 52.73 124.49 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.143 0.977 . . . . 0.0 113.615 -178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.799 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 73.1 m -50.33 -61.87 3.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 33.5 Cg_endo -89.73 -5.25 5.32 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.98 1.786 . . . . 0.0 113.413 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.6 m 74.15 113.41 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.964 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 42.4 Cg_endo -73.49 113.16 3.71 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.623 2.216 . . . . 0.0 110.907 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -154.13 -39.28 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.346 -173.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 91.6 m 60.47 89.9 0.07 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.877 0.846 . . . . 0.0 111.872 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 10.1 mt -84.61 160.46 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.643 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 444' ' ' ARG . 21.3 ttp-105 -81.91 111.51 18.17 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.642 0.734 . . . . 0.0 109.898 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--N 1.309 -1.159 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.661 -177.795 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.905 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 8.5 mmt180 . . . . . 0 CA--C 1.51 -0.589 0 CA-C-O 121.738 0.78 . . . . 0.0 112.925 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 2.6 mptp? -121.68 91.49 3.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.792 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 23.9 m -61.47 130.36 45.64 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.018 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -98.13 127.73 44.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.466 ' CE2' HD21 ' A' ' 394' ' ' LEU . 16.6 t80 -83.3 120.22 75.35 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.431 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -88.34 -171.99 0.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.26 2.64 . . . . 0.0 112.997 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -92.54 129.68 38.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.596 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.466 HD21 ' CE2' ' A' ' 391' ' ' PHE . 2.7 mm? -89.78 124.15 34.39 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.67 130.78 45.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 50.32 26.1 2.12 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 124.206 0.942 . . . . 0.0 111.796 -173.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -115.49 169.85 13.07 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.387 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -90.3 102.72 15.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.534 0.683 . . . . 0.0 110.288 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 2.0 p-10 -78.47 60.64 2.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.792 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -88.12 -29.9 20.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.148 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -97.26 -6.5 34.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.175 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.412 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 23.7 t80 -62.14 129.15 39.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.085 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.22 13.7 47.86 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.35 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 404' ' ' ARG . 53.6 mtt180 -108.53 149.43 28.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.136 0.493 . . . . 0.0 111.509 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -111.91 131.36 55.42 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.431 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.404 ' CD2' ' HH2' ' A' ' 436' ' ' TRP . 96.9 m-85 -128.86 138.81 52.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.163 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.1 m -76.2 152.44 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.464 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.694 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 52.1 tt0 -60.75 127.04 29.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.258 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.73 -18.13 17.37 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.218 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -86.79 145.59 26.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.864 0.364 . . . . 0.0 110.853 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.3 t -121.12 158.79 27.15 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.987 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.6 tp -155.22 146.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.04 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.82 133.93 38.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.377 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.01 137.23 30.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.778 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -105.69 112.34 25.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.994 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 48.4 m -124.77 172.35 9.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.069 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.433 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 12.3 m170 -54.89 159.98 3.3 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-O 121.125 0.488 . . . . 0.0 111.67 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 418' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 73.3 Cg_endo -75.46 103.45 1.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.243 2.629 . . . . 0.0 111.475 -175.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.01 -4.57 13.96 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.921 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -111.87 133.93 53.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.1 162.9 40.89 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.645 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 440' ' ' PRO . 92.0 mt -69.29 155.55 93.32 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.654 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.95 152.12 30.75 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.912 2.408 . . . . 0.0 111.978 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 73.46 23.93 2.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.93 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.11 42.08 26.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.043 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 98.5 mt-30 -116.21 162.75 17.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.92 -176.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 61.8 p -124.45 -6.8 7.55 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.62 144.66 41.75 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.759 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.727 HG12 ' HG2' ' A' ' 438' ' ' PRO . 23.6 m -120.43 158.78 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.055 0.455 . . . . 0.0 109.954 172.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 90.6 m -113.79 132.63 55.78 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.425 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.2 t -68.34 118.62 11.67 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 177.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.694 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 6.2 ptt? -142.87 133.68 25.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.12 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 434' ' ' ASN . 0.9 OUTLIER 34.65 40.68 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.783 -174.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ASN . . . . . 0.905 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 7.5 t30 76.67 -23.85 0.24 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.384 0.674 . . . . 0.0 111.952 176.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -103.39 109.59 3.49 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.578 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 94.0 m95 -39.64 125.09 1.76 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 124.17 0.571 . . . . 0.0 112.073 -175.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.728 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 74.1 p -43.06 -52.08 12.31 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -166.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.728 ' HD3' ' OG ' ' A' ' 437' ' ' SER . 5.2 Cg_endo -105.53 2.05 0.22 Allowed 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.084 1.856 . . . . 0.0 112.495 -176.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 25.5 m 72.76 116.49 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.21 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 32.0 Cg_endo -64.32 92.15 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.801 2.334 . . . . 0.0 111.592 174.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 441' ' ' ARG . 9.2 mmm180 -105.21 -50.33 3.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.221 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 83.1 m 60.0 81.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.599 0.714 . . . . 0.0 110.918 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 3.7 pt -95.57 155.08 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.274 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -73.68 107.66 6.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.002 0.906 . . . . 0.0 111.192 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 85.8 t . . . . . 0 C--N 1.31 -1.145 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.79 176.431 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 31.0 mt . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 121.965 0.888 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.782 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 8.6 mtt-85 -98.88 178.16 5.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.127 -168.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -129.13 98.32 4.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.395 177.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 434' ' ' ASN . 6.2 m -57.32 125.64 23.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.002 -175.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -86.74 130.22 34.56 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 168.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -80.86 120.59 79.33 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.539 0.209 . . . . 0.0 110.476 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.72 179.2 3.45 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.098 2.532 . . . . 0.0 113.819 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -86.91 127.43 35.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.176 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 394' ' ' LEU . 2.0 mm? -93.69 118.0 30.82 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -65.38 -36.69 84.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.945 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -117.89 28.13 8.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.311 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -143.96 162.32 27.79 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.067 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -83.64 108.46 16.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.265 0.555 . . . . 0.0 110.052 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 1.7 p-10 -80.67 54.78 2.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.045 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -63.47 -32.75 74.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.353 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -100.46 -0.3 38.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.011 -173.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 64.8 t80 -62.95 120.41 11.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.018 0.437 . . . . 0.0 110.402 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.8 -14.64 19.65 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.843 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -90.86 156.88 17.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 111.434 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -126.1 132.91 51.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.146 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -127.84 148.08 50.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.044 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 16.9 m -81.99 148.53 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.515 0.198 . . . . 0.0 110.61 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 1.008 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 49.0 tt0 -61.09 133.04 55.62 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.314 0.578 . . . . 0.0 111.229 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.3 27.02 6.67 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 9.3 mmmt -127.69 163.66 23.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.135 -0.532 . . . . 0.0 110.637 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 44.3 t -135.04 161.17 36.06 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 413' ' ' ASP . 0.3 OUTLIER -164.88 143.77 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.544 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.486 ' H ' HD13 ' A' ' 412' ' ' ILE . 13.5 t70 -78.92 138.11 37.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.731 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 37.9 t -127.4 102.03 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.073 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -78.19 117.71 19.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.975 0.417 . . . . 0.0 111.115 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 35.2 m -103.54 167.61 9.69 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -65.24 158.92 69.73 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.497 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.58 110.34 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 123.518 2.812 . . . . 0.0 112.573 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 103.58 7.23 42.78 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.903 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 95.1 m-85 -125.85 139.16 53.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -159.81 -172.34 3.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.058 0.456 . . . . 0.0 111.049 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 440' ' ' PRO . 82.9 mt -97.06 161.4 26.39 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.435 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.09 152.18 15.05 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.254 2.636 . . . . 0.0 112.074 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 63.69 26.16 14.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.143 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.27 24.71 13.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.638 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 97.7 mt-30 -86.68 161.35 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.134 0.492 . . . . 0.0 111.4 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.0 t -121.01 -6.48 9.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -114.31 140.04 48.95 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.626 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 438' ' ' PRO . 5.1 m -107.34 144.34 16.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.25 0.548 . . . . 0.0 110.57 176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 26.0 m -101.98 121.86 42.95 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.2 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.1 t -66.78 113.55 4.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' MET . . . . . 1.008 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 7.5 mtt -143.18 136.29 28.01 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.29 0.567 . . . . 0.0 111.353 174.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 34.46 46.03 0.16 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.699 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.782 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 55.3 t30 71.97 -24.14 0.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.601 175.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -108.03 33.29 6.37 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.136 -1.031 . . . . 0.0 113.893 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.556 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 95.7 m95 40.56 111.34 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.509 1.124 . . . . 0.0 113.891 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.735 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 73.0 m -40.28 -60.59 1.43 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -172.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 48.6 Cg_endo -88.6 -6.86 5.84 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.737 1.625 . . . . 0.0 112.871 -176.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 54.8 m 71.88 116.05 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.551 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 66.0 Cg_endo -80.49 109.52 2.3 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.84 2.36 . . . . 0.0 111.072 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -147.65 -14.78 0.38 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 61.3 m 56.63 83.34 0.1 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.939 0.399 . . . . 0.0 111.839 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.8 mt -85.61 157.8 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 30.5 ttp180 -86.73 105.95 17.32 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.345 1.069 . . . . 0.0 111.374 -175.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 36.9 t -73.72 -38.08 50.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 113.014 -1.903 . . . . 0.0 110.285 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? . . . . . 0 C--O 1.248 0.985 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.532 -171.949 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.634 0 CA-C-O 121.456 0.646 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 9.2 mtt180 -83.93 165.3 18.79 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.262 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -133.62 101.4 5.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.162 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 6.8 p -68.43 144.76 54.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.694 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -107.08 132.1 53.37 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 168.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 39.9 t80 -81.57 118.87 73.93 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.337 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 86.1 Cg_endo -90.95 -173.58 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.44 2.76 . . . . 0.0 113.549 -176.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -93.32 138.68 31.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.215 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.96 -96.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 173.79 -33.36 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.574 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -145.07 38.75 1.19 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.317 -1.31 . . . . 0.0 108.825 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -127.88 147.43 17.24 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.505 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.25 99.9 1.61 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.005 0.431 . . . . 0.0 110.013 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 2.5 p30 -79.16 51.34 1.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.928 -175.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -71.29 -24.45 62.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.186 0.517 . . . . 0.0 110.171 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -93.96 -9.63 36.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.738 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.492 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 83.1 t80 -63.9 114.29 3.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.391 0.615 . . . . 0.0 110.749 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 118.48 -19.14 10.74 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.82 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -82.66 153.5 25.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.152 0.501 . . . . 0.0 111.366 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 42.6 mtmt -127.52 134.13 49.8 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.136 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.644 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 96.2 m-85 -125.5 151.92 45.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 31.8 m -82.97 148.12 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.851 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.9 OUTLIER -59.24 140.79 55.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.799 0.333 . . . . 0.0 110.504 -177.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.64 6.9 57.12 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -103.4 167.66 9.66 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.431 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 39.4 t -138.33 160.22 40.04 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.912 0.387 . . . . 0.0 110.12 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.9 tp -159.5 139.38 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.094 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -76.0 135.69 39.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.35 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.635 ' HB ' HD11 ' A' ' 422' ' ' LEU . 56.1 t -126.71 101.09 7.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.311 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.2 122.12 28.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.186 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.504 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 73.5 m -98.03 163.12 12.89 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -67.21 155.97 89.24 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.284 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.01 122.17 10.07 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.762 2.975 . . . . 0.0 112.277 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.76 30.74 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 70.3 m-85 -122.0 144.06 49.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.721 0.296 . . . . 0.0 110.291 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -142.87 178.64 7.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.132 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.635 HD11 ' HB ' ' A' ' 414' ' ' VAL . 34.2 mt -95.68 148.33 34.41 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.884 0.373 . . . . 0.0 110.561 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 441' ' ' ARG . 31.7 Cg_exo -59.14 150.02 76.38 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.97 2.447 . . . . 0.0 112.115 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 67.04 28.4 8.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.393 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.31 44.43 27.39 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.772 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.573 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 98.0 mt-30 -106.9 161.93 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.14 -175.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.7 p -128.91 -13.4 4.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.987 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.15 139.63 50.97 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.253 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 438' ' ' PRO . 21.6 t -108.43 133.83 52.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 89.6 m -92.78 130.66 38.32 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.19 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.84 106.95 6.62 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.106 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.851 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 11.6 mtm -141.8 141.45 33.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.748 173.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.638 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 61.9 mm-40 46.89 36.37 3.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.876 -1.966 . . . . 0.0 111.476 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 6.2 t30 69.18 -20.94 0.16 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.803 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -112.64 49.96 0.81 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.511 -0.852 . . . . 0.0 114.061 -172.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 93.5 m95 35.69 106.81 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 169.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.827 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 55.8 m -51.7 -59.17 8.64 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 35.4 Cg_endo -85.53 -3.85 9.24 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.675 1.583 . . . . 0.0 113.079 -175.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.752 HG22 ' HG2' ' A' ' 441' ' ' ARG . 23.0 m 72.6 113.45 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.197 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -68.62 94.12 0.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.4 2.067 . . . . 0.0 110.812 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.752 ' HG2' HG22 ' A' ' 439' ' ' THR . 24.9 mmm180 -131.53 118.95 20.84 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 66.7 m -83.47 82.69 8.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.088 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 6.3 pt -76.4 144.89 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.657 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -73.17 111.24 8.1 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.577 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.9 p -78.66 -16.85 13.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.998 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.69 -0.671 . . . . 0.0 110.002 178.027 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.443 -0.825 0 CA-C-O 121.328 0.585 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.91 ' HG3' ' HG3' ' A' ' 433' ' ' GLU . 1.4 mmp_? -97.1 172.23 7.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.793 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -135.51 99.92 4.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.774 -175.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 10.4 m -67.87 146.49 53.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.932 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -107.57 128.22 54.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.176 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -74.15 122.31 87.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.97 -177.23 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.167 2.578 . . . . 0.0 113.475 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -93.63 117.16 29.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.683 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.596 HD11 ' HB2' ' A' ' 440' ' ' PRO . 0.0 OUTLIER -80.37 8.13 8.22 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -171.195 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 59.97 -84.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -97.17 13.23 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.463 0.649 . . . . 0.0 110.246 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -112.9 -161.11 14.81 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.76 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' TYR . . . . . 0.516 ' HB2' ' HB1' ' A' ' 415' ' ' ALA . 57.6 m-85 -92.79 162.65 14.03 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.184 0.516 . . . . 0.0 109.782 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 1.6 p30 -129.47 41.62 3.42 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.519 0.676 . . . . 0.0 109.685 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.45 ' HG3' ' HB3' ' A' ' 398' ' ' TYR . 75.1 mt-30 -61.05 -46.36 91.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.149 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -94.08 -1.05 54.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.04 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.511 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 73.1 t80 -61.8 119.36 8.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.325 0.584 . . . . 0.0 110.28 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 110.22 -12.63 31.25 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.307 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -95.22 150.65 19.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -118.53 134.6 54.96 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.134 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.97 140.76 52.63 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.215 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.91 147.38 8.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.368 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.713 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 49.4 tt0 -56.47 129.43 40.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.077 0.465 . . . . 0.0 110.667 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 115.43 -22.19 12.24 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -81.74 150.99 27.69 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 24.2 t -140.07 146.7 39.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.824 0.821 . . . . 0.0 111.406 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.7 tp 177.72 132.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.865 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.675 ' HB2' HG23 ' A' ' 429' ' ' VAL . 27.3 t70 -125.71 -89.46 0.57 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.478 -1.237 . . . . 0.0 107.953 173.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.9 t 34.74 75.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 111.728 -2.487 . . . . 0.0 112.943 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.516 ' O ' HD23 ' A' ' 394' ' ' LEU . . . -176.06 52.06 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.771 -172.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 56.4 m -130.99 133.95 46.26 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 173.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -61.05 157.42 42.03 Favored Pre-proline 0 N--CA 1.463 0.209 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.34 115.21 1.63 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.522 2.815 . . . . 0.0 112.522 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 113.52 -11.69 23.54 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.633 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.549 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 63.6 m-85 -113.66 144.04 43.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.537 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.34 -177.95 6.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.034 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 61.1 mt -90.49 151.45 44.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 174.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.95 153.24 58.86 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.79 2.327 . . . . 0.0 111.554 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm 65.73 28.24 11.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.037 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.82 40.16 30.67 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.472 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 26.2 mt-30 -90.15 152.43 21.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.431 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 413' ' ' ASP . 2.1 p -140.93 20.3 2.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -152.39 136.74 16.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.344 0.593 . . . . 0.0 110.108 -177.074 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.926 HG13 ' HD2' ' A' ' 438' ' ' PRO . 79.4 t -115.81 132.03 66.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.118 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.526 ' HB ' ' OG ' ' A' ' 437' ' ' SER . 49.1 m -91.5 134.92 34.24 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.543 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 18.3 t -75.14 120.2 20.32 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.713 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 21.2 ptm -107.39 -140.13 0.37 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.91 ' HG3' ' HG3' ' A' ' 387' ' ' ARG . 44.8 tt0 -70.35 71.39 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.233 0.924 . . . . 0.0 111.657 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.722 ' HB2' ' HD3' ' A' ' 387' ' ' ARG . 4.0 t30 78.43 -11.43 1.21 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.755 168.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -111.2 170.83 14.0 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 170.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.621 ' HB3' HG11 ' A' ' 429' ' ' VAL . 98.7 m95 -93.44 128.46 39.52 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.742 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 35.2 p -56.28 -54.03 57.35 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -165.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.926 ' HD2' HG13 ' A' ' 429' ' ' VAL . 6.9 Cg_endo -98.04 -4.31 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.693 1.595 . . . . 0.0 111.875 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.482 HG22 ' HG3' ' A' ' 441' ' ' ARG . 24.8 m 72.66 117.65 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.546 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.596 ' HB2' HD11 ' A' ' 394' ' ' LEU . 18.2 Cg_exo -64.44 93.81 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.858 2.372 . . . . 0.0 111.563 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.482 ' HG3' HG22 ' A' ' 439' ' ' THR . 43.8 mtp180 -125.82 91.66 3.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.675 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 66.3 m -63.07 98.89 0.15 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.579 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 2.4 pp -98.75 170.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.088 0.47 . . . . 0.0 110.313 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -93.75 118.58 31.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.426 -173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.07 -48.26 41.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.817 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.568 ' HD3' ' OXT' ' A' ' 446' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.33 172.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 121.207 0.527 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.686 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 32.1 mtp180 -127.64 -176.23 3.7 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.505 0.669 . . . . 0.0 111.461 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -128.55 109.79 11.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.805 174.458 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 7.6 p -70.52 144.7 51.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.363 0.601 . . . . 0.0 112.246 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -104.67 126.31 51.63 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 171.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.609 ' HE1' HD21 ' A' ' 394' ' ' LEU . 2.5 t80 -76.27 117.93 67.74 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -177.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -84.71 -179.14 3.59 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.101 2.534 . . . . 0.0 113.481 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -80.77 128.7 33.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.879 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.701 HD23 ' HA ' ' A' ' 399' ' ' ASN . 1.4 mm? -89.92 103.22 15.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 396' ' ' ASN . 33.4 tt0 -71.4 117.03 12.43 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 395' ' ' GLU . 23.0 m120 71.86 28.51 2.63 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.955 0.785 . . . . 0.0 109.984 -173.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -136.08 164.05 25.05 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.485 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -80.9 99.56 8.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.701 ' HA ' HD23 ' A' ' 394' ' ' LEU . 3.1 p30 -77.77 44.49 0.46 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.753 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.9 -29.96 70.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.672 0.749 . . . . 0.0 109.607 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -96.39 -7.51 34.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.34 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -64.06 122.57 16.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.882 0.373 . . . . 0.0 110.269 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.17 -10.98 33.94 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.11 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -82.5 166.42 19.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.243 0.544 . . . . 0.0 111.299 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -137.04 136.5 38.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.699 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.62 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 55.8 m-85 -132.14 153.1 50.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.138 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 14.7 m -79.38 139.14 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.734 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.838 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 33.1 tt0 -61.98 135.52 57.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.566 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 99.24 22.22 13.48 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 13.7 mmtm -127.4 173.79 9.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.029 -0.586 . . . . 0.0 109.819 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 30.6 t -144.65 163.5 33.76 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.45 HD13 ' N ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -160.84 145.73 5.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.155 -177.362 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 412' ' ' ILE . 14.2 t70 -81.14 138.66 35.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.317 -174.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 422' ' ' LEU . 48.4 t -119.76 119.77 61.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -100.8 106.33 17.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.048 0.452 . . . . 0.0 111.105 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 56.8 m -94.72 172.57 8.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -73.19 156.75 89.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.846 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.88 112.28 0.98 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.447 2.765 . . . . 0.0 111.984 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.68 -11.79 13.72 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -118.84 143.36 47.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.183 -0.508 . . . . 0.0 109.777 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.75 39.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.49 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 91.3 mt -73.65 158.67 85.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.273 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.495 ' HG3' HD11 ' A' ' 443' ' ' ILE . 31.6 Cg_exo -57.84 149.05 71.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.838 2.359 . . . . 0.0 111.609 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 68.81 17.43 8.78 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.987 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.83 36.8 28.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.051 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 98.0 mt-30 -94.47 162.14 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.846 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 26.2 p -115.62 -11.3 11.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.357 0.599 . . . . 0.0 110.477 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.46 142.69 51.12 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.115 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.5 HG13 ' HG2' ' A' ' 438' ' ' PRO . 17.0 t -114.2 129.78 69.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.624 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 25.7 m -80.87 135.49 35.93 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.176 177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.73 110.13 15.94 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.905 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.838 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 0.6 OUTLIER -149.65 143.12 25.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.923 0.868 . . . . 0.0 112.579 179.041 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.741 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 37.0 mt-10 45.27 35.06 1.63 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.358 -176.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 389' ' ' CYS . 5.7 t-20 67.9 -16.51 0.18 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.763 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -114.67 25.23 10.42 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.586 -172.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.575 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 84.7 m95 58.31 148.15 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.908 0.883 . . . . 0.0 112.955 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.797 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 58.3 m -71.12 -63.68 1.42 Allowed Pre-proline 0 C--N 1.321 -0.639 0 O-C-N 121.967 -0.458 . . . . 0.0 111.171 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.797 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 36.2 Cg_endo -89.03 -2.64 6.25 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.044 1.829 . . . . 0.0 113.149 -176.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 29.8 m 71.71 111.08 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.765 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 12.2 Cg_exo -63.18 111.13 1.34 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.131 2.554 . . . . 0.0 111.989 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 422' ' ' LEU . 75.6 mtm180 -146.23 124.71 12.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.746 -176.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 74.9 m -89.82 82.53 6.22 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.495 HD11 ' HG3' ' A' ' 423' ' ' PRO . 3.9 mt -87.11 150.92 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.823 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 446' ' ' LYS . 8.9 ttm180 -79.43 126.16 30.48 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.656 -175.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.594 HG12 ' HG3' ' A' ' 446' ' ' LYS . 78.6 t -68.93 -52.09 37.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.674 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.594 ' HG3' HG12 ' A' ' 445' ' ' VAL . 97.7 mttt . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.116 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.44 -0.933 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.748 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 26.9 mtt180 -66.73 -170.89 0.11 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.708 0.766 . . . . 0.0 111.052 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -134.33 93.0 3.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.697 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 12.3 m -59.76 141.6 54.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.579 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.458 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 68.0 t80 -104.57 137.3 42.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.43 ' HZ ' ' CG2' ' A' ' 414' ' ' VAL . 2.3 t80 -93.97 115.06 64.68 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.718 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -92.75 -176.3 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.465 2.776 . . . . 0.0 113.63 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -80.15 134.71 36.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.649 HD11 HG21 ' A' ' 414' ' ' VAL . 8.1 mt -110.38 128.2 55.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.491 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.6 151.92 44.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 43.17 41.85 3.1 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.672 0.607 . . . . 0.0 111.665 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -139.87 147.8 19.47 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.28 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -89.16 96.28 10.65 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.695 0.748 . . . . 0.0 110.362 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.485 ' HB3' ' CB ' ' A' ' 402' ' ' TYR . 35.7 m-80 -78.05 70.15 4.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.562 -173.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -79.2 -26.55 42.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.102 0.477 . . . . 0.0 110.418 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -108.45 14.84 24.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.674 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.485 ' CB ' ' HB3' ' A' ' 399' ' ' ASN . 21.5 t80 -70.87 132.24 44.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.781 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.458 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 95.12 15.16 45.9 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.234 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -103.19 156.34 17.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.022 0.439 . . . . 0.0 111.676 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -120.15 125.29 47.85 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.624 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -120.44 137.59 54.25 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.3 144.19 14.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.311 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.846 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.8 tt0 -66.29 144.57 56.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.644 -173.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 100.99 7.06 51.08 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -107.43 175.8 5.37 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.485 -0.857 . . . . 0.0 109.667 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 31.9 t -152.3 147.79 26.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.868 0.842 . . . . 0.0 111.475 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.775 ' HA ' HG22 ' A' ' 428' ' ' THR . 9.9 tp 173.44 134.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.425 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.96 ' CB ' ' HA ' ' A' ' 428' ' ' THR . 34.9 t70 -130.97 -140.79 0.22 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.229 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.67 HG23 ' CG ' ' A' ' 413' ' ' ASP . 0.6 OUTLIER -147.17 147.75 17.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.226 -151.506 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.98 88.06 7.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.793 167.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.543 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 14.7 m -80.04 167.17 20.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.186 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -54.37 157.03 5.21 Favored Pre-proline 0 N--CA 1.469 0.484 0 CA-C-O 121.079 0.466 . . . . 0.0 111.528 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.21 110.78 0.49 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.709 2.939 . . . . 0.0 112.629 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.07 -2.09 38.09 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.691 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.626 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 87.8 m-85 -114.3 129.05 56.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' ALA . . . . . 0.442 ' C ' ' HA ' ' A' ' 442' ' ' CYS . . . -162.71 161.34 26.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.289 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.486 ' CD2' ' H ' ' A' ' 441' ' ' ARG . 73.9 mt -61.55 145.18 91.69 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.152 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 25.9 Cg_exo -62.54 158.15 42.82 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.75 2.3 . . . . 0.0 111.09 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 68.96 21.36 7.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.467 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.61 50.92 8.39 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.385 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 96.3 mt-30 -109.66 160.91 15.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.049 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' THR . . . . . 0.841 ' O ' ' HB3' ' A' ' 413' ' ' ASP . 2.9 p -141.62 12.86 2.12 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.313 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.96 ' HA ' ' CB ' ' A' ' 413' ' ' ASP . 0.5 OUTLIER -148.47 125.54 11.39 Favored 'General case' 0 N--CA 1.436 -1.129 0 O-C-N 123.66 0.6 . . . . 0.0 111.652 178.307 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.664 ' N ' ' HB2' ' A' ' 413' ' ' ASP . 2.1 t -90.88 136.36 24.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.998 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.648 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 64.2 m -81.55 132.21 35.3 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 24.4 t -77.19 109.32 10.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.846 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 27.0 mtp -148.56 153.29 38.18 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.652 0.739 . . . . 0.0 112.394 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 435' ' ' GLY . 4.1 mt-10 28.54 43.09 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 112.782 -2.008 . . . . 0.0 113.36 -164.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 65.13 -17.76 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.869 0.868 . . . . 0.0 112.147 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -112.79 41.82 2.12 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.912 -172.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.624 ' HB3' HG11 ' A' ' 429' ' ' VAL . 98.3 m95 42.55 111.22 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.753 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 60.6 m -50.1 -66.48 0.62 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.201 -0.908 . . . . 0.0 113.278 -167.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 31.8 Cg_endo -85.76 -2.76 9.04 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.54 1.493 . . . . 0.0 112.313 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.814 ' HB ' ' HD2' ' A' ' 441' ' ' ARG . 51.5 m 76.01 131.16 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.96 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 11.5 Cg_endo -70.72 84.5 0.81 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.841 2.361 . . . . 0.0 110.885 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.814 ' HD2' ' HB ' ' A' ' 439' ' ' THR . 0.5 OUTLIER -132.55 70.94 1.46 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.269 -172.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.442 ' HA ' ' C ' ' A' ' 421' ' ' ALA . 4.2 p -70.64 90.78 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.799 0.809 . . . . 0.0 110.501 175.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 14.6 pt -85.84 176.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.339 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -86.67 107.89 18.4 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.917 0.865 . . . . 0.0 110.475 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.28 -13.38 10.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.651 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 12.3 ttpp . . . . . 0 C--O 1.247 0.928 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.237 -178.724 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 386' ' ' LEU . 2.3 pt? . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 122.136 0.97 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 1.075 ' HG3' ' HB3' ' A' ' 408' ' ' GLN . 0.9 OUTLIER 48.52 -172.15 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 115.616 1.709 . . . . 0.0 115.616 173.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 387' ' ' ARG . 5.3 mptp? 73.39 37.55 0.71 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.338 -1.756 . . . . 0.0 111.947 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 32.3 m -51.68 120.4 5.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.731 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -97.5 127.46 43.48 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.411 ' HA ' ' HE1' ' A' ' 436' ' ' TRP . 31.1 t80 -79.42 115.46 53.36 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.049 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -87.32 174.38 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.156 2.571 . . . . 0.0 112.731 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -77.41 116.95 18.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.282 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.492 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 8.2 mt -71.63 127.5 32.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.267 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.625 ' HG2' ' HB2' ' A' ' 442' ' ' CYS . 1.4 pm0 -65.1 108.59 1.89 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.014 0.435 . . . . 0.0 110.279 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 63.74 36.52 10.56 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.483 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -129.26 172.31 19.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.919 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -77.33 88.2 3.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.341 0.591 . . . . 0.0 110.71 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.572 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 2.1 p-10 -80.58 49.3 1.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.364 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -67.76 -22.79 65.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.844 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -104.06 -1.7 27.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.052 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.572 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 45.7 t80 -62.75 115.48 4.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.278 0.561 . . . . 0.0 110.427 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.61 -11.36 21.26 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.873 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.39 150.61 22.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.064 0.459 . . . . 0.0 110.949 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 405' ' ' LYS . 8.9 mptt -121.72 148.51 44.52 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.711 176.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.407 ' CD2' ' HH2' ' A' ' 436' ' ' TRP . 98.6 m-85 -142.32 156.46 45.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.206 0.527 . . . . 0.0 110.541 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.27 143.37 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.279 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 1.075 ' HB3' ' HG3' ' A' ' 387' ' ' ARG . 7.9 tt0 -57.86 139.94 53.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.408 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.8 19.19 12.32 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -125.39 169.91 11.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.629 -0.785 . . . . 0.0 110.145 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.1 t -148.02 157.51 43.55 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.331 0.586 . . . . 0.0 110.415 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.6 tp -151.08 140.45 15.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.2 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.8 133.52 37.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.363 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.92 139.42 48.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.662 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -142.44 133.66 26.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.232 0.539 . . . . 0.0 111.406 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.666 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 0.1 OUTLIER -103.07 -178.43 3.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.574 ' NE2' ' HE2' ' A' ' 420' ' ' TYR . 19.1 p-80 -77.72 157.46 79.51 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.842 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 417' ' ' HIS . 9.9 Cg_exo -34.4 120.71 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.385 3.39 . . . . 0.0 115.007 -171.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 444' ' ' ARG . . . 101.71 -20.42 46.25 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.589 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.666 ' HB2' ' HB3' ' A' ' 416' ' ' CYS . 51.6 m-85 -109.83 142.48 41.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.954 0.377 . . . . 0.0 110.757 -174.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -175.75 -170.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.411 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.617 HD21 ' HA ' ' A' ' 440' ' ' PRO . 94.7 mt -80.88 162.23 60.64 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.403 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.72 147.1 73.64 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.021 2.481 . . . . 0.0 110.761 171.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.6 10.6 7.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.605 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 62.44 35.07 15.03 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.697 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -66.93 152.44 45.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.071 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.4 p -123.79 -3.38 8.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.272 0.558 . . . . 0.0 110.341 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.84 136.29 44.3 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.961 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.54 HG13 HD11 ' A' ' 422' ' ' LEU . 5.5 m -104.28 134.77 44.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.554 0.692 . . . . 0.0 110.205 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 14.8 m -92.92 117.91 30.56 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.219 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 47.3 t -66.81 116.9 8.21 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' MET . . . . . 1.009 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 23.4 mtp -131.82 -166.8 1.77 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.37 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.608 ' OE1' ' HB3' ' A' ' 432' ' ' MET . 1.7 mp0 -37.49 76.97 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.841 1.338 . . . . 0.0 114.454 -170.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 432' ' ' MET . 15.6 t-20 64.7 23.99 12.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.777 175.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -173.92 119.16 0.73 Allowed Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.254 -174.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.411 ' HE1' ' HA ' ' A' ' 391' ' ' PHE . 47.5 m95 -37.87 113.56 0.28 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.976 0.91 . . . . 0.0 110.374 165.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 6.6 m -56.92 -50.88 85.61 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.793 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.441 ' HG2' HG12 ' A' ' 429' ' ' VAL . 33.1 Cg_endo -83.41 -8.11 10.65 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.149 1.233 . . . . 0.0 112.379 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 9.1 m 70.99 112.81 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.957 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.617 ' HA ' HD21 ' A' ' 422' ' ' LEU . 35.9 Cg_endo -66.46 86.08 0.27 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.747 2.298 . . . . 0.0 112.392 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -114.08 130.93 56.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.85 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.625 ' HB2' ' HG2' ' A' ' 395' ' ' GLU . 56.7 m -90.41 83.09 5.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.119 0.485 . . . . 0.0 110.821 173.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 2.5 pt -99.68 153.43 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 172.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 419' ' ' GLY . 72.4 ttt180 -79.3 113.69 17.64 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.489 0.661 . . . . 0.0 109.703 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.66 -29.6 5.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.408 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 56.0 tptt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.095 177.281 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 121.671 0.748 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 24.1 mtt180 -96.08 164.66 12.6 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.304 -173.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -118.94 90.72 3.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.934 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 31.1 m -56.72 122.85 13.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.842 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -91.36 113.47 25.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.558 ' HE2' HD21 ' A' ' 394' ' ' LEU . 27.0 t80 -76.57 117.95 68.13 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -94.78 -175.9 0.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.402 2.735 . . . . 0.0 113.479 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 395' ' ' GLU . 47.7 t80 -75.51 130.81 39.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.831 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.558 HD21 ' HE2' ' A' ' 391' ' ' PHE . 2.5 mm? -81.11 -5.39 57.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -171.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.566 ' HA ' ' CE2' ' A' ' 393' ' ' TYR . 63.0 mm-40 66.49 -71.67 0.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.482 0.489 . . . . 0.0 110.996 -173.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.56 24.08 7.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.851 -175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -140.8 169.25 24.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.466 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -82.9 138.8 33.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.559 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 3.6 p30 -105.68 59.26 0.66 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.01 0.433 . . . . 0.0 112.162 -173.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -78.74 -14.54 59.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.726 0.298 . . . . 0.0 110.732 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -117.7 9.65 13.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.728 0.299 . . . . 0.0 111.008 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.559 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 24.9 t80 -64.75 127.82 33.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 0.0 111.007 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 91.87 16.34 51.75 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.111 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -105.81 149.39 26.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.851 0.358 . . . . 0.0 110.915 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 60.4 mtpt -112.17 126.69 55.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.525 175.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -118.65 150.84 39.04 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.595 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 35.6 m -83.12 147.53 5.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.553 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.799 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.8 OUTLIER -64.18 128.27 35.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.374 -177.119 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.38 7.79 36.69 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 7.3 mmtt -114.79 163.32 15.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 20.3 t -138.89 164.88 28.51 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.367 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.0 tp -155.96 142.17 10.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.931 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -84.39 133.25 34.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.567 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 69.5 t -117.89 128.45 75.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.598 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.26 113.74 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.722 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.642 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 56.0 m -95.66 170.4 9.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -65.21 154.97 85.99 Favored Pre-proline 0 C--N 1.332 -0.164 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.025 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.9 105.92 0.16 Allowed 'Trans proline' 0 CA--C 1.521 -0.14 0 C-N-CA 123.747 2.965 . . . . 0.0 112.63 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.16 -11.75 11.52 Favored Glycine 0 C--N 1.317 -0.523 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.513 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -115.35 146.58 41.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.16 -179.05 7.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.703 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 97.9 mt -79.77 158.1 73.47 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-O 120.971 0.415 . . . . 0.0 110.544 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.33 150.37 41.57 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.528 2.152 . . . . 0.0 110.771 171.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.472 ' HB2' ' HG3' ' A' ' 426' ' ' GLN . 6.9 mtpm? 64.06 19.08 11.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.941 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 61.19 26.63 16.48 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.173 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.472 ' HG3' ' HB2' ' A' ' 424' ' ' LYS . 50.4 mt-30 -73.67 158.99 33.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.907 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 28.1 p -124.62 -23.13 4.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.313 0.578 . . . . 0.0 110.22 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.88 135.95 49.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.52 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.446 HG13 ' HG2' ' A' ' 438' ' ' PRO . 2.5 t -110.5 125.07 67.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 60.8 m -88.32 135.17 33.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.777 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 31.4 t -72.7 112.67 8.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.799 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 7.3 mtt -146.84 142.1 27.33 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.705 0.764 . . . . 0.0 111.321 174.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.545 ' C ' ' HD2' ' A' ' 387' ' ' ARG . 5.8 mm-40 39.09 40.32 0.47 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.232 -1.804 . . . . 0.0 113.084 -170.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 46.1 t30 70.33 -24.05 0.16 Allowed 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.704 0.628 . . . . 0.0 111.706 174.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -104.81 22.3 34.09 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.562 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.571 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 94.0 m95 56.35 128.78 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.858 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 71.8 m -51.38 -64.45 1.4 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.359 -169.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.858 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 42.6 Cg_endo -89.11 -2.53 6.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.049 1.832 . . . . 0.0 112.478 -176.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 18.6 m 73.74 121.61 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.295 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 30.7 Cg_endo -66.6 94.64 0.32 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.727 2.284 . . . . 0.0 111.699 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -131.03 106.54 8.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.778 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 76.4 m -83.36 81.39 8.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.916 0.389 . . . . 0.0 110.63 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 9.8 pt -87.76 161.42 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.884 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -75.38 121.77 22.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.385 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.9 p -112.05 13.68 8.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.336 -174.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 53.6 mttp . . . . . 0 C--O 1.25 1.106 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.211 179.669 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 73.0 mt . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 122.366 1.079 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 8.7 mtt-85 -78.95 166.49 22.31 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.591 -1.64 . . . . 0.0 112.388 -172.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 38.9 mmtm -117.65 90.57 3.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.014 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 15.2 m -59.62 120.97 10.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.511 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -90.33 124.81 35.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.655 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -80.32 120.72 80.31 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.278 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -83.53 -179.2 4.07 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.295 2.663 . . . . 0.0 112.636 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -93.87 121.99 35.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.4 0.619 . . . . 0.0 110.715 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.2 mp -89.31 129.26 35.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.392 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.89 -47.84 64.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.948 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -107.5 16.54 23.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.914 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -132.26 155.75 21.66 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.512 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -77.7 111.23 13.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.554 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 1.7 p-10 -79.22 61.61 3.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.869 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -66.18 -19.57 65.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.257 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -117.9 1.8 12.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.309 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.554 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 37.4 t80 -63.12 124.86 22.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 111.302 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.65 -9.79 41.24 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.304 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -100.66 152.76 20.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.69 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 52.2 mtmt -116.91 152.93 33.48 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.846 173.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 97.4 m-85 -134.9 150.31 50.41 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.914 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.7 m -80.08 144.93 9.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.159 0.504 . . . . 0.0 110.349 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.828 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.3 OUTLIER -62.01 125.68 24.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.555 -173.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.97 -0.95 24.28 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -95.88 161.61 13.93 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.153 -0.524 . . . . 0.0 110.387 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 21.1 t -141.33 163.29 33.36 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.1 tp -170.02 130.39 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.673 0.749 . . . . 0.0 110.517 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.768 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 14.1 t70 -83.66 132.55 34.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.336 -171.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 22.6 t -113.05 120.81 63.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.677 -175.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.02 122.87 29.86 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.518 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 67.5 m -116.02 173.11 6.75 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -62.48 158.15 51.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.212 0.529 . . . . 0.0 110.956 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.89 114.55 1.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.556 2.837 . . . . 0.0 111.949 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 444' ' ' ARG . . . 110.22 -5.03 30.1 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.207 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.671 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 84.6 m-85 -115.62 145.09 43.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.141 0.496 . . . . 0.0 110.946 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 442' ' ' CYS . . . -160.08 160.19 32.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.259 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.516 HD11 HG22 ' A' ' 429' ' ' VAL . 69.6 mt -71.55 151.45 93.79 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 121.064 0.459 . . . . 0.0 111.792 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 72.9 Cg_exo -53.14 147.66 34.03 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.415 2.743 . . . . 0.0 111.913 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 70.1 27.5 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.71 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.32 53.78 8.42 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.391 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -119.51 160.66 21.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.53 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 41.7 p -119.88 -17.15 8.57 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.004 0.431 . . . . 0.0 110.143 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.768 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 0.5 OUTLIER -120.11 160.1 23.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.837 0.827 . . . . 0.0 111.603 178.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.516 HG22 HD11 ' A' ' 422' ' ' LEU . 1.4 t -116.6 148.6 19.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.344 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 86.7 m -108.55 122.99 48.21 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.816 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.1 t -67.96 111.13 4.22 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.828 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 4.7 mtm -144.45 135.79 25.47 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.966 0.889 . . . . 0.0 112.583 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.758 ' H ' ' HG3' ' A' ' 408' ' ' GLN . 0.8 OUTLIER 46.66 37.41 4.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.064 -178.316 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.729 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 8.1 t30 72.66 -24.95 0.19 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.929 0.892 . . . . 0.0 112.7 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -108.13 43.75 1.64 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.037 -1.078 . . . . 0.0 114.257 -169.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.514 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.3 m95 36.25 105.41 0.0 OUTLIER 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 172.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.788 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 69.5 m -45.64 -59.57 4.41 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.244 -168.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 13.5 Cg_endo -90.65 -6.19 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.631 1.554 . . . . 0.0 113.248 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.653 HG22 ' HG3' ' A' ' 441' ' ' ARG . 24.4 m 71.95 121.9 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.517 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.514 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 1.2 Cg_endo -78.67 97.48 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.51 2.807 . . . . 0.0 111.413 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.653 ' HG3' HG22 ' A' ' 439' ' ' THR . 53.8 mtm180 -131.38 -45.77 0.99 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.608 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 68.0 m 64.78 91.97 0.07 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.074 0.94 . . . . 0.0 111.301 -177.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 7.0 mt -96.9 159.53 3.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.096 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 419' ' ' GLY . 31.7 ttt180 -64.67 121.91 15.61 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.986 0.898 . . . . 0.0 110.613 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 80.5 t -48.56 -45.24 14.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.914 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 446' ' ' LYS . 21.4 tptp . . . . . 0 C--O 1.243 0.716 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.392 171.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 121.312 0.577 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.894 ' HG3' ' HA ' ' A' ' 433' ' ' GLU . 34.2 mmt180 -76.08 171.2 14.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.448 -174.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.478 ' HD2' ' C ' ' A' ' 387' ' ' ARG . 0.1 OUTLIER -124.45 79.6 1.77 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.732 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 19.8 m -59.86 125.92 25.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.249 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -90.3 127.53 36.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 172.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.538 ' HE1' HD21 ' A' ' 394' ' ' LEU . 2.0 t80 -81.71 111.76 28.81 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' PRO . . . . . 0.409 ' C ' ' HD1' ' A' ' 402' ' ' TYR . 95.9 Cg_endo -88.92 -166.65 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.245 2.63 . . . . 0.0 113.241 -176.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' TYR . . . . . 0.458 ' HD1' HD22 ' A' ' 399' ' ' ASN . 55.3 t80 -78.14 134.84 37.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.002 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.626 HD23 ' HA ' ' A' ' 399' ' ' ASN . 2.6 mm? -86.05 106.97 17.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.656 177.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.73 ' O ' ' HB2' ' A' ' 442' ' ' CYS . 12.8 pt-20 -63.49 116.87 5.99 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 69.16 25.34 5.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.023 0.44 . . . . 0.0 110.351 -174.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -135.73 176.05 20.41 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.451 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -99.16 120.86 40.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.263 0.554 . . . . 0.0 110.45 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.626 ' HA ' HD23 ' A' ' 394' ' ' LEU . 9.2 p30 -79.37 59.56 2.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.759 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -70.13 -28.87 65.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.9 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -111.75 7.55 20.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.215 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.541 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 81.2 t80 -63.97 126.07 26.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.144 0.497 . . . . 0.0 110.371 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.66 -5.31 54.22 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.86 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.31 150.03 21.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.977 0.418 . . . . 0.0 110.888 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 59.3 mtpt -126.75 136.61 52.65 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.208 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -126.97 153.59 45.67 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.783 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 387' ' ' ARG . 27.0 m -86.66 144.94 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.975 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 42.0 tt0 -57.5 132.03 51.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 0.0 110.914 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.05 12.72 23.27 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 53.9 mmtt -115.14 155.51 26.98 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.185 -0.507 . . . . 0.0 110.533 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.6 t -132.4 161.53 33.4 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.3 tp -162.39 138.31 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.439 0.638 . . . . 0.0 110.294 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -89.3 137.24 32.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.835 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.42 137.57 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.288 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.89 118.84 34.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.281 0.562 . . . . 0.0 111.343 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.56 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 58.2 m -89.0 -175.9 4.99 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.598 173.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -64.5 152.05 90.18 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.05 103.07 0.14 Allowed 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 123.204 2.602 . . . . 0.0 111.58 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.702 ' O ' ' HB3' ' A' ' 444' ' ' ARG . . . 126.92 -10.08 7.07 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.571 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 1.037 ' HA ' ' CB ' ' A' ' 444' ' ' ARG . 59.8 m-85 -119.66 159.81 23.71 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 444' ' ' ARG . . . -151.18 173.66 14.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.821 -175.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 427' ' ' THR . 3.2 mm? -73.96 160.14 82.51 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 171.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.487 ' HG3' HD11 ' A' ' 443' ' ' ILE . 71.8 Cg_exo -48.61 136.74 26.85 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.947 2.431 . . . . 0.0 111.237 174.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 78.81 20.36 0.79 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.349 1.031 . . . . 0.0 110.061 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.76 44.2 20.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.071 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 422' ' ' LEU . 91.4 mt-30 -100.21 169.94 8.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.753 -177.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' THR . . . . . 0.483 ' HA ' HD23 ' A' ' 422' ' ' LEU . 74.8 p -123.05 -8.62 8.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.357 0.599 . . . . 0.0 109.477 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -113.76 149.85 34.28 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.474 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 19.9 m -124.83 144.74 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 172.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 39.1 m -108.1 129.19 55.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.326 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.2 t -72.33 110.03 6.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.975 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 9.1 mtt -142.02 137.6 31.24 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.812 0.815 . . . . 0.0 111.698 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.894 ' HA ' ' HG3' ' A' ' 387' ' ' ARG . 1.2 tp10 40.43 40.14 0.82 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.732 -2.031 . . . . 0.0 112.759 -174.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 9.3 t30 73.02 -16.33 0.47 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.021 0.528 . . . . 0.0 112.009 174.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -118.91 45.87 1.2 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.741 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.55 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.1 m95 35.21 106.2 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 172.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.744 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 64.0 m -41.15 -62.13 1.13 Allowed Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -172.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 62.6 Cg_endo -88.67 -2.86 6.56 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.681 1.588 . . . . 0.0 113.156 -174.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.759 HG22 ' HG3' ' A' ' 441' ' ' ARG . 28.8 m 72.94 119.37 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.575 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 61.5 Cg_endo -74.57 82.71 1.85 Allowed 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.729 2.286 . . . . 0.0 112.205 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.759 ' HG3' HG22 ' A' ' 439' ' ' THR . 49.5 mtp180 -133.18 132.29 41.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.825 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.73 ' HB2' ' O ' ' A' ' 395' ' ' GLU . 81.6 m -95.42 74.68 3.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.716 0.77 . . . . 0.0 111.38 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.487 HD11 ' HG3' ' A' ' 423' ' ' PRO . 1.6 pt -101.27 144.01 13.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.703 174.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 1.037 ' CB ' ' HA ' ' A' ' 420' ' ' TYR . 0.0 OUTLIER -175.35 -154.64 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -177.299 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.652 ' H ' ' HD2' ' A' ' 444' ' ' ARG . 7.6 p -87.06 -6.54 10.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 111.488 -2.596 . . . . 0.0 111.643 -169.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.082 176.272 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 N--CA 1.445 -0.692 0 CA-C-O 122.967 1.365 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.71 ' HG3' ' N ' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -59.42 174.98 0.37 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 112.846 -1.979 . . . . 0.0 116.041 -167.07 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.72 ' H ' ' HB2' ' A' ' 434' ' ' ASN . 0.1 OUTLIER -166.97 65.32 0.09 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 112.615 -2.084 . . . . 0.0 106.792 152.385 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.698 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 61.5 m -50.84 108.8 0.26 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.47 -1.695 . . . . 0.0 113.271 -166.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -90.64 120.95 32.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -69.55 122.84 87.05 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.75 167.15 24.39 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.187 2.591 . . . . 0.0 113.155 -175.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -85.96 116.41 24.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.598 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.5 117.17 28.98 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.784 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 0.0 OUTLIER -75.21 -31.51 60.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.111 0.481 . . . . 0.0 110.338 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 41.6 m-80 -98.48 20.05 13.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.047 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -134.19 178.49 18.35 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.207 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -90.01 -10.12 46.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.779 0.323 . . . . 0.0 111.591 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 6.8 p30 42.21 36.69 0.75 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.355 1.062 . . . . 0.0 113.558 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -62.99 -26.06 68.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.778 0.323 . . . . 0.0 111.183 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -94.88 -6.76 41.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.352 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -61.23 118.64 7.12 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.36 -10.22 22.14 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.511 -174.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -100.38 146.64 26.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.719 0.295 . . . . 0.0 110.723 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' LYS . . . . . 0.698 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 56.7 mtpt -119.46 152.17 37.33 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.261 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.469 ' CD1' ' HH2' ' A' ' 436' ' ' TRP . 94.8 m-85 -139.79 162.87 34.09 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.385 0.612 . . . . 0.0 111.437 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 35.3 m -97.54 146.22 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.644 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.9 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 40.7 tt0 -69.42 122.76 19.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.041 0.448 . . . . 0.0 110.558 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.45 12.67 11.47 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 1.1 tmtm? -116.41 162.68 17.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.813 -0.693 . . . . 0.0 109.481 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.5 t -132.25 158.23 42.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.934 0.397 . . . . 0.0 110.171 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.1 tp -149.68 140.73 16.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.146 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -82.41 132.2 35.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.738 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 422' ' ' LEU . 92.3 t -111.83 139.97 33.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.156 0.503 . . . . 0.0 111.191 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -113.35 103.07 10.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.17 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.611 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 70.7 m -99.17 165.8 11.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 171.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -68.3 153.17 95.92 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.107 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.77 108.71 0.3 Allowed 'Trans proline' 0 CA--C 1.521 -0.156 0 C-N-CA 123.702 2.935 . . . . 0.0 112.278 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.76 -11.03 11.14 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.612 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 99.3 m-85 -116.49 141.33 48.31 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -144.47 178.9 7.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.066 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 59.4 mt -92.27 156.93 41.38 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.85 0.357 . . . . 0.0 111.044 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 58.2 Cg_exo -54.1 144.65 57.23 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.174 2.583 . . . . 0.0 111.562 173.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 29.1 mtpp 72.45 19.14 4.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.188 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.1 26.29 13.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.317 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.632 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 27.3 mt-30 -85.26 157.31 20.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.062 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.9 p -116.37 0.92 12.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.541 0.686 . . . . 0.0 109.846 173.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.25 140.43 52.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.941 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.512 HG23 HG21 ' A' ' 414' ' ' VAL . 45.6 t -115.4 132.29 65.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.102 0.477 . . . . 0.0 109.718 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 19.3 m -88.02 129.66 35.21 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.138 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 33.8 t -71.41 111.59 6.86 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.9 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 1.0 OUTLIER -141.96 121.83 13.59 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 122.466 1.126 . . . . 0.0 112.105 172.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' A' ' 433' ' ' GLU . 35.5 tt0 51.51 36.65 17.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 111.978 -2.374 . . . . 0.0 112.295 177.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.72 ' HB2' ' H ' ' A' ' 388' ' ' LYS . 63.9 t30 61.98 15.46 7.28 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.066 0.936 . . . . 0.0 109.681 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -123.2 17.05 8.05 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.768 -173.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.469 ' HH2' ' CD1' ' A' ' 406' ' ' PHE . 93.4 m95 36.42 101.42 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.92 1.012 . . . . 0.0 113.073 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.716 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 62.6 m -44.52 -61.81 1.92 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -165.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.716 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 41.2 Cg_endo -83.31 -3.12 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.043 1.828 . . . . 0.0 112.961 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.647 HG22 ' HG3' ' A' ' 441' ' ' ARG . 26.3 m 74.35 114.19 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.972 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.423 ' HG3' HG11 ' A' ' 429' ' ' VAL . 13.1 Cg_exo -68.78 95.95 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.948 2.432 . . . . 0.0 111.94 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.647 ' HG3' HG22 ' A' ' 439' ' ' THR . 51.6 mtp180 -135.89 117.84 15.27 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.732 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 62.4 m -82.05 82.86 7.49 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 5.1 pt -82.88 144.67 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.378 0.608 . . . . 0.0 111.066 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.5 ttm105 -71.49 120.22 16.76 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.416 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.6 p -96.63 15.57 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.957 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.705 175.825 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 N--CA 1.443 -0.786 0 CA-C-O 121.401 0.619 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.952 ' HD3' ' HA ' ' A' ' 434' ' ' ASN . 0.3 OUTLIER -71.2 162.52 29.29 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.585 178.264 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 387' ' ' ARG . 0.0 OUTLIER -115.64 108.16 16.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.063 0.459 . . . . 0.0 111.897 -170.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 71.2 m -86.98 143.89 27.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.327 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -125.78 119.77 28.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 26.7 t80 -70.12 118.86 67.75 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.749 0.309 . . . . 0.0 110.41 -174.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 93.2 Cg_endo -90.26 -175.57 0.95 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.194 2.596 . . . . 0.0 113.525 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' TYR . . . . . 0.458 ' HA ' ' OD1' ' A' ' 399' ' ' ASN . 87.7 t80 -91.04 116.92 29.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.61 -173.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 440' ' ' PRO . 3.5 mm? -74.41 117.91 16.77 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.44 -26.63 63.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.535 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -136.41 38.58 2.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.395 0.617 . . . . 0.0 110.519 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -124.29 168.32 16.45 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.4 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -87.39 -4.96 59.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 393' ' ' TYR . 53.7 m-80 44.04 47.55 7.31 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 170.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -65.45 -15.31 62.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.743 0.306 . . . . 0.0 111.039 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -122.38 12.34 10.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -68.91 129.21 39.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.66 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 102.17 8.4 44.49 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.174 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -98.84 152.34 19.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.401 0.62 . . . . 0.0 111.888 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -116.64 143.42 45.65 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.434 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -141.22 151.24 43.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.274 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 29.3 m -93.81 150.99 3.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 170.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 1.0 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 46.2 tt0 -62.48 138.19 58.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.341 0.591 . . . . 0.0 111.207 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.16 14.17 23.15 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -174.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 7.7 mmmt -118.92 161.37 20.31 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.699 -0.75 . . . . 0.0 110.05 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.2 t -131.81 165.96 22.64 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.26 144.16 11.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.173 0.511 . . . . 0.0 110.722 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -84.32 143.05 29.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.853 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.414 HG22 ' HZ ' ' A' ' 391' ' ' PHE . 46.8 t -126.57 127.61 70.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.962 0.411 . . . . 0.0 110.922 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -97.43 95.01 7.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.616 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 34.3 m -87.04 145.73 26.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.614 ' ND1' ' HD2' ' A' ' 418' ' ' PRO . 16.4 t60 -59.19 144.44 83.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 0.0 110.979 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' PRO . . . . . 0.614 ' HD2' ' ND1' ' A' ' 417' ' ' HIS . 95.3 Cg_exo -45.21 106.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.477 1 C-N-CA 125.427 4.084 . . . . 0.0 112.734 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 125.11 -17.5 7.09 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.127 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -110.16 150.14 29.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.001 0.429 . . . . 0.0 111.117 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -149.3 166.96 27.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.733 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 62.9 mt -88.88 153.14 49.44 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 120.69 0.281 . . . . 0.0 110.892 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.61 144.27 33.93 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.192 2.595 . . . . 0.0 112.141 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 68.88 23.7 6.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.876 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 54.18 47.22 23.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.249 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 93.7 mt-30 -108.33 167.64 9.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.534 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 12.2 t -126.57 0.09 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -119.7 145.84 46.16 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.161 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.633 HG13 ' HG2' ' A' ' 438' ' ' PRO . 12.5 t -115.7 133.23 62.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.945 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 18.0 m -93.99 124.47 38.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.81 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.5 t -71.86 111.41 7.09 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.604 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' MET . . . . . 1.0 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 30.0 mtp -140.08 -177.38 4.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.533 ' HG2' HE22 ' A' ' 408' ' ' GLN . 9.4 mm-40 -32.98 88.55 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 125.95 2.031 . . . . 0.0 114.387 -175.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.952 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 10.3 t-20 68.9 12.28 8.59 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 112.088 -2.324 . . . . 0.0 110.653 168.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 179.23 134.64 2.2 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.403 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.436 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 91.1 m95 -38.93 117.89 0.71 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 165.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.599 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 14.8 m -67.1 -52.27 31.52 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -168.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.633 ' HG2' HG13 ' A' ' 429' ' ' VAL . 25.5 Cg_endo -83.56 -9.14 10.26 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 120.919 1.079 . . . . 0.0 112.196 -175.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.581 HG22 ' HG2' ' A' ' 441' ' ' ARG . 11.0 m 71.61 109.53 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.23 173.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.416 ' HB2' HD11 ' A' ' 394' ' ' LEU . 37.5 Cg_endo -69.42 98.31 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.35 2.033 . . . . 0.0 110.945 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.581 ' HG2' HG22 ' A' ' 439' ' ' THR . 21.9 mmm180 -120.58 -36.89 3.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.735 -175.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 82.9 m 56.68 69.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.498 0.666 . . . . 0.0 110.117 -174.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 5.7 pt -87.04 154.42 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.714 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -61.09 121.72 13.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.989 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.4 p -74.44 -5.79 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.032 -171.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 48.7 pttt . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.55 -1.214 . . . . 0.0 111.971 -178.862 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 386' ' ' LEU . 14.0 mt . . . . . 0 N--CA 1.432 -1.349 0 CA-C-O 123.762 1.744 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.799 ' NH1' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -109.45 -156.41 0.58 Allowed 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 110.456 -3.065 . . . . 0.0 112.571 -168.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 387' ' ' ARG . 12.9 tptt -164.61 88.63 0.49 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.602 167.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 434' ' ' ASN . 58.6 m -51.3 111.99 0.66 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.584 0.553 . . . . 0.0 111.295 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -89.45 118.28 28.99 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -72.8 123.22 89.31 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.805 0.336 . . . . 0.0 110.128 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.74 169.02 18.74 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.094 2.53 . . . . 0.0 113.765 -174.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -88.34 106.83 18.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.813 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.38 108.25 17.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -63.22 -40.2 96.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.867 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -100.49 19.69 16.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.568 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -132.14 172.98 20.88 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.093 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -88.03 104.47 16.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 2.3 p30 -74.54 55.41 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.38 -178.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -64.62 -42.85 95.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.779 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -101.72 0.88 36.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.419 -170.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 23.6 t80 -61.5 124.07 19.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.112 0.482 . . . . 0.0 110.38 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.42 -9.3 38.44 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.704 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -89.75 147.32 23.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.247 0.546 . . . . 0.0 111.134 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 37.6 mtpt -121.66 135.47 54.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.797 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -129.25 158.15 39.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.213 0.53 . . . . 0.0 111.34 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.8 m -87.78 144.48 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.006 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.827 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.8 OUTLIER -52.55 139.79 24.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.963 0.411 . . . . 0.0 111.492 177.339 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.47 10.89 57.71 Favored Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -110.89 154.62 23.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 30.8 t -132.47 159.15 40.19 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.047 0.451 . . . . 0.0 110.409 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.2 tp -155.57 141.43 10.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.501 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -91.56 139.99 30.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.822 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 19.3 t -126.05 146.08 32.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.277 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -122.63 131.43 53.81 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.614 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 56.4 m -103.79 170.54 7.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -72.7 156.7 89.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.814 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.32 110.68 0.48 Allowed 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.821 3.014 . . . . 0.0 112.529 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.45 -6.02 16.82 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.788 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 96.1 m-85 -122.97 145.6 48.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.792 0.33 . . . . 0.0 110.769 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -149.83 157.16 42.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.945 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.645 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 46.6 mt -78.44 156.21 78.55 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.82 0.343 . . . . 0.0 111.199 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.481 ' HG3' HD11 ' A' ' 443' ' ' ILE . 50.2 Cg_exo -53.04 144.49 45.91 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.067 2.511 . . . . 0.0 112.018 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 71.73 14.76 6.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.436 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 60.4 30.47 19.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.515 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.645 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 76.1 mt-30 -92.18 168.77 11.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.846 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 79.8 p -126.12 -26.11 3.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.474 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.89 134.53 35.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.426 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.546 HG13 ' HG2' ' A' ' 438' ' ' PRO . 3.5 t -109.88 142.89 21.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.451 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 27.6 m -103.91 126.81 51.31 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.212 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.404 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.6 t -70.08 108.72 4.21 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.827 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 9.7 mtt -144.55 132.89 21.86 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.324 1.059 . . . . 0.0 112.42 174.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.684 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 2.4 tm-20 46.38 32.16 1.48 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.09 -2.323 . . . . 0.0 110.687 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.492 ' HA ' ' SG ' ' A' ' 389' ' ' CYS . 45.5 t-20 76.03 -27.71 0.18 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.45 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -97.91 40.05 2.61 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.237 -171.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.548 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.0 m95 35.99 106.44 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 172.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.775 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 72.2 m -44.54 -60.09 3.31 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -170.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.775 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 31.3 Cg_endo -88.36 -6.6 6.13 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.882 1.722 . . . . 0.0 112.874 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 80.9 m 72.8 116.33 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 114.898 -1.047 . . . . 0.0 113.072 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.548 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 18.4 Cg_endo -88.76 109.76 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.498 2.799 . . . . 0.0 110.734 174.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -147.2 -17.65 0.39 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 77.2 m 58.1 87.07 0.07 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.406 0.622 . . . . 0.0 111.489 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.481 HD11 ' HG3' ' A' ' 423' ' ' PRO . 11.0 mt -85.54 158.84 3.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -78.88 124.86 28.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.215 0.531 . . . . 0.0 109.923 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 5.6 p -93.62 -15.16 8.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.119 -177.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.092 -179.586 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.436 -1.145 0 CA-C-O 121.007 0.432 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.732 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 2.0 mmp_? -121.81 177.1 5.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.539 0.685 . . . . 0.0 111.801 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -125.17 94.56 4.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.932 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 20.5 m -62.52 113.45 2.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.129 0.49 . . . . 0.0 111.707 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.505 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 53.2 t80 -79.65 112.01 16.5 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.779 173.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -62.68 123.38 79.14 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.23 172.03 13.22 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.259 2.639 . . . . 0.0 113.297 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -90.62 125.17 35.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.323 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 29.3 mt -103.92 130.06 51.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.571 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -91.79 -32.76 15.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.668 0.747 . . . . 0.0 109.105 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -94.63 5.04 53.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.61 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -142.19 170.9 24.81 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.202 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -87.59 113.94 23.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.941 0.401 . . . . 0.0 110.356 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -83.31 51.77 2.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.577 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -70.31 -17.24 63.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.94 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -114.25 1.16 14.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.992 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -63.0 127.99 33.8 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.31 0.576 . . . . 0.0 111.473 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.505 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 103.05 -0.24 47.88 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.684 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -108.72 141.93 39.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.868 0.366 . . . . 0.0 110.472 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -105.66 130.43 53.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.617 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -109.52 150.86 27.53 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.747 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.34 139.33 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.276 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.842 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 12.6 tt0 -60.28 126.21 26.64 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.557 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 101.07 13.42 33.81 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -173.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -110.25 151.71 27.02 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.2 t -124.84 160.63 28.32 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -170.8 127.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.666 0.746 . . . . 0.0 110.013 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.714 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 29.8 t70 -79.09 130.0 35.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.876 -172.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 429' ' ' VAL . 31.6 t -106.38 157.53 6.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.278 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -120.55 94.34 4.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.864 0.364 . . . . 0.0 111.221 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 92.9 m -83.79 150.96 25.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.615 ' NE2' ' HE2' ' A' ' 420' ' ' TYR . 1.5 p-80 -74.68 152.23 87.14 Favored Pre-proline 0 N--CA 1.461 0.103 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.765 -170.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 417' ' ' HIS . 2.7 Cg_exo -32.32 112.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.856 3.704 . . . . 0.0 114.639 -173.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.21 -5.14 35.76 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.22 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.615 ' HE2' ' NE2' ' A' ' 417' ' ' HIS . 63.2 m-85 -120.74 144.49 48.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.989 0.423 . . . . 0.0 111.147 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -152.09 -167.12 2.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.574 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.505 HD13 HG22 ' A' ' 429' ' ' VAL . 70.4 mt -108.27 160.43 27.05 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-O 120.904 0.383 . . . . 0.0 111.918 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.421 ' HG3' HD11 ' A' ' 443' ' ' ILE . 87.7 Cg_exo -47.69 143.26 12.8 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.597 2.865 . . . . 0.0 112.715 175.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt 67.47 30.45 6.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.729 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.49 33.02 20.15 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.609 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -97.35 169.41 9.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.028 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' THR . . . . . 0.477 ' C ' HD12 ' A' ' 422' ' ' LEU . 39.2 p -126.94 1.19 6.61 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.781 173.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.714 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 1.9 t -124.46 163.81 21.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.635 0.731 . . . . 0.0 111.654 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.523 HG13 ' HG2' ' A' ' 438' ' ' PRO . 2.0 t -129.77 142.56 43.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.34 -177.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 78.6 m -99.94 136.9 39.15 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.101 174.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 13.6 t -74.93 119.67 19.43 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.842 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 11.5 mtp -152.1 136.9 17.09 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.73 0.776 . . . . 0.0 111.657 174.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.761 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 18.9 mt-10 45.33 38.83 3.83 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.149 -1.842 . . . . 0.0 111.947 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.469 ' HB2' ' HD3' ' A' ' 387' ' ' ARG . 43.3 t30 68.89 -24.57 0.14 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.232 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -102.26 18.54 51.25 Favored Glycine 0 CA--C 1.501 -0.834 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.898 -169.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.714 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 96.4 m95 59.45 128.87 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 124.539 0.788 . . . . 0.0 112.989 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.806 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 71.1 m -49.76 -64.55 1.18 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.224 -170.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.806 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 28.2 Cg_endo -87.69 -7.6 6.42 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.692 1.594 . . . . 0.0 112.278 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 27.3 m 74.39 123.3 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.841 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.714 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 11.2 Cg_exo -62.99 93.35 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.166 2.577 . . . . 0.0 111.721 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -130.49 108.94 10.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 82.1 m -75.55 90.01 2.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.228 0.537 . . . . 0.0 110.567 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.421 HD11 ' HG3' ' A' ' 423' ' ' PRO . 11.2 mt -87.24 159.43 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.543 -0.753 . . . . 0.0 108.969 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -80.4 119.77 23.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.278 0.561 . . . . 0.0 110.303 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 445' ' ' VAL . 10.5 p -106.35 45.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.209 1.004 . . . . 0.0 110.679 -172.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.903 ' H ' ' HD3' ' A' ' 446' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.542 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.43 -1.473 0 CA-C-O 122.279 1.037 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 1.032 ' HG2' ' HB3' ' A' ' 408' ' ' GLN . 1.0 OUTLIER 55.53 -169.11 0.08 Allowed 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 159.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 0.0 OUTLIER 53.3 62.71 2.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 112.012 -2.358 . . . . 0.0 111.757 -168.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 14.5 m -67.57 134.02 50.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.223 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -91.89 132.36 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 401' ' ' ASN . 26.7 t80 -93.72 111.69 53.69 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.754 0.311 . . . . 0.0 110.702 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -92.61 -163.4 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.235 2.624 . . . . 0.0 113.442 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -85.88 140.66 30.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.355 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 394' ' ' LEU . 2.6 mm? -89.14 15.77 8.27 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -173.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 67.59 -69.54 0.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.498 0.666 . . . . 0.0 111.497 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -131.76 45.52 2.77 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.798 -177.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -142.07 177.03 21.75 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.053 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -88.8 118.99 28.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.222 0.534 . . . . 0.0 111.263 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . 2.5 p30 -87.62 86.52 7.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.034 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.79 -19.24 49.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.508 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 44.9 m-80 -136.73 28.92 2.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.49 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 50.4 t80 -69.09 122.24 18.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.09 0.471 . . . . 0.0 110.624 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 100.93 0.11 55.07 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.977 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -97.46 154.51 17.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.932 0.396 . . . . 0.0 111.304 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 39.0 mtmt -127.35 138.86 53.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.131 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 98.8 m-85 -128.84 158.45 38.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 -173.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.9 m -76.4 155.5 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.304 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 1.032 ' HB3' ' HG2' ' A' ' 387' ' ' ARG . 11.1 tt0 -77.5 124.43 27.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.466 0.651 . . . . 0.0 109.859 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.45 5.7 26.01 Favored Glycine 0 C--N 1.315 -0.633 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -104.12 149.06 25.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.536 -0.832 . . . . 0.0 109.15 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.4 t -129.75 158.71 38.64 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.046 0.45 . . . . 0.0 110.211 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.6 tp -156.54 139.09 6.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.079 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.63 133.48 34.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.145 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 35.2 t -123.41 133.44 69.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.166 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -109.21 128.07 54.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.575 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 0.8 OUTLIER -100.77 -169.25 1.68 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 174.3 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -82.13 157.44 68.45 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -54.08 110.99 0.58 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.43 2.753 . . . . 0.0 112.206 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.08 -9.95 10.21 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.185 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 77.2 m-85 -119.74 132.13 55.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -153.72 159.68 42.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 92.4 mt -70.1 153.41 95.34 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.643 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.36 150.88 47.82 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.593 2.195 . . . . 0.0 110.805 172.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.52 ' HB2' ' HG3' ' A' ' 426' ' ' GLN . 53.2 mttp 70.84 21.11 5.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.65 0.594 . . . . 0.0 110.492 -177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.97 26.73 15.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.489 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 53.7 mt-30 -84.44 158.03 21.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.195 0.521 . . . . 0.0 111.225 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 65.9 p -126.34 -9.54 6.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.87 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.24 137.62 41.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.441 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.609 HG13 ' HG2' ' A' ' 438' ' ' PRO . 2.6 t -112.98 128.07 69.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 26.0 m -99.29 124.68 44.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.593 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 38.1 t -69.03 115.91 8.88 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.911 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 29.9 mtp -138.48 129.33 26.66 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 122.745 1.26 . . . . 0.0 113.064 175.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.633 ' H ' ' CG ' ' A' ' 408' ' ' GLN . 2.2 tp10 46.43 43.48 11.99 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 111.872 -2.422 . . . . 0.0 111.428 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 433' ' ' GLU . 26.3 t-20 78.77 -9.49 1.5 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.408 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -131.64 88.89 0.28 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.712 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -12.55 114.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.793 1.237 . . . . 0.0 112.713 170.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.712 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 30.3 m -62.88 -54.49 46.54 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.279 -171.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.609 ' HG2' HG13 ' A' ' 429' ' ' VAL . 24.2 Cg_endo -85.36 -8.15 8.69 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.54 1.493 . . . . 0.0 111.957 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 9.9 m 71.17 121.27 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.59 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.07 76.95 2.47 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.636 2.224 . . . . 0.0 112.207 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -139.16 95.89 3.02 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.681 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 420' ' ' TYR . 2.1 p -76.33 92.21 3.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.386 0.612 . . . . 0.0 110.336 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.1 pt -73.22 160.39 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.782 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -81.48 114.2 20.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.141 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 5.9 p -106.5 -5.65 10.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.992 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp . . . . . 0 C--O 1.249 1.047 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.373 -179.15 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 63.1 mt . . . . . 0 N--CA 1.441 -0.905 0 CA-C-O 121.286 0.565 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.574 ' HD2' ' C ' ' A' ' 433' ' ' GLU . 62.5 mtt180 -91.18 158.31 16.69 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.671 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 12.5 mptt -118.54 109.56 16.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.481 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 5.5 p -69.82 144.14 52.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.283 0.563 . . . . 0.0 112.196 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -116.24 120.8 40.12 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 21.2 t80 -77.87 121.62 84.39 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 -176.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 78.8 Cg_endo -88.83 -177.14 1.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.491 2.794 . . . . 0.0 112.942 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -94.45 126.9 40.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.695 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 3.4 mm? -81.93 6.18 16.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 57.14 -89.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.248 0.547 . . . . 0.0 110.312 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.22 50.67 1.8 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.841 175.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -153.08 163.63 30.6 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -77.03 -22.74 52.55 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.616 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . 8.1 p30 39.54 54.62 2.39 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.423 0.689 . . . . 0.0 112.426 175.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -22.92 63.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.141 -173.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.417 ' HB2' ' HD3' ' A' ' 404' ' ' ARG . 5.7 p30 -127.18 34.28 4.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.243 0.544 . . . . 0.0 111.613 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.616 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 27.9 t80 -63.95 133.45 53.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.194 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 92.6 15.91 51.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.495 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.417 ' HD3' ' HB2' ' A' ' 401' ' ' ASN . 42.0 mtp180 -107.07 154.69 20.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.294 0.568 . . . . 0.0 111.644 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 49.8 mtmt -118.97 140.84 49.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.46 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.642 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 88.2 m-85 -140.13 159.6 41.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.645 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.52 147.2 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.976 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 51.9 tt0 -63.15 141.18 58.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.111 0.482 . . . . 0.0 111.337 -176.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.15 8.97 35.1 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 61.9 mmtt -113.23 179.56 3.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.365 -176.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.8 t -150.45 160.97 43.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.11 0.481 . . . . 0.0 110.365 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.452 HD13 ' H ' ' A' ' 413' ' ' ASP . 0.4 OUTLIER -154.15 149.65 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.574 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.452 ' H ' HD13 ' A' ' 412' ' ' ILE . 15.2 t70 -90.7 141.89 28.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.75 -176.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 28.9 t -126.63 141.22 46.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.27 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -125.23 118.16 25.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.833 0.349 . . . . 0.0 110.736 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 74.7 m -103.46 -178.64 3.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -58.32 154.14 33.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.169 174.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.83 108.53 0.49 Allowed 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.7 2.934 . . . . 0.0 112.179 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.63 -13.12 15.34 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -113.3 147.98 36.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.375 -0.412 . . . . 0.0 109.908 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -159.47 179.23 9.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.162 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.656 HD13 HG13 ' A' ' 429' ' ' VAL . 87.2 mt -76.86 160.7 76.01 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.9 141.11 22.35 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.978 2.452 . . . . 0.0 111.937 173.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 68.0 30.5 5.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.173 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.44 30.09 16.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.659 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 97.6 mt-30 -91.29 158.53 16.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.991 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 8.2 p -118.38 -4.82 10.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.141 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.66 140.72 52.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.96 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.656 HG13 HD13 ' A' ' 422' ' ' LEU . 3.3 m -108.61 133.23 54.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.129 0.49 . . . . 0.0 110.16 174.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 76.9 m -85.44 128.18 34.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.513 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 53.4 t -69.54 106.09 2.88 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.976 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 6.4 mtt -143.09 139.26 30.38 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.633 0.73 . . . . 0.0 111.552 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.574 ' C ' ' HD2' ' A' ' 387' ' ' ARG . 7.0 mm-40 41.41 40.5 1.29 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 112.956 -1.929 . . . . 0.0 112.637 -176.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 4.3 t-20 70.22 -23.6 0.16 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.49 176.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -103.9 15.35 52.05 Favored Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.799 -170.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.46 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 85.1 m95 56.04 125.72 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.735 0.814 . . . . 0.0 112.523 -174.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.769 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 58.5 m -44.47 -61.87 1.88 Allowed Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -172.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 64.3 Cg_endo -88.42 -3.62 6.71 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.704 1.603 . . . . 0.0 112.817 -175.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 28.5 m 68.98 109.3 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.606 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 11.5 Cg_endo -55.14 102.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.794 2.996 . . . . 0.0 112.455 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -141.76 131.62 24.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.992 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 76.6 m -87.05 91.21 8.63 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.137 0.494 . . . . 0.0 109.869 175.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 8.9 mt -94.28 157.73 3.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -88.84 108.18 19.38 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.4 0.619 . . . . 0.0 109.712 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.87 -15.67 15.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.753 -173.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.647 -179.584 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.604 ' N ' ' HG3' ' A' ' 433' ' ' GLU . 74.3 mt . . . . . 0 N--CA 1.444 -0.764 0 CA-C-O 121.836 0.826 . . . . 0.0 111.844 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.94 ' HG3' ' CB ' ' A' ' 408' ' ' GLN . 7.8 mpt_? -44.7 -174.29 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 177.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 39.3 ttmt 73.98 79.17 0.12 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 112.471 -2.15 . . . . 0.0 112.362 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 435' ' ' GLY . 3.2 m -87.28 155.87 19.88 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.755 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -119.18 128.53 54.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -81.25 122.43 81.3 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.587 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.6 172.27 11.45 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.205 2.603 . . . . 0.0 113.388 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -85.94 123.33 31.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.07 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 394' ' ' LEU . 2.2 mm? -95.74 119.49 34.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -76.91 -32.09 57.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.319 0.58 . . . . 0.0 109.867 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 8.9 m120 -100.63 10.37 41.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.556 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.627 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -131.46 175.95 19.37 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.582 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -92.81 109.99 21.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 1.8 p-10 -81.12 48.04 1.08 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.239 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.89 -32.86 74.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.328 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.535 ' ND2' HD12 ' A' ' 412' ' ' ILE . 78.7 m-20 -95.63 -9.42 32.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.126 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 52.0 t80 -59.94 129.74 43.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.221 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 95.29 5.15 60.71 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.247 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -104.43 148.3 26.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.086 0.47 . . . . 0.0 110.759 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -124.59 143.78 50.52 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.86 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 87.4 m-85 -139.39 156.39 47.02 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.306 -173.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 26.2 m -88.03 137.59 20.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.818 174.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.94 ' CB ' ' HG3' ' A' ' 387' ' ' ARG . 11.7 tt0 -53.14 137.84 32.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.016 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.79 7.76 25.15 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -112.75 151.55 30.16 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.439 -0.88 . . . . 0.0 110.025 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 35.6 t -131.4 153.32 49.8 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.535 HD12 ' ND2' ' A' ' 401' ' ' ASN . 0.2 OUTLIER -152.72 144.14 15.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.781 -173.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.477 ' N ' HD13 ' A' ' 412' ' ' ILE . 28.5 t70 -81.89 137.64 35.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.392 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 64.3 t -121.84 126.83 75.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.46 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.72 128.25 54.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.315 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.627 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 61.2 m -105.92 -178.45 3.65 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -76.13 154.95 84.56 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.12 112.07 0.77 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.655 2.904 . . . . 0.0 112.457 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 445' ' ' VAL . . . 115.08 -12.76 19.7 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.905 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -111.06 148.73 31.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.709 0.29 . . . . 0.0 110.643 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.87 162.11 39.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.453 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.14 158.38 81.67 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.809 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.67 135.17 61.31 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.771 2.314 . . . . 0.0 111.555 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 69.86 17.46 7.56 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.992 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 63.53 39.67 8.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.436 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -78.46 158.84 28.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.492 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 49.9 p -121.93 -13.58 8.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.48 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.83 149.74 47.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.585 -175.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.639 HG11 ' HG3' ' A' ' 440' ' ' PRO . 13.0 t -126.88 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.469 ' H ' ' CD ' ' A' ' 438' ' ' PRO . 38.6 m -103.53 123.1 46.29 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.49 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 43.2 t -64.12 116.35 5.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.313 174.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.803 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 32.7 mtt -145.46 133.27 21.16 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.762 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 33.4 tt0 28.47 68.09 0.08 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.135 -169.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.415 ' HA ' ' C ' ' A' ' 388' ' ' LYS . 2.3 p-10 56.57 31.31 18.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.224 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' A' ' 389' ' ' CYS . . . -150.55 -158.19 8.14 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.723 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.45 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 96.9 m95 -136.36 113.25 10.34 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -174.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 12.7 t -66.32 -51.24 44.75 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.951 -168.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.526 ' CG ' ' HA ' ' A' ' 429' ' ' VAL . 25.7 Cg_endo -91.29 0.97 4.7 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.44 1.427 . . . . 0.0 112.504 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.53 HG22 ' HG3' ' A' ' 441' ' ' ARG . 13.3 m 73.71 112.0 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.928 171.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.639 ' HG3' HG11 ' A' ' 429' ' ' VAL . 1.3 Cg_endo -79.77 93.53 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.031 2.487 . . . . 0.0 112.07 175.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.53 ' HG3' HG22 ' A' ' 439' ' ' THR . 78.7 mtp180 -138.94 114.74 10.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.271 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 396' ' ' ASN . 76.2 m -81.88 83.32 7.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.491 . . . . 0.0 110.557 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 10.5 mt -83.12 158.08 3.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -78.92 114.58 17.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.264 0.554 . . . . 0.0 109.879 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 446' ' ' LYS . 9.8 p -87.16 -33.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.163 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 445' ' ' VAL . 58.5 tttp . . . . . 0 C--O 1.245 0.846 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.118 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 N--CA 1.44 -0.934 0 CA-C-O 121.558 0.694 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.955 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 9.9 mmt180 -63.47 166.19 6.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.291 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.88 90.93 3.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.379 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 23.9 m -64.79 133.72 52.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.773 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.565 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 55.9 t80 -102.63 123.98 47.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 401' ' ' ASN . 27.5 t80 -80.46 119.46 76.42 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -87.76 -171.03 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.387 2.725 . . . . 0.0 113.323 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' TYR . . . . . 0.419 ' HA ' ' OD1' ' A' ' 399' ' ' ASN . 80.4 t80 -105.59 111.94 24.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.497 -174.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.07 117.79 25.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.46 -36.1 82.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.155 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -108.04 28.2 8.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.905 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -138.9 165.75 25.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.589 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -90.74 111.11 22.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.156 0.503 . . . . 0.0 110.139 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.63 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . 42.3 m-80 -92.63 70.03 4.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.106 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -76.71 -6.57 52.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.255 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 40.4 m-80 -135.22 23.23 3.49 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.591 0.234 . . . . 0.0 111.372 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.63 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 22.9 t80 -68.89 129.35 39.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 110.931 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.565 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 90.44 14.51 58.47 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.702 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -111.04 145.38 38.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.931 0.396 . . . . 0.0 110.903 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 98.0 mttt -108.72 134.87 50.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.287 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -126.88 149.87 49.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.651 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 32.3 m -85.6 148.68 4.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 1.068 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 49.9 tt0 -59.6 140.25 56.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.189 0.518 . . . . 0.0 111.175 -176.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.03 10.92 35.67 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -109.93 152.99 25.14 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.537 -0.831 . . . . 0.0 109.417 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 41.1 t -128.48 157.21 41.78 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 11.1 tp -148.86 139.69 16.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.545 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.84 132.5 36.13 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.808 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.621 ' HB ' HD11 ' A' ' 422' ' ' LEU . 46.7 t -130.77 101.63 5.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.017 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.72 115.74 27.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.406 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.654 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 82.9 m -84.81 174.12 10.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.906 174.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -62.84 156.75 64.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.722 0.296 . . . . 0.0 110.485 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.21 110.08 0.44 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.657 2.905 . . . . 0.0 112.53 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.55 -12.04 15.95 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.898 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.33 156.05 26.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.946 0.403 . . . . 0.0 110.706 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -157.21 167.63 29.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.153 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.621 HD11 ' HB ' ' A' ' 414' ' ' VAL . 87.3 mt -72.74 153.23 91.4 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.851 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.58 141.58 62.79 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.949 2.433 . . . . 0.0 111.63 176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 64.8 mttm 71.4 24.85 3.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.044 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.01 51.3 7.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.319 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 97.5 mt-30 -114.45 165.44 12.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.217 -176.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 29.0 p -129.7 -4.1 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.14 137.93 53.07 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.555 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.542 HG13 ' HG2' ' A' ' 438' ' ' PRO . 16.3 t -113.63 132.94 61.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.639 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 25.1 m -101.02 124.19 46.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.719 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.7 t -64.01 113.88 3.77 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' MET . . . . . 1.068 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 44.0 mtt -142.07 132.37 24.96 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.742 0.782 . . . . 0.0 111.838 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 387' ' ' ARG . 0.7 OUTLIER 28.78 52.74 0.07 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.05 -171.767 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.955 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 0.2 OUTLIER 76.29 -25.18 0.21 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.561 171.351 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -115.71 60.91 0.4 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-O 119.361 -0.688 . . . . 0.0 112.971 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.423 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 96.3 m95 20.39 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.033 1.333 . . . . 0.0 114.346 169.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.662 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 31.1 t -47.51 -59.56 5.39 Favored Pre-proline 0 N--CA 1.467 0.421 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -168.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' A' ' 437' ' ' SER . 44.3 Cg_endo -85.45 -5.04 9.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.497 1.464 . . . . 0.0 113.384 -174.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.466 HG22 ' HG3' ' A' ' 441' ' ' ARG . 28.2 m 73.42 116.64 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.989 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 51.7 Cg_endo -76.47 109.34 2.85 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.547 2.164 . . . . 0.0 112.273 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.535 ' O ' HD23 ' A' ' 422' ' ' LEU . 71.7 mtp180 -146.52 151.84 38.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.18 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 74.0 m -111.29 90.7 3.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.119 0.485 . . . . 0.0 110.311 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 12.7 mt -92.59 155.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -82.22 121.77 27.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.438 0.637 . . . . 0.0 110.138 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 10.0 p -91.87 -12.41 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.522 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 20.4 tptp . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.673 -0.68 . . . . 0.0 110.132 179.474 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 388' ' ' LYS . 30.1 mt . . . . . 0 N--CA 1.443 -0.796 0 CA-C-O 121.259 0.552 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -50.53 151.1 2.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.733 -1.121 . . . . 0.0 113.559 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 2.9 mptp? -113.87 96.23 5.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.464 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 7.9 p -68.44 136.86 53.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.922 0.392 . . . . 0.0 111.094 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -99.78 130.83 46.02 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.475 ' HZ ' HG22 ' A' ' 414' ' ' VAL . 1.2 t80 -92.44 104.34 10.91 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.89 -90.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.369 2.713 . . . . 0.0 114.609 -170.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' TYR . . . . . 0.432 ' N ' ' CE1' ' A' ' 402' ' ' TYR . 0.9 OUTLIER 167.52 128.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.736 0.814 . . . . 0.0 110.278 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.612 ' HG ' ' SG ' ' A' ' 442' ' ' CYS . 0.9 OUTLIER -73.4 -131.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.045 0.45 . . . . 0.0 110.408 173.738 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -155.63 -40.99 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -105.49 17.22 24.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.514 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -119.11 141.19 15.66 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.59 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' TYR . . . . . 0.401 ' HD1' ' O ' ' A' ' 415' ' ' ALA . 71.6 m-85 -65.78 114.53 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.239 0.542 . . . . 0.0 111.128 -176.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.798 ' HA ' ' HD2' ' A' ' 402' ' ' TYR . 0.4 OUTLIER -80.2 68.59 6.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.685 0.755 . . . . 0.0 110.321 176.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -70.95 -64.21 0.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.658 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.401 ' HB3' ' HD3' ' A' ' 404' ' ' ARG . 13.6 m120 -108.11 39.11 2.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.69 -176.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.798 ' HD2' ' HA ' ' A' ' 399' ' ' ASN . 0.9 OUTLIER -92.58 148.2 22.27 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.535 -173.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 90.61 11.44 62.18 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.401 ' HD3' ' HB3' ' A' ' 401' ' ' ASN . 36.6 mtp180 -104.54 162.9 12.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.477 0.656 . . . . 0.0 111.995 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' LYS . . . . . 0.542 ' NZ ' ' HB2' ' A' ' 405' ' ' LYS . 10.2 mtmp? -117.72 134.36 54.98 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.324 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.658 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 97.0 m-85 -124.31 163.17 22.23 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.578 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 27.2 m -100.48 148.33 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.075 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.826 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.3 OUTLIER -57.12 139.38 52.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.99 -176.218 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.5 7.64 56.73 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 5.4 mmtm -107.73 175.41 5.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.144 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 35.6 t -146.83 165.8 28.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.6 tp -156.1 137.79 5.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.382 0.61 . . . . 0.0 110.094 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -83.72 129.83 34.95 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.914 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.475 HG22 ' HZ ' ' A' ' 391' ' ' PHE . 46.4 t -117.02 114.19 45.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.609 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.401 ' O ' ' HD1' ' A' ' 398' ' ' TYR . . . -94.68 93.49 7.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.056 0.455 . . . . 0.0 111.102 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.495 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 60.1 m -73.94 154.59 39.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 171.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -60.29 157.18 35.72 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.724 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.41 115.97 2.24 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.817 3.011 . . . . 0.0 112.641 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.24 -16.79 17.35 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.547 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 81.6 m-85 -110.75 148.09 33.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.593 0.235 . . . . 0.0 110.42 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -152.88 168.7 24.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.75 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 77.7 mt -83.09 155.74 67.12 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.118 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.12 155.87 27.13 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.396 2.731 . . . . 0.0 112.001 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 64.98 23.77 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.351 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 51.95 41.41 29.59 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.328 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.582 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 84.1 mt-30 -105.11 163.02 12.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.13 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 32.6 p -120.07 -6.0 9.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.471 0.653 . . . . 0.0 109.988 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 146.3 49.37 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.223 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.573 HG13 ' HG2' ' A' ' 438' ' ' PRO . 6.1 t -112.2 132.13 61.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 51.7 m -93.71 131.53 38.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.389 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 51.0 t -77.25 110.26 11.81 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.324 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.826 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 28.1 mtt -143.38 142.74 31.36 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.682 0.753 . . . . 0.0 112.977 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 5.1 tt0 37.91 42.84 0.46 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.213 -174.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 433' ' ' GLU . 8.9 t-20 71.24 -20.62 0.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.125 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -117.88 60.74 0.46 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.381 -172.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 88.7 m95 24.72 107.43 0.0 OUTLIER 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.097 1.359 . . . . 0.0 114.282 169.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.758 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 58.6 m -51.12 -58.97 8.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.333 -166.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.652 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 24.6 Cg_endo -86.08 -7.67 8.05 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.831 1.687 . . . . 0.0 112.595 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.58 HG22 ' HG3' ' A' ' 441' ' ' ARG . 55.4 m 73.61 118.46 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.719 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 439' ' ' THR . 5.0 Cg_exo -70.61 101.85 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.732 2.288 . . . . 0.0 111.804 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.58 ' HG3' HG22 ' A' ' 439' ' ' THR . 72.3 mtp180 -141.98 124.23 15.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.086 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.612 ' SG ' ' HG ' ' A' ' 394' ' ' LEU . 73.8 m -92.66 97.65 10.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.1 mt -99.93 155.65 4.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -81.14 116.59 21.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.475 0.655 . . . . 0.0 109.748 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.54 -7.84 11.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.491 -172.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 53.0 tptt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.352 -0.833 . . . . 0.0 109.695 -178.917 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.443 -0.808 0 CA-C-O 122.134 0.969 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.576 ' HD2' ' CB ' ' A' ' 434' ' ' ASN . 1.8 mmt180 -96.24 148.96 22.19 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.159 -1.382 . . . . 0.0 111.201 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.533 ' HE2' HG12 ' A' ' 407' ' ' VAL . 1.5 mptm? -118.25 106.92 13.29 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.224 -178.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 8.2 p -74.24 141.6 45.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.661 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -102.31 128.79 48.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -82.85 113.36 44.8 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.79 -176.89 2.37 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.047 2.498 . . . . 0.0 113.356 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -90.6 118.05 29.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.6 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.31 110.59 19.76 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -67.27 -29.81 69.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.0 109.728 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -100.71 15.36 28.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.093 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.677 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -134.1 -179.14 16.14 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.38 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -90.25 -1.66 57.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.71 0.29 . . . . 0.0 111.773 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 2.3 p30 40.9 41.04 1.12 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.445 1.098 . . . . 0.0 113.266 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -61.32 -26.58 67.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.382 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -114.25 18.24 17.13 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.553 -174.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -58.99 121.19 10.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.555 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.2 -6.75 36.95 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.917 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -85.04 147.23 26.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.049 0.452 . . . . 0.0 110.867 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -118.91 133.27 55.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.448 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.697 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 63.8 m-85 -124.3 159.33 30.5 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.533 HG12 ' HE2' ' A' ' 388' ' ' LYS . 27.1 m -92.21 146.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.996 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 49.8 tt0 -60.05 136.5 58.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.031 0.443 . . . . 0.0 110.824 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 104.57 12.79 27.71 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 22.8 mmtp -112.62 175.65 5.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.28 -0.46 . . . . 0.0 111.036 -176.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 40.0 t -149.77 162.82 39.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.28 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.3 tp -169.73 125.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.623 0.725 . . . . 0.0 110.507 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.748 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 18.4 t70 -77.27 137.52 38.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.314 -172.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.82 123.59 71.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.256 0.55 . . . . 0.0 111.303 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.92 112.45 23.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.193 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.677 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 80.5 m -112.59 163.31 14.67 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -63.06 149.14 91.34 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.338 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.83 107.6 0.22 Allowed 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.926 3.084 . . . . 0.0 112.676 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 123.89 -15.15 7.92 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.051 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 91.8 m-85 -108.04 136.37 47.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 176.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 442' ' ' CYS . . . -153.65 160.19 42.31 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.263 -176.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.471 HD11 HG22 ' A' ' 429' ' ' VAL . 84.5 mt -75.65 152.76 85.29 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.909 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 54.1 Cg_exo -53.69 144.75 52.16 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.758 2.305 . . . . 0.0 110.564 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 90.2 mttt 77.34 16.18 1.66 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.064 0.852 . . . . 0.0 109.843 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.8 40.34 19.61 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.917 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.408 ' HG3' ' HB2' ' A' ' 424' ' ' LYS . 96.7 mt-30 -93.54 159.33 15.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.097 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 60.2 p -110.18 -22.53 11.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.21 172.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.748 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 1.3 t -121.52 164.35 17.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.483 0.659 . . . . 0.0 111.662 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 440' ' ' PRO . 2.2 t -120.59 137.13 55.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.645 -175.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 83.5 m -94.13 130.65 40.23 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.205 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.2 t -75.83 113.4 13.27 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.996 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 20.0 mtp -145.24 139.68 27.33 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.532 0.682 . . . . 0.0 111.743 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 6.1 mm-40 41.77 38.95 1.07 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.783 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.576 ' CB ' ' HD2' ' A' ' 387' ' ' ARG . 4.5 t-20 69.56 -19.8 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.359 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -107.37 20.76 32.08 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.663 -170.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.566 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 96.7 m95 52.73 124.49 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.143 0.977 . . . . 0.0 113.615 -178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.799 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 73.1 m -50.33 -61.87 3.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 33.5 Cg_endo -89.73 -5.25 5.32 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.98 1.786 . . . . 0.0 113.413 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.6 m 74.15 113.41 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.964 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 42.4 Cg_endo -73.49 113.16 3.71 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.623 2.216 . . . . 0.0 110.907 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -154.13 -39.28 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.346 -173.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 91.6 m 60.47 89.9 0.07 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.877 0.846 . . . . 0.0 111.872 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 10.1 mt -84.61 160.46 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.643 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 444' ' ' ARG . 21.3 ttp-105 -81.91 111.51 18.17 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.642 0.734 . . . . 0.0 109.898 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.22 6.51 9.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.661 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm . . . . . 0 C--O 1.244 0.779 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.45 -176.784 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.911 0.863 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.905 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 8.5 mmt180 -83.77 164.24 19.68 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.925 -167.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 2.6 mptp? -121.68 91.49 3.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.792 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 23.9 m -61.47 130.36 45.64 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.018 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -98.13 127.73 44.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.466 ' CE2' HD21 ' A' ' 394' ' ' LEU . 16.6 t80 -83.3 120.22 75.35 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.431 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -88.34 -171.99 0.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.26 2.64 . . . . 0.0 112.997 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -92.54 129.68 38.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.596 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.466 HD21 ' CE2' ' A' ' 391' ' ' PHE . 2.7 mm? -89.78 124.15 34.39 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.67 130.78 45.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 50.32 26.1 2.12 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 124.206 0.942 . . . . 0.0 111.796 -173.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -115.49 169.85 13.07 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.387 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -90.3 102.72 15.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.534 0.683 . . . . 0.0 110.288 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 2.0 p-10 -78.47 60.64 2.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.792 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -88.12 -29.9 20.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.148 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -97.26 -6.5 34.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.175 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.412 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 23.7 t80 -62.14 129.15 39.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.085 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.22 13.7 47.86 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.35 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 404' ' ' ARG . 53.6 mtt180 -108.53 149.43 28.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.136 0.493 . . . . 0.0 111.509 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -111.91 131.36 55.42 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.431 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.404 ' CD2' ' HH2' ' A' ' 436' ' ' TRP . 96.9 m-85 -128.86 138.81 52.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.163 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.1 m -76.2 152.44 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.464 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.694 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 52.1 tt0 -60.75 127.04 29.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.258 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.73 -18.13 17.37 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.218 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -86.79 145.59 26.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.864 0.364 . . . . 0.0 110.853 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.3 t -121.12 158.79 27.15 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.987 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.6 tp -155.22 146.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.04 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.82 133.93 38.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.377 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.01 137.23 30.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.778 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -105.69 112.34 25.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.994 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 48.4 m -124.77 172.35 9.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.069 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.433 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 12.3 m170 -54.89 159.98 3.3 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-O 121.125 0.488 . . . . 0.0 111.67 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 73.3 Cg_endo -75.46 103.45 1.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.243 2.629 . . . . 0.0 111.475 -175.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.01 -4.57 13.96 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.921 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -111.87 133.93 53.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.1 162.9 40.89 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.645 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 440' ' ' PRO . 92.0 mt -69.29 155.55 93.32 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.654 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.95 152.12 30.75 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.912 2.408 . . . . 0.0 111.978 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 73.46 23.93 2.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.93 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.11 42.08 26.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.043 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 98.5 mt-30 -116.21 162.75 17.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.92 -176.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 61.8 p -124.45 -6.8 7.55 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.62 144.66 41.75 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.759 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.727 HG12 ' HG2' ' A' ' 438' ' ' PRO . 23.6 m -120.43 158.78 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.055 0.455 . . . . 0.0 109.954 172.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 90.6 m -113.79 132.63 55.78 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.425 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.2 t -68.34 118.62 11.67 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 177.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.694 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 6.2 ptt? -142.87 133.68 25.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.12 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 434' ' ' ASN . 0.9 OUTLIER 34.65 40.68 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.783 -174.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.905 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 7.5 t30 76.67 -23.85 0.24 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.384 0.674 . . . . 0.0 111.952 176.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -103.39 109.59 3.49 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.578 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 94.0 m95 -39.64 125.09 1.76 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 124.17 0.571 . . . . 0.0 112.073 -175.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.728 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 74.1 p -43.06 -52.08 12.31 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -166.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.728 ' HD3' ' OG ' ' A' ' 437' ' ' SER . 5.2 Cg_endo -105.53 2.05 0.22 Allowed 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.084 1.856 . . . . 0.0 112.495 -176.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 25.5 m 72.76 116.49 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.21 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 32.0 Cg_endo -64.32 92.15 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.801 2.334 . . . . 0.0 111.592 174.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 441' ' ' ARG . 9.2 mmm180 -105.21 -50.33 3.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.221 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 83.1 m 60.0 81.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.599 0.714 . . . . 0.0 110.918 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 3.7 pt -95.57 155.08 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.274 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -73.68 107.66 6.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.002 0.906 . . . . 0.0 111.192 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.66 -48.32 72.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.79 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 52.0 tttp . . . . . 0 C--O 1.249 1.031 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.019 -177.425 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.782 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 8.6 mtt-85 . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 122.038 0.923 . . . . 0.0 113.127 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -129.13 98.32 4.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.395 177.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 434' ' ' ASN . 6.2 m -57.32 125.64 23.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.002 -175.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -86.74 130.22 34.56 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 168.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -80.86 120.59 79.33 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.539 0.209 . . . . 0.0 110.476 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.72 179.2 3.45 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.098 2.532 . . . . 0.0 113.819 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -86.91 127.43 35.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.176 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 394' ' ' LEU . 2.0 mm? -93.69 118.0 30.82 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -65.38 -36.69 84.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.945 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -117.89 28.13 8.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.311 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -143.96 162.32 27.79 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.067 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -83.64 108.46 16.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.265 0.555 . . . . 0.0 110.052 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 2.0 p30 -80.67 54.78 2.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.045 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -63.47 -32.75 74.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.353 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.496 ' ND2' HD12 ' A' ' 412' ' ' ILE . 49.3 m-20 -100.46 -0.3 38.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.011 -173.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 64.8 t80 -62.95 120.41 11.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.018 0.437 . . . . 0.0 110.402 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.8 -14.64 19.65 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.843 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -90.86 156.88 17.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 111.434 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -126.1 132.91 51.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.146 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -127.84 148.08 50.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.044 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 16.9 m -81.99 148.53 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.515 0.198 . . . . 0.0 110.61 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 1.008 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.4 tt0 -61.09 133.04 55.62 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.314 0.578 . . . . 0.0 111.229 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.3 27.02 6.67 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 9.3 mmmt -127.69 163.66 23.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.135 -0.532 . . . . 0.0 110.637 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 44.3 t -135.04 161.17 36.06 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.496 HD12 ' ND2' ' A' ' 401' ' ' ASN . 0.3 OUTLIER -164.88 143.77 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.544 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.486 ' H ' HD13 ' A' ' 412' ' ' ILE . 13.5 t70 -78.92 138.11 37.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.731 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 37.9 t -127.4 102.03 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.073 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -78.19 117.71 19.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.975 0.417 . . . . 0.0 111.115 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 35.2 m -103.54 167.61 9.69 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -65.24 158.92 69.73 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.497 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.58 110.34 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 123.518 2.812 . . . . 0.0 112.573 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 103.58 7.23 42.78 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.903 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 95.1 m-85 -125.85 139.16 53.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -159.81 -172.34 3.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.058 0.456 . . . . 0.0 111.049 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 440' ' ' PRO . 82.9 mt -97.06 161.4 26.39 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.435 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.09 152.18 15.05 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.254 2.636 . . . . 0.0 112.074 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 63.69 26.16 14.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.143 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.27 24.71 13.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.638 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 25.1 mt-30 -86.68 161.35 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.134 0.492 . . . . 0.0 111.4 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.0 t -121.01 -6.48 9.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -114.31 140.04 48.95 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.626 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 438' ' ' PRO . 5.1 m -107.34 144.34 16.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.25 0.548 . . . . 0.0 110.57 176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 26.0 m -101.98 121.86 42.95 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.2 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.1 t -66.78 113.55 4.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 1.008 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 7.5 mtt -143.18 136.29 28.01 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.29 0.567 . . . . 0.0 111.353 174.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.462 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 3.4 mt-10 34.46 46.03 0.16 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.699 -177.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.782 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 55.3 t30 71.97 -24.14 0.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.601 175.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -108.03 33.29 6.37 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.136 -1.031 . . . . 0.0 113.893 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.556 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 95.7 m95 40.56 111.34 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.509 1.124 . . . . 0.0 113.891 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.735 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 73.0 m -40.28 -60.59 1.43 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -172.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 48.6 Cg_endo -88.6 -6.86 5.84 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.737 1.625 . . . . 0.0 112.871 -176.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 54.8 m 71.88 116.05 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.551 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 66.0 Cg_endo -80.49 109.52 2.3 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.84 2.36 . . . . 0.0 111.072 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -147.65 -14.78 0.38 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 61.3 m 56.63 83.34 0.1 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.939 0.399 . . . . 0.0 111.839 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.8 mt -85.61 157.8 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 30.5 ttp180 -86.73 105.95 17.32 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.345 1.069 . . . . 0.0 111.374 -175.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 36.9 t . . . . . 0 C--N 1.31 -1.129 0 CA-C-N 113.014 -1.903 . . . . 0.0 110.285 178.272 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 9.2 mtt180 . . . . . 0 CA--C 1.514 -0.412 0 CA-C-O 121.388 0.614 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -133.62 101.4 5.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.162 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 6.8 p -68.43 144.76 54.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.694 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -107.08 132.1 53.37 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 168.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 39.9 t80 -81.57 118.87 73.93 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.337 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 86.1 Cg_endo -90.95 -173.58 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.44 2.76 . . . . 0.0 113.549 -176.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -93.32 138.68 31.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.215 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.96 -96.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 173.79 -33.36 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.574 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -145.07 38.75 1.19 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.317 -1.31 . . . . 0.0 108.825 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -127.88 147.43 17.24 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.505 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.25 99.9 1.61 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.005 0.431 . . . . 0.0 110.013 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 2.5 p30 -79.16 51.34 1.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.928 -175.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -71.29 -24.45 62.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.186 0.517 . . . . 0.0 110.171 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -93.96 -9.63 36.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.738 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.492 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 83.1 t80 -63.9 114.29 3.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.391 0.615 . . . . 0.0 110.749 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 118.48 -19.14 10.74 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.82 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -82.66 153.5 25.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.152 0.501 . . . . 0.0 111.366 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 42.6 mtmt -127.52 134.13 49.8 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.136 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.644 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 96.2 m-85 -125.5 151.92 45.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 31.8 m -82.97 148.12 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.851 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 3.4 tt0 -59.24 140.79 55.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.799 0.333 . . . . 0.0 110.504 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.64 6.9 57.12 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -103.4 167.66 9.66 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.431 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 39.4 t -138.33 160.22 40.04 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.912 0.387 . . . . 0.0 110.12 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.9 tp -159.5 139.38 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.094 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -76.0 135.69 39.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.35 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.635 ' HB ' HD11 ' A' ' 422' ' ' LEU . 56.1 t -126.71 101.09 7.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.311 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.2 122.12 28.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.186 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.504 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 73.5 m -98.03 163.12 12.89 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -67.21 155.97 89.24 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.284 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.01 122.17 10.07 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.762 2.975 . . . . 0.0 112.277 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.76 30.74 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 70.3 m-85 -122.0 144.06 49.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.721 0.296 . . . . 0.0 110.291 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -142.87 178.64 7.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.132 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.635 HD11 ' HB ' ' A' ' 414' ' ' VAL . 34.2 mt -95.68 148.33 34.41 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.884 0.373 . . . . 0.0 110.561 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 441' ' ' ARG . 31.7 Cg_exo -59.14 150.02 76.38 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.97 2.447 . . . . 0.0 112.115 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 67.04 28.4 8.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.393 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.31 44.43 27.39 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.772 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.573 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 24.5 mt-30 -106.9 161.93 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.14 -175.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.7 p -128.91 -13.4 4.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.987 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.15 139.63 50.97 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.253 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 438' ' ' PRO . 21.6 t -108.43 133.83 52.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 89.6 m -92.78 130.66 38.32 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.19 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.84 106.95 6.62 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.106 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.851 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 11.6 mtm -141.8 141.45 33.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.748 173.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.689 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 61.9 mm-40 46.89 36.37 3.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.876 -1.966 . . . . 0.0 111.476 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 6.2 t30 69.18 -20.94 0.16 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.803 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -112.64 49.96 0.81 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.511 -0.852 . . . . 0.0 114.061 -172.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 93.5 m95 35.69 106.81 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 169.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.827 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 55.8 m -51.7 -59.17 8.64 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 35.4 Cg_endo -85.53 -3.85 9.24 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.675 1.583 . . . . 0.0 113.079 -175.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.752 HG22 ' HG2' ' A' ' 441' ' ' ARG . 23.0 m 72.6 113.45 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.197 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -68.62 94.12 0.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.4 2.067 . . . . 0.0 110.812 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.752 ' HG2' HG22 ' A' ' 439' ' ' THR . 24.9 mmm180 -131.53 118.95 20.84 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 66.7 m -83.47 82.69 8.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.088 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 6.3 pt -76.4 144.89 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.657 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -73.17 111.24 8.1 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.577 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.319 -0.74 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.998 -173.27 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.91 ' HG3' ' HG3' ' A' ' 433' ' ' GLU . 1.4 mmp_? . . . . . 0 CA--C 1.514 -0.412 0 CA-C-O 121.216 0.531 . . . . 0.0 111.793 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -135.51 99.92 4.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.774 -175.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 10.4 m -67.87 146.49 53.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.932 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -107.57 128.22 54.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.176 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -74.15 122.31 87.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.97 -177.23 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.167 2.578 . . . . 0.0 113.475 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -93.63 117.16 29.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.683 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.596 HD11 ' HB2' ' A' ' 440' ' ' PRO . 0.0 OUTLIER -80.37 8.13 8.22 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -171.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 59.97 -84.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -97.17 13.23 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.463 0.649 . . . . 0.0 110.246 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -112.9 -161.11 14.81 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.76 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . 0.516 ' HB2' ' HB1' ' A' ' 415' ' ' ALA . 57.6 m-85 -92.79 162.65 14.03 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.184 0.516 . . . . 0.0 109.782 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 1.6 p30 -129.47 41.62 3.42 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.519 0.676 . . . . 0.0 109.685 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.45 ' HG3' ' HB3' ' A' ' 398' ' ' TYR . 75.1 mt-30 -61.05 -46.36 91.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.149 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -94.08 -1.05 54.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.04 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.511 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 73.1 t80 -61.8 119.36 8.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.325 0.584 . . . . 0.0 110.28 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 110.22 -12.63 31.25 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.307 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -95.22 150.65 19.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -118.53 134.6 54.96 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.134 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.97 140.76 52.63 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.215 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.91 147.38 8.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.368 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.713 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 8.3 tt0 -56.47 129.43 40.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.077 0.465 . . . . 0.0 110.667 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 115.43 -22.19 12.24 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -81.74 150.99 27.69 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 24.2 t -140.07 146.7 39.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.824 0.821 . . . . 0.0 111.406 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.7 tp 177.72 132.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.865 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.675 ' HB2' HG23 ' A' ' 429' ' ' VAL . 27.3 t70 -125.71 -89.46 0.57 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.478 -1.237 . . . . 0.0 107.953 173.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.9 t 34.74 75.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 111.728 -2.487 . . . . 0.0 112.943 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.516 ' O ' HD23 ' A' ' 394' ' ' LEU . . . -176.06 52.06 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.771 -172.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 56.4 m -130.99 133.95 46.26 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 173.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -61.05 157.42 42.03 Favored Pre-proline 0 N--CA 1.463 0.209 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.34 115.21 1.63 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.522 2.815 . . . . 0.0 112.522 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 113.52 -11.69 23.54 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.633 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.549 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 63.6 m-85 -113.66 144.04 43.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.537 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.34 -177.95 6.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.034 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 61.1 mt -90.49 151.45 44.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 174.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.95 153.24 58.86 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.79 2.327 . . . . 0.0 111.554 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm 65.73 28.24 11.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.037 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.82 40.16 30.67 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.472 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 26.2 mt-30 -90.15 152.43 21.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.431 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 413' ' ' ASP . 2.1 p -140.93 20.3 2.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -152.39 136.74 16.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.344 0.593 . . . . 0.0 110.108 -177.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.926 HG13 ' HD2' ' A' ' 438' ' ' PRO . 79.4 t -115.81 132.03 66.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.118 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.526 ' HB ' ' OG ' ' A' ' 437' ' ' SER . 49.1 m -91.5 134.92 34.24 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.543 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 18.3 t -75.14 120.2 20.32 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.713 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 21.2 ptm -107.39 -140.13 0.37 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.91 ' HG3' ' HG3' ' A' ' 387' ' ' ARG . 44.8 tt0 -70.35 71.39 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.233 0.924 . . . . 0.0 111.657 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.722 ' HB2' ' HD3' ' A' ' 387' ' ' ARG . 4.0 t30 78.43 -11.43 1.21 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.755 168.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -111.2 170.83 14.0 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 170.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.621 ' HB3' HG11 ' A' ' 429' ' ' VAL . 98.7 m95 -93.44 128.46 39.52 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.742 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 35.2 p -56.28 -54.03 57.35 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -165.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.926 ' HD2' HG13 ' A' ' 429' ' ' VAL . 6.9 Cg_endo -98.04 -4.31 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.693 1.595 . . . . 0.0 111.875 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.482 HG22 ' HG3' ' A' ' 441' ' ' ARG . 24.8 m 72.66 117.65 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.546 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.596 ' HB2' HD11 ' A' ' 394' ' ' LEU . 18.2 Cg_exo -64.44 93.81 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.858 2.372 . . . . 0.0 111.563 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.482 ' HG3' HG22 ' A' ' 439' ' ' THR . 43.8 mtp180 -125.82 91.66 3.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.675 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 66.3 m -63.07 98.89 0.15 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.579 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 2.4 pp -98.75 170.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.088 0.47 . . . . 0.0 110.313 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -93.75 118.58 31.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.426 -173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.817 178.847 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.686 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 32.1 mtp180 . . . . . 0 CA--C 1.516 -0.35 0 CA-C-O 121.505 0.669 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -128.55 109.79 11.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.805 174.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 7.6 p -70.52 144.7 51.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.363 0.601 . . . . 0.0 112.246 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -104.67 126.31 51.63 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 171.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.609 ' HE1' HD21 ' A' ' 394' ' ' LEU . 2.5 t80 -76.27 117.93 67.74 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -177.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -84.71 -179.14 3.59 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.101 2.534 . . . . 0.0 113.481 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -80.77 128.7 33.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.879 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.701 HD23 ' HA ' ' A' ' 399' ' ' ASN . 1.4 mm? -89.92 103.22 15.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 396' ' ' ASN . 33.4 tt0 -71.4 117.03 12.43 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 395' ' ' GLU . 52.1 m-80 71.86 28.51 2.63 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.955 0.785 . . . . 0.0 109.984 -173.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -136.08 164.05 25.05 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.485 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -80.9 99.56 8.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.701 ' HA ' HD23 ' A' ' 394' ' ' LEU . 3.1 p30 -77.77 44.49 0.46 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.753 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.9 -29.96 70.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.672 0.749 . . . . 0.0 109.607 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -96.39 -7.51 34.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.34 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -64.06 122.57 16.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.882 0.373 . . . . 0.0 110.269 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.17 -10.98 33.94 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.11 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -82.5 166.42 19.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.243 0.544 . . . . 0.0 111.299 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -137.04 136.5 38.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.699 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.62 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 55.8 m-85 -132.14 153.1 50.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.138 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 14.7 m -79.38 139.14 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.734 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.838 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 33.1 tt0 -61.98 135.52 57.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.566 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 99.24 22.22 13.48 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 13.7 mmtm -127.4 173.79 9.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.029 -0.586 . . . . 0.0 109.819 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 30.6 t -144.65 163.5 33.76 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.45 HD13 ' N ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -160.84 145.73 5.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.155 -177.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 412' ' ' ILE . 14.2 t70 -81.14 138.66 35.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.317 -174.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 422' ' ' LEU . 48.4 t -119.76 119.77 61.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -100.8 106.33 17.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.048 0.452 . . . . 0.0 111.105 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 56.8 m -94.72 172.57 8.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -73.19 156.75 89.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.846 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.88 112.28 0.98 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.447 2.765 . . . . 0.0 111.984 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.68 -11.79 13.72 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -118.84 143.36 47.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.183 -0.508 . . . . 0.0 109.777 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.75 39.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.49 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 91.3 mt -73.65 158.67 85.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.273 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.495 ' HG3' HD11 ' A' ' 443' ' ' ILE . 31.6 Cg_exo -57.84 149.05 71.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.838 2.359 . . . . 0.0 111.609 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 68.81 17.43 8.78 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.987 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.83 36.8 28.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.051 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 24.2 mt-30 -94.47 162.14 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.846 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 26.2 p -115.62 -11.3 11.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.357 0.599 . . . . 0.0 110.477 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.46 142.69 51.12 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.115 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.5 HG13 ' HG2' ' A' ' 438' ' ' PRO . 17.0 t -114.2 129.78 69.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.624 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 25.7 m -80.87 135.49 35.93 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.176 177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.73 110.13 15.94 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.905 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.838 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 0.6 OUTLIER -149.65 143.12 25.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.923 0.868 . . . . 0.0 112.579 179.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.741 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 37.0 mt-10 45.27 35.06 1.63 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.358 -176.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 389' ' ' CYS . 5.7 t-20 67.9 -16.51 0.18 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.763 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -114.67 25.23 10.42 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.586 -172.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.575 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 84.7 m95 58.31 148.15 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.908 0.883 . . . . 0.0 112.955 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.797 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 58.3 m -71.12 -63.68 1.42 Allowed Pre-proline 0 C--N 1.321 -0.639 0 O-C-N 121.967 -0.458 . . . . 0.0 111.171 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.797 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 36.2 Cg_endo -89.03 -2.64 6.25 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.044 1.829 . . . . 0.0 113.149 -176.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 29.8 m 71.71 111.08 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.765 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 12.2 Cg_exo -63.18 111.13 1.34 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.131 2.554 . . . . 0.0 111.989 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 422' ' ' LEU . 75.6 mtm180 -146.23 124.71 12.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.746 -176.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 74.9 m -89.82 82.53 6.22 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.495 HD11 ' HG3' ' A' ' 423' ' ' PRO . 3.9 mt -87.11 150.92 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.823 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -79.43 126.16 30.48 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.656 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--N 1.315 -0.898 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.674 179.676 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.748 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 26.9 mtt180 . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.708 0.766 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -134.33 93.0 3.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.697 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 12.3 m -59.76 141.6 54.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.579 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . 0.458 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 68.0 t80 -104.57 137.3 42.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.43 ' HZ ' ' CG2' ' A' ' 414' ' ' VAL . 2.3 t80 -93.97 115.06 64.68 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.718 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -92.75 -176.3 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.465 2.776 . . . . 0.0 113.63 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -80.15 134.71 36.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.649 HD11 HG21 ' A' ' 414' ' ' VAL . 8.1 mt -110.38 128.2 55.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.491 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.6 151.92 44.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 43.17 41.85 3.1 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.672 0.607 . . . . 0.0 111.665 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -139.87 147.8 19.47 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.28 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -89.16 96.28 10.65 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.695 0.748 . . . . 0.0 110.362 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.485 ' HB3' ' CB ' ' A' ' 402' ' ' TYR . 35.7 m-80 -78.05 70.15 4.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.562 -173.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -79.2 -26.55 42.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.102 0.477 . . . . 0.0 110.418 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -108.45 14.84 24.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.674 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.485 ' CB ' ' HB3' ' A' ' 399' ' ' ASN . 21.5 t80 -70.87 132.24 44.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.781 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.458 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 95.12 15.16 45.9 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.234 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -103.19 156.34 17.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.022 0.439 . . . . 0.0 111.676 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -120.15 125.29 47.85 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.624 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -120.44 137.59 54.25 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.3 144.19 14.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.311 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.846 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.8 tt0 -66.29 144.57 56.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.644 -173.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 100.99 7.06 51.08 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -107.43 175.8 5.37 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.485 -0.857 . . . . 0.0 109.667 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 31.9 t -152.3 147.79 26.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.868 0.842 . . . . 0.0 111.475 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.775 ' HA ' HG22 ' A' ' 428' ' ' THR . 9.9 tp 173.44 134.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.425 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.96 ' CB ' ' HA ' ' A' ' 428' ' ' THR . 34.9 t70 -130.97 -140.79 0.22 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.229 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.67 HG23 ' CG ' ' A' ' 413' ' ' ASP . 0.6 OUTLIER -147.17 147.75 17.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.226 -151.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.98 88.06 7.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.793 167.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.543 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 14.7 m -80.04 167.17 20.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.186 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -54.37 157.03 5.21 Favored Pre-proline 0 N--CA 1.469 0.484 0 CA-C-O 121.079 0.466 . . . . 0.0 111.528 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.21 110.78 0.49 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.709 2.939 . . . . 0.0 112.629 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.07 -2.09 38.09 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.691 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.626 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 87.8 m-85 -114.3 129.05 56.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . 0.442 ' C ' ' HA ' ' A' ' 442' ' ' CYS . . . -162.71 161.34 26.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.289 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.486 ' CD2' ' H ' ' A' ' 441' ' ' ARG . 73.9 mt -61.55 145.18 91.69 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.152 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 25.9 Cg_exo -62.54 158.15 42.82 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.75 2.3 . . . . 0.0 111.09 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 68.96 21.36 7.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.467 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.61 50.92 8.39 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.385 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 23.9 mt-30 -109.66 160.91 15.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.049 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . 0.841 ' O ' ' HB3' ' A' ' 413' ' ' ASP . 2.9 p -141.62 12.86 2.12 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.313 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.96 ' HA ' ' CB ' ' A' ' 413' ' ' ASP . 0.5 OUTLIER -148.47 125.54 11.39 Favored 'General case' 0 N--CA 1.436 -1.129 0 O-C-N 123.66 0.6 . . . . 0.0 111.652 178.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.664 ' N ' ' HB2' ' A' ' 413' ' ' ASP . 2.1 t -90.88 136.36 24.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.998 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.648 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 64.2 m -81.55 132.21 35.3 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 24.4 t -77.19 109.32 10.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.846 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 27.0 mtp -148.56 153.29 38.18 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.652 0.739 . . . . 0.0 112.394 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 435' ' ' GLY . 4.1 mt-10 28.54 43.09 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 112.782 -2.008 . . . . 0.0 113.36 -164.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 65.13 -17.76 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.869 0.868 . . . . 0.0 112.147 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -112.79 41.82 2.12 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.912 -172.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.624 ' HB3' HG11 ' A' ' 429' ' ' VAL . 98.3 m95 42.55 111.22 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.753 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 60.6 m -50.1 -66.48 0.62 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.201 -0.908 . . . . 0.0 113.278 -167.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 31.8 Cg_endo -85.76 -2.76 9.04 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.54 1.493 . . . . 0.0 112.313 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.814 ' HB ' ' HD2' ' A' ' 441' ' ' ARG . 51.5 m 76.01 131.16 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.96 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 11.5 Cg_endo -70.72 84.5 0.81 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.841 2.361 . . . . 0.0 110.885 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.814 ' HD2' ' HB ' ' A' ' 439' ' ' THR . 0.5 OUTLIER -132.55 70.94 1.46 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.269 -172.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.442 ' HA ' ' C ' ' A' ' 421' ' ' ALA . 4.2 p -70.64 90.78 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.799 0.809 . . . . 0.0 110.501 175.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 14.6 pt -85.84 176.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.339 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -86.67 107.89 18.4 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.917 0.865 . . . . 0.0 110.475 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.308 -1.23 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.651 -177.589 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 1.075 ' HG3' ' HB3' ' A' ' 408' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.44 -0.95 0 N-CA-C 115.616 1.709 . . . . 0.0 115.616 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 387' ' ' ARG . 5.3 mptp? 73.39 37.55 0.71 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.338 -1.756 . . . . 0.0 111.947 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 32.3 m -51.68 120.4 5.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.731 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -97.5 127.46 43.48 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.411 ' HA ' ' HE1' ' A' ' 436' ' ' TRP . 31.1 t80 -79.42 115.46 53.36 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.049 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -87.32 174.38 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.156 2.571 . . . . 0.0 112.731 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -77.41 116.95 18.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.282 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.492 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 8.2 mt -71.63 127.5 32.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.267 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.625 ' HG2' ' HB2' ' A' ' 442' ' ' CYS . 1.4 pm0 -65.1 108.59 1.89 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.014 0.435 . . . . 0.0 110.279 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 63.74 36.52 10.56 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.483 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -129.26 172.31 19.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.919 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -77.33 88.2 3.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.341 0.591 . . . . 0.0 110.71 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.572 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 3.1 p30 -80.58 49.3 1.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.364 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -67.76 -22.79 65.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.844 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -104.06 -1.7 27.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.052 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.572 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 45.7 t80 -62.75 115.48 4.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.278 0.561 . . . . 0.0 110.427 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.61 -11.36 21.26 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.873 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.39 150.61 22.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.064 0.459 . . . . 0.0 110.949 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 405' ' ' LYS . 8.9 mptt -121.72 148.51 44.52 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.711 176.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.407 ' CD2' ' HH2' ' A' ' 436' ' ' TRP . 98.6 m-85 -142.32 156.46 45.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.206 0.527 . . . . 0.0 110.541 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.27 143.37 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.279 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 1.075 ' HB3' ' HG3' ' A' ' 387' ' ' ARG . 0.9 OUTLIER -57.86 139.94 53.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.408 -176.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.8 19.19 12.32 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -125.39 169.91 11.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.629 -0.785 . . . . 0.0 110.145 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.1 t -148.02 157.51 43.55 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.331 0.586 . . . . 0.0 110.415 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.6 tp -151.08 140.45 15.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.2 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.8 133.52 37.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.363 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.92 139.42 48.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.662 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -142.44 133.66 26.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.232 0.539 . . . . 0.0 111.406 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.666 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 0.1 OUTLIER -103.07 -178.43 3.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.574 ' NE2' ' HE2' ' A' ' 420' ' ' TYR . 19.1 p-80 -77.72 157.46 79.51 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.842 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 417' ' ' HIS . 9.9 Cg_exo -34.4 120.71 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.385 3.39 . . . . 0.0 115.007 -171.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 444' ' ' ARG . . . 101.71 -20.42 46.25 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.589 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.666 ' HB2' ' HB3' ' A' ' 416' ' ' CYS . 51.6 m-85 -109.83 142.48 41.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.954 0.377 . . . . 0.0 110.757 -174.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -175.75 -170.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.411 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.617 HD21 ' HA ' ' A' ' 440' ' ' PRO . 94.7 mt -80.88 162.23 60.64 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.403 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.72 147.1 73.64 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.021 2.481 . . . . 0.0 110.761 171.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.6 10.6 7.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.605 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 62.44 35.07 15.03 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.697 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -66.93 152.44 45.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.071 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.4 p -123.79 -3.38 8.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.272 0.558 . . . . 0.0 110.341 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.84 136.29 44.3 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.961 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.54 HG13 HD11 ' A' ' 422' ' ' LEU . 5.5 m -104.28 134.77 44.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.554 0.692 . . . . 0.0 110.205 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 14.8 m -92.92 117.91 30.56 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.219 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 47.3 t -66.81 116.9 8.21 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 1.009 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 23.4 mtp -131.82 -166.8 1.77 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.37 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.608 ' OE1' ' HB3' ' A' ' 432' ' ' MET . 1.7 mp0 -37.49 76.97 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.841 1.338 . . . . 0.0 114.454 -170.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 432' ' ' MET . 15.6 t-20 64.7 23.99 12.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.777 175.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -173.92 119.16 0.73 Allowed Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.254 -174.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.411 ' HE1' ' HA ' ' A' ' 391' ' ' PHE . 47.5 m95 -37.87 113.56 0.28 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.976 0.91 . . . . 0.0 110.374 165.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 6.6 m -56.92 -50.88 85.61 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.793 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.441 ' HG2' HG12 ' A' ' 429' ' ' VAL . 33.1 Cg_endo -83.41 -8.11 10.65 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.149 1.233 . . . . 0.0 112.379 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 9.1 m 70.99 112.81 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.957 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.617 ' HA ' HD21 ' A' ' 422' ' ' LEU . 35.9 Cg_endo -66.46 86.08 0.27 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.747 2.298 . . . . 0.0 112.392 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -114.08 130.93 56.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.85 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.625 ' HB2' ' HG2' ' A' ' 395' ' ' GLU . 56.7 m -90.41 83.09 5.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.119 0.485 . . . . 0.0 110.821 173.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 2.5 pt -99.68 153.43 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 172.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 419' ' ' GLY . 72.4 ttt180 -79.3 113.69 17.64 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.489 0.661 . . . . 0.0 109.703 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.408 -174.435 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 24.1 mtt180 . . . . . 0 CA--C 1.51 -0.558 0 CA-C-O 121.375 0.607 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -118.94 90.72 3.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.934 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 31.1 m -56.72 122.85 13.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.842 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -91.36 113.47 25.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.558 ' HE2' HD21 ' A' ' 394' ' ' LEU . 27.0 t80 -76.57 117.95 68.13 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -94.78 -175.9 0.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.402 2.735 . . . . 0.0 113.479 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 395' ' ' GLU . 47.7 t80 -75.51 130.81 39.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.831 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.558 HD21 ' HE2' ' A' ' 391' ' ' PHE . 2.5 mm? -81.11 -5.39 57.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -171.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.566 ' HA ' ' CE2' ' A' ' 393' ' ' TYR . 63.0 mm-40 66.49 -71.67 0.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.482 0.489 . . . . 0.0 110.996 -173.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.56 24.08 7.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.851 -175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -140.8 169.25 24.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.466 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -82.9 138.8 33.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.559 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 3.6 p30 -105.68 59.26 0.66 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.01 0.433 . . . . 0.0 112.162 -173.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -78.74 -14.54 59.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.726 0.298 . . . . 0.0 110.732 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -117.7 9.65 13.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.728 0.299 . . . . 0.0 111.008 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.559 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 24.9 t80 -64.75 127.82 33.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 0.0 111.007 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 91.87 16.34 51.75 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.111 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -105.81 149.39 26.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.851 0.358 . . . . 0.0 110.915 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 60.4 mtpt -112.17 126.69 55.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.525 175.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -118.65 150.84 39.04 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.595 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 35.6 m -83.12 147.53 5.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.553 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.799 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 3.2 tt0 -64.18 128.27 35.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.374 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.38 7.79 36.69 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 7.3 mmtt -114.79 163.32 15.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 20.3 t -138.89 164.88 28.51 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.367 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.0 tp -155.96 142.17 10.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.931 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -84.39 133.25 34.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.567 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 69.5 t -117.89 128.45 75.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.598 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.26 113.74 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.722 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.642 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 56.0 m -95.66 170.4 9.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -65.21 154.97 85.99 Favored Pre-proline 0 C--N 1.332 -0.164 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.025 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.9 105.92 0.16 Allowed 'Trans proline' 0 CA--C 1.521 -0.14 0 C-N-CA 123.747 2.965 . . . . 0.0 112.63 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.16 -11.75 11.52 Favored Glycine 0 C--N 1.317 -0.523 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.513 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -115.35 146.58 41.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.16 -179.05 7.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.703 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 97.9 mt -79.77 158.1 73.47 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-O 120.971 0.415 . . . . 0.0 110.544 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.33 150.37 41.57 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.528 2.152 . . . . 0.0 110.771 171.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.472 ' HB2' ' HG3' ' A' ' 426' ' ' GLN . 6.9 mtpm? 64.06 19.08 11.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.941 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 61.19 26.63 16.48 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.173 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.472 ' HG3' ' HB2' ' A' ' 424' ' ' LYS . 51.8 mt-30 -73.67 158.99 33.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.907 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 28.1 p -124.62 -23.13 4.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.313 0.578 . . . . 0.0 110.22 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.88 135.95 49.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.52 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.446 HG13 ' HG2' ' A' ' 438' ' ' PRO . 2.5 t -110.5 125.07 67.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 60.8 m -88.32 135.17 33.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.777 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 31.4 t -72.7 112.67 8.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.799 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 7.3 mtt -146.84 142.1 27.33 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.705 0.764 . . . . 0.0 111.321 174.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.545 ' C ' ' HD2' ' A' ' 387' ' ' ARG . 5.8 mm-40 39.09 40.32 0.47 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.232 -1.804 . . . . 0.0 113.084 -170.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 46.1 t30 70.33 -24.05 0.16 Allowed 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.704 0.628 . . . . 0.0 111.706 174.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -104.81 22.3 34.09 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.562 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.571 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 94.0 m95 56.35 128.78 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.858 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 71.8 m -51.38 -64.45 1.4 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.359 -169.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.858 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 42.6 Cg_endo -89.11 -2.53 6.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.049 1.832 . . . . 0.0 112.478 -176.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 18.6 m 73.74 121.61 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.295 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 30.7 Cg_endo -66.6 94.64 0.32 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.727 2.284 . . . . 0.0 111.699 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -131.03 106.54 8.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.778 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 76.4 m -83.36 81.39 8.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.916 0.389 . . . . 0.0 110.63 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 9.8 pt -87.76 161.42 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.884 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -75.38 121.77 22.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.385 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.336 -174.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 8.7 mtt-85 . . . . . 0 N--CA 1.442 -0.831 0 CA-C-O 121.672 0.748 . . . . 0.0 112.388 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 38.9 mmtm -117.65 90.57 3.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.014 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 15.2 m -59.62 120.97 10.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.511 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -90.33 124.81 35.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.655 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -80.32 120.72 80.31 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.278 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -83.53 -179.2 4.07 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.295 2.663 . . . . 0.0 112.636 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -93.87 121.99 35.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.4 0.619 . . . . 0.0 110.715 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.2 mp -89.31 129.26 35.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.392 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.89 -47.84 64.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.948 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -107.5 16.54 23.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.914 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -132.26 155.75 21.66 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.512 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -77.7 111.23 13.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.554 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 1.7 p30 -79.22 61.61 3.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.869 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -66.18 -19.57 65.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.257 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -117.9 1.8 12.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.309 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.554 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 37.4 t80 -63.12 124.86 22.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 111.302 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.65 -9.79 41.24 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.304 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -100.66 152.76 20.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.69 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 52.2 mtmt -116.91 152.93 33.48 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.846 173.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 97.4 m-85 -134.9 150.31 50.41 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.914 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.7 m -80.08 144.93 9.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.159 0.504 . . . . 0.0 110.349 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.828 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.8 OUTLIER -62.01 125.68 24.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.555 -173.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.97 -0.95 24.28 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -95.88 161.61 13.93 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.153 -0.524 . . . . 0.0 110.387 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 21.1 t -141.33 163.29 33.36 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.1 tp -170.02 130.39 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.673 0.749 . . . . 0.0 110.517 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.768 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 14.1 t70 -83.66 132.55 34.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.336 -171.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 22.6 t -113.05 120.81 63.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.677 -175.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.02 122.87 29.86 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.518 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 67.5 m -116.02 173.11 6.75 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -62.48 158.15 51.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.212 0.529 . . . . 0.0 110.956 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.89 114.55 1.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.556 2.837 . . . . 0.0 111.949 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 444' ' ' ARG . . . 110.22 -5.03 30.1 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.207 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.671 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 84.6 m-85 -115.62 145.09 43.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.141 0.496 . . . . 0.0 110.946 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 442' ' ' CYS . . . -160.08 160.19 32.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.259 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.516 HD11 HG22 ' A' ' 429' ' ' VAL . 69.6 mt -71.55 151.45 93.79 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 121.064 0.459 . . . . 0.0 111.792 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 72.9 Cg_exo -53.14 147.66 34.03 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.415 2.743 . . . . 0.0 111.913 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.513 ' HB2' HE21 ' A' ' 426' ' ' GLN . 99.7 mttt 70.1 27.5 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.71 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.32 53.78 8.42 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.391 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.513 HE21 ' HB2' ' A' ' 424' ' ' LYS . 48.5 mt-30 -119.51 160.66 21.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.53 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 41.7 p -119.88 -17.15 8.57 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.004 0.431 . . . . 0.0 110.143 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.768 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 0.5 OUTLIER -120.11 160.1 23.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.837 0.827 . . . . 0.0 111.603 178.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.516 HG22 HD11 ' A' ' 422' ' ' LEU . 1.4 t -116.6 148.6 19.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.344 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 86.7 m -108.55 122.99 48.21 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.816 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.1 t -67.96 111.13 4.22 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.828 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 4.7 mtm -144.45 135.79 25.47 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.966 0.889 . . . . 0.0 112.583 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.758 ' H ' ' HG3' ' A' ' 408' ' ' GLN . 0.8 OUTLIER 46.66 37.41 4.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.064 -178.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.729 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 8.1 t30 72.66 -24.95 0.19 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.929 0.892 . . . . 0.0 112.7 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -108.13 43.75 1.64 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.037 -1.078 . . . . 0.0 114.257 -169.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.514 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.3 m95 36.25 105.41 0.0 OUTLIER 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 172.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.788 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 69.5 m -45.64 -59.57 4.41 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.244 -168.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 13.5 Cg_endo -90.65 -6.19 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.631 1.554 . . . . 0.0 113.248 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.653 HG22 ' HG3' ' A' ' 441' ' ' ARG . 24.4 m 71.95 121.9 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.517 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.514 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 1.2 Cg_endo -78.67 97.48 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.51 2.807 . . . . 0.0 111.413 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.653 ' HG3' HG22 ' A' ' 439' ' ' THR . 53.8 mtm180 -131.38 -45.77 0.99 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.608 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 68.0 m 64.78 91.97 0.07 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.074 0.94 . . . . 0.0 111.301 -177.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 7.0 mt -96.9 159.53 3.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.096 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 419' ' ' GLY . 31.7 ttt180 -64.67 121.91 15.61 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.986 0.898 . . . . 0.0 110.613 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 80.5 t . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.914 178.394 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.894 ' HG3' ' HA ' ' A' ' 433' ' ' GLU . 34.2 mmt180 . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.1 0.476 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.478 ' HD2' ' C ' ' A' ' 387' ' ' ARG . 0.1 OUTLIER -124.45 79.6 1.77 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.732 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 19.8 m -59.86 125.92 25.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.249 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -90.3 127.53 36.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 172.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.538 ' HE1' HD21 ' A' ' 394' ' ' LEU . 2.0 t80 -81.71 111.76 28.81 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . 0.409 ' C ' ' HD1' ' A' ' 402' ' ' TYR . 95.9 Cg_endo -88.92 -166.65 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.245 2.63 . . . . 0.0 113.241 -176.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . 0.458 ' HD1' HD22 ' A' ' 399' ' ' ASN . 55.3 t80 -78.14 134.84 37.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.002 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.626 HD23 ' HA ' ' A' ' 399' ' ' ASN . 2.6 mm? -86.05 106.97 17.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.656 177.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.73 ' O ' ' HB2' ' A' ' 442' ' ' CYS . 12.8 pt-20 -63.49 116.87 5.99 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 69.16 25.34 5.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.023 0.44 . . . . 0.0 110.351 -174.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -135.73 176.05 20.41 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.451 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -99.16 120.86 40.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.263 0.554 . . . . 0.0 110.45 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.626 ' HA ' HD23 ' A' ' 394' ' ' LEU . 9.2 p30 -79.37 59.56 2.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.759 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -70.13 -28.87 65.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.9 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -111.75 7.55 20.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.215 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.541 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 81.2 t80 -63.97 126.07 26.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.144 0.497 . . . . 0.0 110.371 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.66 -5.31 54.22 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.86 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.31 150.03 21.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.977 0.418 . . . . 0.0 110.888 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 59.3 mtpt -126.75 136.61 52.65 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.208 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -126.97 153.59 45.67 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.783 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 387' ' ' ARG . 27.0 m -86.66 144.94 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.975 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.3 tt0 -57.5 132.03 51.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 0.0 110.914 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.05 12.72 23.27 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 53.9 mmtt -115.14 155.51 26.98 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.185 -0.507 . . . . 0.0 110.533 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.6 t -132.4 161.53 33.4 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.3 tp -162.39 138.31 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.439 0.638 . . . . 0.0 110.294 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -89.3 137.24 32.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.835 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.42 137.57 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.288 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.89 118.84 34.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.281 0.562 . . . . 0.0 111.343 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.56 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 58.2 m -89.0 -175.9 4.99 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.598 173.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -64.5 152.05 90.18 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.05 103.07 0.14 Allowed 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 123.204 2.602 . . . . 0.0 111.58 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.702 ' O ' ' HB3' ' A' ' 444' ' ' ARG . . . 126.92 -10.08 7.07 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.571 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 1.037 ' HA ' ' CB ' ' A' ' 444' ' ' ARG . 59.8 m-85 -119.66 159.81 23.71 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 444' ' ' ARG . . . -151.18 173.66 14.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.821 -175.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 427' ' ' THR . 3.2 mm? -73.96 160.14 82.51 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 171.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.487 ' HG3' HD11 ' A' ' 443' ' ' ILE . 71.8 Cg_exo -48.61 136.74 26.85 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.947 2.431 . . . . 0.0 111.237 174.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 78.81 20.36 0.79 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.349 1.031 . . . . 0.0 110.061 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.76 44.2 20.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.071 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 422' ' ' LEU . 23.6 mt-30 -100.21 169.94 8.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.753 -177.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . 0.483 ' HA ' HD23 ' A' ' 422' ' ' LEU . 74.8 p -123.05 -8.62 8.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.357 0.599 . . . . 0.0 109.477 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -113.76 149.85 34.28 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.474 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 19.9 m -124.83 144.74 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 172.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 39.1 m -108.1 129.19 55.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.326 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.2 t -72.33 110.03 6.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.975 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 9.1 mtt -142.02 137.6 31.24 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.812 0.815 . . . . 0.0 111.698 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.894 ' HA ' ' HG3' ' A' ' 387' ' ' ARG . 1.2 tp10 40.43 40.14 0.82 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.732 -2.031 . . . . 0.0 112.759 -174.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 9.3 t30 73.02 -16.33 0.47 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.021 0.528 . . . . 0.0 112.009 174.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -118.91 45.87 1.2 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.741 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.55 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.1 m95 35.21 106.2 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 172.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.744 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 64.0 m -41.15 -62.13 1.13 Allowed Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -172.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 62.6 Cg_endo -88.67 -2.86 6.56 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.681 1.588 . . . . 0.0 113.156 -174.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.759 HG22 ' HG3' ' A' ' 441' ' ' ARG . 28.8 m 72.94 119.37 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.575 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 61.5 Cg_endo -74.57 82.71 1.85 Allowed 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.729 2.286 . . . . 0.0 112.205 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.759 ' HG3' HG22 ' A' ' 439' ' ' THR . 49.5 mtp180 -133.18 132.29 41.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.825 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.73 ' HB2' ' O ' ' A' ' 395' ' ' GLU . 81.6 m -95.42 74.68 3.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.716 0.77 . . . . 0.0 111.38 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.487 HD11 ' HG3' ' A' ' 423' ' ' PRO . 1.6 pt -101.27 144.01 13.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.703 174.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 1.037 ' CB ' ' HA ' ' A' ' 420' ' ' TYR . 0.0 OUTLIER -175.35 -154.64 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -177.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.652 ' H ' ' HD2' ' A' ' 444' ' ' ARG . 7.6 p . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 111.488 -2.596 . . . . 0.0 111.643 -169.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.71 ' HG3' ' N ' ' A' ' 408' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.72 ' H ' ' HB2' ' A' ' 434' ' ' ASN . 0.1 OUTLIER -166.97 65.32 0.09 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 112.615 -2.084 . . . . 0.0 106.792 152.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.698 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 61.5 m -50.84 108.8 0.26 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.47 -1.695 . . . . 0.0 113.271 -166.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -90.64 120.95 32.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -69.55 122.84 87.05 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.75 167.15 24.39 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.187 2.591 . . . . 0.0 113.155 -175.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -85.96 116.41 24.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.598 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.5 117.17 28.98 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.784 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 0.0 OUTLIER -75.21 -31.51 60.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.111 0.481 . . . . 0.0 110.338 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 41.6 m-80 -98.48 20.05 13.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.047 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -134.19 178.49 18.35 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.207 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -90.01 -10.12 46.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.779 0.323 . . . . 0.0 111.591 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 6.8 p30 42.21 36.69 0.75 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.355 1.062 . . . . 0.0 113.558 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -62.99 -26.06 68.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.778 0.323 . . . . 0.0 111.183 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -94.88 -6.76 41.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.352 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -61.23 118.64 7.12 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.36 -10.22 22.14 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.511 -174.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -100.38 146.64 26.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.719 0.295 . . . . 0.0 110.723 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . 0.698 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 56.7 mtpt -119.46 152.17 37.33 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.261 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.469 ' CD1' ' HH2' ' A' ' 436' ' ' TRP . 94.8 m-85 -139.79 162.87 34.09 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.385 0.612 . . . . 0.0 111.437 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 35.3 m -97.54 146.22 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.644 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.9 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 6.1 tt0 -69.42 122.76 19.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.041 0.448 . . . . 0.0 110.558 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.45 12.67 11.47 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 1.1 tmtm? -116.41 162.68 17.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.813 -0.693 . . . . 0.0 109.481 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.5 t -132.25 158.23 42.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.934 0.397 . . . . 0.0 110.171 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.1 tp -149.68 140.73 16.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.146 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -82.41 132.2 35.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.738 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 422' ' ' LEU . 92.3 t -111.83 139.97 33.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.156 0.503 . . . . 0.0 111.191 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -113.35 103.07 10.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.17 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.611 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 70.7 m -99.17 165.8 11.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 171.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -68.3 153.17 95.92 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.107 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.77 108.71 0.3 Allowed 'Trans proline' 0 CA--C 1.521 -0.156 0 C-N-CA 123.702 2.935 . . . . 0.0 112.278 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.76 -11.03 11.14 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.612 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 99.3 m-85 -116.49 141.33 48.31 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -144.47 178.9 7.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.066 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 59.4 mt -92.27 156.93 41.38 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.85 0.357 . . . . 0.0 111.044 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 58.2 Cg_exo -54.1 144.65 57.23 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.174 2.583 . . . . 0.0 111.562 173.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 29.1 mtpp 72.45 19.14 4.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.188 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.1 26.29 13.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.317 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.632 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 27.3 mt-30 -85.26 157.31 20.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.062 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.9 p -116.37 0.92 12.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.541 0.686 . . . . 0.0 109.846 173.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.25 140.43 52.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.941 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.512 HG23 HG21 ' A' ' 414' ' ' VAL . 45.6 t -115.4 132.29 65.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.102 0.477 . . . . 0.0 109.718 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 19.3 m -88.02 129.66 35.21 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.138 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 33.8 t -71.41 111.59 6.86 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.9 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 1.0 OUTLIER -141.96 121.83 13.59 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 122.466 1.126 . . . . 0.0 112.105 172.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' A' ' 433' ' ' GLU . 35.5 tt0 51.51 36.65 17.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 111.978 -2.374 . . . . 0.0 112.295 177.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.72 ' HB2' ' H ' ' A' ' 388' ' ' LYS . 63.9 t30 61.98 15.46 7.28 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.066 0.936 . . . . 0.0 109.681 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -123.2 17.05 8.05 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.768 -173.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.469 ' HH2' ' CD1' ' A' ' 406' ' ' PHE . 93.4 m95 36.42 101.42 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.92 1.012 . . . . 0.0 113.073 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.716 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 62.6 m -44.52 -61.81 1.92 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -165.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.716 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 41.2 Cg_endo -83.31 -3.12 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.043 1.828 . . . . 0.0 112.961 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.647 HG22 ' HG3' ' A' ' 441' ' ' ARG . 26.3 m 74.35 114.19 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.972 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.423 ' HG3' HG11 ' A' ' 429' ' ' VAL . 13.1 Cg_exo -68.78 95.95 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.948 2.432 . . . . 0.0 111.94 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.647 ' HG3' HG22 ' A' ' 439' ' ' THR . 51.6 mtp180 -135.89 117.84 15.27 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.732 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 62.4 m -82.05 82.86 7.49 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 5.1 pt -82.88 144.67 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.378 0.608 . . . . 0.0 111.066 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.5 ttm105 -71.49 120.22 16.76 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.416 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.957 -173.376 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.952 ' HD3' ' HA ' ' A' ' 434' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 387' ' ' ARG . 0.0 OUTLIER -115.64 108.16 16.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.063 0.459 . . . . 0.0 111.897 -170.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 71.2 m -86.98 143.89 27.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.327 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -125.78 119.77 28.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 26.7 t80 -70.12 118.86 67.75 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.749 0.309 . . . . 0.0 110.41 -174.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 93.2 Cg_endo -90.26 -175.57 0.95 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.194 2.596 . . . . 0.0 113.525 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . 0.458 ' HA ' ' OD1' ' A' ' 399' ' ' ASN . 87.7 t80 -91.04 116.92 29.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.61 -173.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 440' ' ' PRO . 3.5 mm? -74.41 117.91 16.77 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.44 -26.63 63.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.535 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -136.41 38.58 2.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.395 0.617 . . . . 0.0 110.519 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -124.29 168.32 16.45 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.4 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -87.39 -4.96 59.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 393' ' ' TYR . 53.7 m-80 44.04 47.55 7.31 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 170.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -65.45 -15.31 62.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.743 0.306 . . . . 0.0 111.039 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -122.38 12.34 10.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -68.91 129.21 39.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.66 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 102.17 8.4 44.49 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.174 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -98.84 152.34 19.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.401 0.62 . . . . 0.0 111.888 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -116.64 143.42 45.65 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.434 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -141.22 151.24 43.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.274 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 29.3 m -93.81 150.99 3.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 170.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 1.0 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.4 tt0 -62.48 138.19 58.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.341 0.591 . . . . 0.0 111.207 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.16 14.17 23.15 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -174.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 7.7 mmmt -118.92 161.37 20.31 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.699 -0.75 . . . . 0.0 110.05 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.2 t -131.81 165.96 22.64 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.26 144.16 11.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.173 0.511 . . . . 0.0 110.722 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -84.32 143.05 29.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.853 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.414 HG22 ' HZ ' ' A' ' 391' ' ' PHE . 46.8 t -126.57 127.61 70.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.962 0.411 . . . . 0.0 110.922 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -97.43 95.01 7.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.616 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 34.3 m -87.04 145.73 26.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.614 ' ND1' ' HD2' ' A' ' 418' ' ' PRO . 16.4 t60 -59.19 144.44 83.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 0.0 110.979 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . 0.614 ' HD2' ' ND1' ' A' ' 417' ' ' HIS . 95.3 Cg_exo -45.21 106.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.477 1 C-N-CA 125.427 4.084 . . . . 0.0 112.734 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 125.11 -17.5 7.09 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.127 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -110.16 150.14 29.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.001 0.429 . . . . 0.0 111.117 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -149.3 166.96 27.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.733 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 62.9 mt -88.88 153.14 49.44 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 120.69 0.281 . . . . 0.0 110.892 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.61 144.27 33.93 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.192 2.595 . . . . 0.0 112.141 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 68.88 23.7 6.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.876 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 54.18 47.22 23.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.249 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 25.8 mt-30 -108.33 167.64 9.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.534 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 12.2 t -126.57 0.09 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -119.7 145.84 46.16 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.161 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.633 HG13 ' HG2' ' A' ' 438' ' ' PRO . 12.5 t -115.7 133.23 62.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.945 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 18.0 m -93.99 124.47 38.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.81 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.5 t -71.86 111.41 7.09 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.604 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 1.0 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 30.0 mtp -140.08 -177.38 4.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 433' ' ' GLU . 9.4 mm-40 -32.98 88.55 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 125.95 2.031 . . . . 0.0 114.387 -175.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.952 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 10.3 t-20 68.9 12.28 8.59 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 112.088 -2.324 . . . . 0.0 110.653 168.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 179.23 134.64 2.2 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.403 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.436 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 91.1 m95 -38.93 117.89 0.71 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 165.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.599 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 14.8 m -67.1 -52.27 31.52 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -168.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.633 ' HG2' HG13 ' A' ' 429' ' ' VAL . 25.5 Cg_endo -83.56 -9.14 10.26 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 120.919 1.079 . . . . 0.0 112.196 -175.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.581 HG22 ' HG2' ' A' ' 441' ' ' ARG . 11.0 m 71.61 109.53 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.23 173.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.416 ' HB2' HD11 ' A' ' 394' ' ' LEU . 37.5 Cg_endo -69.42 98.31 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.35 2.033 . . . . 0.0 110.945 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.581 ' HG2' HG22 ' A' ' 439' ' ' THR . 21.9 mmm180 -120.58 -36.89 3.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.735 -175.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 82.9 m 56.68 69.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.498 0.666 . . . . 0.0 110.117 -174.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 5.7 pt -87.04 154.42 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.714 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -61.09 121.72 13.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.989 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.032 -171.125 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.799 ' NH1' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.728 0 CA-C-O 122.085 0.945 . . . . 0.0 112.571 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 387' ' ' ARG . 12.9 tptt -164.61 88.63 0.49 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.602 167.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 434' ' ' ASN . 58.6 m -51.3 111.99 0.66 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.584 0.553 . . . . 0.0 111.295 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -89.45 118.28 28.99 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -72.8 123.22 89.31 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.805 0.336 . . . . 0.0 110.128 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.74 169.02 18.74 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.094 2.53 . . . . 0.0 113.765 -174.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -88.34 106.83 18.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.813 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.38 108.25 17.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -63.22 -40.2 96.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.867 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.431 ' C ' ' HD2' ' A' ' 417' ' ' HIS . 2.0 p30 -100.49 19.69 16.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.568 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -132.14 172.98 20.88 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.093 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -88.03 104.47 16.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 2.3 p30 -74.54 55.41 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.38 -178.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -64.62 -42.85 95.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.779 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -101.72 0.88 36.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.419 -170.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 23.6 t80 -61.5 124.07 19.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.112 0.482 . . . . 0.0 110.38 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.42 -9.3 38.44 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.704 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -89.75 147.32 23.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.247 0.546 . . . . 0.0 111.134 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 37.6 mtpt -121.66 135.47 54.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.797 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -129.25 158.15 39.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.213 0.53 . . . . 0.0 111.34 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.8 m -87.78 144.48 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.006 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.827 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.2 tt0 -52.55 139.79 24.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.963 0.411 . . . . 0.0 111.492 177.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.47 10.89 57.71 Favored Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -110.89 154.62 23.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 30.8 t -132.47 159.15 40.19 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.047 0.451 . . . . 0.0 110.409 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.2 tp -155.57 141.43 10.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.501 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -91.56 139.99 30.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.822 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 19.3 t -126.05 146.08 32.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.277 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -122.63 131.43 53.81 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.614 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 56.4 m -103.79 170.54 7.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.431 ' HD2' ' C ' ' A' ' 396' ' ' ASN . 94.3 m-70 -72.7 156.7 89.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.814 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.32 110.68 0.48 Allowed 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.821 3.014 . . . . 0.0 112.529 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.45 -6.02 16.82 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.788 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 96.1 m-85 -122.97 145.6 48.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.792 0.33 . . . . 0.0 110.769 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -149.83 157.16 42.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.945 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.645 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 46.6 mt -78.44 156.21 78.55 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.82 0.343 . . . . 0.0 111.199 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.481 ' HG3' HD11 ' A' ' 443' ' ' ILE . 50.2 Cg_exo -53.04 144.49 45.91 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.067 2.511 . . . . 0.0 112.018 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 71.73 14.76 6.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.436 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 60.4 30.47 19.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.515 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.645 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 27.6 mt-30 -92.18 168.77 11.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.846 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 79.8 p -126.12 -26.11 3.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.474 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.89 134.53 35.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.426 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.546 HG13 ' HG2' ' A' ' 438' ' ' PRO . 3.5 t -109.88 142.89 21.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.451 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 27.6 m -103.91 126.81 51.31 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.212 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.404 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.6 t -70.08 108.72 4.21 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.827 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 9.7 mtt -144.55 132.89 21.86 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.324 1.059 . . . . 0.0 112.42 174.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.684 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 2.4 tm-20 46.38 32.16 1.48 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.09 -2.323 . . . . 0.0 110.687 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.492 ' HA ' ' SG ' ' A' ' 389' ' ' CYS . 45.5 t-20 76.03 -27.71 0.18 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.45 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -97.91 40.05 2.61 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.237 -171.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.548 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.0 m95 35.99 106.44 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 172.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.775 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 72.2 m -44.54 -60.09 3.31 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -170.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.775 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 31.3 Cg_endo -88.36 -6.6 6.13 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.882 1.722 . . . . 0.0 112.874 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 80.9 m 72.8 116.33 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 114.898 -1.047 . . . . 0.0 113.072 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.548 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 18.4 Cg_endo -88.76 109.76 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.498 2.799 . . . . 0.0 110.734 174.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -147.2 -17.65 0.39 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 77.2 m 58.1 87.07 0.07 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.406 0.622 . . . . 0.0 111.489 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.481 HD11 ' HG3' ' A' ' 423' ' ' PRO . 11.0 mt -85.54 158.84 3.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -78.88 124.86 28.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.215 0.531 . . . . 0.0 109.923 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--N 1.313 -1.01 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.119 -177.768 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.732 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 2.0 mmp_? . . . . . 0 CA--C 1.514 -0.407 0 CA-C-O 121.539 0.685 . . . . 0.0 111.801 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -125.17 94.56 4.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.932 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 20.5 m -62.52 113.45 2.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.129 0.49 . . . . 0.0 111.707 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . 0.505 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 53.2 t80 -79.65 112.01 16.5 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.779 173.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -62.68 123.38 79.14 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.23 172.03 13.22 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.259 2.639 . . . . 0.0 113.297 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -90.62 125.17 35.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.323 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 29.3 mt -103.92 130.06 51.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.571 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -91.79 -32.76 15.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.668 0.747 . . . . 0.0 109.105 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -94.63 5.04 53.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.61 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -142.19 170.9 24.81 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.202 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -87.59 113.94 23.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.941 0.401 . . . . 0.0 110.356 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -83.31 51.77 2.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.577 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -70.31 -17.24 63.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.94 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -114.25 1.16 14.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.992 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -63.0 127.99 33.8 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.31 0.576 . . . . 0.0 111.473 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.505 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 103.05 -0.24 47.88 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.684 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -108.72 141.93 39.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.868 0.366 . . . . 0.0 110.472 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -105.66 130.43 53.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.617 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -109.52 150.86 27.53 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.747 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.34 139.33 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.276 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.842 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 12.6 tt0 -60.28 126.21 26.64 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.557 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 101.07 13.42 33.81 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -173.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -110.25 151.71 27.02 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.2 t -124.84 160.63 28.32 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -170.8 127.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.666 0.746 . . . . 0.0 110.013 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.714 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 29.8 t70 -79.09 130.0 35.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.876 -172.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 429' ' ' VAL . 31.6 t -106.38 157.53 6.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.278 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -120.55 94.34 4.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.864 0.364 . . . . 0.0 111.221 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 92.9 m -83.79 150.96 25.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.615 ' NE2' ' HE2' ' A' ' 420' ' ' TYR . 1.5 p-80 -74.68 152.23 87.14 Favored Pre-proline 0 N--CA 1.461 0.103 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.765 -170.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 417' ' ' HIS . 2.7 Cg_exo -32.32 112.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.856 3.704 . . . . 0.0 114.639 -173.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.21 -5.14 35.76 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.22 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.615 ' HE2' ' NE2' ' A' ' 417' ' ' HIS . 63.2 m-85 -120.74 144.49 48.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.989 0.423 . . . . 0.0 111.147 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -152.09 -167.12 2.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.574 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.505 HD13 HG22 ' A' ' 429' ' ' VAL . 70.4 mt -108.27 160.43 27.05 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-O 120.904 0.383 . . . . 0.0 111.918 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.421 ' HG3' HD11 ' A' ' 443' ' ' ILE . 87.7 Cg_exo -47.69 143.26 12.8 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.597 2.865 . . . . 0.0 112.715 175.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt 67.47 30.45 6.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.729 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.49 33.02 20.15 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.609 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -97.35 169.41 9.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.028 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . 0.477 ' C ' HD12 ' A' ' 422' ' ' LEU . 39.2 p -126.94 1.19 6.61 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.781 173.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.714 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 1.9 t -124.46 163.81 21.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.635 0.731 . . . . 0.0 111.654 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.523 HG13 ' HG2' ' A' ' 438' ' ' PRO . 2.0 t -129.77 142.56 43.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.34 -177.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 78.6 m -99.94 136.9 39.15 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.101 174.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 13.6 t -74.93 119.67 19.43 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.842 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 11.5 mtp -152.1 136.9 17.09 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.73 0.776 . . . . 0.0 111.657 174.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.761 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 18.9 mt-10 45.33 38.83 3.83 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.149 -1.842 . . . . 0.0 111.947 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.469 ' HB2' ' HD3' ' A' ' 387' ' ' ARG . 43.3 t30 68.89 -24.57 0.14 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.232 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -102.26 18.54 51.25 Favored Glycine 0 CA--C 1.501 -0.834 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.898 -169.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.714 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 96.4 m95 59.45 128.87 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 124.539 0.788 . . . . 0.0 112.989 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.806 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 71.1 m -49.76 -64.55 1.18 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.224 -170.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.806 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 28.2 Cg_endo -87.69 -7.6 6.42 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.692 1.594 . . . . 0.0 112.278 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 27.3 m 74.39 123.3 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.841 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.714 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 11.2 Cg_exo -62.99 93.35 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.166 2.577 . . . . 0.0 111.721 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -130.49 108.94 10.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 82.1 m -75.55 90.01 2.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.228 0.537 . . . . 0.0 110.567 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.421 HD11 ' HG3' ' A' ' 423' ' ' PRO . 11.2 mt -87.24 159.43 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.543 -0.753 . . . . 0.0 108.969 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -80.4 119.77 23.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.278 0.561 . . . . 0.0 110.303 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 445' ' ' VAL . 10.5 p . . . . . 0 C--N 1.32 -0.712 0 CA-C-O 122.209 1.004 . . . . 0.0 110.679 -172.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 1.032 ' HG2' ' HB3' ' A' ' 408' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.427 -1.593 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 0.0 OUTLIER 53.3 62.71 2.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 112.012 -2.358 . . . . 0.0 111.757 -168.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 14.5 m -67.57 134.02 50.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.223 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -91.89 132.36 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 401' ' ' ASN . 26.7 t80 -93.72 111.69 53.69 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.754 0.311 . . . . 0.0 110.702 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -92.61 -163.4 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.235 2.624 . . . . 0.0 113.442 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -85.88 140.66 30.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.355 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 394' ' ' LEU . 2.6 mm? -89.14 15.77 8.27 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -173.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 67.59 -69.54 0.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.498 0.666 . . . . 0.0 111.497 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.571 ' O ' ' HD2' ' A' ' 417' ' ' HIS . 0.2 OUTLIER -131.76 45.52 2.77 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.798 -177.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -142.07 177.03 21.75 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.053 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -88.8 118.99 28.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.222 0.534 . . . . 0.0 111.263 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . 2.5 p30 -87.62 86.52 7.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.034 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.79 -19.24 49.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.508 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 44.9 m-80 -136.73 28.92 2.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.49 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 50.4 t80 -69.09 122.24 18.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.09 0.471 . . . . 0.0 110.624 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 100.93 0.11 55.07 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.977 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -97.46 154.51 17.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.932 0.396 . . . . 0.0 111.304 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 39.0 mtmt -127.35 138.86 53.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.131 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 98.8 m-85 -128.84 158.45 38.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 -173.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.9 m -76.4 155.5 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.304 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 1.032 ' HB3' ' HG2' ' A' ' 387' ' ' ARG . 1.3 tt0 -77.5 124.43 27.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.466 0.651 . . . . 0.0 109.859 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.45 5.7 26.01 Favored Glycine 0 C--N 1.315 -0.633 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -104.12 149.06 25.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.536 -0.832 . . . . 0.0 109.15 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.4 t -129.75 158.71 38.64 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.046 0.45 . . . . 0.0 110.211 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.6 tp -156.54 139.09 6.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.079 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.63 133.48 34.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.145 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 35.2 t -123.41 133.44 69.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.166 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -109.21 128.07 54.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.575 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 0.8 OUTLIER -100.77 -169.25 1.68 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 174.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.571 ' HD2' ' O ' ' A' ' 396' ' ' ASN . 85.8 m-70 -82.13 157.44 68.45 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -54.08 110.99 0.58 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.43 2.753 . . . . 0.0 112.206 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.08 -9.95 10.21 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.185 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 77.2 m-85 -119.74 132.13 55.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -153.72 159.68 42.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 92.4 mt -70.1 153.41 95.34 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.643 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.36 150.88 47.82 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.593 2.195 . . . . 0.0 110.805 172.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.52 ' HB2' ' HG3' ' A' ' 426' ' ' GLN . 53.2 mttp 70.84 21.11 5.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.65 0.594 . . . . 0.0 110.492 -177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.97 26.73 15.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.489 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 53.7 mt-30 -84.44 158.03 21.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.195 0.521 . . . . 0.0 111.225 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 65.9 p -126.34 -9.54 6.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.87 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.24 137.62 41.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.441 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.609 HG13 ' HG2' ' A' ' 438' ' ' PRO . 2.6 t -112.98 128.07 69.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 26.0 m -99.29 124.68 44.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.593 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 38.1 t -69.03 115.91 8.88 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.911 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 29.9 mtp -138.48 129.33 26.66 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 122.745 1.26 . . . . 0.0 113.064 175.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.655 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 2.2 tp10 46.43 43.48 11.99 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 111.872 -2.422 . . . . 0.0 111.428 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 433' ' ' GLU . 26.3 t-20 78.77 -9.49 1.5 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.408 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -131.64 88.89 0.28 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.712 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -12.55 114.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.793 1.237 . . . . 0.0 112.713 170.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.712 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 30.3 m -62.88 -54.49 46.54 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.279 -171.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.609 ' HG2' HG13 ' A' ' 429' ' ' VAL . 24.2 Cg_endo -85.36 -8.15 8.69 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.54 1.493 . . . . 0.0 111.957 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 9.9 m 71.17 121.27 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.59 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.07 76.95 2.47 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.636 2.224 . . . . 0.0 112.207 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -139.16 95.89 3.02 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.681 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 420' ' ' TYR . 2.1 p -76.33 92.21 3.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.386 0.612 . . . . 0.0 110.336 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.1 pt -73.22 160.39 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.782 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -81.48 114.2 20.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.141 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--N 1.316 -0.881 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.992 -178.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.574 ' HD2' ' C ' ' A' ' 433' ' ' GLU . 62.5 mtt180 . . . . . 0 CA--C 1.516 -0.359 0 CA-C-O 121.051 0.453 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 12.5 mptt -118.54 109.56 16.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.481 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 5.5 p -69.82 144.14 52.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.283 0.563 . . . . 0.0 112.196 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -116.24 120.8 40.12 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 21.2 t80 -77.87 121.62 84.39 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 -176.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 78.8 Cg_endo -88.83 -177.14 1.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.491 2.794 . . . . 0.0 112.942 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -94.45 126.9 40.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.695 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 3.4 mm? -81.93 6.18 16.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 57.14 -89.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.248 0.547 . . . . 0.0 110.312 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.56 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 0.1 OUTLIER -83.22 50.67 1.8 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.841 175.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -153.08 163.63 30.6 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -77.03 -22.74 52.55 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.616 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . 8.1 p30 39.54 54.62 2.39 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.423 0.689 . . . . 0.0 112.426 175.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -22.92 63.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.141 -173.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.417 ' HB2' ' HD3' ' A' ' 404' ' ' ARG . 5.7 p30 -127.18 34.28 4.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.243 0.544 . . . . 0.0 111.613 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.616 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 27.9 t80 -63.95 133.45 53.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.194 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 92.6 15.91 51.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.495 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.417 ' HD3' ' HB2' ' A' ' 401' ' ' ASN . 42.0 mtp180 -107.07 154.69 20.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.294 0.568 . . . . 0.0 111.644 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 49.8 mtmt -118.97 140.84 49.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.46 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.642 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 88.2 m-85 -140.13 159.6 41.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.645 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.52 147.2 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.976 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.7 tt0 -63.15 141.18 58.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.111 0.482 . . . . 0.0 111.337 -176.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.15 8.97 35.1 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 61.9 mmtt -113.23 179.56 3.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.365 -176.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.8 t -150.45 160.97 43.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.11 0.481 . . . . 0.0 110.365 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.452 HD13 ' H ' ' A' ' 413' ' ' ASP . 0.4 OUTLIER -154.15 149.65 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.574 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.452 ' H ' HD13 ' A' ' 412' ' ' ILE . 15.2 t70 -90.7 141.89 28.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.75 -176.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 28.9 t -126.63 141.22 46.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.27 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -125.23 118.16 25.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.833 0.349 . . . . 0.0 110.736 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 74.7 m -103.46 -178.64 3.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -58.32 154.14 33.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.169 174.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.83 108.53 0.49 Allowed 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.7 2.934 . . . . 0.0 112.179 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.63 -13.12 15.34 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -113.3 147.98 36.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.375 -0.412 . . . . 0.0 109.908 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -159.47 179.23 9.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.162 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.656 HD13 HG13 ' A' ' 429' ' ' VAL . 87.2 mt -76.86 160.7 76.01 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.9 141.11 22.35 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.978 2.452 . . . . 0.0 111.937 173.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 68.0 30.5 5.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.173 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.44 30.09 16.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.659 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 22.4 mt-30 -91.29 158.53 16.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.991 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 8.2 p -118.38 -4.82 10.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.141 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.66 140.72 52.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.96 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.656 HG13 HD13 ' A' ' 422' ' ' LEU . 3.3 m -108.61 133.23 54.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.129 0.49 . . . . 0.0 110.16 174.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 76.9 m -85.44 128.18 34.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.513 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 53.4 t -69.54 106.09 2.88 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.976 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 6.4 mtt -143.09 139.26 30.38 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.633 0.73 . . . . 0.0 111.552 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.789 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 7.0 mm-40 41.41 40.5 1.29 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 112.956 -1.929 . . . . 0.0 112.637 -176.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 4.3 t-20 70.22 -23.6 0.16 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.49 176.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -103.9 15.35 52.05 Favored Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.799 -170.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.46 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 85.1 m95 56.04 125.72 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.735 0.814 . . . . 0.0 112.523 -174.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.769 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 58.5 m -44.47 -61.87 1.88 Allowed Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -172.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 64.3 Cg_endo -88.42 -3.62 6.71 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.704 1.603 . . . . 0.0 112.817 -175.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 28.5 m 68.98 109.3 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.606 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 11.5 Cg_endo -55.14 102.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.794 2.996 . . . . 0.0 112.455 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -141.76 131.62 24.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.992 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 76.6 m -87.05 91.21 8.63 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.137 0.494 . . . . 0.0 109.869 175.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 8.9 mt -94.28 157.73 3.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -88.84 108.18 19.38 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.4 0.619 . . . . 0.0 109.712 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.753 -173.021 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.94 ' HG3' ' CB ' ' A' ' 408' ' ' GLN . 7.8 mpt_? . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 39.3 ttmt 73.98 79.17 0.12 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 112.471 -2.15 . . . . 0.0 112.362 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 435' ' ' GLY . 3.2 m -87.28 155.87 19.88 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.755 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -119.18 128.53 54.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -81.25 122.43 81.3 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.587 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.6 172.27 11.45 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.205 2.603 . . . . 0.0 113.388 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -85.94 123.33 31.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.07 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 394' ' ' LEU . 2.2 mm? -95.74 119.49 34.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -76.91 -32.09 57.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.319 0.58 . . . . 0.0 109.867 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 8.9 m120 -100.63 10.37 41.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.556 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.627 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -131.46 175.95 19.37 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.582 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -92.81 109.99 21.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 2.9 p30 -81.12 48.04 1.08 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.239 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.89 -32.86 74.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.328 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.535 ' ND2' HD12 ' A' ' 412' ' ' ILE . 78.7 m-20 -95.63 -9.42 32.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.126 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 52.0 t80 -59.94 129.74 43.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.221 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 95.29 5.15 60.71 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.247 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -104.43 148.3 26.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.086 0.47 . . . . 0.0 110.759 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -124.59 143.78 50.52 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.86 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 87.4 m-85 -139.39 156.39 47.02 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.306 -173.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 26.2 m -88.03 137.59 20.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.818 174.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.94 ' CB ' ' HG3' ' A' ' 387' ' ' ARG . 1.5 tt0 -53.14 137.84 32.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.016 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.79 7.76 25.15 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -112.75 151.55 30.16 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.439 -0.88 . . . . 0.0 110.025 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 35.6 t -131.4 153.32 49.8 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.535 HD12 ' ND2' ' A' ' 401' ' ' ASN . 0.2 OUTLIER -152.72 144.14 15.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.781 -173.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.477 ' N ' HD13 ' A' ' 412' ' ' ILE . 28.5 t70 -81.89 137.64 35.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.392 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 64.3 t -121.84 126.83 75.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.46 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.72 128.25 54.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.315 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.627 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 61.2 m -105.92 -178.45 3.65 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -76.13 154.95 84.56 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.12 112.07 0.77 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.655 2.904 . . . . 0.0 112.457 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 445' ' ' VAL . . . 115.08 -12.76 19.7 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.905 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -111.06 148.73 31.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.709 0.29 . . . . 0.0 110.643 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.87 162.11 39.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.453 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.14 158.38 81.67 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.809 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.67 135.17 61.31 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.771 2.314 . . . . 0.0 111.555 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 69.86 17.46 7.56 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.992 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 63.53 39.67 8.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.436 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.592 HE22 ' HB2' ' A' ' 438' ' ' PRO . 23.4 mt-30 -78.46 158.84 28.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.492 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 49.9 p -121.93 -13.58 8.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.48 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.83 149.74 47.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.585 -175.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.639 HG11 ' HG3' ' A' ' 440' ' ' PRO . 13.0 t -126.88 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.469 ' H ' ' CD ' ' A' ' 438' ' ' PRO . 38.6 m -103.53 123.1 46.29 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.49 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 43.2 t -64.12 116.35 5.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.313 174.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.803 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 32.7 mtt -145.46 133.27 21.16 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.762 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 33.4 tt0 28.47 68.09 0.08 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.135 -169.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.415 ' HA ' ' C ' ' A' ' 388' ' ' LYS . 2.3 p-10 56.57 31.31 18.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.224 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' A' ' 389' ' ' CYS . . . -150.55 -158.19 8.14 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.723 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.45 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 96.9 m95 -136.36 113.25 10.34 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -174.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 12.7 t -66.32 -51.24 44.75 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.951 -168.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.592 ' HB2' HE22 ' A' ' 426' ' ' GLN . 25.7 Cg_endo -91.29 0.97 4.7 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.44 1.427 . . . . 0.0 112.504 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.53 HG22 ' HG3' ' A' ' 441' ' ' ARG . 13.3 m 73.71 112.0 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.928 171.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.639 ' HG3' HG11 ' A' ' 429' ' ' VAL . 1.3 Cg_endo -79.77 93.53 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.031 2.487 . . . . 0.0 112.07 175.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.53 ' HG3' HG22 ' A' ' 439' ' ' THR . 78.7 mtp180 -138.94 114.74 10.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.271 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 396' ' ' ASN . 76.2 m -81.88 83.32 7.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.491 . . . . 0.0 110.557 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 10.5 mt -83.12 158.08 3.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -78.92 114.58 17.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.264 0.554 . . . . 0.0 109.879 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 419' ' ' GLY . 9.8 p . . . . . 0 C--N 1.316 -0.851 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.163 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.955 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 9.9 mmt180 . . . . . 0 N--CA 1.463 0.215 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.88 90.93 3.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.379 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 23.9 m -64.79 133.72 52.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.773 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . 0.565 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 55.9 t80 -102.63 123.98 47.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 401' ' ' ASN . 27.5 t80 -80.46 119.46 76.42 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -87.76 -171.03 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.387 2.725 . . . . 0.0 113.323 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . 0.419 ' HA ' ' OD1' ' A' ' 399' ' ' ASN . 80.4 t80 -105.59 111.94 24.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.497 -174.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.07 117.79 25.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.46 -36.1 82.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.155 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -108.04 28.2 8.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.905 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -138.9 165.75 25.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.589 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -90.74 111.11 22.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.156 0.503 . . . . 0.0 110.139 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.63 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . 42.3 m-80 -92.63 70.03 4.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.106 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -76.71 -6.57 52.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.255 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 40.4 m-80 -135.22 23.23 3.49 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.591 0.234 . . . . 0.0 111.372 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.63 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 22.9 t80 -68.89 129.35 39.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 110.931 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.565 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 90.44 14.51 58.47 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.702 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -111.04 145.38 38.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.931 0.396 . . . . 0.0 110.903 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 98.0 mttt -108.72 134.87 50.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.287 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -126.88 149.87 49.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.651 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 32.3 m -85.6 148.68 4.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 1.068 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.8 tt0 -59.6 140.25 56.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.189 0.518 . . . . 0.0 111.175 -176.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.03 10.92 35.67 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -109.93 152.99 25.14 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.537 -0.831 . . . . 0.0 109.417 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 41.1 t -128.48 157.21 41.78 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 11.1 tp -148.86 139.69 16.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.545 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.84 132.5 36.13 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.808 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.621 ' HB ' HD11 ' A' ' 422' ' ' LEU . 46.7 t -130.77 101.63 5.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.017 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.72 115.74 27.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.406 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.654 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 82.9 m -84.81 174.12 10.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.906 174.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -62.84 156.75 64.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.722 0.296 . . . . 0.0 110.485 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.21 110.08 0.44 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.657 2.905 . . . . 0.0 112.53 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.55 -12.04 15.95 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.898 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.33 156.05 26.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.946 0.403 . . . . 0.0 110.706 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -157.21 167.63 29.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.153 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.621 HD11 ' HB ' ' A' ' 414' ' ' VAL . 87.3 mt -72.74 153.23 91.4 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.851 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.58 141.58 62.79 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.949 2.433 . . . . 0.0 111.63 176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 64.8 mttm 71.4 24.85 3.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.044 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.01 51.3 7.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.319 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.868 HE22 ' HB2' ' A' ' 438' ' ' PRO . 23.9 mt-30 -114.45 165.44 12.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.217 -176.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 29.0 p -129.7 -4.1 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.14 137.93 53.07 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.555 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.542 HG13 ' HG2' ' A' ' 438' ' ' PRO . 16.3 t -113.63 132.94 61.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.639 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 25.1 m -101.02 124.19 46.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.719 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.7 t -64.01 113.88 3.77 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 1.068 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 44.0 mtt -142.07 132.37 24.96 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.742 0.782 . . . . 0.0 111.838 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.676 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 0.7 OUTLIER 28.78 52.74 0.07 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.05 -171.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.955 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 0.2 OUTLIER 76.29 -25.18 0.21 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.561 171.351 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -115.71 60.91 0.4 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-O 119.361 -0.688 . . . . 0.0 112.971 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.423 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 96.3 m95 20.39 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.033 1.333 . . . . 0.0 114.346 169.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.662 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 31.1 t -47.51 -59.56 5.39 Favored Pre-proline 0 N--CA 1.467 0.421 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -168.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.868 ' HB2' HE22 ' A' ' 426' ' ' GLN . 44.3 Cg_endo -85.45 -5.04 9.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.497 1.464 . . . . 0.0 113.384 -174.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.466 HG22 ' HG3' ' A' ' 441' ' ' ARG . 28.2 m 73.42 116.64 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.989 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 51.7 Cg_endo -76.47 109.34 2.85 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.547 2.164 . . . . 0.0 112.273 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.535 ' O ' HD23 ' A' ' 422' ' ' LEU . 71.7 mtp180 -146.52 151.84 38.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.18 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 74.0 m -111.29 90.7 3.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.119 0.485 . . . . 0.0 110.311 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 12.7 mt -92.59 155.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -82.22 121.77 27.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.438 0.637 . . . . 0.0 110.138 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--N 1.315 -0.899 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.522 -175.064 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 2.9 mptp? -113.87 96.23 5.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.464 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 7.9 p -68.44 136.86 53.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.922 0.392 . . . . 0.0 111.094 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -99.78 130.83 46.02 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.475 ' HZ ' HG22 ' A' ' 414' ' ' VAL . 1.2 t80 -92.44 104.34 10.91 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.89 -90.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.369 2.713 . . . . 0.0 114.609 -170.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . 0.432 ' N ' ' CE1' ' A' ' 402' ' ' TYR . 0.9 OUTLIER 167.52 128.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.736 0.814 . . . . 0.0 110.278 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.612 ' HG ' ' SG ' ' A' ' 442' ' ' CYS . 0.9 OUTLIER -73.4 -131.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.045 0.45 . . . . 0.0 110.408 173.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -155.63 -40.99 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -105.49 17.22 24.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.514 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -119.11 141.19 15.66 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.59 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . 0.401 ' HD1' ' O ' ' A' ' 415' ' ' ALA . 71.6 m-85 -65.78 114.53 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.239 0.542 . . . . 0.0 111.128 -176.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.798 ' HA ' ' HD2' ' A' ' 402' ' ' TYR . 0.4 OUTLIER -80.2 68.59 6.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.685 0.755 . . . . 0.0 110.321 176.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -70.95 -64.21 0.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.658 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.401 ' HB3' ' HD3' ' A' ' 404' ' ' ARG . 22.8 m-80 -108.11 39.11 2.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.69 -176.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.798 ' HD2' ' HA ' ' A' ' 399' ' ' ASN . 0.9 OUTLIER -92.58 148.2 22.27 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.535 -173.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 90.61 11.44 62.18 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.401 ' HD3' ' HB3' ' A' ' 401' ' ' ASN . 36.6 mtp180 -104.54 162.9 12.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.477 0.656 . . . . 0.0 111.995 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . 0.542 ' NZ ' ' HB2' ' A' ' 405' ' ' LYS . 10.2 mtmp? -117.72 134.36 54.98 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.324 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.658 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 97.0 m-85 -124.31 163.17 22.23 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.578 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 27.2 m -100.48 148.33 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.075 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.826 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.9 tt0 -57.12 139.38 52.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.99 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.5 7.64 56.73 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 5.4 mmtm -107.73 175.41 5.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.144 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 35.6 t -146.83 165.8 28.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.6 tp -156.1 137.79 5.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.382 0.61 . . . . 0.0 110.094 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -83.72 129.83 34.95 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.914 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.475 HG22 ' HZ ' ' A' ' 391' ' ' PHE . 46.4 t -117.02 114.19 45.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.609 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.401 ' O ' ' HD1' ' A' ' 398' ' ' TYR . . . -94.68 93.49 7.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.056 0.455 . . . . 0.0 111.102 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.495 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 60.1 m -73.94 154.59 39.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 171.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -60.29 157.18 35.72 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.724 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.41 115.97 2.24 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.817 3.011 . . . . 0.0 112.641 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.24 -16.79 17.35 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.547 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 81.6 m-85 -110.75 148.09 33.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.593 0.235 . . . . 0.0 110.42 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -152.88 168.7 24.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.75 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 77.7 mt -83.09 155.74 67.12 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.118 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.12 155.87 27.13 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.396 2.731 . . . . 0.0 112.001 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 64.98 23.77 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.351 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 51.95 41.41 29.59 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.328 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.582 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 25.3 mt-30 -105.11 163.02 12.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.13 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 32.6 p -120.07 -6.0 9.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.471 0.653 . . . . 0.0 109.988 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 146.3 49.37 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.223 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.573 HG13 ' HG2' ' A' ' 438' ' ' PRO . 6.1 t -112.2 132.13 61.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 51.7 m -93.71 131.53 38.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.389 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 51.0 t -77.25 110.26 11.81 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.324 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.826 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 28.1 mtt -143.38 142.74 31.36 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.682 0.753 . . . . 0.0 112.977 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 5.1 tt0 37.91 42.84 0.46 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.213 -174.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 433' ' ' GLU . 8.9 t-20 71.24 -20.62 0.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.125 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -117.88 60.74 0.46 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.381 -172.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 88.7 m95 24.72 107.43 0.0 OUTLIER 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.097 1.359 . . . . 0.0 114.282 169.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.758 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 58.6 m -51.12 -58.97 8.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.333 -166.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.652 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 24.6 Cg_endo -86.08 -7.67 8.05 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.831 1.687 . . . . 0.0 112.595 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.58 HG22 ' HG3' ' A' ' 441' ' ' ARG . 55.4 m 73.61 118.46 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.719 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 439' ' ' THR . 5.0 Cg_exo -70.61 101.85 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.732 2.288 . . . . 0.0 111.804 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.58 ' HG3' HG22 ' A' ' 439' ' ' THR . 72.3 mtp180 -141.98 124.23 15.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.086 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.612 ' SG ' ' HG ' ' A' ' 394' ' ' LEU . 73.8 m -92.66 97.65 10.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.1 mt -99.93 155.65 4.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -81.14 116.59 21.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.475 0.655 . . . . 0.0 109.748 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.313 -1.002 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.491 -172.635 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.576 ' HD2' ' CB ' ' A' ' 434' ' ' ASN . 1.8 mmt180 . . . . . 0 CA--C 1.506 -0.732 0 CA-C-O 121.409 0.623 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.533 ' HE2' HG12 ' A' ' 407' ' ' VAL . 1.5 mptm? -118.25 106.92 13.29 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.224 -178.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 8.2 p -74.24 141.6 45.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.661 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -102.31 128.79 48.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -82.85 113.36 44.8 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.79 -176.89 2.37 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.047 2.498 . . . . 0.0 113.356 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -90.6 118.05 29.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.6 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.31 110.59 19.76 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -67.27 -29.81 69.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.0 109.728 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -100.71 15.36 28.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.093 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.677 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -134.1 -179.14 16.14 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.38 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -90.25 -1.66 57.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.71 0.29 . . . . 0.0 111.773 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 2.3 p30 40.9 41.04 1.12 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.445 1.098 . . . . 0.0 113.266 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -61.32 -26.58 67.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.382 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -114.25 18.24 17.13 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.553 -174.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -58.99 121.19 10.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.555 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.2 -6.75 36.95 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.917 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -85.04 147.23 26.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.049 0.452 . . . . 0.0 110.867 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -118.91 133.27 55.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.448 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.697 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 63.8 m-85 -124.3 159.33 30.5 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.533 HG12 ' HE2' ' A' ' 388' ' ' LYS . 27.1 m -92.21 146.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.996 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.7 tt0 -60.05 136.5 58.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.031 0.443 . . . . 0.0 110.824 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 104.57 12.79 27.71 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 22.8 mmtp -112.62 175.65 5.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.28 -0.46 . . . . 0.0 111.036 -176.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 40.0 t -149.77 162.82 39.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.28 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.3 tp -169.73 125.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.623 0.725 . . . . 0.0 110.507 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.748 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 18.4 t70 -77.27 137.52 38.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.314 -172.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.82 123.59 71.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.256 0.55 . . . . 0.0 111.303 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.92 112.45 23.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.193 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.677 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 80.5 m -112.59 163.31 14.67 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -63.06 149.14 91.34 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.338 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.83 107.6 0.22 Allowed 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.926 3.084 . . . . 0.0 112.676 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 123.89 -15.15 7.92 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.051 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 91.8 m-85 -108.04 136.37 47.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 176.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 442' ' ' CYS . . . -153.65 160.19 42.31 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.263 -176.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.471 HD11 HG22 ' A' ' 429' ' ' VAL . 84.5 mt -75.65 152.76 85.29 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.909 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 54.1 Cg_exo -53.69 144.75 52.16 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.758 2.305 . . . . 0.0 110.564 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 90.2 mttt 77.34 16.18 1.66 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.064 0.852 . . . . 0.0 109.843 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.8 40.34 19.61 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.917 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.408 ' HG3' ' HB2' ' A' ' 424' ' ' LYS . 96.7 mt-30 -93.54 159.33 15.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.097 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 60.2 p -110.18 -22.53 11.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.21 172.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.748 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 1.3 t -121.52 164.35 17.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.483 0.659 . . . . 0.0 111.662 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 440' ' ' PRO . 2.2 t -120.59 137.13 55.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.645 -175.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 83.5 m -94.13 130.65 40.23 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.205 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.2 t -75.83 113.4 13.27 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.996 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 20.0 mtp -145.24 139.68 27.33 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.532 0.682 . . . . 0.0 111.743 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.694 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 6.1 mm-40 41.77 38.95 1.07 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.783 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.576 ' CB ' ' HD2' ' A' ' 387' ' ' ARG . 4.5 t-20 69.56 -19.8 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.359 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -107.37 20.76 32.08 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.663 -170.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.566 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 96.7 m95 52.73 124.49 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.143 0.977 . . . . 0.0 113.615 -178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.799 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 73.1 m -50.33 -61.87 3.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 33.5 Cg_endo -89.73 -5.25 5.32 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.98 1.786 . . . . 0.0 113.413 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.6 m 74.15 113.41 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.964 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 42.4 Cg_endo -73.49 113.16 3.71 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.623 2.216 . . . . 0.0 110.907 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -154.13 -39.28 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.346 -173.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 91.6 m 60.47 89.9 0.07 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.877 0.846 . . . . 0.0 111.872 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 10.1 mt -84.61 160.46 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.643 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 444' ' ' ARG . 21.3 ttp-105 -81.91 111.51 18.17 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.642 0.734 . . . . 0.0 109.898 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--N 1.309 -1.159 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.661 -177.795 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.905 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 8.5 mmt180 . . . . . 0 CA--C 1.51 -0.589 0 CA-C-O 121.738 0.78 . . . . 0.0 112.925 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 2.6 mptp? -121.68 91.49 3.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.792 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 23.9 m -61.47 130.36 45.64 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.018 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -98.13 127.73 44.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.466 ' CE2' HD21 ' A' ' 394' ' ' LEU . 16.6 t80 -83.3 120.22 75.35 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.431 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -88.34 -171.99 0.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.26 2.64 . . . . 0.0 112.997 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . 0.401 ' HE1' ' ND2' ' A' ' 399' ' ' ASN . 75.9 t80 -92.54 129.68 38.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.596 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.466 HD21 ' CE2' ' A' ' 391' ' ' PHE . 2.7 mm? -89.78 124.15 34.39 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.67 130.78 45.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 8.2 p30 50.32 26.1 2.12 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 124.206 0.942 . . . . 0.0 111.796 -173.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -115.49 169.85 13.07 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.387 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -90.3 102.72 15.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.534 0.683 . . . . 0.0 110.288 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.415 ' H ' ' ND2' ' A' ' 399' ' ' ASN . 2.0 p30 -78.47 60.64 2.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.792 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -88.12 -29.9 20.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.148 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -97.26 -6.5 34.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.175 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.412 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 23.7 t80 -62.14 129.15 39.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.085 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.22 13.7 47.86 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.35 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 404' ' ' ARG . 53.6 mtt180 -108.53 149.43 28.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.136 0.493 . . . . 0.0 111.509 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -111.91 131.36 55.42 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.431 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.404 ' CD2' ' HH2' ' A' ' 436' ' ' TRP . 96.9 m-85 -128.86 138.81 52.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.163 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.1 m -76.2 152.44 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.464 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.694 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 9.2 tt0 -60.75 127.04 29.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.258 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.73 -18.13 17.37 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.218 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -86.79 145.59 26.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.864 0.364 . . . . 0.0 110.853 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.3 t -121.12 158.79 27.15 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.987 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.6 tp -155.22 146.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.04 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.82 133.93 38.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.377 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.01 137.23 30.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.778 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -105.69 112.34 25.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.994 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 48.4 m -124.77 172.35 9.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.069 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.433 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 12.3 m170 -54.89 159.98 3.3 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-O 121.125 0.488 . . . . 0.0 111.67 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 73.3 Cg_endo -75.46 103.45 1.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.243 2.629 . . . . 0.0 111.475 -175.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.01 -4.57 13.96 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.921 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -111.87 133.93 53.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.1 162.9 40.89 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.645 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 440' ' ' PRO . 92.0 mt -69.29 155.55 93.32 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.654 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.95 152.12 30.75 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.912 2.408 . . . . 0.0 111.978 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 73.46 23.93 2.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.93 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.11 42.08 26.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.043 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 22.7 mt-30 -116.21 162.75 17.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.92 -176.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 61.8 p -124.45 -6.8 7.55 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.62 144.66 41.75 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.759 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.727 HG12 ' HG2' ' A' ' 438' ' ' PRO . 23.6 m -120.43 158.78 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.055 0.455 . . . . 0.0 109.954 172.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 90.6 m -113.79 132.63 55.78 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.425 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.2 t -68.34 118.62 11.67 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 177.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.694 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 6.2 ptt? -142.87 133.68 25.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.12 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 434' ' ' ASN . 0.9 OUTLIER 34.65 40.68 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.783 -174.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . 0.905 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 7.5 t30 76.67 -23.85 0.24 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.384 0.674 . . . . 0.0 111.952 176.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -103.39 109.59 3.49 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.578 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 94.0 m95 -39.64 125.09 1.76 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 124.17 0.571 . . . . 0.0 112.073 -175.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.728 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 74.1 p -43.06 -52.08 12.31 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -166.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.728 ' HD3' ' OG ' ' A' ' 437' ' ' SER . 5.2 Cg_endo -105.53 2.05 0.22 Allowed 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.084 1.856 . . . . 0.0 112.495 -176.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 25.5 m 72.76 116.49 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.21 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 32.0 Cg_endo -64.32 92.15 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.801 2.334 . . . . 0.0 111.592 174.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 441' ' ' ARG . 9.2 mmm180 -105.21 -50.33 3.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.221 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 83.1 m 60.0 81.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.599 0.714 . . . . 0.0 110.918 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 3.7 pt -95.57 155.08 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.274 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -73.68 107.66 6.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.002 0.906 . . . . 0.0 111.192 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 85.8 t . . . . . 0 C--N 1.31 -1.145 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.79 176.431 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 31.0 mt . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 121.965 0.888 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.782 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 8.6 mtt-85 -98.88 178.16 5.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.127 -168.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -129.13 98.32 4.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.395 177.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 434' ' ' ASN . 6.2 m -57.32 125.64 23.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.002 -175.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -86.74 130.22 34.56 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 168.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -80.86 120.59 79.33 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.539 0.209 . . . . 0.0 110.476 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.72 179.2 3.45 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.098 2.532 . . . . 0.0 113.819 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -86.91 127.43 35.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.176 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 394' ' ' LEU . 2.0 mm? -93.69 118.0 30.82 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -65.38 -36.69 84.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.945 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -117.89 28.13 8.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.311 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -143.96 162.32 27.79 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.067 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -83.64 108.46 16.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.265 0.555 . . . . 0.0 110.052 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 2.0 p30 -80.67 54.78 2.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.045 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -63.47 -32.75 74.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.353 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.496 ' ND2' HD12 ' A' ' 412' ' ' ILE . 49.3 m-20 -100.46 -0.3 38.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.011 -173.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 64.8 t80 -62.95 120.41 11.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.018 0.437 . . . . 0.0 110.402 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.8 -14.64 19.65 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.843 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -90.86 156.88 17.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 111.434 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -126.1 132.91 51.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.146 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -127.84 148.08 50.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.044 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 16.9 m -81.99 148.53 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.515 0.198 . . . . 0.0 110.61 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 1.008 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.4 tt0 -61.09 133.04 55.62 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.314 0.578 . . . . 0.0 111.229 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.3 27.02 6.67 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 9.3 mmmt -127.69 163.66 23.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.135 -0.532 . . . . 0.0 110.637 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 44.3 t -135.04 161.17 36.06 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.496 HD12 ' ND2' ' A' ' 401' ' ' ASN . 0.3 OUTLIER -164.88 143.77 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.544 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.486 ' H ' HD13 ' A' ' 412' ' ' ILE . 13.5 t70 -78.92 138.11 37.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.731 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 37.9 t -127.4 102.03 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.073 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -78.19 117.71 19.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.975 0.417 . . . . 0.0 111.115 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 35.2 m -103.54 167.61 9.69 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -65.24 158.92 69.73 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.497 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.58 110.34 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 123.518 2.812 . . . . 0.0 112.573 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 103.58 7.23 42.78 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.903 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 95.1 m-85 -125.85 139.16 53.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -159.81 -172.34 3.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.058 0.456 . . . . 0.0 111.049 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 440' ' ' PRO . 82.9 mt -97.06 161.4 26.39 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.435 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.09 152.18 15.05 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.254 2.636 . . . . 0.0 112.074 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 63.69 26.16 14.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.143 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.27 24.71 13.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.638 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 25.1 mt-30 -86.68 161.35 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.134 0.492 . . . . 0.0 111.4 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.0 t -121.01 -6.48 9.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -114.31 140.04 48.95 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.626 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 438' ' ' PRO . 5.1 m -107.34 144.34 16.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.25 0.548 . . . . 0.0 110.57 176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 26.0 m -101.98 121.86 42.95 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.2 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.1 t -66.78 113.55 4.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 1.008 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 7.5 mtt -143.18 136.29 28.01 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.29 0.567 . . . . 0.0 111.353 174.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.462 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 3.4 mt-10 34.46 46.03 0.16 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.699 -177.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.782 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 55.3 t30 71.97 -24.14 0.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.601 175.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -108.03 33.29 6.37 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.136 -1.031 . . . . 0.0 113.893 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.556 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 95.7 m95 40.56 111.34 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.509 1.124 . . . . 0.0 113.891 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.735 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 73.0 m -40.28 -60.59 1.43 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -172.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 48.6 Cg_endo -88.6 -6.86 5.84 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.737 1.625 . . . . 0.0 112.871 -176.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 54.8 m 71.88 116.05 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.551 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 66.0 Cg_endo -80.49 109.52 2.3 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.84 2.36 . . . . 0.0 111.072 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -147.65 -14.78 0.38 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 61.3 m 56.63 83.34 0.1 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.939 0.399 . . . . 0.0 111.839 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.8 mt -85.61 157.8 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 30.5 ttp180 -86.73 105.95 17.32 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.345 1.069 . . . . 0.0 111.374 -175.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 36.9 t -73.72 -38.08 50.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 113.014 -1.903 . . . . 0.0 110.285 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? . . . . . 0 C--O 1.248 0.985 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.532 -171.949 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.634 0 CA-C-O 121.456 0.646 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 9.2 mtt180 -83.93 165.3 18.79 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.262 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -133.62 101.4 5.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.162 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 6.8 p -68.43 144.76 54.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.694 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -107.08 132.1 53.37 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 168.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 39.9 t80 -81.57 118.87 73.93 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.337 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 86.1 Cg_endo -90.95 -173.58 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.44 2.76 . . . . 0.0 113.549 -176.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -93.32 138.68 31.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.215 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.96 -96.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 173.79 -33.36 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.574 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -145.07 38.75 1.19 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.317 -1.31 . . . . 0.0 108.825 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -127.88 147.43 17.24 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.505 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.25 99.9 1.61 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.005 0.431 . . . . 0.0 110.013 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 2.5 p30 -79.16 51.34 1.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.928 -175.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -71.29 -24.45 62.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.186 0.517 . . . . 0.0 110.171 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -93.96 -9.63 36.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.738 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.492 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 83.1 t80 -63.9 114.29 3.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.391 0.615 . . . . 0.0 110.749 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 118.48 -19.14 10.74 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.82 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -82.66 153.5 25.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.152 0.501 . . . . 0.0 111.366 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 42.6 mtmt -127.52 134.13 49.8 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.136 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.644 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 96.2 m-85 -125.5 151.92 45.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 31.8 m -82.97 148.12 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.851 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 3.4 tt0 -59.24 140.79 55.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.799 0.333 . . . . 0.0 110.504 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.64 6.9 57.12 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -103.4 167.66 9.66 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.431 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 39.4 t -138.33 160.22 40.04 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.912 0.387 . . . . 0.0 110.12 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.9 tp -159.5 139.38 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.094 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -76.0 135.69 39.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.35 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.635 ' HB ' HD11 ' A' ' 422' ' ' LEU . 56.1 t -126.71 101.09 7.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.311 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.2 122.12 28.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.186 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.504 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 73.5 m -98.03 163.12 12.89 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -67.21 155.97 89.24 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.284 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.01 122.17 10.07 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.762 2.975 . . . . 0.0 112.277 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.76 30.74 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 70.3 m-85 -122.0 144.06 49.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.721 0.296 . . . . 0.0 110.291 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -142.87 178.64 7.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.132 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.635 HD11 ' HB ' ' A' ' 414' ' ' VAL . 34.2 mt -95.68 148.33 34.41 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.884 0.373 . . . . 0.0 110.561 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 441' ' ' ARG . 31.7 Cg_exo -59.14 150.02 76.38 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.97 2.447 . . . . 0.0 112.115 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 67.04 28.4 8.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.393 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.31 44.43 27.39 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.772 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.573 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 24.5 mt-30 -106.9 161.93 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.14 -175.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.7 p -128.91 -13.4 4.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.987 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.15 139.63 50.97 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.253 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 438' ' ' PRO . 21.6 t -108.43 133.83 52.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 89.6 m -92.78 130.66 38.32 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.19 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.84 106.95 6.62 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.106 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.851 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 11.6 mtm -141.8 141.45 33.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.748 173.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.689 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 61.9 mm-40 46.89 36.37 3.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.876 -1.966 . . . . 0.0 111.476 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 6.2 t30 69.18 -20.94 0.16 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.803 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -112.64 49.96 0.81 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.511 -0.852 . . . . 0.0 114.061 -172.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 93.5 m95 35.69 106.81 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 169.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.827 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 55.8 m -51.7 -59.17 8.64 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 35.4 Cg_endo -85.53 -3.85 9.24 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.675 1.583 . . . . 0.0 113.079 -175.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.752 HG22 ' HG2' ' A' ' 441' ' ' ARG . 23.0 m 72.6 113.45 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.197 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -68.62 94.12 0.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.4 2.067 . . . . 0.0 110.812 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.752 ' HG2' HG22 ' A' ' 439' ' ' THR . 24.9 mmm180 -131.53 118.95 20.84 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 66.7 m -83.47 82.69 8.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.088 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 6.3 pt -76.4 144.89 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.657 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -73.17 111.24 8.1 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.577 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.9 p -78.66 -16.85 13.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.998 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.69 -0.671 . . . . 0.0 110.002 178.027 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.443 -0.825 0 CA-C-O 121.328 0.585 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.91 ' HG3' ' HG3' ' A' ' 433' ' ' GLU . 1.4 mmp_? -97.1 172.23 7.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.793 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -135.51 99.92 4.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.774 -175.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 10.4 m -67.87 146.49 53.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.932 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -107.57 128.22 54.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.176 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -74.15 122.31 87.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.97 -177.23 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.167 2.578 . . . . 0.0 113.475 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -93.63 117.16 29.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.683 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.596 HD11 ' HB2' ' A' ' 440' ' ' PRO . 0.0 OUTLIER -80.37 8.13 8.22 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -171.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 59.97 -84.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -97.17 13.23 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.463 0.649 . . . . 0.0 110.246 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -112.9 -161.11 14.81 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.76 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . 0.516 ' HB2' ' HB1' ' A' ' 415' ' ' ALA . 57.6 m-85 -92.79 162.65 14.03 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.184 0.516 . . . . 0.0 109.782 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 1.6 p30 -129.47 41.62 3.42 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.519 0.676 . . . . 0.0 109.685 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.45 ' HG3' ' HB3' ' A' ' 398' ' ' TYR . 75.1 mt-30 -61.05 -46.36 91.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.149 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -94.08 -1.05 54.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.04 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.511 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 73.1 t80 -61.8 119.36 8.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.325 0.584 . . . . 0.0 110.28 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 110.22 -12.63 31.25 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.307 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -95.22 150.65 19.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -118.53 134.6 54.96 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.134 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.97 140.76 52.63 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.215 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.91 147.38 8.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.368 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.713 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 8.3 tt0 -56.47 129.43 40.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.077 0.465 . . . . 0.0 110.667 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 115.43 -22.19 12.24 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -81.74 150.99 27.69 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 24.2 t -140.07 146.7 39.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.824 0.821 . . . . 0.0 111.406 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.7 tp 177.72 132.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.865 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.675 ' HB2' HG23 ' A' ' 429' ' ' VAL . 27.3 t70 -125.71 -89.46 0.57 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.478 -1.237 . . . . 0.0 107.953 173.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.9 t 34.74 75.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 111.728 -2.487 . . . . 0.0 112.943 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.516 ' O ' HD23 ' A' ' 394' ' ' LEU . . . -176.06 52.06 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.771 -172.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 56.4 m -130.99 133.95 46.26 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 173.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -61.05 157.42 42.03 Favored Pre-proline 0 N--CA 1.463 0.209 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.34 115.21 1.63 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.522 2.815 . . . . 0.0 112.522 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 113.52 -11.69 23.54 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.633 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.549 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 63.6 m-85 -113.66 144.04 43.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.537 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.34 -177.95 6.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.034 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 61.1 mt -90.49 151.45 44.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 174.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.95 153.24 58.86 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.79 2.327 . . . . 0.0 111.554 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm 65.73 28.24 11.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.037 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.82 40.16 30.67 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.472 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 26.2 mt-30 -90.15 152.43 21.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.431 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 413' ' ' ASP . 2.1 p -140.93 20.3 2.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -152.39 136.74 16.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.344 0.593 . . . . 0.0 110.108 -177.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.926 HG13 ' HD2' ' A' ' 438' ' ' PRO . 79.4 t -115.81 132.03 66.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.118 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.526 ' HB ' ' OG ' ' A' ' 437' ' ' SER . 49.1 m -91.5 134.92 34.24 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.543 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 18.3 t -75.14 120.2 20.32 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.713 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 21.2 ptm -107.39 -140.13 0.37 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.91 ' HG3' ' HG3' ' A' ' 387' ' ' ARG . 44.8 tt0 -70.35 71.39 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.233 0.924 . . . . 0.0 111.657 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.722 ' HB2' ' HD3' ' A' ' 387' ' ' ARG . 4.0 t30 78.43 -11.43 1.21 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.755 168.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -111.2 170.83 14.0 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 170.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.621 ' HB3' HG11 ' A' ' 429' ' ' VAL . 98.7 m95 -93.44 128.46 39.52 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.742 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 35.2 p -56.28 -54.03 57.35 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -165.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.926 ' HD2' HG13 ' A' ' 429' ' ' VAL . 6.9 Cg_endo -98.04 -4.31 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.693 1.595 . . . . 0.0 111.875 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.482 HG22 ' HG3' ' A' ' 441' ' ' ARG . 24.8 m 72.66 117.65 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.546 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.596 ' HB2' HD11 ' A' ' 394' ' ' LEU . 18.2 Cg_exo -64.44 93.81 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.858 2.372 . . . . 0.0 111.563 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.482 ' HG3' HG22 ' A' ' 439' ' ' THR . 43.8 mtp180 -125.82 91.66 3.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.675 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 66.3 m -63.07 98.89 0.15 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.579 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 2.4 pp -98.75 170.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.088 0.47 . . . . 0.0 110.313 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -93.75 118.58 31.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.426 -173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.07 -48.26 41.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.817 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.568 ' HD3' ' OXT' ' A' ' 446' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.33 172.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 121.207 0.527 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.686 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 32.1 mtp180 -127.64 -176.23 3.7 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.505 0.669 . . . . 0.0 111.461 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -128.55 109.79 11.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.805 174.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 7.6 p -70.52 144.7 51.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.363 0.601 . . . . 0.0 112.246 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -104.67 126.31 51.63 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 171.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.609 ' HE1' HD21 ' A' ' 394' ' ' LEU . 2.5 t80 -76.27 117.93 67.74 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -177.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -84.71 -179.14 3.59 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.101 2.534 . . . . 0.0 113.481 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -80.77 128.7 33.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.879 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.701 HD23 ' HA ' ' A' ' 399' ' ' ASN . 1.4 mm? -89.92 103.22 15.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 396' ' ' ASN . 33.4 tt0 -71.4 117.03 12.43 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 395' ' ' GLU . 52.1 m-80 71.86 28.51 2.63 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.955 0.785 . . . . 0.0 109.984 -173.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -136.08 164.05 25.05 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.485 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -80.9 99.56 8.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.701 ' HA ' HD23 ' A' ' 394' ' ' LEU . 3.1 p30 -77.77 44.49 0.46 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.753 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.9 -29.96 70.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.672 0.749 . . . . 0.0 109.607 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -96.39 -7.51 34.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.34 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -64.06 122.57 16.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.882 0.373 . . . . 0.0 110.269 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.17 -10.98 33.94 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.11 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -82.5 166.42 19.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.243 0.544 . . . . 0.0 111.299 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -137.04 136.5 38.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.699 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.62 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 55.8 m-85 -132.14 153.1 50.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.138 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 14.7 m -79.38 139.14 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.734 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.838 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 33.1 tt0 -61.98 135.52 57.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.566 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 99.24 22.22 13.48 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 13.7 mmtm -127.4 173.79 9.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.029 -0.586 . . . . 0.0 109.819 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 30.6 t -144.65 163.5 33.76 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.45 HD13 ' N ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -160.84 145.73 5.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.155 -177.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 412' ' ' ILE . 14.2 t70 -81.14 138.66 35.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.317 -174.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 422' ' ' LEU . 48.4 t -119.76 119.77 61.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -100.8 106.33 17.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.048 0.452 . . . . 0.0 111.105 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 56.8 m -94.72 172.57 8.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -73.19 156.75 89.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.846 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.88 112.28 0.98 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.447 2.765 . . . . 0.0 111.984 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.68 -11.79 13.72 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -118.84 143.36 47.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.183 -0.508 . . . . 0.0 109.777 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.75 39.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.49 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 91.3 mt -73.65 158.67 85.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.273 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.495 ' HG3' HD11 ' A' ' 443' ' ' ILE . 31.6 Cg_exo -57.84 149.05 71.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.838 2.359 . . . . 0.0 111.609 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 68.81 17.43 8.78 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.987 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.83 36.8 28.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.051 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 24.2 mt-30 -94.47 162.14 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.846 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 26.2 p -115.62 -11.3 11.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.357 0.599 . . . . 0.0 110.477 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.46 142.69 51.12 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.115 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.5 HG13 ' HG2' ' A' ' 438' ' ' PRO . 17.0 t -114.2 129.78 69.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.624 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 25.7 m -80.87 135.49 35.93 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.176 177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.73 110.13 15.94 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.905 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.838 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 0.6 OUTLIER -149.65 143.12 25.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.923 0.868 . . . . 0.0 112.579 179.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.741 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 37.0 mt-10 45.27 35.06 1.63 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.358 -176.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 389' ' ' CYS . 5.7 t-20 67.9 -16.51 0.18 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.763 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -114.67 25.23 10.42 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.586 -172.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.575 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 84.7 m95 58.31 148.15 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.908 0.883 . . . . 0.0 112.955 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.797 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 58.3 m -71.12 -63.68 1.42 Allowed Pre-proline 0 C--N 1.321 -0.639 0 O-C-N 121.967 -0.458 . . . . 0.0 111.171 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.797 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 36.2 Cg_endo -89.03 -2.64 6.25 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.044 1.829 . . . . 0.0 113.149 -176.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 29.8 m 71.71 111.08 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.765 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 12.2 Cg_exo -63.18 111.13 1.34 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.131 2.554 . . . . 0.0 111.989 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 422' ' ' LEU . 75.6 mtm180 -146.23 124.71 12.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.746 -176.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 74.9 m -89.82 82.53 6.22 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.495 HD11 ' HG3' ' A' ' 423' ' ' PRO . 3.9 mt -87.11 150.92 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.823 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 446' ' ' LYS . 8.9 ttm180 -79.43 126.16 30.48 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.656 -175.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.594 HG12 ' HG3' ' A' ' 446' ' ' LYS . 78.6 t -68.93 -52.09 37.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.674 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.594 ' HG3' HG12 ' A' ' 445' ' ' VAL . 97.7 mttt . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.116 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.44 -0.933 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.748 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 26.9 mtt180 -66.73 -170.89 0.11 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.708 0.766 . . . . 0.0 111.052 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -134.33 93.0 3.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.697 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 12.3 m -59.76 141.6 54.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.579 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.458 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 68.0 t80 -104.57 137.3 42.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.43 ' HZ ' ' CG2' ' A' ' 414' ' ' VAL . 2.3 t80 -93.97 115.06 64.68 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.718 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -92.75 -176.3 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.465 2.776 . . . . 0.0 113.63 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -80.15 134.71 36.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.649 HD11 HG21 ' A' ' 414' ' ' VAL . 8.1 mt -110.38 128.2 55.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.491 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.6 151.92 44.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 43.17 41.85 3.1 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.672 0.607 . . . . 0.0 111.665 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -139.87 147.8 19.47 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.28 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -89.16 96.28 10.65 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.695 0.748 . . . . 0.0 110.362 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.485 ' HB3' ' CB ' ' A' ' 402' ' ' TYR . 35.7 m-80 -78.05 70.15 4.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.562 -173.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -79.2 -26.55 42.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.102 0.477 . . . . 0.0 110.418 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -108.45 14.84 24.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.674 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.485 ' CB ' ' HB3' ' A' ' 399' ' ' ASN . 21.5 t80 -70.87 132.24 44.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.781 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.458 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 95.12 15.16 45.9 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.234 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -103.19 156.34 17.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.022 0.439 . . . . 0.0 111.676 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -120.15 125.29 47.85 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.624 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -120.44 137.59 54.25 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.3 144.19 14.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.311 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.846 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.8 tt0 -66.29 144.57 56.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.644 -173.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 100.99 7.06 51.08 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -107.43 175.8 5.37 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.485 -0.857 . . . . 0.0 109.667 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 31.9 t -152.3 147.79 26.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.868 0.842 . . . . 0.0 111.475 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.775 ' HA ' HG22 ' A' ' 428' ' ' THR . 9.9 tp 173.44 134.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.425 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.96 ' CB ' ' HA ' ' A' ' 428' ' ' THR . 34.9 t70 -130.97 -140.79 0.22 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.229 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.67 HG23 ' CG ' ' A' ' 413' ' ' ASP . 0.6 OUTLIER -147.17 147.75 17.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.226 -151.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.98 88.06 7.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.793 167.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.543 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 14.7 m -80.04 167.17 20.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.186 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -54.37 157.03 5.21 Favored Pre-proline 0 N--CA 1.469 0.484 0 CA-C-O 121.079 0.466 . . . . 0.0 111.528 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.21 110.78 0.49 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.709 2.939 . . . . 0.0 112.629 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.07 -2.09 38.09 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.691 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.626 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 87.8 m-85 -114.3 129.05 56.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . 0.442 ' C ' ' HA ' ' A' ' 442' ' ' CYS . . . -162.71 161.34 26.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.289 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.486 ' CD2' ' H ' ' A' ' 441' ' ' ARG . 73.9 mt -61.55 145.18 91.69 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.152 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 25.9 Cg_exo -62.54 158.15 42.82 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.75 2.3 . . . . 0.0 111.09 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 68.96 21.36 7.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.467 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.61 50.92 8.39 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.385 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 23.9 mt-30 -109.66 160.91 15.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.049 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . 0.841 ' O ' ' HB3' ' A' ' 413' ' ' ASP . 2.9 p -141.62 12.86 2.12 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.313 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.96 ' HA ' ' CB ' ' A' ' 413' ' ' ASP . 0.5 OUTLIER -148.47 125.54 11.39 Favored 'General case' 0 N--CA 1.436 -1.129 0 O-C-N 123.66 0.6 . . . . 0.0 111.652 178.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.664 ' N ' ' HB2' ' A' ' 413' ' ' ASP . 2.1 t -90.88 136.36 24.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.998 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.648 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 64.2 m -81.55 132.21 35.3 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 24.4 t -77.19 109.32 10.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.846 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 27.0 mtp -148.56 153.29 38.18 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.652 0.739 . . . . 0.0 112.394 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 435' ' ' GLY . 4.1 mt-10 28.54 43.09 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 112.782 -2.008 . . . . 0.0 113.36 -164.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 65.13 -17.76 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.869 0.868 . . . . 0.0 112.147 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -112.79 41.82 2.12 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.912 -172.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.624 ' HB3' HG11 ' A' ' 429' ' ' VAL . 98.3 m95 42.55 111.22 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.753 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 60.6 m -50.1 -66.48 0.62 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.201 -0.908 . . . . 0.0 113.278 -167.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 31.8 Cg_endo -85.76 -2.76 9.04 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.54 1.493 . . . . 0.0 112.313 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.814 ' HB ' ' HD2' ' A' ' 441' ' ' ARG . 51.5 m 76.01 131.16 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.96 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 11.5 Cg_endo -70.72 84.5 0.81 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.841 2.361 . . . . 0.0 110.885 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.814 ' HD2' ' HB ' ' A' ' 439' ' ' THR . 0.5 OUTLIER -132.55 70.94 1.46 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.269 -172.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.442 ' HA ' ' C ' ' A' ' 421' ' ' ALA . 4.2 p -70.64 90.78 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.799 0.809 . . . . 0.0 110.501 175.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 14.6 pt -85.84 176.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.339 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -86.67 107.89 18.4 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.917 0.865 . . . . 0.0 110.475 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.28 -13.38 10.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.651 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 12.3 ttpp . . . . . 0 C--O 1.247 0.928 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.237 -178.724 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 386' ' ' LEU . 2.3 pt? . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 122.136 0.97 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 1.075 ' HG3' ' HB3' ' A' ' 408' ' ' GLN . 0.9 OUTLIER 48.52 -172.15 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 115.616 1.709 . . . . 0.0 115.616 173.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 387' ' ' ARG . 5.3 mptp? 73.39 37.55 0.71 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.338 -1.756 . . . . 0.0 111.947 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 32.3 m -51.68 120.4 5.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.731 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -97.5 127.46 43.48 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.411 ' HA ' ' HE1' ' A' ' 436' ' ' TRP . 31.1 t80 -79.42 115.46 53.36 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.049 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -87.32 174.38 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.156 2.571 . . . . 0.0 112.731 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -77.41 116.95 18.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.282 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.492 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 8.2 mt -71.63 127.5 32.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.267 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.625 ' HG2' ' HB2' ' A' ' 442' ' ' CYS . 1.4 pm0 -65.1 108.59 1.89 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.014 0.435 . . . . 0.0 110.279 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 63.74 36.52 10.56 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.483 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -129.26 172.31 19.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.919 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -77.33 88.2 3.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.341 0.591 . . . . 0.0 110.71 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.572 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 3.1 p30 -80.58 49.3 1.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.364 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -67.76 -22.79 65.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.844 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -104.06 -1.7 27.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.052 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.572 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 45.7 t80 -62.75 115.48 4.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.278 0.561 . . . . 0.0 110.427 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.61 -11.36 21.26 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.873 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.39 150.61 22.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.064 0.459 . . . . 0.0 110.949 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 405' ' ' LYS . 8.9 mptt -121.72 148.51 44.52 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.711 176.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.407 ' CD2' ' HH2' ' A' ' 436' ' ' TRP . 98.6 m-85 -142.32 156.46 45.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.206 0.527 . . . . 0.0 110.541 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.27 143.37 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.279 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 1.075 ' HB3' ' HG3' ' A' ' 387' ' ' ARG . 0.9 OUTLIER -57.86 139.94 53.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.408 -176.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.8 19.19 12.32 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -125.39 169.91 11.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.629 -0.785 . . . . 0.0 110.145 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.1 t -148.02 157.51 43.55 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.331 0.586 . . . . 0.0 110.415 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.6 tp -151.08 140.45 15.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.2 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.8 133.52 37.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.363 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.92 139.42 48.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.662 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -142.44 133.66 26.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.232 0.539 . . . . 0.0 111.406 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.666 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 0.1 OUTLIER -103.07 -178.43 3.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.574 ' NE2' ' HE2' ' A' ' 420' ' ' TYR . 19.1 p-80 -77.72 157.46 79.51 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.842 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 417' ' ' HIS . 9.9 Cg_exo -34.4 120.71 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.385 3.39 . . . . 0.0 115.007 -171.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 444' ' ' ARG . . . 101.71 -20.42 46.25 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.589 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.666 ' HB2' ' HB3' ' A' ' 416' ' ' CYS . 51.6 m-85 -109.83 142.48 41.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.954 0.377 . . . . 0.0 110.757 -174.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -175.75 -170.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.411 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.617 HD21 ' HA ' ' A' ' 440' ' ' PRO . 94.7 mt -80.88 162.23 60.64 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.403 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.72 147.1 73.64 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.021 2.481 . . . . 0.0 110.761 171.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.6 10.6 7.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.605 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 62.44 35.07 15.03 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.697 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -66.93 152.44 45.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.071 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.4 p -123.79 -3.38 8.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.272 0.558 . . . . 0.0 110.341 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.84 136.29 44.3 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.961 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.54 HG13 HD11 ' A' ' 422' ' ' LEU . 5.5 m -104.28 134.77 44.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.554 0.692 . . . . 0.0 110.205 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 14.8 m -92.92 117.91 30.56 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.219 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 47.3 t -66.81 116.9 8.21 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 1.009 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 23.4 mtp -131.82 -166.8 1.77 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.37 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.608 ' OE1' ' HB3' ' A' ' 432' ' ' MET . 1.7 mp0 -37.49 76.97 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.841 1.338 . . . . 0.0 114.454 -170.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 432' ' ' MET . 15.6 t-20 64.7 23.99 12.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.777 175.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -173.92 119.16 0.73 Allowed Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.254 -174.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.411 ' HE1' ' HA ' ' A' ' 391' ' ' PHE . 47.5 m95 -37.87 113.56 0.28 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.976 0.91 . . . . 0.0 110.374 165.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 6.6 m -56.92 -50.88 85.61 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.793 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.441 ' HG2' HG12 ' A' ' 429' ' ' VAL . 33.1 Cg_endo -83.41 -8.11 10.65 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.149 1.233 . . . . 0.0 112.379 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 9.1 m 70.99 112.81 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.957 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.617 ' HA ' HD21 ' A' ' 422' ' ' LEU . 35.9 Cg_endo -66.46 86.08 0.27 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.747 2.298 . . . . 0.0 112.392 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -114.08 130.93 56.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.85 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.625 ' HB2' ' HG2' ' A' ' 395' ' ' GLU . 56.7 m -90.41 83.09 5.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.119 0.485 . . . . 0.0 110.821 173.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 2.5 pt -99.68 153.43 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 172.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 419' ' ' GLY . 72.4 ttt180 -79.3 113.69 17.64 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.489 0.661 . . . . 0.0 109.703 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.66 -29.6 5.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.408 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 56.0 tptt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.095 177.281 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 121.671 0.748 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 24.1 mtt180 -96.08 164.66 12.6 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.304 -173.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -118.94 90.72 3.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.934 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 31.1 m -56.72 122.85 13.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.842 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -91.36 113.47 25.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.558 ' HE2' HD21 ' A' ' 394' ' ' LEU . 27.0 t80 -76.57 117.95 68.13 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -94.78 -175.9 0.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.402 2.735 . . . . 0.0 113.479 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 395' ' ' GLU . 47.7 t80 -75.51 130.81 39.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.831 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.558 HD21 ' HE2' ' A' ' 391' ' ' PHE . 2.5 mm? -81.11 -5.39 57.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -171.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.566 ' HA ' ' CE2' ' A' ' 393' ' ' TYR . 63.0 mm-40 66.49 -71.67 0.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.482 0.489 . . . . 0.0 110.996 -173.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.56 24.08 7.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.851 -175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -140.8 169.25 24.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.466 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -82.9 138.8 33.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.559 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 3.6 p30 -105.68 59.26 0.66 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.01 0.433 . . . . 0.0 112.162 -173.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -78.74 -14.54 59.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.726 0.298 . . . . 0.0 110.732 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -117.7 9.65 13.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.728 0.299 . . . . 0.0 111.008 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.559 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 24.9 t80 -64.75 127.82 33.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 0.0 111.007 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 91.87 16.34 51.75 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.111 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -105.81 149.39 26.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.851 0.358 . . . . 0.0 110.915 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 60.4 mtpt -112.17 126.69 55.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.525 175.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -118.65 150.84 39.04 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.595 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 35.6 m -83.12 147.53 5.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.553 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.799 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 3.2 tt0 -64.18 128.27 35.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.374 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.38 7.79 36.69 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 7.3 mmtt -114.79 163.32 15.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 20.3 t -138.89 164.88 28.51 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.367 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.0 tp -155.96 142.17 10.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.931 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -84.39 133.25 34.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.567 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 69.5 t -117.89 128.45 75.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.598 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.26 113.74 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.722 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.642 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 56.0 m -95.66 170.4 9.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -65.21 154.97 85.99 Favored Pre-proline 0 C--N 1.332 -0.164 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.025 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.9 105.92 0.16 Allowed 'Trans proline' 0 CA--C 1.521 -0.14 0 C-N-CA 123.747 2.965 . . . . 0.0 112.63 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.16 -11.75 11.52 Favored Glycine 0 C--N 1.317 -0.523 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.513 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -115.35 146.58 41.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.16 -179.05 7.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.703 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 97.9 mt -79.77 158.1 73.47 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-O 120.971 0.415 . . . . 0.0 110.544 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.33 150.37 41.57 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.528 2.152 . . . . 0.0 110.771 171.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.472 ' HB2' ' HG3' ' A' ' 426' ' ' GLN . 6.9 mtpm? 64.06 19.08 11.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.941 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 61.19 26.63 16.48 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.173 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.472 ' HG3' ' HB2' ' A' ' 424' ' ' LYS . 51.8 mt-30 -73.67 158.99 33.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.907 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 28.1 p -124.62 -23.13 4.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.313 0.578 . . . . 0.0 110.22 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.88 135.95 49.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.52 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.446 HG13 ' HG2' ' A' ' 438' ' ' PRO . 2.5 t -110.5 125.07 67.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 60.8 m -88.32 135.17 33.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.777 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 31.4 t -72.7 112.67 8.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.799 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 7.3 mtt -146.84 142.1 27.33 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.705 0.764 . . . . 0.0 111.321 174.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.545 ' C ' ' HD2' ' A' ' 387' ' ' ARG . 5.8 mm-40 39.09 40.32 0.47 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.232 -1.804 . . . . 0.0 113.084 -170.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 46.1 t30 70.33 -24.05 0.16 Allowed 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.704 0.628 . . . . 0.0 111.706 174.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -104.81 22.3 34.09 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.562 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.571 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 94.0 m95 56.35 128.78 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.858 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 71.8 m -51.38 -64.45 1.4 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.359 -169.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.858 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 42.6 Cg_endo -89.11 -2.53 6.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.049 1.832 . . . . 0.0 112.478 -176.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 18.6 m 73.74 121.61 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.295 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 30.7 Cg_endo -66.6 94.64 0.32 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.727 2.284 . . . . 0.0 111.699 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -131.03 106.54 8.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.778 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 76.4 m -83.36 81.39 8.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.916 0.389 . . . . 0.0 110.63 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 9.8 pt -87.76 161.42 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.884 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -75.38 121.77 22.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.385 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.9 p -112.05 13.68 8.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.336 -174.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 53.6 mttp . . . . . 0 C--O 1.25 1.106 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.211 179.669 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 73.0 mt . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 122.366 1.079 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' A' ' 434' ' ' ASN . 8.7 mtt-85 -78.95 166.49 22.31 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.591 -1.64 . . . . 0.0 112.388 -172.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 38.9 mmtm -117.65 90.57 3.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.014 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 15.2 m -59.62 120.97 10.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.511 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -90.33 124.81 35.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.655 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -80.32 120.72 80.31 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.278 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -83.53 -179.2 4.07 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.295 2.663 . . . . 0.0 112.636 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -93.87 121.99 35.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.4 0.619 . . . . 0.0 110.715 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.2 mp -89.31 129.26 35.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.392 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.89 -47.84 64.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.948 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -107.5 16.54 23.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.914 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -132.26 155.75 21.66 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.512 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -77.7 111.23 13.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.554 ' HB2' ' CB ' ' A' ' 402' ' ' TYR . 1.7 p30 -79.22 61.61 3.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.869 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -66.18 -19.57 65.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.257 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -117.9 1.8 12.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.309 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.554 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 37.4 t80 -63.12 124.86 22.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 111.302 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.65 -9.79 41.24 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.304 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -100.66 152.76 20.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.69 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 52.2 mtmt -116.91 152.93 33.48 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.846 173.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 97.4 m-85 -134.9 150.31 50.41 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.914 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.7 m -80.08 144.93 9.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.159 0.504 . . . . 0.0 110.349 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.828 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 0.8 OUTLIER -62.01 125.68 24.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.555 -173.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.97 -0.95 24.28 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -95.88 161.61 13.93 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.153 -0.524 . . . . 0.0 110.387 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 21.1 t -141.33 163.29 33.36 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.1 tp -170.02 130.39 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.673 0.749 . . . . 0.0 110.517 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.768 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 14.1 t70 -83.66 132.55 34.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.336 -171.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 22.6 t -113.05 120.81 63.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.677 -175.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.02 122.87 29.86 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.518 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 67.5 m -116.02 173.11 6.75 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -62.48 158.15 51.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.212 0.529 . . . . 0.0 110.956 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.89 114.55 1.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.556 2.837 . . . . 0.0 111.949 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 444' ' ' ARG . . . 110.22 -5.03 30.1 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.207 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.671 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 84.6 m-85 -115.62 145.09 43.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.141 0.496 . . . . 0.0 110.946 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 442' ' ' CYS . . . -160.08 160.19 32.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.259 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.516 HD11 HG22 ' A' ' 429' ' ' VAL . 69.6 mt -71.55 151.45 93.79 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 121.064 0.459 . . . . 0.0 111.792 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 72.9 Cg_exo -53.14 147.66 34.03 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.415 2.743 . . . . 0.0 111.913 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.513 ' HB2' HE21 ' A' ' 426' ' ' GLN . 99.7 mttt 70.1 27.5 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.71 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.32 53.78 8.42 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.391 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.513 HE21 ' HB2' ' A' ' 424' ' ' LYS . 48.5 mt-30 -119.51 160.66 21.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.53 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 41.7 p -119.88 -17.15 8.57 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.004 0.431 . . . . 0.0 110.143 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.768 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 0.5 OUTLIER -120.11 160.1 23.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.837 0.827 . . . . 0.0 111.603 178.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.516 HG22 HD11 ' A' ' 422' ' ' LEU . 1.4 t -116.6 148.6 19.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.344 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 86.7 m -108.55 122.99 48.21 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.816 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.1 t -67.96 111.13 4.22 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.828 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 4.7 mtm -144.45 135.79 25.47 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.966 0.889 . . . . 0.0 112.583 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.758 ' H ' ' HG3' ' A' ' 408' ' ' GLN . 0.8 OUTLIER 46.66 37.41 4.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.064 -178.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.729 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 8.1 t30 72.66 -24.95 0.19 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.929 0.892 . . . . 0.0 112.7 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -108.13 43.75 1.64 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.037 -1.078 . . . . 0.0 114.257 -169.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.514 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.3 m95 36.25 105.41 0.0 OUTLIER 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 172.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.788 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 69.5 m -45.64 -59.57 4.41 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.244 -168.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 13.5 Cg_endo -90.65 -6.19 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.631 1.554 . . . . 0.0 113.248 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.653 HG22 ' HG3' ' A' ' 441' ' ' ARG . 24.4 m 71.95 121.9 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.517 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.514 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 1.2 Cg_endo -78.67 97.48 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.51 2.807 . . . . 0.0 111.413 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.653 ' HG3' HG22 ' A' ' 439' ' ' THR . 53.8 mtm180 -131.38 -45.77 0.99 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.608 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 68.0 m 64.78 91.97 0.07 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.074 0.94 . . . . 0.0 111.301 -177.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 7.0 mt -96.9 159.53 3.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.096 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 419' ' ' GLY . 31.7 ttt180 -64.67 121.91 15.61 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.986 0.898 . . . . 0.0 110.613 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 80.5 t -48.56 -45.24 14.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.914 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 446' ' ' LYS . 21.4 tptp . . . . . 0 C--O 1.243 0.716 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.392 171.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 121.312 0.577 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.894 ' HG3' ' HA ' ' A' ' 433' ' ' GLU . 34.2 mmt180 -76.08 171.2 14.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.448 -174.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.478 ' HD2' ' C ' ' A' ' 387' ' ' ARG . 0.1 OUTLIER -124.45 79.6 1.77 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.732 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 19.8 m -59.86 125.92 25.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.249 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -90.3 127.53 36.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 172.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.538 ' HE1' HD21 ' A' ' 394' ' ' LEU . 2.0 t80 -81.71 111.76 28.81 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . 0.409 ' C ' ' HD1' ' A' ' 402' ' ' TYR . 95.9 Cg_endo -88.92 -166.65 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.245 2.63 . . . . 0.0 113.241 -176.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . 0.458 ' HD1' HD22 ' A' ' 399' ' ' ASN . 55.3 t80 -78.14 134.84 37.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.002 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.626 HD23 ' HA ' ' A' ' 399' ' ' ASN . 2.6 mm? -86.05 106.97 17.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.656 177.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.73 ' O ' ' HB2' ' A' ' 442' ' ' CYS . 12.8 pt-20 -63.49 116.87 5.99 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 69.16 25.34 5.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.023 0.44 . . . . 0.0 110.351 -174.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -135.73 176.05 20.41 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.451 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -99.16 120.86 40.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.263 0.554 . . . . 0.0 110.45 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.626 ' HA ' HD23 ' A' ' 394' ' ' LEU . 9.2 p30 -79.37 59.56 2.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.759 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -70.13 -28.87 65.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.9 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -111.75 7.55 20.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.215 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.541 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 81.2 t80 -63.97 126.07 26.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.144 0.497 . . . . 0.0 110.371 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.66 -5.31 54.22 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.86 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.31 150.03 21.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.977 0.418 . . . . 0.0 110.888 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 59.3 mtpt -126.75 136.61 52.65 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.208 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -126.97 153.59 45.67 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.783 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 387' ' ' ARG . 27.0 m -86.66 144.94 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.975 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.3 tt0 -57.5 132.03 51.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 0.0 110.914 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.05 12.72 23.27 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 53.9 mmtt -115.14 155.51 26.98 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.185 -0.507 . . . . 0.0 110.533 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.6 t -132.4 161.53 33.4 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.3 tp -162.39 138.31 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.439 0.638 . . . . 0.0 110.294 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -89.3 137.24 32.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.835 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.42 137.57 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.288 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.89 118.84 34.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.281 0.562 . . . . 0.0 111.343 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.56 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 58.2 m -89.0 -175.9 4.99 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.598 173.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -64.5 152.05 90.18 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.05 103.07 0.14 Allowed 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 123.204 2.602 . . . . 0.0 111.58 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.702 ' O ' ' HB3' ' A' ' 444' ' ' ARG . . . 126.92 -10.08 7.07 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.571 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 1.037 ' HA ' ' CB ' ' A' ' 444' ' ' ARG . 59.8 m-85 -119.66 159.81 23.71 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 444' ' ' ARG . . . -151.18 173.66 14.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.821 -175.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 427' ' ' THR . 3.2 mm? -73.96 160.14 82.51 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 171.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.487 ' HG3' HD11 ' A' ' 443' ' ' ILE . 71.8 Cg_exo -48.61 136.74 26.85 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.947 2.431 . . . . 0.0 111.237 174.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 78.81 20.36 0.79 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.349 1.031 . . . . 0.0 110.061 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.76 44.2 20.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.071 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 422' ' ' LEU . 23.6 mt-30 -100.21 169.94 8.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.753 -177.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . 0.483 ' HA ' HD23 ' A' ' 422' ' ' LEU . 74.8 p -123.05 -8.62 8.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.357 0.599 . . . . 0.0 109.477 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -113.76 149.85 34.28 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.474 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 19.9 m -124.83 144.74 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 172.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 39.1 m -108.1 129.19 55.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.326 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.2 t -72.33 110.03 6.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.975 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 9.1 mtt -142.02 137.6 31.24 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.812 0.815 . . . . 0.0 111.698 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.894 ' HA ' ' HG3' ' A' ' 387' ' ' ARG . 1.2 tp10 40.43 40.14 0.82 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.732 -2.031 . . . . 0.0 112.759 -174.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 9.3 t30 73.02 -16.33 0.47 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.021 0.528 . . . . 0.0 112.009 174.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -118.91 45.87 1.2 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.741 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.55 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.1 m95 35.21 106.2 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 172.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.744 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 64.0 m -41.15 -62.13 1.13 Allowed Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -172.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 62.6 Cg_endo -88.67 -2.86 6.56 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.681 1.588 . . . . 0.0 113.156 -174.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.759 HG22 ' HG3' ' A' ' 441' ' ' ARG . 28.8 m 72.94 119.37 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.575 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 61.5 Cg_endo -74.57 82.71 1.85 Allowed 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.729 2.286 . . . . 0.0 112.205 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.759 ' HG3' HG22 ' A' ' 439' ' ' THR . 49.5 mtp180 -133.18 132.29 41.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.825 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.73 ' HB2' ' O ' ' A' ' 395' ' ' GLU . 81.6 m -95.42 74.68 3.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.716 0.77 . . . . 0.0 111.38 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.487 HD11 ' HG3' ' A' ' 423' ' ' PRO . 1.6 pt -101.27 144.01 13.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.703 174.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 1.037 ' CB ' ' HA ' ' A' ' 420' ' ' TYR . 0.0 OUTLIER -175.35 -154.64 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -177.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.652 ' H ' ' HD2' ' A' ' 444' ' ' ARG . 7.6 p -87.06 -6.54 10.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 111.488 -2.596 . . . . 0.0 111.643 -169.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.082 176.272 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 N--CA 1.445 -0.692 0 CA-C-O 122.967 1.365 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.71 ' HG3' ' N ' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -59.42 174.98 0.37 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 112.846 -1.979 . . . . 0.0 116.041 -167.07 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.72 ' H ' ' HB2' ' A' ' 434' ' ' ASN . 0.1 OUTLIER -166.97 65.32 0.09 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 112.615 -2.084 . . . . 0.0 106.792 152.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.698 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 61.5 m -50.84 108.8 0.26 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.47 -1.695 . . . . 0.0 113.271 -166.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -90.64 120.95 32.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -69.55 122.84 87.05 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.75 167.15 24.39 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.187 2.591 . . . . 0.0 113.155 -175.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -85.96 116.41 24.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.598 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.5 117.17 28.98 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.784 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 0.0 OUTLIER -75.21 -31.51 60.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.111 0.481 . . . . 0.0 110.338 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 41.6 m-80 -98.48 20.05 13.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.047 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -134.19 178.49 18.35 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.207 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -90.01 -10.12 46.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.779 0.323 . . . . 0.0 111.591 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 6.8 p30 42.21 36.69 0.75 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.355 1.062 . . . . 0.0 113.558 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -62.99 -26.06 68.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.778 0.323 . . . . 0.0 111.183 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -94.88 -6.76 41.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.352 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -61.23 118.64 7.12 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 114.36 -10.22 22.14 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.511 -174.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -100.38 146.64 26.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.719 0.295 . . . . 0.0 110.723 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . 0.698 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 56.7 mtpt -119.46 152.17 37.33 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.261 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.469 ' CD1' ' HH2' ' A' ' 436' ' ' TRP . 94.8 m-85 -139.79 162.87 34.09 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.385 0.612 . . . . 0.0 111.437 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 35.3 m -97.54 146.22 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.644 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.9 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 6.1 tt0 -69.42 122.76 19.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.041 0.448 . . . . 0.0 110.558 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.45 12.67 11.47 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 1.1 tmtm? -116.41 162.68 17.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.813 -0.693 . . . . 0.0 109.481 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.5 t -132.25 158.23 42.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.934 0.397 . . . . 0.0 110.171 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.1 tp -149.68 140.73 16.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.146 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -82.41 132.2 35.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.738 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 422' ' ' LEU . 92.3 t -111.83 139.97 33.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.156 0.503 . . . . 0.0 111.191 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -113.35 103.07 10.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.17 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.611 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 70.7 m -99.17 165.8 11.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 171.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -68.3 153.17 95.92 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.107 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.77 108.71 0.3 Allowed 'Trans proline' 0 CA--C 1.521 -0.156 0 C-N-CA 123.702 2.935 . . . . 0.0 112.278 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.76 -11.03 11.14 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.612 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 99.3 m-85 -116.49 141.33 48.31 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -144.47 178.9 7.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.066 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 59.4 mt -92.27 156.93 41.38 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.85 0.357 . . . . 0.0 111.044 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 58.2 Cg_exo -54.1 144.65 57.23 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.174 2.583 . . . . 0.0 111.562 173.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 29.1 mtpp 72.45 19.14 4.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.188 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.1 26.29 13.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.317 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.632 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 27.3 mt-30 -85.26 157.31 20.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.062 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.9 p -116.37 0.92 12.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.541 0.686 . . . . 0.0 109.846 173.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.25 140.43 52.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.941 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.512 HG23 HG21 ' A' ' 414' ' ' VAL . 45.6 t -115.4 132.29 65.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.102 0.477 . . . . 0.0 109.718 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 19.3 m -88.02 129.66 35.21 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.138 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 33.8 t -71.41 111.59 6.86 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.9 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 1.0 OUTLIER -141.96 121.83 13.59 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 122.466 1.126 . . . . 0.0 112.105 172.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' A' ' 433' ' ' GLU . 35.5 tt0 51.51 36.65 17.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 111.978 -2.374 . . . . 0.0 112.295 177.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.72 ' HB2' ' H ' ' A' ' 388' ' ' LYS . 63.9 t30 61.98 15.46 7.28 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.066 0.936 . . . . 0.0 109.681 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -123.2 17.05 8.05 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.768 -173.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.469 ' HH2' ' CD1' ' A' ' 406' ' ' PHE . 93.4 m95 36.42 101.42 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.92 1.012 . . . . 0.0 113.073 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.716 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 62.6 m -44.52 -61.81 1.92 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -165.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.716 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 41.2 Cg_endo -83.31 -3.12 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.043 1.828 . . . . 0.0 112.961 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.647 HG22 ' HG3' ' A' ' 441' ' ' ARG . 26.3 m 74.35 114.19 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.972 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.423 ' HG3' HG11 ' A' ' 429' ' ' VAL . 13.1 Cg_exo -68.78 95.95 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.948 2.432 . . . . 0.0 111.94 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.647 ' HG3' HG22 ' A' ' 439' ' ' THR . 51.6 mtp180 -135.89 117.84 15.27 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.732 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 62.4 m -82.05 82.86 7.49 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 5.1 pt -82.88 144.67 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.378 0.608 . . . . 0.0 111.066 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.5 ttm105 -71.49 120.22 16.76 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.416 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.6 p -96.63 15.57 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.957 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.705 175.825 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 N--CA 1.443 -0.786 0 CA-C-O 121.401 0.619 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.952 ' HD3' ' HA ' ' A' ' 434' ' ' ASN . 0.3 OUTLIER -71.2 162.52 29.29 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.585 178.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 387' ' ' ARG . 0.0 OUTLIER -115.64 108.16 16.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.063 0.459 . . . . 0.0 111.897 -170.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 71.2 m -86.98 143.89 27.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.327 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -125.78 119.77 28.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 26.7 t80 -70.12 118.86 67.75 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.749 0.309 . . . . 0.0 110.41 -174.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 93.2 Cg_endo -90.26 -175.57 0.95 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.194 2.596 . . . . 0.0 113.525 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . 0.458 ' HA ' ' OD1' ' A' ' 399' ' ' ASN . 87.7 t80 -91.04 116.92 29.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.61 -173.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 440' ' ' PRO . 3.5 mm? -74.41 117.91 16.77 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.44 -26.63 63.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.535 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -136.41 38.58 2.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.395 0.617 . . . . 0.0 110.519 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -124.29 168.32 16.45 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.4 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -87.39 -4.96 59.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 393' ' ' TYR . 53.7 m-80 44.04 47.55 7.31 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 170.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -65.45 -15.31 62.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.743 0.306 . . . . 0.0 111.039 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -122.38 12.34 10.12 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -68.91 129.21 39.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.66 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 102.17 8.4 44.49 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.174 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -98.84 152.34 19.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.401 0.62 . . . . 0.0 111.888 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -116.64 143.42 45.65 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.434 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -141.22 151.24 43.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.274 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 29.3 m -93.81 150.99 3.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 170.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 1.0 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.4 tt0 -62.48 138.19 58.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.341 0.591 . . . . 0.0 111.207 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.16 14.17 23.15 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -174.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 7.7 mmmt -118.92 161.37 20.31 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.699 -0.75 . . . . 0.0 110.05 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.2 t -131.81 165.96 22.64 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.26 144.16 11.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.173 0.511 . . . . 0.0 110.722 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -84.32 143.05 29.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.853 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.414 HG22 ' HZ ' ' A' ' 391' ' ' PHE . 46.8 t -126.57 127.61 70.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.962 0.411 . . . . 0.0 110.922 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -97.43 95.01 7.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.616 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 34.3 m -87.04 145.73 26.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.614 ' ND1' ' HD2' ' A' ' 418' ' ' PRO . 16.4 t60 -59.19 144.44 83.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 0.0 110.979 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . 0.614 ' HD2' ' ND1' ' A' ' 417' ' ' HIS . 95.3 Cg_exo -45.21 106.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.477 1 C-N-CA 125.427 4.084 . . . . 0.0 112.734 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 125.11 -17.5 7.09 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.127 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -110.16 150.14 29.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.001 0.429 . . . . 0.0 111.117 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -149.3 166.96 27.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.733 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 62.9 mt -88.88 153.14 49.44 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 120.69 0.281 . . . . 0.0 110.892 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.61 144.27 33.93 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.192 2.595 . . . . 0.0 112.141 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 68.88 23.7 6.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.876 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 54.18 47.22 23.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.249 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 25.8 mt-30 -108.33 167.64 9.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.534 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 12.2 t -126.57 0.09 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.1 p -119.7 145.84 46.16 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.161 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.633 HG13 ' HG2' ' A' ' 438' ' ' PRO . 12.5 t -115.7 133.23 62.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.945 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 18.0 m -93.99 124.47 38.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.81 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.5 t -71.86 111.41 7.09 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.604 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 1.0 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 30.0 mtp -140.08 -177.38 4.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 433' ' ' GLU . 9.4 mm-40 -32.98 88.55 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 125.95 2.031 . . . . 0.0 114.387 -175.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.952 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 10.3 t-20 68.9 12.28 8.59 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 112.088 -2.324 . . . . 0.0 110.653 168.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 179.23 134.64 2.2 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.403 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.436 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 91.1 m95 -38.93 117.89 0.71 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 165.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.599 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 14.8 m -67.1 -52.27 31.52 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -168.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.633 ' HG2' HG13 ' A' ' 429' ' ' VAL . 25.5 Cg_endo -83.56 -9.14 10.26 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 120.919 1.079 . . . . 0.0 112.196 -175.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.581 HG22 ' HG2' ' A' ' 441' ' ' ARG . 11.0 m 71.61 109.53 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.23 173.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.416 ' HB2' HD11 ' A' ' 394' ' ' LEU . 37.5 Cg_endo -69.42 98.31 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.35 2.033 . . . . 0.0 110.945 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.581 ' HG2' HG22 ' A' ' 439' ' ' THR . 21.9 mmm180 -120.58 -36.89 3.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.735 -175.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 82.9 m 56.68 69.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.498 0.666 . . . . 0.0 110.117 -174.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 5.7 pt -87.04 154.42 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.714 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -61.09 121.72 13.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.989 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.4 p -74.44 -5.79 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.032 -171.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 48.7 pttt . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.55 -1.214 . . . . 0.0 111.971 -178.862 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 386' ' ' LEU . 14.0 mt . . . . . 0 N--CA 1.432 -1.349 0 CA-C-O 123.762 1.744 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.799 ' NH1' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -109.45 -156.41 0.58 Allowed 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 110.456 -3.065 . . . . 0.0 112.571 -168.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 387' ' ' ARG . 12.9 tptt -164.61 88.63 0.49 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.602 167.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 434' ' ' ASN . 58.6 m -51.3 111.99 0.66 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.584 0.553 . . . . 0.0 111.295 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -89.45 118.28 28.99 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -72.8 123.22 89.31 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.805 0.336 . . . . 0.0 110.128 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.74 169.02 18.74 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.094 2.53 . . . . 0.0 113.765 -174.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -88.34 106.83 18.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.813 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.38 108.25 17.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -63.22 -40.2 96.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.867 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.431 ' C ' ' HD2' ' A' ' 417' ' ' HIS . 2.0 p30 -100.49 19.69 16.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.568 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -132.14 172.98 20.88 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.093 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -88.03 104.47 16.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 2.3 p30 -74.54 55.41 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.38 -178.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -64.62 -42.85 95.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.779 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -101.72 0.88 36.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.419 -170.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 23.6 t80 -61.5 124.07 19.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.112 0.482 . . . . 0.0 110.38 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.42 -9.3 38.44 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.704 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -89.75 147.32 23.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.247 0.546 . . . . 0.0 111.134 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 37.6 mtpt -121.66 135.47 54.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.797 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -129.25 158.15 39.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.213 0.53 . . . . 0.0 111.34 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.8 m -87.78 144.48 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.006 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.827 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.2 tt0 -52.55 139.79 24.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.963 0.411 . . . . 0.0 111.492 177.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.47 10.89 57.71 Favored Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -110.89 154.62 23.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 30.8 t -132.47 159.15 40.19 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.047 0.451 . . . . 0.0 110.409 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.2 tp -155.57 141.43 10.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.501 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -91.56 139.99 30.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.822 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 19.3 t -126.05 146.08 32.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.277 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -122.63 131.43 53.81 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.614 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 56.4 m -103.79 170.54 7.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.431 ' HD2' ' C ' ' A' ' 396' ' ' ASN . 94.3 m-70 -72.7 156.7 89.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.814 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.32 110.68 0.48 Allowed 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.821 3.014 . . . . 0.0 112.529 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.45 -6.02 16.82 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.788 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 96.1 m-85 -122.97 145.6 48.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.792 0.33 . . . . 0.0 110.769 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -149.83 157.16 42.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.945 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.645 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 46.6 mt -78.44 156.21 78.55 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.82 0.343 . . . . 0.0 111.199 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.481 ' HG3' HD11 ' A' ' 443' ' ' ILE . 50.2 Cg_exo -53.04 144.49 45.91 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.067 2.511 . . . . 0.0 112.018 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 71.73 14.76 6.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.436 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 60.4 30.47 19.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.515 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.645 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 27.6 mt-30 -92.18 168.77 11.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.846 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 79.8 p -126.12 -26.11 3.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.474 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.89 134.53 35.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.426 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.546 HG13 ' HG2' ' A' ' 438' ' ' PRO . 3.5 t -109.88 142.89 21.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.451 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 437' ' ' SER . 27.6 m -103.91 126.81 51.31 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.212 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.404 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.6 t -70.08 108.72 4.21 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.827 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 9.7 mtt -144.55 132.89 21.86 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.324 1.059 . . . . 0.0 112.42 174.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.684 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 2.4 tm-20 46.38 32.16 1.48 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.09 -2.323 . . . . 0.0 110.687 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.492 ' HA ' ' SG ' ' A' ' 389' ' ' CYS . 45.5 t-20 76.03 -27.71 0.18 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.45 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -97.91 40.05 2.61 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.237 -171.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.548 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 97.0 m95 35.99 106.44 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 172.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.775 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 72.2 m -44.54 -60.09 3.31 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -170.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.775 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 31.3 Cg_endo -88.36 -6.6 6.13 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.882 1.722 . . . . 0.0 112.874 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 80.9 m 72.8 116.33 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 114.898 -1.047 . . . . 0.0 113.072 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.548 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 18.4 Cg_endo -88.76 109.76 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.498 2.799 . . . . 0.0 110.734 174.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -147.2 -17.65 0.39 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 77.2 m 58.1 87.07 0.07 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.406 0.622 . . . . 0.0 111.489 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.481 HD11 ' HG3' ' A' ' 423' ' ' PRO . 11.0 mt -85.54 158.84 3.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -78.88 124.86 28.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.215 0.531 . . . . 0.0 109.923 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 5.6 p -93.62 -15.16 8.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.119 -177.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.092 -179.586 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.436 -1.145 0 CA-C-O 121.007 0.432 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.732 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 2.0 mmp_? -121.81 177.1 5.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.539 0.685 . . . . 0.0 111.801 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -125.17 94.56 4.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.932 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 20.5 m -62.52 113.45 2.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.129 0.49 . . . . 0.0 111.707 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.505 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 53.2 t80 -79.65 112.01 16.5 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.779 173.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -62.68 123.38 79.14 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.23 172.03 13.22 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.259 2.639 . . . . 0.0 113.297 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -90.62 125.17 35.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.323 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 29.3 mt -103.92 130.06 51.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.571 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -91.79 -32.76 15.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.668 0.747 . . . . 0.0 109.105 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -94.63 5.04 53.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.61 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -142.19 170.9 24.81 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.202 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -87.59 113.94 23.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.941 0.401 . . . . 0.0 110.356 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -83.31 51.77 2.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.577 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -70.31 -17.24 63.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.94 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -114.25 1.16 14.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.992 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -63.0 127.99 33.8 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.31 0.576 . . . . 0.0 111.473 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.505 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 103.05 -0.24 47.88 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.684 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -108.72 141.93 39.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.868 0.366 . . . . 0.0 110.472 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -105.66 130.43 53.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.617 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -109.52 150.86 27.53 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.747 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.34 139.33 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.276 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.842 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 12.6 tt0 -60.28 126.21 26.64 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.557 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 101.07 13.42 33.81 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -173.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -110.25 151.71 27.02 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.2 t -124.84 160.63 28.32 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -170.8 127.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.666 0.746 . . . . 0.0 110.013 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.714 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 29.8 t70 -79.09 130.0 35.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.876 -172.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 429' ' ' VAL . 31.6 t -106.38 157.53 6.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.278 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -120.55 94.34 4.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.864 0.364 . . . . 0.0 111.221 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 92.9 m -83.79 150.96 25.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.615 ' NE2' ' HE2' ' A' ' 420' ' ' TYR . 1.5 p-80 -74.68 152.23 87.14 Favored Pre-proline 0 N--CA 1.461 0.103 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.765 -170.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 417' ' ' HIS . 2.7 Cg_exo -32.32 112.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.856 3.704 . . . . 0.0 114.639 -173.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.21 -5.14 35.76 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.22 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.615 ' HE2' ' NE2' ' A' ' 417' ' ' HIS . 63.2 m-85 -120.74 144.49 48.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.989 0.423 . . . . 0.0 111.147 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -152.09 -167.12 2.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.574 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.505 HD13 HG22 ' A' ' 429' ' ' VAL . 70.4 mt -108.27 160.43 27.05 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-O 120.904 0.383 . . . . 0.0 111.918 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.421 ' HG3' HD11 ' A' ' 443' ' ' ILE . 87.7 Cg_exo -47.69 143.26 12.8 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.597 2.865 . . . . 0.0 112.715 175.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt 67.47 30.45 6.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.729 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.49 33.02 20.15 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.609 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -97.35 169.41 9.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.028 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . 0.477 ' C ' HD12 ' A' ' 422' ' ' LEU . 39.2 p -126.94 1.19 6.61 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.781 173.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.714 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 1.9 t -124.46 163.81 21.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.635 0.731 . . . . 0.0 111.654 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.523 HG13 ' HG2' ' A' ' 438' ' ' PRO . 2.0 t -129.77 142.56 43.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.34 -177.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 78.6 m -99.94 136.9 39.15 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.101 174.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 13.6 t -74.93 119.67 19.43 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.842 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 11.5 mtp -152.1 136.9 17.09 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.73 0.776 . . . . 0.0 111.657 174.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.761 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 18.9 mt-10 45.33 38.83 3.83 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.149 -1.842 . . . . 0.0 111.947 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.469 ' HB2' ' HD3' ' A' ' 387' ' ' ARG . 43.3 t30 68.89 -24.57 0.14 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.232 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -102.26 18.54 51.25 Favored Glycine 0 CA--C 1.501 -0.834 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.898 -169.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.714 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 96.4 m95 59.45 128.87 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 124.539 0.788 . . . . 0.0 112.989 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.806 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 71.1 m -49.76 -64.55 1.18 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.224 -170.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.806 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 28.2 Cg_endo -87.69 -7.6 6.42 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.692 1.594 . . . . 0.0 112.278 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 27.3 m 74.39 123.3 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.841 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.714 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 11.2 Cg_exo -62.99 93.35 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.166 2.577 . . . . 0.0 111.721 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -130.49 108.94 10.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 82.1 m -75.55 90.01 2.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.228 0.537 . . . . 0.0 110.567 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.421 HD11 ' HG3' ' A' ' 423' ' ' PRO . 11.2 mt -87.24 159.43 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.543 -0.753 . . . . 0.0 108.969 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -80.4 119.77 23.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.278 0.561 . . . . 0.0 110.303 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 445' ' ' VAL . 10.5 p -106.35 45.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.209 1.004 . . . . 0.0 110.679 -172.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.903 ' H ' ' HD3' ' A' ' 446' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.542 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.43 -1.473 0 CA-C-O 122.279 1.037 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 1.032 ' HG2' ' HB3' ' A' ' 408' ' ' GLN . 1.0 OUTLIER 55.53 -169.11 0.08 Allowed 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 159.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 0.0 OUTLIER 53.3 62.71 2.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 112.012 -2.358 . . . . 0.0 111.757 -168.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 14.5 m -67.57 134.02 50.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.223 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -91.89 132.36 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 401' ' ' ASN . 26.7 t80 -93.72 111.69 53.69 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.754 0.311 . . . . 0.0 110.702 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -92.61 -163.4 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.235 2.624 . . . . 0.0 113.442 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -85.88 140.66 30.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.355 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 394' ' ' LEU . 2.6 mm? -89.14 15.77 8.27 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -173.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 67.59 -69.54 0.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.498 0.666 . . . . 0.0 111.497 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.571 ' O ' ' HD2' ' A' ' 417' ' ' HIS . 0.2 OUTLIER -131.76 45.52 2.77 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.798 -177.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -142.07 177.03 21.75 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.053 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -88.8 118.99 28.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.222 0.534 . . . . 0.0 111.263 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . 2.5 p30 -87.62 86.52 7.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.034 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.79 -19.24 49.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.508 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 44.9 m-80 -136.73 28.92 2.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.49 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 50.4 t80 -69.09 122.24 18.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.09 0.471 . . . . 0.0 110.624 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 100.93 0.11 55.07 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.977 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -97.46 154.51 17.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.932 0.396 . . . . 0.0 111.304 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 39.0 mtmt -127.35 138.86 53.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.131 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 98.8 m-85 -128.84 158.45 38.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 -173.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.9 m -76.4 155.5 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.304 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 1.032 ' HB3' ' HG2' ' A' ' 387' ' ' ARG . 1.3 tt0 -77.5 124.43 27.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.466 0.651 . . . . 0.0 109.859 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.45 5.7 26.01 Favored Glycine 0 C--N 1.315 -0.633 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -104.12 149.06 25.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.536 -0.832 . . . . 0.0 109.15 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.4 t -129.75 158.71 38.64 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.046 0.45 . . . . 0.0 110.211 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.6 tp -156.54 139.09 6.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.079 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.63 133.48 34.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.145 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 35.2 t -123.41 133.44 69.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.166 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -109.21 128.07 54.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.575 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 0.8 OUTLIER -100.77 -169.25 1.68 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 174.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.571 ' HD2' ' O ' ' A' ' 396' ' ' ASN . 85.8 m-70 -82.13 157.44 68.45 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -54.08 110.99 0.58 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.43 2.753 . . . . 0.0 112.206 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.08 -9.95 10.21 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.185 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 77.2 m-85 -119.74 132.13 55.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -153.72 159.68 42.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 92.4 mt -70.1 153.41 95.34 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.643 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.36 150.88 47.82 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.593 2.195 . . . . 0.0 110.805 172.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.52 ' HB2' ' HG3' ' A' ' 426' ' ' GLN . 53.2 mttp 70.84 21.11 5.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.65 0.594 . . . . 0.0 110.492 -177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.97 26.73 15.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.489 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 53.7 mt-30 -84.44 158.03 21.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.195 0.521 . . . . 0.0 111.225 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 65.9 p -126.34 -9.54 6.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.87 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.24 137.62 41.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.441 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.609 HG13 ' HG2' ' A' ' 438' ' ' PRO . 2.6 t -112.98 128.07 69.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 26.0 m -99.29 124.68 44.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.593 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 38.1 t -69.03 115.91 8.88 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.911 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 29.9 mtp -138.48 129.33 26.66 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 122.745 1.26 . . . . 0.0 113.064 175.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.655 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 2.2 tp10 46.43 43.48 11.99 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 111.872 -2.422 . . . . 0.0 111.428 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 433' ' ' GLU . 26.3 t-20 78.77 -9.49 1.5 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.408 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -131.64 88.89 0.28 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.712 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -12.55 114.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.793 1.237 . . . . 0.0 112.713 170.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.712 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 30.3 m -62.88 -54.49 46.54 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.279 -171.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.609 ' HG2' HG13 ' A' ' 429' ' ' VAL . 24.2 Cg_endo -85.36 -8.15 8.69 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.54 1.493 . . . . 0.0 111.957 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 9.9 m 71.17 121.27 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.59 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.07 76.95 2.47 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.636 2.224 . . . . 0.0 112.207 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -139.16 95.89 3.02 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.681 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 420' ' ' TYR . 2.1 p -76.33 92.21 3.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.386 0.612 . . . . 0.0 110.336 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.1 pt -73.22 160.39 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.782 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -81.48 114.2 20.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.141 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 5.9 p -106.5 -5.65 10.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.992 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp . . . . . 0 C--O 1.249 1.047 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.373 -179.15 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 63.1 mt . . . . . 0 N--CA 1.441 -0.905 0 CA-C-O 121.286 0.565 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.574 ' HD2' ' C ' ' A' ' 433' ' ' GLU . 62.5 mtt180 -91.18 158.31 16.69 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.671 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 12.5 mptt -118.54 109.56 16.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.481 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 5.5 p -69.82 144.14 52.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.283 0.563 . . . . 0.0 112.196 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -116.24 120.8 40.12 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 21.2 t80 -77.87 121.62 84.39 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 -176.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 78.8 Cg_endo -88.83 -177.14 1.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.491 2.794 . . . . 0.0 112.942 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -94.45 126.9 40.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.695 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 3.4 mm? -81.93 6.18 16.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 57.14 -89.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.248 0.547 . . . . 0.0 110.312 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.56 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 0.1 OUTLIER -83.22 50.67 1.8 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.841 175.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -153.08 163.63 30.6 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -77.03 -22.74 52.55 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.616 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . 8.1 p30 39.54 54.62 2.39 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.423 0.689 . . . . 0.0 112.426 175.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -22.92 63.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.141 -173.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.417 ' HB2' ' HD3' ' A' ' 404' ' ' ARG . 5.7 p30 -127.18 34.28 4.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.243 0.544 . . . . 0.0 111.613 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.616 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 27.9 t80 -63.95 133.45 53.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.194 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 92.6 15.91 51.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.495 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.417 ' HD3' ' HB2' ' A' ' 401' ' ' ASN . 42.0 mtp180 -107.07 154.69 20.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.294 0.568 . . . . 0.0 111.644 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 49.8 mtmt -118.97 140.84 49.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.46 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.642 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 88.2 m-85 -140.13 159.6 41.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.645 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.52 147.2 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.976 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.7 tt0 -63.15 141.18 58.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.111 0.482 . . . . 0.0 111.337 -176.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 105.15 8.97 35.1 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 61.9 mmtt -113.23 179.56 3.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.365 -176.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 32.8 t -150.45 160.97 43.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.11 0.481 . . . . 0.0 110.365 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.452 HD13 ' H ' ' A' ' 413' ' ' ASP . 0.4 OUTLIER -154.15 149.65 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.574 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.452 ' H ' HD13 ' A' ' 412' ' ' ILE . 15.2 t70 -90.7 141.89 28.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.75 -176.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 28.9 t -126.63 141.22 46.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.27 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -125.23 118.16 25.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.833 0.349 . . . . 0.0 110.736 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 74.7 m -103.46 -178.64 3.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -58.32 154.14 33.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.169 174.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.83 108.53 0.49 Allowed 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.7 2.934 . . . . 0.0 112.179 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.63 -13.12 15.34 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -113.3 147.98 36.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.375 -0.412 . . . . 0.0 109.908 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -159.47 179.23 9.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.162 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.656 HD13 HG13 ' A' ' 429' ' ' VAL . 87.2 mt -76.86 160.7 76.01 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.9 141.11 22.35 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.978 2.452 . . . . 0.0 111.937 173.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 68.0 30.5 5.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.173 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.44 30.09 16.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.659 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 22.4 mt-30 -91.29 158.53 16.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.991 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 8.2 p -118.38 -4.82 10.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.141 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.66 140.72 52.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.96 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.656 HG13 HD13 ' A' ' 422' ' ' LEU . 3.3 m -108.61 133.23 54.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.129 0.49 . . . . 0.0 110.16 174.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 76.9 m -85.44 128.18 34.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.513 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 53.4 t -69.54 106.09 2.88 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.976 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 6.4 mtt -143.09 139.26 30.38 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.633 0.73 . . . . 0.0 111.552 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.789 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 7.0 mm-40 41.41 40.5 1.29 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 112.956 -1.929 . . . . 0.0 112.637 -176.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 387' ' ' ARG . 4.3 t-20 70.22 -23.6 0.16 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.49 176.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 433' ' ' GLU . . . -103.9 15.35 52.05 Favored Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.799 -170.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.46 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 85.1 m95 56.04 125.72 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.735 0.814 . . . . 0.0 112.523 -174.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.769 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 58.5 m -44.47 -61.87 1.88 Allowed Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -172.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 64.3 Cg_endo -88.42 -3.62 6.71 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.704 1.603 . . . . 0.0 112.817 -175.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 28.5 m 68.98 109.3 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.606 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 11.5 Cg_endo -55.14 102.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.794 2.996 . . . . 0.0 112.455 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -141.76 131.62 24.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.992 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 76.6 m -87.05 91.21 8.63 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.137 0.494 . . . . 0.0 109.869 175.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 8.9 mt -94.28 157.73 3.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -88.84 108.18 19.38 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.4 0.619 . . . . 0.0 109.712 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.87 -15.67 15.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.753 -173.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.647 -179.584 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.604 ' N ' ' HG3' ' A' ' 433' ' ' GLU . 74.3 mt . . . . . 0 N--CA 1.444 -0.764 0 CA-C-O 121.836 0.826 . . . . 0.0 111.844 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.94 ' HG3' ' CB ' ' A' ' 408' ' ' GLN . 7.8 mpt_? -44.7 -174.29 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 177.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 39.3 ttmt 73.98 79.17 0.12 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 112.471 -2.15 . . . . 0.0 112.362 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 435' ' ' GLY . 3.2 m -87.28 155.87 19.88 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.755 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -119.18 128.53 54.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -81.25 122.43 81.3 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.587 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.6 172.27 11.45 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.205 2.603 . . . . 0.0 113.388 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -85.94 123.33 31.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.07 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 394' ' ' LEU . 2.2 mm? -95.74 119.49 34.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -76.91 -32.09 57.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.319 0.58 . . . . 0.0 109.867 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 8.9 m120 -100.63 10.37 41.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.556 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.627 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -131.46 175.95 19.37 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.582 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -92.81 109.99 21.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 402' ' ' TYR . 2.9 p30 -81.12 48.04 1.08 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.239 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.89 -32.86 74.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.328 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.535 ' ND2' HD12 ' A' ' 412' ' ' ILE . 78.7 m-20 -95.63 -9.42 32.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.126 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 52.0 t80 -59.94 129.74 43.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.221 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 95.29 5.15 60.71 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.247 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -104.43 148.3 26.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.086 0.47 . . . . 0.0 110.759 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -124.59 143.78 50.52 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.86 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 388' ' ' LYS . 87.4 m-85 -139.39 156.39 47.02 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.306 -173.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 26.2 m -88.03 137.59 20.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.818 174.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.94 ' CB ' ' HG3' ' A' ' 387' ' ' ARG . 1.5 tt0 -53.14 137.84 32.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.016 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.79 7.76 25.15 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -112.75 151.55 30.16 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.439 -0.88 . . . . 0.0 110.025 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 35.6 t -131.4 153.32 49.8 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.535 HD12 ' ND2' ' A' ' 401' ' ' ASN . 0.2 OUTLIER -152.72 144.14 15.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.781 -173.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.477 ' N ' HD13 ' A' ' 412' ' ' ILE . 28.5 t70 -81.89 137.64 35.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.392 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 64.3 t -121.84 126.83 75.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.46 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.72 128.25 54.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.315 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.627 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 61.2 m -105.92 -178.45 3.65 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -76.13 154.95 84.56 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.12 112.07 0.77 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.655 2.904 . . . . 0.0 112.457 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 445' ' ' VAL . . . 115.08 -12.76 19.7 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.905 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -111.06 148.73 31.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.709 0.29 . . . . 0.0 110.643 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.87 162.11 39.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.453 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.14 158.38 81.67 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.809 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.67 135.17 61.31 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.771 2.314 . . . . 0.0 111.555 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 69.86 17.46 7.56 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.992 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 63.53 39.67 8.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.436 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.592 HE22 ' HB2' ' A' ' 438' ' ' PRO . 23.4 mt-30 -78.46 158.84 28.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.492 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 49.9 p -121.93 -13.58 8.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.48 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.83 149.74 47.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.585 -175.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.639 HG11 ' HG3' ' A' ' 440' ' ' PRO . 13.0 t -126.88 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.469 ' H ' ' CD ' ' A' ' 438' ' ' PRO . 38.6 m -103.53 123.1 46.29 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.49 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 408' ' ' GLN . 43.2 t -64.12 116.35 5.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.313 174.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.803 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 32.7 mtt -145.46 133.27 21.16 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.762 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 33.4 tt0 28.47 68.09 0.08 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.135 -169.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.415 ' HA ' ' C ' ' A' ' 388' ' ' LYS . 2.3 p-10 56.57 31.31 18.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.224 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' A' ' 389' ' ' CYS . . . -150.55 -158.19 8.14 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.723 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.45 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 96.9 m95 -136.36 113.25 10.34 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -174.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 12.7 t -66.32 -51.24 44.75 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.951 -168.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.592 ' HB2' HE22 ' A' ' 426' ' ' GLN . 25.7 Cg_endo -91.29 0.97 4.7 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.44 1.427 . . . . 0.0 112.504 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.53 HG22 ' HG3' ' A' ' 441' ' ' ARG . 13.3 m 73.71 112.0 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.928 171.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.639 ' HG3' HG11 ' A' ' 429' ' ' VAL . 1.3 Cg_endo -79.77 93.53 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.031 2.487 . . . . 0.0 112.07 175.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.53 ' HG3' HG22 ' A' ' 439' ' ' THR . 78.7 mtp180 -138.94 114.74 10.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.271 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 396' ' ' ASN . 76.2 m -81.88 83.32 7.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.491 . . . . 0.0 110.557 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 10.5 mt -83.12 158.08 3.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -78.92 114.58 17.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.264 0.554 . . . . 0.0 109.879 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 446' ' ' LYS . 9.8 p -87.16 -33.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.163 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 445' ' ' VAL . 58.5 tttp . . . . . 0 C--O 1.245 0.846 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.118 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 N--CA 1.44 -0.934 0 CA-C-O 121.558 0.694 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.955 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 9.9 mmt180 -63.47 166.19 6.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.291 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.88 90.93 3.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.379 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 405' ' ' LYS . 23.9 m -64.79 133.72 52.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.773 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.565 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 55.9 t80 -102.63 123.98 47.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 401' ' ' ASN . 27.5 t80 -80.46 119.46 76.42 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -87.76 -171.03 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.387 2.725 . . . . 0.0 113.323 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . 0.419 ' HA ' ' OD1' ' A' ' 399' ' ' ASN . 80.4 t80 -105.59 111.94 24.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.497 -174.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.07 117.79 25.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.46 -36.1 82.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.155 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -108.04 28.2 8.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.905 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -138.9 165.75 25.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.589 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -90.74 111.11 22.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.156 0.503 . . . . 0.0 110.139 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.63 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . 42.3 m-80 -92.63 70.03 4.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.106 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -76.71 -6.57 52.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.255 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 40.4 m-80 -135.22 23.23 3.49 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.591 0.234 . . . . 0.0 111.372 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.63 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 22.9 t80 -68.89 129.35 39.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 110.931 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.565 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 90.44 14.51 58.47 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.702 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -111.04 145.38 38.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.931 0.396 . . . . 0.0 110.903 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 389' ' ' CYS . 98.0 mttt -108.72 134.87 50.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.287 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -126.88 149.87 49.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.651 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 32.3 m -85.6 148.68 4.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 1.068 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.8 tt0 -59.6 140.25 56.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.189 0.518 . . . . 0.0 111.175 -176.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.03 10.92 35.67 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -109.93 152.99 25.14 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.537 -0.831 . . . . 0.0 109.417 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 41.1 t -128.48 157.21 41.78 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 11.1 tp -148.86 139.69 16.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.545 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.84 132.5 36.13 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.808 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.621 ' HB ' HD11 ' A' ' 422' ' ' LEU . 46.7 t -130.77 101.63 5.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.017 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.72 115.74 27.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.406 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.654 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 82.9 m -84.81 174.12 10.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.906 174.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -62.84 156.75 64.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.722 0.296 . . . . 0.0 110.485 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.21 110.08 0.44 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.657 2.905 . . . . 0.0 112.53 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.55 -12.04 15.95 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.898 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.33 156.05 26.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.946 0.403 . . . . 0.0 110.706 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -157.21 167.63 29.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.153 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.621 HD11 ' HB ' ' A' ' 414' ' ' VAL . 87.3 mt -72.74 153.23 91.4 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.851 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.58 141.58 62.79 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.949 2.433 . . . . 0.0 111.63 176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 64.8 mttm 71.4 24.85 3.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.044 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.01 51.3 7.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.319 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.868 HE22 ' HB2' ' A' ' 438' ' ' PRO . 23.9 mt-30 -114.45 165.44 12.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.217 -176.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 29.0 p -129.7 -4.1 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.14 137.93 53.07 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.555 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.542 HG13 ' HG2' ' A' ' 438' ' ' PRO . 16.3 t -113.63 132.94 61.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.639 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 25.1 m -101.02 124.19 46.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.719 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 41.7 t -64.01 113.88 3.77 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 1.068 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 44.0 mtt -142.07 132.37 24.96 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.742 0.782 . . . . 0.0 111.838 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.676 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 0.7 OUTLIER 28.78 52.74 0.07 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.05 -171.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.955 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 0.2 OUTLIER 76.29 -25.18 0.21 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.561 171.351 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -115.71 60.91 0.4 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-O 119.361 -0.688 . . . . 0.0 112.971 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.423 ' HB3' ' CG1' ' A' ' 429' ' ' VAL . 96.3 m95 20.39 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.033 1.333 . . . . 0.0 114.346 169.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.662 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 31.1 t -47.51 -59.56 5.39 Favored Pre-proline 0 N--CA 1.467 0.421 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -168.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.868 ' HB2' HE22 ' A' ' 426' ' ' GLN . 44.3 Cg_endo -85.45 -5.04 9.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.497 1.464 . . . . 0.0 113.384 -174.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.466 HG22 ' HG3' ' A' ' 441' ' ' ARG . 28.2 m 73.42 116.64 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.989 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 51.7 Cg_endo -76.47 109.34 2.85 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.547 2.164 . . . . 0.0 112.273 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.535 ' O ' HD23 ' A' ' 422' ' ' LEU . 71.7 mtp180 -146.52 151.84 38.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.18 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 74.0 m -111.29 90.7 3.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.119 0.485 . . . . 0.0 110.311 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 12.7 mt -92.59 155.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -82.22 121.77 27.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.438 0.637 . . . . 0.0 110.138 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 10.0 p -91.87 -12.41 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.522 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 20.4 tptp . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.673 -0.68 . . . . 0.0 110.132 179.474 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 388' ' ' LYS . 30.1 mt . . . . . 0 N--CA 1.443 -0.796 0 CA-C-O 121.259 0.552 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -50.53 151.1 2.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.733 -1.121 . . . . 0.0 113.559 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 406' ' ' PHE . 2.9 mptp? -113.87 96.23 5.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.464 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 7.9 p -68.44 136.86 53.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.922 0.392 . . . . 0.0 111.094 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -99.78 130.83 46.02 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.475 ' HZ ' HG22 ' A' ' 414' ' ' VAL . 1.2 t80 -92.44 104.34 10.91 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.89 -90.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.369 2.713 . . . . 0.0 114.609 -170.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . 0.432 ' N ' ' CE1' ' A' ' 402' ' ' TYR . 0.9 OUTLIER 167.52 128.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.736 0.814 . . . . 0.0 110.278 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.612 ' HG ' ' SG ' ' A' ' 442' ' ' CYS . 0.9 OUTLIER -73.4 -131.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.045 0.45 . . . . 0.0 110.408 173.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -155.63 -40.99 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -105.49 17.22 24.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.514 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -119.11 141.19 15.66 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.59 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . 0.401 ' HD1' ' O ' ' A' ' 415' ' ' ALA . 71.6 m-85 -65.78 114.53 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.239 0.542 . . . . 0.0 111.128 -176.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.798 ' HA ' ' HD2' ' A' ' 402' ' ' TYR . 0.4 OUTLIER -80.2 68.59 6.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.685 0.755 . . . . 0.0 110.321 176.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -70.95 -64.21 0.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.658 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.401 ' HB3' ' HD3' ' A' ' 404' ' ' ARG . 22.8 m-80 -108.11 39.11 2.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.69 -176.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.798 ' HD2' ' HA ' ' A' ' 399' ' ' ASN . 0.9 OUTLIER -92.58 148.2 22.27 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.535 -173.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 90.61 11.44 62.18 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.401 ' HD3' ' HB3' ' A' ' 401' ' ' ASN . 36.6 mtp180 -104.54 162.9 12.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.477 0.656 . . . . 0.0 111.995 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . 0.542 ' NZ ' ' HB2' ' A' ' 405' ' ' LYS . 10.2 mtmp? -117.72 134.36 54.98 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.324 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.658 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 97.0 m-85 -124.31 163.17 22.23 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.578 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 27.2 m -100.48 148.33 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.075 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.826 ' CG ' ' HA ' ' A' ' 432' ' ' MET . 1.9 tt0 -57.12 139.38 52.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.99 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.5 7.64 56.73 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 5.4 mmtm -107.73 175.41 5.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.144 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 35.6 t -146.83 165.8 28.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.6 tp -156.1 137.79 5.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.382 0.61 . . . . 0.0 110.094 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -83.72 129.83 34.95 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.914 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.475 HG22 ' HZ ' ' A' ' 391' ' ' PHE . 46.4 t -117.02 114.19 45.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.609 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.401 ' O ' ' HD1' ' A' ' 398' ' ' TYR . . . -94.68 93.49 7.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.056 0.455 . . . . 0.0 111.102 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.495 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 60.1 m -73.94 154.59 39.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 171.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -60.29 157.18 35.72 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.724 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.41 115.97 2.24 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.817 3.011 . . . . 0.0 112.641 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.24 -16.79 17.35 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.547 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 443' ' ' ILE . 81.6 m-85 -110.75 148.09 33.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.593 0.235 . . . . 0.0 110.42 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -152.88 168.7 24.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.75 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 77.7 mt -83.09 155.74 67.12 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.118 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.12 155.87 27.13 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.396 2.731 . . . . 0.0 112.001 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 64.98 23.77 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.351 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 51.95 41.41 29.59 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.328 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.582 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 25.3 mt-30 -105.11 163.02 12.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.13 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 32.6 p -120.07 -6.0 9.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.471 0.653 . . . . 0.0 109.988 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 146.3 49.37 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.223 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.573 HG13 ' HG2' ' A' ' 438' ' ' PRO . 6.1 t -112.2 132.13 61.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 51.7 m -93.71 131.53 38.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.389 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 51.0 t -77.25 110.26 11.81 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.324 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.826 ' HA ' ' CG ' ' A' ' 408' ' ' GLN . 28.1 mtt -143.38 142.74 31.36 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.682 0.753 . . . . 0.0 112.977 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 408' ' ' GLN . 5.1 tt0 37.91 42.84 0.46 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.213 -174.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 433' ' ' GLU . 8.9 t-20 71.24 -20.62 0.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.125 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -117.88 60.74 0.46 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.381 -172.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . . . . . . . . . 88.7 m95 24.72 107.43 0.0 OUTLIER 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.097 1.359 . . . . 0.0 114.282 169.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.758 ' OG ' ' HB2' ' A' ' 432' ' ' MET . 58.6 m -51.12 -58.97 8.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.333 -166.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.652 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 24.6 Cg_endo -86.08 -7.67 8.05 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.831 1.687 . . . . 0.0 112.595 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.58 HG22 ' HG3' ' A' ' 441' ' ' ARG . 55.4 m 73.61 118.46 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.719 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 439' ' ' THR . 5.0 Cg_exo -70.61 101.85 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.732 2.288 . . . . 0.0 111.804 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.58 ' HG3' HG22 ' A' ' 439' ' ' THR . 72.3 mtp180 -141.98 124.23 15.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.086 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.612 ' SG ' ' HG ' ' A' ' 394' ' ' LEU . 73.8 m -92.66 97.65 10.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 9.1 mt -99.93 155.65 4.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -81.14 116.59 21.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.475 0.655 . . . . 0.0 109.748 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.54 -7.84 11.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.491 -172.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 53.0 tptt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.352 -0.833 . . . . 0.0 109.695 -178.917 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.443 -0.808 0 CA-C-O 122.134 0.969 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.576 ' HD2' ' CB ' ' A' ' 434' ' ' ASN . 1.8 mmt180 -96.24 148.96 22.19 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.159 -1.382 . . . . 0.0 111.201 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.533 ' HE2' HG12 ' A' ' 407' ' ' VAL . 1.5 mptm? -118.25 106.92 13.29 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.224 -178.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 8.2 p -74.24 141.6 45.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.661 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -102.31 128.79 48.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -82.85 113.36 44.8 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.79 -176.89 2.37 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.047 2.498 . . . . 0.0 113.356 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -90.6 118.05 29.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.6 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.31 110.59 19.76 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -67.27 -29.81 69.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.0 109.728 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -100.71 15.36 28.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.093 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.677 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -134.1 -179.14 16.14 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.38 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -90.25 -1.66 57.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.71 0.29 . . . . 0.0 111.773 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 2.3 p30 40.9 41.04 1.12 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.445 1.098 . . . . 0.0 113.266 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -61.32 -26.58 67.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.382 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -114.25 18.24 17.13 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.553 -174.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -58.99 121.19 10.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.555 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.2 -6.75 36.95 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.917 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -85.04 147.23 26.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.049 0.452 . . . . 0.0 110.867 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -118.91 133.27 55.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.448 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.697 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 63.8 m-85 -124.3 159.33 30.5 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.533 HG12 ' HE2' ' A' ' 388' ' ' LYS . 27.1 m -92.21 146.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.996 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 7.7 tt0 -60.05 136.5 58.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.031 0.443 . . . . 0.0 110.824 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 104.57 12.79 27.71 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 22.8 mmtp -112.62 175.65 5.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.28 -0.46 . . . . 0.0 111.036 -176.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 40.0 t -149.77 162.82 39.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.28 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.3 tp -169.73 125.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.623 0.725 . . . . 0.0 110.507 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.748 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 18.4 t70 -77.27 137.52 38.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.314 -172.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.82 123.59 71.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.256 0.55 . . . . 0.0 111.303 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.92 112.45 23.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.193 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.677 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 80.5 m -112.59 163.31 14.67 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -63.06 149.14 91.34 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.338 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.83 107.6 0.22 Allowed 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.926 3.084 . . . . 0.0 112.676 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 123.89 -15.15 7.92 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.051 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 91.8 m-85 -108.04 136.37 47.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 176.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 442' ' ' CYS . . . -153.65 160.19 42.31 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.263 -176.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.471 HD11 HG22 ' A' ' 429' ' ' VAL . 84.5 mt -75.65 152.76 85.29 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.909 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 54.1 Cg_exo -53.69 144.75 52.16 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.758 2.305 . . . . 0.0 110.564 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 90.2 mttt 77.34 16.18 1.66 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.064 0.852 . . . . 0.0 109.843 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.8 40.34 19.61 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.917 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.408 ' HG3' ' HB2' ' A' ' 424' ' ' LYS . 96.7 mt-30 -93.54 159.33 15.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.097 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 60.2 p -110.18 -22.53 11.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.21 172.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.748 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 1.3 t -121.52 164.35 17.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.483 0.659 . . . . 0.0 111.662 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 440' ' ' PRO . 2.2 t -120.59 137.13 55.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.645 -175.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 83.5 m -94.13 130.65 40.23 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.205 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.2 t -75.83 113.4 13.27 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.996 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 20.0 mtp -145.24 139.68 27.33 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.532 0.682 . . . . 0.0 111.743 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.694 ' H ' ' NE2' ' A' ' 408' ' ' GLN . 6.1 mm-40 41.77 38.95 1.07 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.783 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.576 ' CB ' ' HD2' ' A' ' 387' ' ' ARG . 4.5 t-20 69.56 -19.8 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.359 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -107.37 20.76 32.08 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.663 -170.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.566 ' CB ' ' HD3' ' A' ' 440' ' ' PRO . 96.7 m95 52.73 124.49 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.143 0.977 . . . . 0.0 113.615 -178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.799 ' HB2' ' HD3' ' A' ' 438' ' ' PRO . 73.1 m -50.33 -61.87 3.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 437' ' ' SER . 33.5 Cg_endo -89.73 -5.25 5.32 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.98 1.786 . . . . 0.0 113.413 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.6 m 74.15 113.41 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.964 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 42.4 Cg_endo -73.49 113.16 3.71 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.623 2.216 . . . . 0.0 110.907 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -154.13 -39.28 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.346 -173.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 91.6 m 60.47 89.9 0.07 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.877 0.846 . . . . 0.0 111.872 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 420' ' ' TYR . 10.1 mt -84.61 160.46 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.643 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 444' ' ' ARG . 21.3 ttp-105 -81.91 111.51 18.17 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.642 0.734 . . . . 0.0 109.898 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.22 6.51 9.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.661 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm . . . . . 0 C--O 1.244 0.779 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.45 -176.784 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.911 0.863 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.905 ' HD2' ' HB2' ' A' ' 434' ' ' ASN . 8.5 mmt180 -83.77 164.24 19.68 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.925 -167.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 388' ' ' LYS . 2.6 mptp? -121.68 91.49 3.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.792 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 23.9 m -61.47 130.36 45.64 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.018 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -98.13 127.73 44.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.466 ' CE2' HD21 ' A' ' 394' ' ' LEU . 16.6 t80 -83.3 120.22 75.35 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.431 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -88.34 -171.99 0.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.26 2.64 . . . . 0.0 112.997 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . 0.401 ' HE1' ' ND2' ' A' ' 399' ' ' ASN . 75.9 t80 -92.54 129.68 38.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.596 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.466 HD21 ' CE2' ' A' ' 391' ' ' PHE . 2.7 mm? -89.78 124.15 34.39 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.67 130.78 45.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 8.2 p30 50.32 26.1 2.12 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 124.206 0.942 . . . . 0.0 111.796 -173.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -115.49 169.85 13.07 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.387 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -90.3 102.72 15.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.534 0.683 . . . . 0.0 110.288 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.415 ' H ' ' ND2' ' A' ' 399' ' ' ASN . 2.0 p30 -78.47 60.64 2.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.792 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -88.12 -29.9 20.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.148 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -97.26 -6.5 34.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.175 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.412 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 23.7 t80 -62.14 129.15 39.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.085 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.22 13.7 47.86 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.35 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 404' ' ' ARG . 53.6 mtt180 -108.53 149.43 28.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.136 0.493 . . . . 0.0 111.509 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -111.91 131.36 55.42 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.431 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.404 ' CD2' ' HH2' ' A' ' 436' ' ' TRP . 96.9 m-85 -128.86 138.81 52.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.163 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.1 m -76.2 152.44 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.464 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.694 ' HG3' ' HA ' ' A' ' 432' ' ' MET . 9.2 tt0 -60.75 127.04 29.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.258 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.73 -18.13 17.37 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.218 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -86.79 145.59 26.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.864 0.364 . . . . 0.0 110.853 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.3 t -121.12 158.79 27.15 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.987 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.6 tp -155.22 146.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.04 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.82 133.93 38.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.377 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.01 137.23 30.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.778 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -105.69 112.34 25.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.994 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 48.4 m -124.77 172.35 9.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.069 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.433 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 12.3 m170 -54.89 159.98 3.3 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-O 121.125 0.488 . . . . 0.0 111.67 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 73.3 Cg_endo -75.46 103.45 1.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.243 2.629 . . . . 0.0 111.475 -175.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 119.01 -4.57 13.96 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.921 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -111.87 133.93 53.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.1 162.9 40.89 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.645 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 440' ' ' PRO . 92.0 mt -69.29 155.55 93.32 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.654 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.95 152.12 30.75 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.912 2.408 . . . . 0.0 111.978 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 73.46 23.93 2.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.93 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.11 42.08 26.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.043 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 22.7 mt-30 -116.21 162.75 17.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.92 -176.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 61.8 p -124.45 -6.8 7.55 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.62 144.66 41.75 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.759 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.727 HG12 ' HG2' ' A' ' 438' ' ' PRO . 23.6 m -120.43 158.78 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.055 0.455 . . . . 0.0 109.954 172.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . . . . . . . . . 90.6 m -113.79 132.63 55.78 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.425 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 34.2 t -68.34 118.62 11.67 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 177.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.694 ' HA ' ' HG3' ' A' ' 408' ' ' GLN . 6.2 ptt? -142.87 133.68 25.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.12 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 434' ' ' ASN . 0.9 OUTLIER 34.65 40.68 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.783 -174.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.905 ' HB2' ' HD2' ' A' ' 387' ' ' ARG . 7.5 t30 76.67 -23.85 0.24 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.384 0.674 . . . . 0.0 111.952 176.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -103.39 109.59 3.49 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.578 ' HB2' ' HD3' ' A' ' 440' ' ' PRO . 94.0 m95 -39.64 125.09 1.76 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 124.17 0.571 . . . . 0.0 112.073 -175.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.728 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 74.1 p -43.06 -52.08 12.31 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -166.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.728 ' HD3' ' OG ' ' A' ' 437' ' ' SER . 5.2 Cg_endo -105.53 2.05 0.22 Allowed 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.084 1.856 . . . . 0.0 112.495 -176.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 440' ' ' PRO . 25.5 m 72.76 116.49 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.21 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 436' ' ' TRP . 32.0 Cg_endo -64.32 92.15 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.801 2.334 . . . . 0.0 111.592 174.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 441' ' ' ARG . 9.2 mmm180 -105.21 -50.33 3.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.221 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 83.1 m 60.0 81.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.599 0.714 . . . . 0.0 110.918 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 3.7 pt -95.57 155.08 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.274 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -73.68 107.66 6.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.002 0.906 . . . . 0.0 111.192 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.66 -48.32 72.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.79 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 52.0 tttp . . . . . 0 C--O 1.249 1.031 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.019 -177.425 . . . . . . . . 0 0 . 1 stop_ save_